data_2m8x_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m8x _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.507 ' HB3' HG23 ' A' ' 468' ' ' ILE . 70.8 Cg_endo . . . . . 0 N--CA 1.458 -0.57 0 N-CA-C 111.227 -0.336 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -121.47 90.37 3.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.228 167.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 71.1 mt -83.03 138.27 33.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.193 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.3 t -140.05 153.77 46.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.173 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.2 m -132.89 156.31 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.212 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 95.8 mt-10 -139.74 136.68 34.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.27 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 94.5 mt -107.43 127.49 63.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.97 147.88 48.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.175 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.47 -167.85 34.65 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.51 142.19 58.33 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.689 1.593 . . . . 0.0 111.099 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -89.35 -38.26 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.235 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.2 t -120.42 130.08 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.207 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.41 151.73 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.204 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.47 159.98 43.23 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 540' ' ' VAL . 3.0 p -76.3 141.58 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.206 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 62.54 28.17 16.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.181 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -123.29 144.63 49.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.25 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 502' ' ' SER . 37.2 tp -87.34 128.49 35.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.182 -173.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.97 145.01 48.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.163 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -103.39 135.26 45.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -129.83 157.18 42.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.478 ' HG2' HG23 ' A' ' 500' ' ' THR . 93.6 mt-10 -130.47 141.07 50.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.185 -175.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 53.1 t -112.35 121.2 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.14 173.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.5 m-70 -103.16 107.85 18.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.158 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.447 HG11 HG22 ' A' ' 475' ' ' VAL . 2.5 m -118.85 130.52 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.217 -173.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -143.04 155.08 44.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 8.3 t-20 -98.44 138.65 35.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.201 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 80.7 mt -134.44 38.26 3.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.204 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -138.3 8.82 3.5 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 63.11 18.6 60.52 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.581 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 14.9 tt -136.13 139.56 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.713 0.292 . . . . 0.0 111.225 171.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -87.26 141.44 17.51 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -174.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.5 119.35 36.16 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 111.254 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.84 -19.53 9.67 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.716 1.611 . . . . 0.0 111.22 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.7 p -92.95 12.74 22.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.254 -168.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 84.8 m -75.95 109.86 9.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.221 -161.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.89 127.61 54.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.145 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.447 HG22 HG11 ' A' ' 462' ' ' VAL . 64.9 t -115.69 126.2 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.109 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -127.14 152.65 47.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.263 -172.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 80.6 t -129.12 131.87 67.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -119.79 145.93 46.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.157 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.433 HG12 HG12 ' A' ' 513' ' ' ILE . 77.0 mt -118.32 114.89 46.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 53.57 40.77 31.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.222 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.8 -19.07 55.74 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 171.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.0 m -97.65 137.4 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.741 0.305 . . . . 0.0 111.174 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.3 tp -68.78 121.81 17.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.171 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -96.78 -40.27 9.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . 0.409 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 48.7 tptt -164.75 158.22 17.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.205 -173.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -143.27 153.28 42.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.233 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . 0.409 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 27.4 m-90 -137.98 142.42 40.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 172.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.8 m -107.54 123.04 47.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 168.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.81 167.8 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 70.5 m -118.5 142.28 47.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 97.1 mt -126.79 130.31 50.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.182 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -86.84 -179.97 48.88 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.78 119.7 6.9 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.706 1.604 . . . . 0.0 111.183 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.3 mttt 55.54 35.61 25.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -101.04 144.41 30.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.229 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -122.36 140.5 52.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.228 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -127.67 147.58 50.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.201 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.4 119.23 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 54.5 mt -102.7 142.89 33.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.189 173.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' THR . . . . . 0.478 HG23 ' HG2' ' A' ' 459' ' ' GLU . 46.5 p -122.49 153.04 39.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -153.84 156.02 36.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 167.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.412 ' HB3' HD11 ' A' ' 455' ' ' LEU . 68.0 m -122.29 128.1 50.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.256 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -131.38 131.59 43.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.167 -169.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.6 m -114.08 105.43 54.25 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.212 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.81 118.9 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.732 1.621 . . . . 0.0 111.195 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 70.9 p -94.87 -12.41 26.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.249 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -117.35 138.06 52.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.272 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.442 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 35.7 tt0 -76.12 140.89 42.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.04 174.97 24.77 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.6 mmm -86.2 129.61 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 111.209 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -120.01 134.02 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.17 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -106.24 118.63 37.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.244 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.433 HG12 HG12 ' A' ' 479' ' ' ILE . 82.2 mt -105.35 123.23 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.244 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -118.5 145.43 45.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.08 140.04 52.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 172.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 66.6 p -131.9 153.2 50.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.25 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.203 170.727 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 90.8 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.702 0.286 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.4 131.8 50.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.7 m -117.15 126.37 52.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.23 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -132.62 129.96 39.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -100.22 129.02 46.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 90.7 t -120.97 135.64 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.25 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.7 t -106.86 123.13 47.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.225 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 94.4 t -102.98 127.09 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.236 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 452' ' ' VAL . 36.0 m -123.07 159.83 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.193 -177.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . 0.442 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 94.5 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.208 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.422 ' HG3' HG22 ' A' ' 470' ' ' VAL . 68.3 Cg_endo . . . . . 0 N--CA 1.457 -0.63 0 N-CA-C 111.236 -0.332 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 62.2 t0 -124.0 76.11 1.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 172.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.45 131.04 35.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.242 -174.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.9 t -138.43 154.87 48.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.215 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 32.8 m -131.79 155.19 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 95.1 mt-10 -139.72 136.26 34.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.2 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.2 mt -106.28 127.14 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.178 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.02 147.88 48.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.235 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.04 -169.28 34.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.81 139.51 48.03 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.713 1.609 . . . . 0.0 111.196 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -87.55 -36.11 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 79.2 t -120.6 130.29 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.34 152.84 38.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.192 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.97 159.28 35.79 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.1 p -74.15 138.17 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.824 0.345 . . . . 0.0 111.145 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 62.49 24.31 14.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -115.32 151.92 33.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 502' ' ' SER . 43.3 tp -88.89 128.4 35.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.23 -175.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.48 147.02 46.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.289 173.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.24 138.21 52.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.218 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -129.09 157.74 40.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -128.59 139.99 52.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.193 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.73 121.02 64.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.168 173.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.9 m-70 -102.6 108.0 19.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.467 HG11 HG22 ' A' ' 475' ' ' VAL . 2.1 m -118.63 130.44 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.25 -173.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.414 ' HD3' HD22 ' A' ' 465' ' ' LEU . 19.1 ptpt -143.65 154.05 43.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.222 -172.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 41.7 t-20 -107.0 142.22 36.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 171.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.414 HD22 ' HD3' ' A' ' 463' ' ' LYS . 55.3 mt -132.11 3.73 4.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.185 -170.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.59 1.25 71.78 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.79 17.67 76.92 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.526 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.7 tt -127.14 150.18 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 111.236 171.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -95.5 132.15 10.97 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.422 HG22 ' HG3' ' A' ' 438' ' ' PRO . 87.1 t -116.67 118.03 37.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.85 0.357 . . . . 0.0 111.176 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.06 -19.14 8.38 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 121.724 1.616 . . . . 0.0 111.194 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 95.4 p -93.92 13.56 22.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -165.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 94.1 m -77.44 112.82 14.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -161.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.61 126.56 55.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.187 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.467 HG22 HG11 ' A' ' 462' ' ' VAL . 59.9 t -118.57 127.42 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.189 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -134.89 156.58 48.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.199 -173.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.03 136.88 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -170.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -116.93 147.89 41.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.185 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.417 HG12 HG12 ' A' ' 513' ' ' ILE . 82.2 mt -119.7 116.09 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.221 167.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.28 41.35 32.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.249 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.65 -11.47 68.39 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.9 m -98.63 136.09 39.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.875 0.369 . . . . 0.0 111.18 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.35 120.58 15.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.21 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -98.2 -40.27 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.166 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -168.46 158.52 9.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 -173.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -143.74 153.89 42.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -136.95 143.04 42.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.209 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.6 m -106.38 125.16 50.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.214 169.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.42 168.47 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.201 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.7 m -120.02 142.22 49.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.18 172.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.0 mt -128.38 130.79 48.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.255 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -90.64 -171.06 43.63 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.83 113.3 1.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.602 1.535 . . . . 0.0 111.201 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 65.4 35.3 7.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.196 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -101.72 143.2 31.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.182 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.87 141.3 52.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.207 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -127.1 146.17 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 94.3 t -112.35 119.69 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.176 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 38.8 mt -102.88 142.17 34.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.223 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 66.2 p -122.25 152.52 39.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.199 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -155.21 157.2 36.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.263 169.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.404 ' HB3' HD11 ' A' ' 455' ' ' LEU . 73.6 m -120.26 128.67 53.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.183 -175.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -130.51 129.87 43.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.236 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.1 m -117.26 109.35 42.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.258 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.74 155.04 44.23 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.715 1.61 . . . . 0.0 111.221 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 73.3 p -125.48 -10.16 6.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.168 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -129.96 136.07 49.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.257 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -71.17 142.88 50.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.198 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.98 174.6 25.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -84.19 125.96 32.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -119.58 132.12 55.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.211 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -104.97 118.69 37.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.215 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.417 HG12 HG12 ' A' ' 479' ' ' ILE . 86.8 mt -104.47 124.25 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.187 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -118.33 144.16 46.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.65 139.24 54.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 172.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 64.0 p -130.91 150.1 52.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.242 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.292 168.021 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 89.2 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.827 0.346 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.16 133.5 48.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.169 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 96.9 m -116.62 126.7 53.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -131.72 131.66 43.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.186 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -103.15 129.27 49.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.228 -173.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 92.8 t -121.29 137.3 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.3 t -108.01 125.15 51.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 96.0 t -103.27 129.37 55.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.183 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.76 164.1 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 93.8 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 179.79 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.458 -0.61 0 N-CA-C 111.238 -0.331 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -124.31 81.88 1.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.263 170.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.01 137.84 35.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.208 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 7.7 t -144.53 154.6 43.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.203 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.59 155.34 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.299 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 97.0 mt-10 -139.95 137.9 35.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.24 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.4 mt -107.6 128.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -135.87 147.52 48.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.153 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.28 -171.18 35.73 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.79 128.78 18.5 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.756 1.637 . . . . 0.0 111.165 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -71.25 -40.32 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.184 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 67.9 t -121.61 131.65 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.181 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 30.0 m -129.88 152.34 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.259 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.26 159.75 43.42 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 176.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 540' ' ' VAL . 1.2 p -79.99 148.02 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.721 0.296 . . . . 0.0 111.215 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 20.8 m120 63.39 26.86 15.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -129.09 144.49 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.231 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' A' ' 502' ' ' SER . 30.8 tp -85.35 126.23 33.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.238 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -124.72 144.13 50.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -110.39 136.88 48.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -174.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -129.58 157.29 42.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -129.33 139.21 51.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.143 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.4 t -112.76 120.71 63.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.21 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.1 m-70 -103.35 107.29 18.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.229 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 475' ' ' VAL . 2.4 m -118.95 129.18 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.169 -172.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 46.4 pttt -143.41 155.0 44.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.246 -171.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 34.0 t30 -104.37 140.42 37.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.243 170.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 70.4 mt -128.47 6.52 5.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -95.64 -12.25 53.83 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 75.08 23.59 73.95 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.501 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 8.3 tt -128.96 139.77 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 0.0 111.219 165.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.58 134.33 13.96 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -173.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.38 116.23 39.48 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 111.28 172.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.46 -19.07 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.692 1.595 . . . . 0.0 111.18 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.7 p -95.05 13.43 25.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.205 -164.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 88.3 m -78.22 110.8 13.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 -163.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -111.27 127.39 55.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.46 HG22 HG11 ' A' ' 462' ' ' VAL . 68.8 t -115.09 126.93 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.282 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -127.89 153.44 46.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.139 -173.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 79.1 t -130.06 133.86 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -119.03 148.07 43.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.248 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.445 HG12 HG12 ' A' ' 513' ' ' ILE . 84.6 mt -118.73 115.55 48.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.253 169.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 53.74 41.17 32.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.267 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.97 -10.43 70.6 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.4 m -97.45 136.51 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 111.135 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.9 tp -69.05 120.79 15.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.147 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -98.26 -40.63 8.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.256 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -167.98 161.1 12.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.198 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -141.83 152.56 43.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -137.37 142.36 41.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.268 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.0 m -108.74 124.56 50.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.195 168.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.56 168.19 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.191 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 49.2 m -120.9 143.09 49.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.171 172.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.2 129.13 47.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.161 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.24 -173.86 48.64 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.6 112.4 1.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.701 1.601 . . . . 0.0 111.146 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.0 mttt 65.95 36.06 6.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.196 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -101.6 144.0 30.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.38 140.41 52.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -129.39 145.75 51.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 89.4 t -112.72 118.99 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.195 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 50.3 mt -103.41 142.71 33.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.212 173.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 63.3 p -124.51 153.3 42.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.257 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.93 156.73 38.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.255 168.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.493 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.8 m -120.46 128.66 53.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 -175.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -129.67 129.57 44.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.232 -170.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 95.3 m -115.9 109.7 44.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.16 141.43 29.32 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.724 1.616 . . . . 0.0 111.148 174.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 81.5 p -111.91 -21.58 11.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.216 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -120.14 139.58 52.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.249 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.404 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 32.5 tt0 -73.2 140.22 46.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.276 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.04 175.3 24.33 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.4 mmm -86.4 129.01 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 111.195 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -120.73 131.37 54.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.282 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.01 119.43 38.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.156 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.445 HG12 HG12 ' A' ' 479' ' ' ILE . 90.2 mt -101.71 122.24 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.161 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -120.67 145.97 46.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.161 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.25 142.06 51.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.5 p -131.04 149.76 52.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.245 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 168.833 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 93.4 t . . . . . 0 CA--C 1.523 -0.068 0 CA-C-O 120.805 0.336 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.12 133.17 46.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 83.7 m -114.48 124.05 50.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -133.13 131.07 40.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.172 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -104.07 130.31 51.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.169 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.51 136.94 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.157 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.1 t -104.84 124.95 50.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.268 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 95.8 t -101.89 127.32 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.189 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 452' ' ' VAL . 34.7 m -120.85 160.31 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . 0.404 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 92.7 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 N--CA 1.458 -0.56 0 N-CA-C 111.224 -0.337 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -129.45 99.27 5.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.228 170.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.4 145.32 25.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.288 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.5 t -149.33 156.77 42.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.17 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.63 153.53 39.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.175 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 47.7 mt-10 -138.2 137.89 38.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.213 177.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 83.4 mt -107.52 126.12 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.181 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -136.96 148.93 47.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.184 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.61 -166.85 33.45 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -55.22 136.62 74.19 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.693 1.595 . . . . 0.0 111.239 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -87.68 -40.1 14.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.223 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.55 130.11 74.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.78 153.83 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.195 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.59 157.87 34.9 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.8 p -70.5 141.67 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.213 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 63.57 29.75 15.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.245 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -124.18 142.42 51.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.163 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 44.2 tp -82.36 126.24 31.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.308 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.27 144.28 49.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.248 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -101.16 134.31 44.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.163 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -128.39 157.19 41.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.242 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.4 ' HG2' HG23 ' A' ' 500' ' ' THR . 87.3 mt-10 -129.91 138.47 50.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.224 -175.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.46 119.9 59.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 95.9 m-70 -98.88 112.92 24.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.179 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.66 131.42 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.215 -174.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -123.04 152.68 40.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.265 -172.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 12.9 t-20 -106.71 129.89 54.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 152.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 75.8 mt -120.12 22.12 11.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.212 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 468' ' ' ILE . . . -112.89 136.7 13.67 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 466' ' ' GLY . . . -9.12 -46.55 0.0 OUTLIER Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 155.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 466' ' ' GLY . 12.6 tt -123.16 142.29 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.744 0.306 . . . . 0.0 111.261 -163.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -89.06 162.5 31.14 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 84.4 t -124.5 119.06 26.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.199 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.52 -19.22 7.74 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.69 1.593 . . . . 0.0 111.158 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 96.5 p -94.83 14.6 20.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -166.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.1 m -76.46 110.85 11.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 -158.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.42 125.99 53.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.186 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 96.3 t -117.29 129.95 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.117 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -125.36 152.58 44.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.168 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 51.8 t -126.89 134.58 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -121.08 148.11 44.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.134 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.33 115.56 47.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.183 171.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 54.35 41.25 32.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.36 -14.87 64.46 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 171.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.2 m -98.96 137.19 37.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.75 0.31 . . . . 0.0 111.254 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.3 tp -68.38 119.36 12.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -100.06 -40.61 7.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.23 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -153.85 160.59 42.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -142.98 149.75 38.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.293 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -137.64 142.13 41.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.1 m -109.45 123.55 49.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.24 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.41 168.08 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.252 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.9 m -116.31 141.48 48.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.166 171.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 83.5 mt -126.88 128.63 46.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -76.97 177.3 52.39 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 172.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . 0.415 ' HB3' ' O ' ' A' ' 467' ' ' GLY . 55.1 Cg_endo -65.75 117.55 4.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.739 1.626 . . . . 0.0 111.202 176.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 93.2 mttt 66.91 36.78 4.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.194 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -112.11 144.03 42.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.235 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -119.34 142.8 47.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.199 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -129.56 150.16 51.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 88.2 t -113.25 120.0 62.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 42.8 mt -103.12 144.45 31.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.246 172.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 459' ' ' GLU . 41.0 p -122.55 154.7 37.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.183 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.71 156.66 38.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.183 168.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.4 m -120.44 136.97 54.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.17 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -140.61 129.08 22.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.243 -167.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.4 m -119.55 111.9 35.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.23 152.89 40.24 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.663 1.575 . . . . 0.0 111.219 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 72.9 p -124.45 -12.44 7.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -123.03 141.21 52.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.202 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 508' ' ' GLU . 4.6 pt-20 -86.88 142.14 28.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.171 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.54 178.28 27.03 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -170.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.3 mmm -84.8 128.25 34.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.204 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -117.61 133.95 55.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 175.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -107.7 118.63 37.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 80.7 mt -105.03 124.98 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.271 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -117.78 147.08 43.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.275 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.93 139.11 53.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 66.0 p -131.92 153.96 49.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.26 171.895 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 97.7 t . . . . . 0 CA--C 1.524 -0.056 0 CA-C-O 120.847 0.356 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.26 131.9 51.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.281 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.6 m -117.49 127.27 53.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.256 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -130.46 131.61 45.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.172 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -100.85 126.15 47.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.202 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.77 136.38 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.212 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -108.56 124.68 50.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 91.7 t -104.29 129.4 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.248 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.81 172.79 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.237 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 179.25 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.534 ' HG3' HG22 ' A' ' 470' ' ' VAL . 64.6 Cg_endo . . . . . 0 N--CA 1.457 -0.618 0 N-CA-C 111.208 -0.343 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -123.47 75.1 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.212 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 48.9 mt -81.47 126.01 31.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 15.4 t -143.22 157.38 44.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.55 154.89 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.25 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 50.4 mt-10 -137.46 136.84 38.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 81.5 mt -102.53 134.63 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.207 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -135.49 143.15 45.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 144.0 -176.34 23.35 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.44 165.92 26.7 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.644 1.562 . . . . 0.0 111.162 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 58.5 p-10 -123.86 10.4 8.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.19 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.56 116.48 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.122 167.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.3 154.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.223 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.64 160.44 28.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.3 p -72.91 135.42 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.744 0.307 . . . . 0.0 111.237 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 62.08 20.43 11.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.212 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -109.76 130.46 55.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.229 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.429 HD11 ' HB2' ' A' ' 502' ' ' SER . 32.0 tp -76.23 128.6 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.193 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.63 142.07 51.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.21 173.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -111.2 139.0 46.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.195 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -130.86 159.08 38.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.41 ' HG2' HG23 ' A' ' 500' ' ' THR . 91.2 mt-10 -129.6 140.14 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 60.7 t -114.33 120.51 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.202 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 85.1 m-70 -99.32 115.8 30.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.237 176.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 496' ' ' GLU . 2.8 m -118.74 131.84 70.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.205 -174.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -128.33 156.3 43.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 62.3 t-20 -118.7 116.18 26.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.219 159.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 57.4 mt -109.6 13.19 23.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.205 -170.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.57 -3.17 69.2 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.9 19.72 78.39 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.515 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 6.4 tt -130.77 148.0 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.731 0.301 . . . . 0.0 111.166 174.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -85.96 131.12 10.3 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.534 HG22 ' HG3' ' A' ' 438' ' ' PRO . 92.0 t -117.95 116.42 36.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.234 170.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.68 -19.64 6.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.753 1.635 . . . . 0.0 111.161 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 78.5 p -98.56 0.13 44.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.134 -158.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 473' ' ' THR . 13.1 t -85.53 124.71 32.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.21 -162.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -111.68 128.65 56.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.227 -172.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.13 125.89 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.231 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -130.33 155.05 46.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.256 -170.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.85 133.23 66.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.262 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -119.91 147.5 44.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.275 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.1 mt -120.59 118.51 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.253 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 54.64 41.01 32.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.195 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.34 -20.09 45.98 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 171.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.3 m -98.31 139.44 34.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.821 0.343 . . . . 0.0 111.189 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.6 tp -68.21 121.15 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.152 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . 0.425 ' OH ' ' O ' ' A' ' 502' ' ' SER . 29.9 t80 -96.48 -39.3 9.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.234 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -163.34 158.69 21.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.187 -173.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -140.19 149.97 43.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -138.68 141.91 38.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.156 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.8 m -104.79 127.42 52.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.0 m -138.1 166.34 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 53.5 m -121.73 142.25 50.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.194 170.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.5 mt -128.85 131.19 47.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.92 -178.03 46.26 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.82 117.76 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.773 1.649 . . . . 0.0 111.21 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.1 mttt 55.56 39.79 31.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.216 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -100.47 145.23 28.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.139 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 462' ' ' VAL . 85.3 tt0 -120.85 140.72 51.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.186 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -127.58 145.7 50.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 173.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.92 119.58 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.4 mt -104.89 142.09 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.147 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 459' ' ' GLU . 44.4 p -122.58 150.86 42.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.192 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.85 156.57 36.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 171.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.429 ' HB2' HD11 ' A' ' 455' ' ' LEU . 95.6 p -122.93 133.72 54.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -140.79 129.71 23.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.2 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.0 m -116.51 112.34 41.28 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.214 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -71.47 153.33 60.73 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.748 1.632 . . . . 0.0 111.176 172.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 65.0 p -122.81 -5.21 8.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.061 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -133.47 137.19 45.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.152 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.09 141.43 52.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.288 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.24 176.91 26.25 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.3 mmm -84.85 128.05 34.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 111.173 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -120.25 132.83 55.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.17 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -104.23 119.58 39.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 94.2 mt -103.68 124.46 57.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.187 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -119.67 146.17 45.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.09 143.74 50.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.205 172.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 77.4 p -130.73 150.04 52.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.202 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 517' ' ' VAL . 7.2 p . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 167.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 58.7 t . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.822 0.344 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.03 134.72 47.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 173.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.9 m -116.74 126.47 53.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.262 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -134.27 123.28 23.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.187 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -102.46 128.11 49.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.163 -172.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 90.6 t -122.79 137.19 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.26 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 71.4 m -98.95 124.9 44.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 86.4 t -102.85 129.37 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.199 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.96 165.84 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.152 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.269 179.713 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo . . . . . 0 N--CA 1.458 -0.56 0 N-CA-C 111.141 -0.369 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 12.1 t0 -129.98 71.97 1.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.208 166.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 85.2 mt -78.81 139.51 38.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.214 -173.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 12.3 t -146.15 157.7 43.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.208 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.5 155.69 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.187 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.4 mt-10 -139.86 136.05 33.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.236 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 95.3 mt -108.82 126.52 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.154 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.71 148.5 47.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.272 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.69 -168.65 34.39 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.82 116.16 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.642 1.562 . . . . 0.0 111.241 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -75.47 -18.22 59.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.205 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 96.7 t -125.96 129.32 72.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.169 169.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.07 154.05 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.188 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.55 149.86 32.39 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.419 HG11 HD21 ' A' ' 541' ' ' LEU . 5.9 p -71.05 136.54 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 111.187 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 61.85 27.36 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.216 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -123.59 148.21 46.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 502' ' ' SER . 29.4 tp -85.58 128.07 34.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -172.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.79 145.85 48.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.195 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -109.09 133.97 52.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.188 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -127.91 157.2 41.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.429 ' HG2' HG23 ' A' ' 500' ' ' THR . 96.8 mt-10 -130.5 141.1 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.179 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 49.7 t -112.88 120.08 62.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.207 170.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.6 m-70 -101.8 111.3 23.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.15 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.444 HG11 HG22 ' A' ' 475' ' ' VAL . 8.9 m -116.05 132.05 66.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.281 -170.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -127.21 155.13 43.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.217 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 61.2 t-20 -116.75 120.84 39.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.206 159.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 63.0 mt -115.0 8.19 15.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -168.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.03 -0.24 74.76 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.68 20.05 75.42 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.525 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.0 tt -131.03 145.68 35.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.786 0.327 . . . . 0.0 111.185 173.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -84.85 134.54 12.73 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.81 116.49 31.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.252 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.66 -18.49 9.27 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.675 1.583 . . . . 0.0 111.14 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.4 p -92.01 10.65 28.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.225 -165.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 99.0 m -80.27 112.91 18.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.142 -162.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -110.48 127.52 55.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.213 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.444 HG22 HG11 ' A' ' 462' ' ' VAL . 93.8 t -115.83 127.1 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -127.09 155.2 43.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.169 -172.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 69.2 t -128.67 132.96 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.279 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -120.17 147.03 45.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.225 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.419 HG12 HG12 ' A' ' 513' ' ' ILE . 83.6 mt -118.72 117.05 53.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.246 172.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 54.08 41.02 32.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.242 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.23 -10.44 66.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.5 m -97.51 138.45 34.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 111.222 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.6 tp -69.8 120.81 16.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.187 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -98.93 -40.69 7.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.262 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -166.57 159.03 13.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 -173.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -140.95 151.82 44.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.212 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 25.9 m-90 -138.16 141.9 40.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.23 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.6 m -109.65 126.02 53.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.252 168.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.04 167.83 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.199 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 30.4 t -118.79 140.93 49.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 170.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 83.9 mt -128.99 126.01 38.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.163 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.78 -173.39 48.32 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.23 111.7 1.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.772 1.648 . . . . 0.0 111.241 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.0 mttt 58.65 41.45 22.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -101.32 143.96 30.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.221 173.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -121.08 139.95 52.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.158 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -128.45 147.85 50.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.248 175.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 96.9 t -112.2 118.95 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.169 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 48.3 mt -102.24 142.19 33.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.222 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 459' ' ' GLU . 36.1 p -122.85 151.92 41.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.248 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -154.41 156.38 36.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.167 166.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.46 ' HB3' HD11 ' A' ' 455' ' ' LEU . 69.9 m -119.73 128.63 53.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.191 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -125.74 129.27 49.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 -171.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.409 ' HA ' ' HD2' ' A' ' 505' ' ' PRO . 96.2 m -117.8 108.76 42.3 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 172.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 504' ' ' THR . 71.7 Cg_endo -71.85 157.65 54.61 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.741 1.627 . . . . 0.0 111.25 174.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 75.5 p -124.9 -21.95 4.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.206 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.97 138.77 52.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -73.74 139.71 45.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.5 174.76 24.11 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.5 mmm -85.59 128.46 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.844 0.354 . . . . 0.0 111.142 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -120.77 130.31 53.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -103.27 119.81 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.19 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.419 HG12 HG12 ' A' ' 479' ' ' ILE . 80.8 mt -102.11 120.22 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.271 176.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -122.35 146.41 47.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.226 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.15 140.25 53.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.9 p -131.79 152.78 50.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.249 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 172.085 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 93.3 t . . . . . 0 CA--C 1.523 -0.076 0 CA-C-O 120.837 0.351 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.58 133.56 49.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.195 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.1 m -115.43 124.2 50.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.266 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -128.31 128.51 44.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -101.1 126.94 47.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.243 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.5 t -121.43 136.18 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.8 t -101.41 127.5 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.9 t -99.78 126.69 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.42 150.72 24.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.183 -173.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . 0.419 HD21 HG11 ' A' ' 452' ' ' VAL . 86.0 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.193 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 N--CA 1.458 -0.562 0 N-CA-C 111.21 -0.342 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -129.7 81.06 1.99 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.182 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 8.9 mt -89.42 130.66 35.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 -175.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.0 t -146.16 163.1 36.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.228 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.09 154.58 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 93.9 mt-10 -135.63 137.94 42.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.208 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 89.3 mt -104.35 132.0 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.67 142.98 45.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.222 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.45 32.79 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.19 141.26 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.743 1.629 . . . . 0.0 111.232 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -97.26 -18.81 18.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.228 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 87.9 t -126.12 125.94 68.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.259 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.57 154.27 39.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.195 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.27 158.1 43.49 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 1.8 p -79.15 142.57 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.799 0.333 . . . . 0.0 111.232 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 63.11 29.41 16.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.22 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -125.93 145.11 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 502' ' ' SER . 33.0 tp -78.53 126.79 31.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.08 143.42 49.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -109.88 135.53 50.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.298 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -129.66 157.87 40.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.216 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.4 ' HG2' HG23 ' A' ' 500' ' ' THR . 80.2 mt-10 -130.09 139.57 50.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.268 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 45.0 t -113.22 120.24 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.175 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 94.2 m-70 -99.59 114.29 27.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 462' ' ' VAL . 2.9 m -117.21 127.0 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.153 -173.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.439 ' HD2' HD22 ' A' ' 465' ' ' LEU . 25.1 pttt -138.18 151.94 48.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 -171.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 52.9 t-20 -111.2 127.59 55.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.276 167.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.439 HD22 ' HD2' ' A' ' 463' ' ' LYS . 68.9 mt -115.61 7.5 14.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.28 -169.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -93.98 -5.2 62.72 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -169.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.02 23.15 76.89 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -171.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.508 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 1.3 mt -130.04 155.18 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 111.168 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . 0.487 ' N ' ' CG2' ' A' ' 468' ' ' ILE . . . -117.08 120.47 4.82 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -172.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 491' ' ' LEU . 74.9 t -119.63 118.22 32.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.185 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -84.29 -17.62 5.4 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.714 1.609 . . . . 0.0 111.152 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 79.3 p -99.0 4.17 47.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -163.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 473' ' ' THR . 3.5 t -83.67 125.34 31.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.176 -163.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.58 130.35 55.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 -170.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 76.6 t -113.11 128.29 69.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.269 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.51 154.26 45.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.2 -173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 78.0 t -127.7 132.89 68.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.201 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -120.31 147.05 45.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.3 mt -120.85 116.22 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.194 172.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 54.38 40.97 32.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.269 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 93.49 -18.79 55.68 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 171.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.4 m -100.08 138.11 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.353 . . . . 0.0 111.149 -175.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.33 121.53 15.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.248 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -93.31 -39.93 10.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.287 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -168.91 159.52 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.233 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -132.08 152.34 51.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.189 -175.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 32.8 m-90 -136.3 141.44 43.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.7 m -109.95 124.72 51.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 166.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 25.9 m -138.74 167.54 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.6 p -114.44 141.08 48.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.24 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 470' ' ' VAL . 82.4 mt -129.82 129.76 44.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.201 174.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -93.76 -173.43 39.56 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.99 111.36 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.656 1.571 . . . . 0.0 111.203 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.4 mttt 63.62 43.64 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.191 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -104.52 142.96 33.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -121.36 139.51 53.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.223 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -128.79 147.25 50.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.199 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 83.2 t -111.62 119.13 59.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -176.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 66.6 mt -104.85 143.93 32.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.179 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 459' ' ' GLU . 61.0 p -124.77 153.65 42.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.143 175.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -154.3 157.0 37.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.208 170.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.432 ' HB3' HD11 ' A' ' 455' ' ' LEU . 60.9 m -122.27 134.77 54.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.199 -175.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -140.33 129.49 23.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.215 -168.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.0 m -118.88 112.42 36.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.182 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.74 151.55 41.02 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.769 1.646 . . . . 0.0 111.286 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 70.1 p -122.02 -15.13 7.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.177 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -120.59 139.46 52.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.233 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -75.79 140.16 42.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.211 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.67 177.13 26.84 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.7 mmm -86.36 129.42 34.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.781 0.324 . . . . 0.0 111.222 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.84 132.62 55.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.263 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -104.74 118.19 35.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 89.1 mt -105.91 122.95 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -122.41 150.23 42.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.146 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.74 141.05 52.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.259 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 59.5 p -130.82 155.08 47.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.23 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.16 172.336 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 92.3 t . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.786 0.327 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -124.38 131.71 53.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.176 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.5 m -116.98 126.55 53.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.195 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -131.95 130.28 41.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.258 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -101.32 129.27 47.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.239 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 93.6 t -121.14 136.4 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.207 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 40.2 t -104.96 124.75 50.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.185 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.6 t -101.7 127.04 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.173 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 31.8 m -124.71 165.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.249 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 69.4 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.24 -175.384 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.496 ' HG3' HG22 ' A' ' 470' ' ' VAL . 84.7 Cg_endo . . . . . 0 N--CA 1.457 -0.665 0 N-CA-C 111.263 -0.322 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 62.0 t0 -122.49 73.91 1.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.278 167.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.48 137.09 36.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 8.2 t -144.19 154.33 43.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.185 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.3 m -128.46 153.65 38.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.153 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.4 mt-10 -141.01 137.82 33.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.66 127.25 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.207 174.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.13 145.2 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.117 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.5 -166.5 38.47 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.1 143.36 64.96 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.694 1.596 . . . . 0.0 111.249 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -90.35 -39.17 12.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.193 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 70.2 t -121.15 130.15 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.253 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.63 153.31 38.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.205 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -82.78 157.27 35.62 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.5 138.07 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.215 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 62.63 25.19 14.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.258 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -114.78 150.97 34.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.197 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 42.5 tp -87.41 127.21 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 -175.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.32 144.57 48.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.232 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.08 138.15 46.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.03 156.65 44.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -129.49 139.36 51.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 47.5 t -111.15 120.81 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.235 173.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 95.4 m-70 -102.42 107.72 18.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.184 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.3 m -118.48 129.95 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.166 -173.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -143.72 154.72 43.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.192 -171.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 39.7 t-20 -108.26 143.67 36.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.223 170.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.53 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 43.6 mt -133.01 3.37 3.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.204 -172.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -96.97 4.63 63.1 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -170.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.07 17.57 75.76 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 174.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.55 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 2.2 tt -125.87 149.72 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.733 0.301 . . . . 0.0 111.181 167.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -95.91 131.76 10.79 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.496 HG22 ' HG3' ' A' ' 438' ' ' PRO . 99.5 t -119.33 119.63 31.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 111.218 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.17 -19.2 6.94 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.632 1.555 . . . . 0.0 111.189 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 91.2 p -94.12 16.51 14.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.185 -164.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 94.7 m -82.36 111.71 18.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.262 -165.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -111.57 127.24 55.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 85.3 t -118.14 128.8 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.159 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -125.05 154.69 40.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 -173.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.71 134.37 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.23 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -122.04 149.17 43.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.211 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 81.6 mt -120.54 115.69 47.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.198 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.26 41.44 31.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.236 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.94 -8.66 79.2 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.0 m -97.97 135.92 38.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.788 0.328 . . . . 0.0 111.298 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 68.2 tp -68.76 118.79 12.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -99.78 -40.42 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.262 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -166.99 158.85 12.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -140.5 151.97 45.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.21 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -137.36 142.23 41.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.168 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.9 m -109.5 124.38 50.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 166.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.93 168.09 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.125 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.1 m -118.79 142.0 48.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.182 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.31 131.08 48.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.39 -175.48 48.72 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.46 113.32 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.7 1.6 . . . . 0.0 111.159 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.7 mttt 65.9 35.32 6.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.173 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -102.97 143.63 32.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.237 176.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.9 141.08 51.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.189 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -128.18 146.76 50.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.28 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.69 119.58 60.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.225 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.3 mt -101.82 143.35 31.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.136 173.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 59.5 p -122.21 151.85 40.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.184 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.72 156.21 35.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.218 167.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.2 m -123.01 133.98 54.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.179 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 45.5 t90 -140.21 130.0 24.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.195 -167.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 95.2 m -118.17 111.78 38.4 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.296 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.12 155.53 56.65 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.596 1.53 . . . . 0.0 111.247 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 76.9 p -125.25 -13.02 6.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.271 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.39 137.57 49.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.17 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.97 142.17 52.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.42 175.59 24.96 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.2 mmm -85.62 126.86 34.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 111.259 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -119.79 126.94 52.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.206 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -103.31 119.24 38.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.252 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.41 124.12 56.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.218 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -116.86 145.14 43.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.151 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.24 139.55 53.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 173.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 76.8 p -131.05 151.51 51.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.235 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 169.732 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 49.4 t . . . . . 0 CA--C 1.523 -0.059 0 CA-C-O 120.835 0.35 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.79 132.37 51.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 88.0 m -116.32 125.63 52.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -131.14 130.39 43.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -102.34 129.98 48.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.23 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 92.3 t -120.52 136.54 57.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.168 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.8 t -105.84 124.82 50.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.172 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.9 t -102.85 129.22 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.196 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.92 164.45 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.14 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.248 -178.159 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo . . . . . 0 N--CA 1.459 -0.558 0 N-CA-C 111.254 -0.325 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 49.7 t0 -130.28 58.37 1.67 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.285 166.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.08 134.67 53.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 -175.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 10.0 t -142.08 153.3 44.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.207 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.9 m -131.63 154.07 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.237 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.1 mt-10 -139.2 137.08 35.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 91.3 mt -107.16 127.4 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.244 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.93 148.76 48.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.205 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 152.5 -163.57 30.36 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.96 144.45 94.29 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.755 1.637 . . . . 0.0 111.196 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -98.55 -37.01 9.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.183 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 84.9 t -122.15 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.228 172.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.81 151.1 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.108 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -77.09 155.86 44.81 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.93 135.76 27.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.788 0.328 . . . . 0.0 111.21 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 63.02 26.57 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -114.0 154.92 26.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 40.2 tp -94.4 128.09 40.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.261 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.29 143.45 50.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.172 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -105.64 136.5 45.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.25 174.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.33 156.57 44.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.183 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.429 ' HG2' HG23 ' A' ' 500' ' ' THR . 92.9 mt-10 -130.19 140.99 50.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 -177.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 53.1 t -113.14 121.39 65.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.239 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 87.5 m-70 -96.57 111.47 23.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.241 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.503 HG11 HG22 ' A' ' 475' ' ' VAL . 2.6 m -119.91 129.18 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.272 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -145.35 155.29 43.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 36.7 t-20 -106.61 142.22 36.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.225 171.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 65.0 mt -134.08 5.06 3.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.231 -172.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -89.14 2.45 83.72 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -175.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.22 16.3 77.0 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.54 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 6.4 tt -126.45 146.06 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.25 171.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -87.11 132.56 11.24 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 173.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 80.7 t -116.17 115.5 40.44 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.841 0.353 . . . . 0.0 111.263 171.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.02 -18.25 8.94 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.591 1.528 . . . . 0.0 111.162 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.9 p -93.33 11.52 27.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.212 -166.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 86.9 m -75.76 114.38 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.161 -158.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.71 128.18 55.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.503 HG22 HG11 ' A' ' 462' ' ' VAL . 63.4 t -116.76 128.75 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.231 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -125.43 154.25 42.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.21 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 76.6 t -128.41 134.01 65.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.238 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.58 147.41 45.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.7 mt -120.7 116.81 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.204 171.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 54.41 41.48 31.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 90.73 -14.27 63.51 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.3 m -97.28 137.43 36.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 111.26 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 67.5 tp -69.52 120.69 15.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.154 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -97.61 -40.19 8.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.258 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -165.7 158.79 15.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -140.05 152.34 46.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.23 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -138.49 142.87 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.178 172.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.8 m -107.27 125.71 51.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 168.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.65 168.06 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.144 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 62.7 m -119.58 141.77 48.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.209 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 87.9 mt -129.39 130.19 45.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.202 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.03 -172.86 47.45 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.16 112.65 1.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.655 1.57 . . . . 0.0 111.212 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.5 mttt 65.7 35.34 6.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -101.91 142.55 33.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.256 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -120.74 141.47 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -127.35 146.27 50.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.264 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.7 t -111.55 119.5 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.146 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.54 143.02 32.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 459' ' ' GLU . 41.6 p -120.84 151.5 39.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.225 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -154.44 156.65 37.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 167.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 67.3 m -122.05 132.5 54.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 46.6 t90 -138.39 129.04 26.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.164 -168.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 88.3 m -116.48 110.29 42.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.192 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.99 144.6 58.68 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.638 1.559 . . . . 0.0 111.151 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 76.2 p -117.36 -14.89 10.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.24 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -118.97 137.31 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.129 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 508' ' ' GLU . 22.0 pm0 -77.04 145.47 37.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.137 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 147.18 178.16 22.26 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -85.33 129.6 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.749 0.309 . . . . 0.0 111.257 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -119.43 133.38 55.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.165 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -106.05 119.16 38.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.257 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 83.1 mt -104.28 124.1 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.252 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -117.62 145.93 44.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.55 138.8 53.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.3 p -131.6 151.03 51.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.22 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.2 172.579 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.793 0.33 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.76 132.01 49.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.189 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.0 m -116.68 125.83 52.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.175 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -130.86 131.35 44.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.321 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -101.06 125.88 47.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -173.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 85.4 t -120.15 135.62 59.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -106.94 125.56 51.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.221 171.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 95.5 t -100.77 126.17 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.156 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.83 170.41 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.158 -174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.204 -177.612 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.48 ' HG3' HG22 ' A' ' 470' ' ' VAL . 72.8 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 N-CA-C 111.231 -0.334 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 56.7 t0 -116.56 62.1 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 169.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.84 137.13 57.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.222 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.1 t -146.66 156.97 43.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.204 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.09 155.21 39.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 47.5 mt-10 -138.75 135.71 34.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.126 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 513' ' ' ILE . 89.6 mt -107.57 125.52 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.156 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -136.86 147.19 46.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.2 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.73 -165.75 34.17 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -56.96 136.67 78.04 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.712 1.608 . . . . 0.0 111.178 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -86.39 -38.63 17.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 538' ' ' SER . 92.2 t -124.84 133.91 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.8 m -130.45 152.65 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -82.4 160.42 39.91 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 540' ' ' VAL . 4.9 p -76.45 139.25 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 0.0 111.144 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 62.57 27.3 16.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.273 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -123.95 142.39 51.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.163 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 502' ' ' SER . 36.7 tp -85.76 127.29 34.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.237 -174.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.58 144.17 49.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.221 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -110.1 135.14 51.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.156 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -129.09 157.64 41.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.476 ' HG2' HG23 ' A' ' 500' ' ' THR . 81.7 mt-10 -130.45 139.23 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.223 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 59.4 t -112.09 120.63 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 172.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.438 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 88.3 m-70 -97.86 118.38 34.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.506 HG11 HG22 ' A' ' 475' ' ' VAL . 11.8 m -117.97 131.86 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -127.04 155.22 43.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.229 -175.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 54.8 t-20 -117.06 131.26 56.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.245 157.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 50.8 mt -127.25 4.7 6.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.171 -167.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -91.8 3.73 78.14 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -175.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.8 20.24 75.78 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.579 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.1 tt -131.81 144.34 37.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.754 0.312 . . . . 0.0 111.231 175.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -85.8 133.18 11.6 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.48 HG22 ' HG3' ' A' ' 438' ' ' PRO . 85.9 t -119.61 118.11 32.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 0.0 111.209 170.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.2 -19.08 8.24 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 121.679 1.586 . . . . 0.0 111.133 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 91.5 p -93.07 10.14 32.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.177 -163.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.6 m -78.28 111.58 14.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.269 -161.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -110.4 127.28 55.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.167 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.506 HG22 HG11 ' A' ' 462' ' ' VAL . 88.8 t -115.78 128.75 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.236 -178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -123.6 151.7 42.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -174.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 87.8 t -130.12 134.77 62.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.205 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -118.41 145.77 44.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.74 117.93 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.202 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 50.7 t30 54.41 41.79 31.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.215 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 96.66 -22.91 37.7 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 172.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.1 m -100.27 139.43 35.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 111.174 -175.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 67.1 tp -68.77 121.64 16.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.231 175.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -98.18 -41.02 8.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.217 -173.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -167.45 162.53 14.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -172.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -141.81 153.44 44.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.26 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -137.49 142.08 41.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.234 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.1 m -108.14 127.58 53.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.248 169.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.97 167.6 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.205 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 49.8 m -121.15 142.22 50.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.215 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 82.4 mt -130.47 128.1 40.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.245 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.37 -170.85 46.87 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.57 112.55 1.64 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.702 1.601 . . . . 0.0 111.205 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.3 mttt 62.08 35.67 15.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.268 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -99.55 144.32 28.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.138 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -120.52 141.69 50.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -126.54 146.76 50.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.188 173.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.7 t -112.44 119.34 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.082 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . 0.424 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 43.7 mt -103.17 141.1 36.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.2 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' THR . . . . . 0.476 HG23 ' HG2' ' A' ' 459' ' ' GLU . 60.7 p -124.76 152.07 44.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.207 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -154.62 157.12 37.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.285 170.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.513 ' HB3' HD11 ' A' ' 455' ' ' LEU . 71.5 m -119.43 131.42 55.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.208 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 42.2 t90 -140.71 129.72 23.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 -169.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 88.9 m -115.94 109.28 45.21 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.279 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.84 118.86 5.61 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.743 1.629 . . . . 0.0 111.104 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 68.2 p -99.02 1.1 45.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.25 137.03 49.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.432 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 37.7 tt0 -73.79 138.49 44.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.184 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.34 174.48 23.69 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.1 mmm -85.22 129.24 34.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.806 0.336 . . . . 0.0 111.185 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -119.48 128.48 54.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.173 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -106.04 119.38 39.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 444' ' ' ILE . 79.7 mt -102.96 122.25 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.1 -176.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -119.97 144.74 47.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.91 140.16 52.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.4 p -131.63 151.17 51.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 174.834 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 63.5 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.731 0.301 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.88 133.43 45.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.179 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 96.9 m -115.98 126.31 53.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.211 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -131.25 130.13 42.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.151 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -100.32 129.14 46.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.181 -172.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.6 t -121.22 135.56 61.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.207 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' SER . . . . . 0.4 ' HB3' HG23 ' A' ' 449' ' ' VAL . 36.3 t -104.82 126.0 51.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.189 174.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.37 127.76 55.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.177 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 452' ' ' VAL . 35.7 m -122.23 159.23 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.131 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . 0.432 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 83.6 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.109 176.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 N--CA 1.458 -0.6 0 N-CA-C 111.188 -0.351 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -138.26 89.68 2.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.6 133.21 37.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.165 -169.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 10.0 t -146.36 155.31 42.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.207 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 517' ' ' VAL . 28.6 m -129.31 153.75 39.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.177 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -135.59 133.69 38.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.251 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 77.6 mt -104.48 124.99 59.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.98 146.55 47.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.182 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.55 -167.44 33.04 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -56.16 133.89 60.8 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.636 1.558 . . . . 0.0 111.181 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -82.66 -40.42 20.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 172.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 64.1 t -122.94 130.88 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.171 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.04 154.43 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.05 152.35 36.41 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.68 137.25 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.797 0.332 . . . . 0.0 111.222 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 64.15 30.78 13.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.213 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -125.02 143.42 50.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.218 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 44.0 tp -81.18 127.2 32.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.259 -175.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.9 144.88 48.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.151 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -103.97 136.43 43.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.18 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -130.04 156.66 44.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.195 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -130.65 140.4 50.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.223 -175.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.69 121.26 64.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.175 172.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -100.46 117.52 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.175 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.52 131.38 71.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.156 -174.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -125.5 154.93 41.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.204 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 61.8 t-20 -117.85 121.7 41.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.222 157.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 61.4 mt -113.75 14.71 18.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.191 -170.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -98.42 -4.83 57.18 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -174.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.9 23.07 78.34 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.49 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.3 tt -134.54 146.92 30.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 111.188 172.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -82.55 135.44 14.09 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 86.0 t -121.88 119.96 28.72 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.741 0.305 . . . . 0.0 111.225 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -84.24 -17.46 5.53 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.668 1.579 . . . . 0.0 111.199 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 84.4 p -91.75 7.98 39.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -162.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 88.4 m -81.23 108.29 14.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.226 -162.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -110.58 124.4 51.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 98.8 t -111.19 126.98 68.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 -173.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -125.53 151.92 45.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 -172.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 73.5 t -126.88 132.8 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.213 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -120.1 147.41 44.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.87 115.07 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.233 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 54.49 40.91 32.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.185 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 95.01 -17.63 58.93 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 171.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.7 m -99.5 135.97 40.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 111.146 -175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.9 tp -67.99 120.54 14.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -96.41 -40.35 9.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.238 -175.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -167.05 158.28 12.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -137.41 152.03 49.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.187 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 -136.73 142.68 43.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.194 174.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.5 m -108.91 124.8 51.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.253 168.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.5 m -139.12 166.81 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 86.8 p -118.02 144.56 45.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 169.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.9 mt -126.72 130.93 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -92.43 -177.34 41.59 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.21 121.04 9.2 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.68 1.586 . . . . 0.0 111.222 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.8 mttt 55.03 41.9 31.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 175.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.91 143.62 34.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.217 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -117.71 140.42 49.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.228 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -126.95 145.85 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 174.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 79.3 t -111.74 119.47 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.178 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 45.4 mt -103.45 143.11 33.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.196 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 52.9 p -122.82 153.23 39.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.25 156.14 36.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.198 166.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 57.6 m -122.18 133.63 54.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.223 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 47.7 t90 -139.86 129.68 24.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 -165.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.5 m -117.8 114.21 37.66 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.221 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -71.32 154.85 61.12 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.706 1.604 . . . . 0.0 111.203 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 74.1 p -124.64 -14.53 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.182 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -122.91 136.51 54.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.254 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 508' ' ' GLU . 21.7 pm0 -76.51 145.76 38.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.58 179.57 22.81 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -173.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.04 129.96 34.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.741 0.305 . . . . 0.0 111.189 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.45 133.49 55.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.226 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -105.21 119.36 38.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.186 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 94.5 mt -103.86 124.88 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -118.73 145.76 45.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.154 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.23 143.28 51.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.215 173.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 68.1 p -130.89 151.26 51.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.194 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . 0.477 ' HB ' HG13 ' A' ' 442' ' ' VAL . 12.4 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.224 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.809 0.338 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.35 133.02 50.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.9 m -116.67 127.15 54.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.24 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -132.55 129.86 39.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.196 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -100.1 128.5 46.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.206 -172.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 96.6 t -121.26 136.22 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 40.2 t -105.52 124.43 49.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.195 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.16 125.45 55.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.213 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.96 161.4 28.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.197 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.175 177.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.407 ' HB3' HD22 ' A' ' 464' ' ' ASN . 69.5 Cg_endo . . . . . 0 N--CA 1.458 -0.598 0 N-CA-C 111.223 -0.337 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -111.47 90.32 3.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 166.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 78.1 mt -85.28 145.69 27.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.0 t -144.28 154.77 43.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.275 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 32.6 m -130.62 156.43 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 460' ' ' VAL . 96.9 mt-10 -140.11 137.43 34.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.204 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 92.7 mt -107.62 127.16 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.249 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.83 149.04 47.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.23 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 153.46 -165.1 31.3 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.72 120.66 7.57 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.708 1.605 . . . . 0.0 111.256 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -83.33 -8.68 59.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.181 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.24 128.45 64.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 169.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 25.4 m -131.08 155.59 42.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -93.67 154.5 21.7 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.89 137.91 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 62.89 27.44 15.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.23 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 454' ' ' LYS . 28.0 mmmt -125.36 142.08 51.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.199 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 502' ' ' SER . 37.2 tp -91.07 127.82 36.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.224 -174.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.71 145.55 48.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -106.93 138.02 43.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.184 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -129.09 157.04 42.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.207 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -129.96 139.6 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.267 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 47.7 t -112.33 121.22 64.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.196 172.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.465 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.5 m-70 -101.39 105.91 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.284 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.42 HG11 HG22 ' A' ' 475' ' ' VAL . 3.2 m -118.51 130.78 72.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -173.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -142.38 152.82 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.222 -171.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.63 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.9 t-20 -98.53 140.8 32.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.259 170.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 72.6 mt -130.55 5.4 4.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.221 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -101.37 -1.39 53.79 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.2 27.02 74.15 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.632 HG13 ' O ' ' A' ' 468' ' ' ILE . 0.6 OUTLIER -120.69 141.74 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.747 0.308 . . . . 0.0 111.201 175.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . 0.504 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -81.39 99.61 1.97 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.685 ' CG1' ' O ' ' A' ' 470' ' ' VAL . 0.4 OUTLIER -103.16 110.53 63.82 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 470' ' ' VAL . 74.4 Cg_endo -72.71 -15.33 27.05 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.721 1.614 . . . . 0.0 111.271 177.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.6 p -89.75 11.18 20.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.195 -157.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' THR . . . . . 0.453 ' OG1' ' CG1' ' A' ' 470' ' ' VAL . 97.3 m -77.16 109.59 11.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 -166.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -110.55 125.75 53.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.266 172.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.42 HG22 HG11 ' A' ' 462' ' ' VAL . 86.3 t -117.35 128.17 74.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.192 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -127.46 154.35 45.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.232 -173.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.2 t -128.16 134.56 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.19 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -122.01 148.0 45.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.297 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 89.6 mt -119.98 117.26 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 172.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 54.16 41.48 31.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.183 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.65 -8.65 74.41 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.9 m -97.55 137.51 36.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 111.288 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 68.5 tp -70.69 120.77 16.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.148 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -98.45 -40.51 8.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.245 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . 0.411 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 51.1 tptt -165.95 159.17 15.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.189 -172.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -141.26 152.8 44.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.233 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . 0.411 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 24.1 m-90 -138.16 142.4 40.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.2 171.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.9 m -106.79 124.33 49.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.227 169.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.73 167.44 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.263 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 70.7 m -121.21 144.16 48.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.14 172.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 94.6 mt -127.07 129.32 47.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.264 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . 0.504 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -83.91 -173.99 50.09 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 174.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.93 111.03 0.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.734 1.623 . . . . 0.0 111.27 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 64.48 34.61 10.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.162 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -99.19 143.31 29.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.236 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.2 140.87 52.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.243 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.46 147.36 49.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.164 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 96.3 t -112.45 119.55 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 54.2 mt -103.51 142.72 33.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.25 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 53.3 p -122.24 153.17 39.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.24 156.15 36.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 167.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.434 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.3 m -121.29 128.28 52.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -128.25 129.8 46.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -171.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.9 m -117.84 109.04 41.81 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.26 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.77 152.19 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.697 1.598 . . . . 0.0 111.247 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.7 p -124.74 -0.77 7.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.25 136.21 48.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.202 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -79.85 143.94 33.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.247 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.28 175.92 22.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -82.25 126.6 32.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.776 0.322 . . . . 0.0 111.13 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -119.84 130.82 55.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.161 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -105.79 118.93 37.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.193 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 84.1 mt -104.22 123.19 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.292 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -119.44 145.7 46.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.249 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.35 142.0 51.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.8 p -130.76 151.38 51.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.216 169.148 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 62.3 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.864 0.364 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.65 135.62 48.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.3 m -114.86 125.58 53.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.219 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -131.46 129.85 41.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.165 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -99.61 124.59 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -173.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 97.0 t -121.28 135.58 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.186 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 36.3 t -104.78 129.33 53.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.224 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 86.3 t -102.41 126.71 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.245 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.32 157.65 38.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.187 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.174 179.861 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.418 ' HG3' HG22 ' A' ' 470' ' ' VAL . 72.2 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 N-CA-C 111.203 -0.345 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -118.74 82.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.146 163.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 87.3 mt -81.1 127.4 32.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.122 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.1 t -148.45 160.92 42.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.196 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.07 155.75 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.276 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -135.99 139.69 43.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.243 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 61.9 mt -108.05 137.27 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.33 142.45 45.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 179.97 179.45 48.8 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.581 ' O ' ' HB2' ' A' ' 448' ' ' ASP . 33.8 Cg_endo -70.98 -31.49 15.04 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.679 1.586 . . . . 0.0 111.224 -172.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . 0.581 ' HB2' ' O ' ' A' ' 447' ' ' PRO . 82.7 m-20 75.59 -11.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.271 -175.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' A' ' 447' ' ' PRO . 47.9 t -139.13 117.15 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 175.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.68 152.54 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.229 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.51 157.74 44.52 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.5 p -76.43 140.22 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.127 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 63.13 29.6 16.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -124.73 139.0 54.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 37.3 tp -76.5 126.39 30.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.87 145.05 48.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.19 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -103.03 136.15 43.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -129.16 156.68 43.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -128.22 139.24 52.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.234 -171.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 57.0 t -115.85 120.3 64.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 173.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -99.56 113.31 25.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.295 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.43 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -116.14 127.33 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.458 ' HD2' HD22 ' A' ' 465' ' ' LEU . 11.3 pttt -131.83 150.49 52.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.224 -170.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.5 t-20 -105.24 137.99 42.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.241 162.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.458 HD22 ' HD2' ' A' ' 463' ' ' LYS . 56.5 mt -123.61 0.07 8.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 -169.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -95.53 -15.4 43.73 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.49 31.19 63.42 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.519 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 0.1 OUTLIER -132.95 130.08 58.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 111.182 177.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.23 131.34 10.81 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -170.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.418 HG22 ' HG3' ' A' ' 438' ' ' PRO . 97.9 t -123.3 120.11 27.29 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.734 0.302 . . . . 0.0 111.148 170.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.62 -19.01 6.48 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.654 1.57 . . . . 0.0 111.12 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.8 p -95.95 12.93 28.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.256 -163.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.9 m -77.32 117.66 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.192 -162.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -109.95 128.26 55.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.285 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.42 128.15 73.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.198 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -125.9 152.8 45.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -171.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 72.9 t -127.95 132.72 68.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.214 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -120.0 148.76 43.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.234 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.8 mt -120.96 115.91 48.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.261 170.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 54.52 41.35 32.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.2 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 95.42 -19.94 51.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 171.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -98.13 137.03 37.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 0.0 111.223 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.03 120.62 14.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.257 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -97.3 -39.89 9.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -166.11 157.95 13.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -141.73 154.63 45.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.175 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -135.29 142.3 45.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.238 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.9 m -102.31 122.51 44.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.201 165.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.56 166.92 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.204 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 67.4 m -120.12 142.28 49.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 96.9 mt -128.9 131.45 47.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.251 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -92.42 -165.68 38.82 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.37 114.2 2.77 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.676 1.584 . . . . 0.0 111.205 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 61.7 41.05 12.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.266 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -102.49 141.32 35.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -120.76 137.95 54.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -123.42 145.59 48.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.203 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.66 117.85 55.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 19.0 mt -109.46 136.14 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.24 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 44.6 p -120.09 155.24 33.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -172.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -153.52 156.57 38.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.215 171.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.8 m -121.1 133.35 55.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 41.2 t90 -140.19 130.1 24.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.188 -166.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.6 m -116.33 112.34 41.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.216 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.52 152.37 48.61 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.712 1.608 . . . . 0.0 111.142 172.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 71.1 p -122.37 -15.07 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.228 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -120.07 139.74 52.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -77.24 139.98 39.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.22 178.38 25.97 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.1 131.14 34.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.781 0.324 . . . . 0.0 111.153 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -117.34 137.51 52.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.245 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -104.85 118.69 37.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.152 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 86.2 mt -104.14 125.24 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.205 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -116.74 146.92 42.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.93 142.31 51.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.283 169.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 36.8 p -131.28 151.05 51.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.257 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.26 171.251 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.74 0.305 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -129.74 136.09 49.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.257 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.5 m -114.99 128.44 56.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.186 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -133.21 127.93 34.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.08 -171.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -102.38 128.28 49.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.21 -170.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 86.8 t -122.33 137.15 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 41.2 t -103.91 124.67 49.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.158 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 93.0 t -102.73 126.27 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.162 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.96 159.61 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.167 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.163 178.043 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . 0.487 ' HB3' HG23 ' A' ' 468' ' ' ILE . 73.5 Cg_endo . . . . . 0 N--CA 1.458 -0.617 0 N-CA-C 111.257 -0.324 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -111.01 76.09 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.243 164.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.4 mt -74.84 137.9 42.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.3 t -144.34 155.1 43.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.112 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.02 155.74 41.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.304 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 97.8 mt-10 -137.32 139.64 40.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.161 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 87.6 mt -107.85 132.07 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.225 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -136.27 142.8 43.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.229 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 162.18 -173.49 38.5 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.58 134.86 34.23 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.727 1.618 . . . . 0.0 111.229 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -75.9 -40.7 53.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.191 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.4 t -122.31 132.4 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.179 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.05 152.13 36.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.5 159.9 46.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.52 149.2 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 111.174 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 19.0 m120 63.38 26.47 14.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.147 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . 0.408 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 28.0 mmmt -128.31 143.3 51.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.082 -177.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 37.3 tp -86.38 127.83 34.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.191 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.35 144.19 49.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.218 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -102.46 135.15 44.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 87.2 m-85 -129.16 157.12 42.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.193 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . 0.43 ' HG2' HG23 ' A' ' 500' ' ' THR . 90.6 mt-10 -129.82 141.11 50.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.195 -174.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.9 t -113.24 121.03 64.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 172.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 94.6 m-70 -99.42 111.1 23.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.156 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.27 130.91 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.425 ' HD3' HD22 ' A' ' 465' ' ' LEU . 19.2 ptpt -143.78 154.1 43.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -175.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.58 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.4 t-20 -104.77 141.46 36.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.208 172.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.425 HD22 ' HD3' ' A' ' 463' ' ' LYS . 63.8 mt -131.69 4.3 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.203 -169.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -91.78 0.06 72.84 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.28 19.04 75.59 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.58 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 5.5 tt -126.72 143.84 38.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.765 0.317 . . . . 0.0 111.289 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -84.9 132.11 10.86 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . 0.461 HG22 ' HG3' ' A' ' 438' ' ' PRO . 85.6 t -118.89 116.01 34.6 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 111.21 173.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.29 -18.19 9.91 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.689 1.592 . . . . 0.0 111.209 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.3 p -91.53 12.56 20.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.259 -167.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 89.8 m -79.64 111.26 15.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.22 -163.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -113.84 125.62 54.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.0 131.02 67.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.198 -173.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -120.42 154.2 35.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.173 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.1 t -128.93 134.81 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.195 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.73 147.28 45.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 93.3 mt -124.24 117.5 50.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.21 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 45.4 t30 54.8 42.18 31.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.195 172.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 96.07 -19.99 52.05 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 174.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.2 m -101.53 138.99 37.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.764 0.316 . . . . 0.0 111.251 -174.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.7 tp -69.96 121.75 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.166 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -97.71 -40.43 8.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.219 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -165.56 158.9 16.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.185 -171.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -140.0 152.77 46.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.221 -177.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -138.49 142.61 39.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.6 m -106.34 126.01 51.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.224 170.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.66 167.85 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.21 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.6 m -120.47 143.34 48.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 170.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.5 mt -129.03 129.21 45.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.259 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -86.44 -173.44 49.1 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.96 112.06 1.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.681 1.587 . . . . 0.0 111.196 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.0 mttt 64.68 33.69 10.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.21 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -101.15 144.96 29.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.167 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -123.5 141.3 52.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.176 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.78 147.22 50.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.182 174.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.9 t -111.87 119.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 43.3 mt -103.81 142.03 35.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.213 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' THR . . . . . 0.43 HG23 ' HG2' ' A' ' 459' ' ' GLU . 47.4 p -122.99 152.95 40.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.226 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.1 p90 -153.97 156.58 37.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.147 168.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 67.1 m -121.28 131.61 54.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.184 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . 0.466 ' CH2' ' HB3' ' A' ' 505' ' ' PRO . 41.1 t90 -140.11 129.92 24.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 -169.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' THR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 505' ' ' PRO . 82.1 m -111.47 110.84 55.32 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.256 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . 0.466 ' HB3' ' CH2' ' A' ' 503' ' ' TRP . 74.0 Cg_endo -70.96 111.57 3.08 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.726 1.618 . . . . 0.0 111.165 174.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 80.8 p -83.61 -20.31 33.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.195 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -121.75 140.9 51.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.189 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.451 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 31.7 tt0 -72.26 141.0 48.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.05 174.58 23.58 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -176.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -85.48 127.83 34.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.783 0.325 . . . . 0.0 111.157 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -120.38 132.04 55.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.295 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -105.53 119.58 39.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.256 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 92.8 mt -100.73 122.74 53.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -120.75 147.06 45.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.57 140.17 52.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 174.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.2 p -130.91 150.64 51.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.113 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.199 176.68 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 89.5 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.861 0.362 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.37 134.11 48.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.273 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.7 m -116.03 126.38 53.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.156 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -132.68 130.69 40.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.332 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.5 129.42 47.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.164 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.9 t -121.59 136.22 59.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.8 t -106.29 126.8 52.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.211 173.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.9 t -102.3 128.63 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.203 176.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.96 159.94 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . 0.451 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 93.2 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 N--CA 1.459 -0.549 0 N-CA-C 111.125 -0.375 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -133.38 83.47 2.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 13.9 mt -91.7 127.08 37.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.253 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 9.0 t -145.77 157.82 43.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.55 154.75 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.199 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 94.9 mt-10 -135.62 137.48 41.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.204 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.6 mt -103.65 131.58 51.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.202 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -135.98 142.24 44.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.186 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.9 -176.02 33.51 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.79 141.19 44.47 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.666 1.577 . . . . 0.0 111.323 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -95.82 -17.24 21.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.204 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.6 t -126.61 124.97 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.8 m -130.03 154.24 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.124 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.44 150.84 27.5 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.79 140.01 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 0.0 111.16 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 63.69 30.11 14.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.161 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 454' ' ' LYS . 29.2 mmmt -126.02 142.93 51.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 36.7 tp -83.48 126.67 33.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.196 -176.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.79 144.98 48.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -102.78 135.87 43.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.133 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.94 157.2 42.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -130.01 139.51 51.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.157 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.83 120.09 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.1 m-70 -100.68 116.08 31.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.429 HG11 HG22 ' A' ' 475' ' ' VAL . 1.4 m -117.41 128.09 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 -175.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.449 ' HD2' HD22 ' A' ' 465' ' ' LEU . 13.4 pttt -133.69 150.76 51.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.176 -174.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 57.8 t-20 -111.51 123.97 51.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.214 167.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.449 HD22 ' HD2' ' A' ' 463' ' ' LYS . 56.0 mt -110.52 5.63 21.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.272 -170.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.77 -14.96 54.34 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -174.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.23 21.88 78.4 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.463 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.0 tt -129.49 139.9 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.88 0.371 . . . . 0.0 111.12 167.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -83.09 134.1 12.53 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -169.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 84.8 t -122.16 119.0 28.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.758 0.314 . . . . 0.0 111.263 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -86.15 -18.16 3.54 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.652 1.568 . . . . 0.0 111.137 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.6 p -97.11 4.0 51.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.178 -160.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' THR . . . . . 0.469 HG21 ' O ' ' A' ' 473' ' ' THR . 10.2 t -85.31 123.52 30.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.22 -166.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -113.34 128.93 56.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.22 -174.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.429 HG22 HG11 ' A' ' 462' ' ' VAL . 88.4 t -112.02 125.79 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 -174.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.02 155.77 44.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.214 -171.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.31 133.31 69.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -120.5 148.26 44.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.219 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 70.5 mt -120.24 114.73 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.226 169.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 53.96 40.97 32.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 91.64 -11.79 71.17 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.6 m -98.29 134.3 41.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 111.195 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.5 tp -68.54 119.18 12.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.278 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -99.08 -40.58 7.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.231 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -167.33 157.51 11.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.168 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -140.4 151.97 45.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.229 -175.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -136.46 142.15 43.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.2 m -103.26 125.0 49.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.21 163.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.43 166.05 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.4 m -121.95 142.43 50.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.169 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . 0.429 HD22 ' HB2' ' A' ' 497' ' ' LYS . 87.3 mt -129.64 131.44 46.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.167 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -89.76 -167.08 42.14 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 172.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.47 117.53 4.79 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.708 1.605 . . . . 0.0 111.224 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.1 mttt 59.69 41.78 18.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.172 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -103.83 144.56 31.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.256 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -120.32 143.25 48.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.163 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.429 ' HB2' HD22 ' A' ' 491' ' ' LEU . 1.8 tttp -137.46 130.75 30.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.217 -173.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 69.4 t -106.37 118.53 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.161 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 37.2 mt -107.07 144.02 34.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.196 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 41.7 p -122.35 152.68 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.175 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.9 156.4 37.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 168.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 68.8 m -120.41 134.02 55.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.286 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -130.31 129.37 43.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.236 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 96.6 m -118.49 110.55 38.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 170.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.61 152.26 47.98 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.74 1.627 . . . . 0.0 111.168 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 59.4 p -123.88 -15.07 7.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -119.26 135.16 54.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.639 ' CD ' ' H ' ' A' ' 508' ' ' GLU . 2.9 pm0 -80.08 124.82 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.168 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 174.47 -179.99 45.45 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.3 mmm -84.39 127.21 33.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 111.253 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -122.1 133.03 54.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.154 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -105.31 119.17 38.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.289 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.0 123.73 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 -176.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -115.19 146.51 41.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.46 142.74 51.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.237 168.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 77.2 p -130.8 150.39 51.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.22 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.278 172.684 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 79.4 t . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.801 0.334 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.86 133.15 45.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.288 174.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.5 m -117.51 127.03 53.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.193 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -133.6 129.34 36.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.245 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -100.22 126.46 46.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.195 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 82.1 t -121.0 135.83 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.188 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -105.17 127.75 53.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.239 173.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.03 127.73 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.183 173.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.51 150.88 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 -172.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . 0.715 ' O ' ' HG ' ' A' ' 541' ' ' LEU . 39.8 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.178 -174.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 N--CA 1.458 -0.585 0 N-CA-C 111.227 -0.336 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -147.78 98.91 3.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.193 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 60.3 mt -96.18 142.64 28.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.192 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.5 t -148.53 159.17 44.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.227 174.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.05 154.91 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.184 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -135.79 138.72 42.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.231 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 82.5 mt -106.19 128.23 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -135.75 149.04 49.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.231 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.84 -173.53 35.15 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.16 145.47 60.74 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.718 1.612 . . . . 0.0 111.117 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -90.07 -41.78 11.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 74.9 t -118.25 126.18 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.267 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.5 m -129.73 152.23 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.232 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.79 158.71 45.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 3.1 p -79.42 146.02 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.839 0.352 . . . . 0.0 111.133 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 63.65 29.06 15.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.25 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.91 141.87 51.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 35.0 tp -81.57 127.55 32.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.205 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.16 144.5 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.202 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -103.01 135.78 44.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.191 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -129.34 157.08 42.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.237 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -129.68 139.63 51.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.218 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.5 t -112.01 120.44 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.186 170.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -101.54 113.17 26.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.411 HG11 HG22 ' A' ' 475' ' ' VAL . 1.5 m -119.66 130.72 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.23 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -142.73 154.97 44.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -172.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 41.2 t30 -106.71 140.12 40.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.208 170.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 65.1 mt -125.88 4.76 7.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.182 -174.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -89.42 -15.33 58.77 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.53 24.28 73.18 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.469 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.3 tt -137.67 136.39 45.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 111.174 171.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -74.45 136.54 21.31 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -168.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.64 118.15 30.95 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.802 0.334 . . . . 0.0 111.216 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.74 -18.5 5.54 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.649 1.566 . . . . 0.0 111.266 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.6 p -94.11 13.06 24.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 -163.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 100.0 m -78.83 111.62 15.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.16 -161.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -109.83 125.89 53.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.411 HG22 HG11 ' A' ' 462' ' ' VAL . 60.1 t -119.9 127.0 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.177 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -135.28 157.24 47.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.178 -172.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 69.4 t -127.68 134.38 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.244 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -116.85 146.73 42.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.174 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 80.2 mt -120.1 115.05 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.171 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 53.68 41.29 32.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.178 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 93.01 -15.4 62.95 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 172.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -99.64 133.71 43.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.803 0.335 . . . . 0.0 111.25 -174.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 56.0 tp -68.79 120.23 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.222 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -97.36 -40.96 8.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.211 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -168.31 157.44 9.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.193 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -140.5 155.17 46.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.228 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -135.21 142.38 46.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.252 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.4 m -109.67 123.32 49.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.206 166.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.11 167.74 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.277 -175.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 82.9 p -116.75 143.89 45.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.143 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 96.4 mt -129.16 131.23 47.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.201 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -90.15 -179.19 44.27 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 172.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.49 120.24 7.72 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.686 1.591 . . . . 0.0 111.255 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.9 mttt 57.08 36.62 27.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.249 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -103.24 144.08 31.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.162 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -122.95 140.67 52.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.243 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -126.81 147.68 50.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.185 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 90.0 t -110.89 119.16 58.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 35.7 mt -104.16 141.65 35.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.199 173.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 46.3 p -124.55 153.86 41.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.23 156.28 36.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.211 166.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 52.7 m -122.47 134.37 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 41.3 t90 -140.17 129.77 24.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.211 -166.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.3 m -117.15 112.88 39.55 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.28 150.32 36.83 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.703 1.602 . . . . 0.0 111.237 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 66.9 p -122.68 -11.71 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.194 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -120.03 139.19 52.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.173 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -80.74 143.6 32.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.135 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.93 177.84 25.18 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.7 mmm -86.31 130.75 34.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 111.184 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -118.71 134.93 54.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.225 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -106.95 119.6 39.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.158 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 85.2 mt -103.5 124.9 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.193 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -117.71 145.7 44.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.228 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.75 141.4 51.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.192 170.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 68.0 p -131.05 150.56 52.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.169 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 169.99 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 71.5 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.828 0.347 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.03 130.61 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -172.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.2 m -117.29 127.05 53.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.247 176.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -130.65 130.2 43.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.206 -175.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -99.08 125.59 44.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -173.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.54 135.58 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.166 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.5 t -105.79 122.41 46.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.221 171.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 98.2 t -102.76 127.08 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.15 165.06 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.287 177.255 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.458 -0.581 0 N-CA-C 111.118 -0.378 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -141.16 73.52 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.204 165.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.01 143.36 34.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.141 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 44.7 p -127.8 162.39 26.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.183 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.82 152.08 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.26 163.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 460' ' ' VAL . 86.2 mt-10 -139.96 135.69 33.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 175.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 84.5 mt -109.66 124.18 66.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.211 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.0 148.66 47.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.227 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.22 -163.92 32.17 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -56.25 136.77 77.07 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.674 1.582 . . . . 0.0 111.247 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -86.99 -37.63 17.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.203 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 93.1 t -124.85 132.87 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.203 174.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.84 151.85 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.24 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.61 158.78 43.62 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.8 136.17 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 111.22 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 62.56 21.99 13.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.19 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -110.3 130.98 55.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.17 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 35.3 tp -74.73 126.81 31.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.156 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.56 146.47 48.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -108.66 132.26 54.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -128.18 157.2 41.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.172 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -130.35 140.36 50.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.211 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 48.8 t -111.77 120.39 62.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 170.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.1 m-70 -105.98 109.09 20.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.195 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 14.6 m -116.42 132.61 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -119.77 159.16 25.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 44.5 t-20 -111.82 121.75 45.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 156.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 48.5 mt -117.16 1.0 12.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 -177.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.72 -19.29 41.17 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 75.28 28.87 61.14 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 15.2 tt -128.14 136.03 61.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 111.193 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.7 122.24 13.76 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.09 112.07 31.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 111.169 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.23 -17.42 11.7 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.738 1.625 . . . . 0.0 111.206 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 58.5 m -87.98 10.73 17.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -162.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.9 m -79.97 108.54 13.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -162.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -109.54 127.44 54.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.194 175.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 80.4 t -113.45 126.16 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.303 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -127.87 153.84 46.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.243 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.75 134.38 64.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -120.99 147.55 45.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.219 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.44 HG12 HG12 ' A' ' 513' ' ' ILE . 86.3 mt -120.39 117.41 53.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 170.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 54.31 41.43 31.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.268 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.95 -9.51 71.94 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.1 m -98.14 137.81 36.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.745 0.307 . . . . 0.0 111.208 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -69.76 120.31 15.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -98.09 -40.39 8.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -165.15 158.07 16.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.213 -173.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -142.23 152.04 42.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.234 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.3 m-90 -137.79 142.66 40.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.288 170.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.7 m -105.97 125.12 50.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.231 170.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.0 m -138.98 167.21 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.5 m -122.79 143.31 49.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.161 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 90.8 mt -128.57 128.81 44.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.268 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.37 -167.79 43.59 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.79 112.84 1.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.658 1.572 . . . . 0.0 111.205 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.0 mttt 66.86 36.19 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -96.61 143.81 27.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.235 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -125.37 141.48 52.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.233 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . 0.445 ' HB3' ' HE3' ' A' ' 497' ' ' LYS . 26.4 mmmt -129.8 144.82 51.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.189 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.3 119.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.128 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 64.6 mt -104.03 143.3 33.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 47.1 p -122.36 152.77 39.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.211 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -153.82 156.61 37.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.236 168.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.2 m -121.1 129.25 53.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.189 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -127.27 129.5 47.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 -172.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.9 m -113.89 110.47 49.02 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.192 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.29 150.99 53.9 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.691 1.594 . . . . 0.0 111.179 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 79.9 p -123.41 -13.53 7.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.223 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -125.76 137.12 53.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.192 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.435 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 30.9 tt0 -77.02 140.05 40.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.242 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.8 175.12 23.95 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.7 mmm -85.67 129.91 34.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.191 176.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -119.63 130.32 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -104.01 119.39 38.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.195 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.44 HG12 HG12 ' A' ' 479' ' ' ILE . 82.5 mt -104.05 123.76 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.201 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -119.76 145.14 46.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.208 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.04 143.09 50.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.192 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 82.7 p -131.17 153.2 49.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.289 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.238 173.552 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.803 0.335 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.18 137.18 49.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.0 m -115.21 126.52 54.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -134.71 129.75 35.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.181 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -100.19 128.71 46.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.226 -173.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 91.9 t -121.13 135.99 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.242 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.6 t -105.66 124.42 49.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.145 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.6 t -102.03 126.61 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.73 155.23 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . 0.435 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 83.4 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.238 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.458 -0.577 0 N-CA-C 111.243 -0.329 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 64.2 t0 -127.62 81.57 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.267 172.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.6 136.01 33.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 -174.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 8.0 t -141.0 153.14 45.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.324 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 26.2 m -131.62 154.9 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.131 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.7 mt-10 -139.4 135.69 33.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.2 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 87.7 mt -107.34 126.86 63.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.192 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.9 147.93 48.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.243 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.89 -169.66 34.67 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.42 114.46 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.693 1.595 . . . . 0.0 111.163 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -69.04 -26.96 65.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 97.5 t -123.69 130.96 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.221 172.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.2 152.01 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.187 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.58 158.91 41.9 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.53 137.91 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 111.248 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 62.21 25.5 15.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.299 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -116.56 150.2 38.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.176 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 37.9 tp -88.87 127.61 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.279 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.41 143.99 49.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.228 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -107.71 137.32 45.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.187 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.86 157.67 41.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.27 141.2 51.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.155 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 47.1 t -113.13 120.95 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.162 170.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.7 m-70 -103.29 108.17 19.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.442 HG11 HG22 ' A' ' 475' ' ' VAL . 2.3 m -118.42 130.55 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.224 -171.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -144.99 151.72 39.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.167 -173.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 44.6 t-20 -106.81 139.58 41.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.163 173.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 73.7 mt -129.37 4.09 5.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.214 -171.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -88.0 -2.04 81.42 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.94 21.4 78.23 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.437 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.8 tt -126.55 148.85 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.773 0.32 . . . . 0.0 111.186 175.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -94.06 115.69 5.06 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 94.3 t -104.76 114.48 63.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.757 0.313 . . . . 0.0 111.194 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.7 -17.98 10.79 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.698 1.598 . . . . 0.0 111.201 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.7 p -91.42 12.08 21.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.164 -164.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 91.1 m -78.75 108.17 11.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.229 -162.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -111.07 128.26 55.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.218 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . 0.442 HG22 HG11 ' A' ' 462' ' ' VAL . 67.1 t -115.05 128.46 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 -176.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -123.67 152.61 41.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 79.7 t -127.7 133.71 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.284 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.22 147.51 44.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.169 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 513' ' ' ILE . 84.1 mt -119.86 117.19 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.292 171.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 54.55 41.16 32.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.176 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.56 -11.82 67.12 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 173.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.2 m -97.71 137.64 36.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 111.224 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 66.5 tp -69.3 120.69 15.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.263 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -98.11 -40.47 8.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 -176.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 486' ' ' ASN . 51.5 tptt -166.16 159.91 15.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 -173.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . 0.405 ' N ' ' HG3' ' A' ' 485' ' ' LYS . 16.5 p30 -141.17 153.13 45.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.182 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -139.17 142.79 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.196 171.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.8 m -107.55 125.09 50.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.204 169.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.61 168.07 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 59.4 m -121.98 143.09 49.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.173 170.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.4 mt -127.38 129.53 47.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.216 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.38 -179.74 48.15 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.06 113.87 1.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.647 1.565 . . . . 0.0 111.211 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.5 mttt 64.73 34.14 9.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -101.5 143.47 31.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.28 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -122.81 140.3 53.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.208 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -128.29 146.43 50.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.206 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.9 t -112.34 119.45 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 49.5 mt -102.86 142.25 34.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.239 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 45.7 p -123.82 152.78 41.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.23 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.95 156.84 38.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.314 167.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 70.5 m -120.12 129.81 54.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.206 -176.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -130.69 129.57 42.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.219 -170.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.1 m -117.34 107.3 45.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.222 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.35 143.48 31.47 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.713 1.608 . . . . 0.0 111.202 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 67.4 p -115.41 -14.85 11.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.169 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -119.94 138.02 53.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . 0.402 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 33.2 tt0 -75.0 140.11 43.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.197 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.87 174.44 24.05 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -176.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.6 mmm -85.17 127.82 34.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.842 0.353 . . . . 0.0 111.111 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -120.89 131.96 54.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.18 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -104.17 118.07 35.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.165 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 479' ' ' ILE . 83.9 mt -104.52 120.22 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -123.02 149.4 44.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.239 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.4 140.81 52.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.233 175.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 60.1 p -131.75 151.75 51.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.163 174.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.216 173.659 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 88.6 t . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.847 0.356 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.87 133.98 46.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.239 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 85.8 m -116.19 125.89 52.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -131.21 129.09 41.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.191 176.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -101.14 125.65 47.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.249 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 85.3 t -121.25 136.26 58.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.9 t -104.61 127.34 52.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.179 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 85.2 t -101.24 126.85 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.144 173.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 32.2 m -122.87 159.77 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.12 -175.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . 0.402 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 94.3 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.153 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.459 -0.557 0 N-CA-C 111.233 -0.334 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -143.17 78.07 1.59 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.232 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 14.7 mt -80.28 125.86 30.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.198 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 14.5 t -138.74 157.15 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.37 155.48 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.308 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 91.5 mt-10 -137.05 133.75 35.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.193 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 92.6 mt -104.56 127.28 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -135.48 146.48 48.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.226 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.61 -171.17 34.19 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.96 140.39 45.58 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.71 1.607 . . . . 0.0 111.205 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -86.03 -36.52 19.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.237 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.2 t -120.03 129.57 75.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.231 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.09 153.18 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.232 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.37 156.54 43.3 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.1 p -76.19 140.29 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.201 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 63.46 28.65 15.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.239 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -121.73 148.04 45.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.82 127.06 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.28 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.25 143.38 49.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.177 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -103.99 135.17 46.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.121 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -130.27 157.22 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -129.81 139.83 51.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.221 -175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 47.7 t -113.45 121.9 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 173.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.5 m-70 -101.71 112.05 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.15 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.408 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -117.89 128.83 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.256 -171.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . 0.454 ' HD2' HD22 ' A' ' 465' ' ' LEU . 45.7 pttt -145.07 154.97 43.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.202 -172.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 63.4 t-20 -113.77 120.88 42.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.156 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . 0.454 HD22 ' HD2' ' A' ' 463' ' ' LYS . 82.6 mt -112.16 15.36 20.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.176 -170.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.28 -9.62 61.7 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -177.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.96 16.79 76.65 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.474 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.7 tt -127.03 146.21 33.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.701 0.286 . . . . 0.0 111.264 170.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -83.6 132.06 10.82 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.7 114.55 32.66 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.222 168.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -84.71 -19.17 4.27 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.811 1.674 . . . . 0.0 111.242 -174.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 99.1 p -97.92 5.32 49.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.233 -160.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' THR . . . . . 0.409 HG21 ' O ' ' A' ' 473' ' ' THR . 8.9 t -84.99 127.03 34.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.212 -160.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.94 130.92 55.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.249 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.89 130.21 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.268 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -129.49 155.09 46.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.176 -170.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 41.4 t -125.55 135.02 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.228 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -124.04 150.15 45.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.218 -174.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 86.3 mt -124.03 116.45 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.221 172.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 54.49 41.19 32.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.19 -13.52 66.87 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 170.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.6 m -99.76 138.53 36.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 111.257 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.7 tp -67.85 120.44 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -99.01 -40.28 8.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.156 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt -158.26 162.9 37.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -138.12 148.32 44.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.157 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -138.48 142.03 39.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.135 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 93.2 m -109.75 126.68 54.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.286 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.5 m -138.19 167.1 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.242 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.7 m -117.32 140.28 49.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.184 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.9 mt -129.44 130.24 45.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.136 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -91.15 -167.21 41.04 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 173.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.2 111.73 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.731 1.62 . . . . 0.0 111.239 175.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.1 mttt 60.01 43.69 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.181 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.06 142.67 31.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.238 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -122.14 137.92 54.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.145 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -127.97 148.61 50.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.188 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 85.9 t -111.2 118.53 57.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.186 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 48.1 mt -104.84 145.65 30.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.259 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 55.5 p -120.51 154.0 35.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.218 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -152.93 155.04 36.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 165.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 65.2 m -124.25 131.59 53.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -131.42 131.53 43.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.201 -170.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.4 m -118.02 110.3 40.02 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.221 174.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.85 154.44 43.28 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.806 1.671 . . . . 0.0 111.107 172.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 74.3 p -124.19 -19.16 5.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.242 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -120.13 138.92 53.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.22 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.21 140.44 46.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.46 176.61 26.1 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.64 128.94 35.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.17 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -121.92 136.55 54.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.209 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -104.68 119.09 38.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.243 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 93.0 mt -103.73 124.05 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.175 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -121.37 151.16 40.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.27 143.18 51.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.163 173.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 64.6 p -131.07 154.1 48.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.215 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.235 165.989 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 92.9 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.857 0.361 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.4 131.74 48.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 80.1 m -115.25 125.34 53.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.171 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -132.58 130.83 40.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.149 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -104.05 129.63 51.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.224 -174.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.0 t -121.27 137.19 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.257 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.6 t -103.97 124.13 48.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.199 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 83.9 t -102.17 126.47 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.242 175.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.07 160.54 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.26 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 76.0 mt . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.185 -176.147 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.459 -0.54 0 N-CA-C 111.064 -0.398 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -143.36 89.72 2.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 15.4 mt -90.14 128.3 36.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.187 -176.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.4 t -143.76 157.59 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.199 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.63 154.59 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.25 -177.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 50.3 mt-10 -135.95 139.82 43.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.233 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 85.4 mt -105.38 132.17 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.24 142.52 44.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.189 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 160.41 -174.97 37.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.15 142.72 42.53 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.762 1.642 . . . . 0.0 111.208 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -75.24 -46.36 34.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.251 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.18 130.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.192 -176.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.37 153.09 38.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.249 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -85.65 159.81 33.62 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 4.7 p -72.41 139.96 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 0.0 111.242 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 63.31 29.95 15.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.22 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -124.52 138.64 54.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.22 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 502' ' ' SER . 34.4 tp -81.49 126.9 32.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.24 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.81 144.47 48.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.223 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -101.88 134.19 45.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.213 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -129.42 156.88 43.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.106 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -130.1 139.94 50.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.124 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.9 t -111.54 120.1 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' HIS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.0 m-70 -99.63 114.17 27.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.225 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' VAL . . . . . 0.4 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -117.42 129.43 73.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.224 -175.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -144.26 153.07 41.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.23 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 31.0 t30 -111.72 130.05 55.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.185 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 78.9 mt -114.61 4.03 15.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.204 -173.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -88.7 -20.54 47.04 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.91 24.37 72.16 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' ILE . . . . . 0.421 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.6 tt -134.44 138.97 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 111.173 169.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -76.07 131.68 12.06 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -166.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.38 117.63 30.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 111.251 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -86.72 -17.74 3.24 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.639 1.559 . . . . 0.0 111.175 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 98.5 p -95.59 4.36 53.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.259 -160.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' THR . . . . . 0.45 HG21 ' O ' ' A' ' 473' ' ' THR . 9.6 t -86.57 124.33 32.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.265 -164.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -113.6 129.13 56.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.191 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 97.0 t -112.22 127.54 69.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.234 -174.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.69 157.65 41.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.27 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.3 t -126.33 133.63 68.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.145 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -120.85 148.53 43.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 77.5 mt -119.77 115.71 48.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.232 169.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 54.23 41.0 32.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.187 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.18 -16.0 61.96 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 171.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -97.88 136.18 38.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.352 . . . . 0.0 111.207 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.5 tp -68.49 120.0 13.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.099 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -98.37 -40.06 8.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -166.36 157.41 12.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.268 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -139.96 151.18 45.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.181 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 30.0 m-90 -136.82 142.05 42.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.178 170.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.7 m -102.82 125.03 49.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.24 164.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.74 166.0 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.234 -172.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.8 m -122.48 143.53 49.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 171.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.9 mt -128.54 130.26 47.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -91.32 -165.09 39.61 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.49 112.35 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.723 1.616 . . . . 0.0 111.182 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 59.94 48.31 8.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.209 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -104.56 142.98 33.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.146 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -117.59 141.76 47.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.269 172.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -139.25 130.13 26.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.227 -172.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 73.7 t -105.58 118.41 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 -170.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 36.0 mt -105.73 143.6 33.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 173.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 50.7 p -122.87 152.67 40.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -153.81 156.41 37.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.189 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 502' ' ' SER . . . . . 0.406 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.7 m -121.07 133.57 55.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.234 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -133.46 131.21 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.165 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.6 m -116.58 109.74 43.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.278 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.54 153.53 34.73 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.714 1.609 . . . . 0.0 111.19 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 69.9 p -128.52 -2.3 5.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.203 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -133.95 135.31 43.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.206 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -72.24 141.79 48.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.4 175.22 25.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.2 mmm -86.03 127.17 34.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 111.188 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -119.98 137.45 54.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.311 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -106.79 119.2 38.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.205 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 83.7 mt -102.98 123.8 56.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.214 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -116.46 144.98 43.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.184 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.45 141.41 52.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.252 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 73.0 p -131.0 150.55 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.272 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.261 174.346 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.866 0.365 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -129.49 134.01 47.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.1 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 83.0 m -116.85 127.97 54.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.227 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -132.23 131.65 42.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.31 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -99.34 128.94 45.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.166 -172.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.5 t -121.27 136.79 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.175 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.2 t -106.38 123.99 48.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.187 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.3 t -103.1 128.31 56.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.138 175.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.24 165.02 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.157 176.19 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' MET . . . . . 0.722 ' HB2' ' HA ' ' A' ' 436' ' ' GLU . 99.5 mmm . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.871 0.367 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . 0.722 ' HA ' ' HB2' ' A' ' 435' ' ' MET . 88.5 tt0 -104.5 156.14 18.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.214 -25.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . 0.443 ' HA ' ' HD2' ' A' ' 438' ' ' PRO . 16.6 m-30 -110.43 105.1 56.9 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.162 -164.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.507 ' HB3' HG23 ' A' ' 468' ' ' ILE . 70.8 Cg_endo -71.07 167.56 25.74 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.712 1.608 . . . . 0.0 111.227 173.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -121.47 90.37 3.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.228 167.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 71.1 mt -83.03 138.27 33.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.193 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 531' ' ' ASN . 13.3 t -140.05 153.77 46.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.173 177.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.2 m -132.89 156.31 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.212 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 95.8 mt-10 -139.74 136.68 34.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.27 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 94.5 mt -107.43 127.49 63.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.97 147.88 48.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.175 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.47 -167.85 34.65 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.51 142.19 58.33 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.689 1.593 . . . . 0.0 111.099 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -89.35 -38.26 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.235 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.2 t -120.42 130.08 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.207 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.41 151.73 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.204 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.47 159.98 43.23 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 540' ' ' VAL . 3.0 p -76.3 141.58 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.206 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 62.54 28.17 16.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.181 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -123.29 144.63 49.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.25 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 502' ' ' SER . 37.2 tp -87.34 128.49 35.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.182 -173.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.97 145.01 48.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.163 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -103.39 135.26 45.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -129.83 157.18 42.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.478 ' HG2' HG23 ' A' ' 500' ' ' THR . 93.6 mt-10 -130.47 141.07 50.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.185 -175.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 53.1 t -112.35 121.2 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.14 173.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.46 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.5 m-70 -103.16 107.85 18.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.158 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.447 HG11 HG22 ' A' ' 475' ' ' VAL . 2.5 m -118.85 130.52 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.217 -173.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -143.04 155.08 44.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 8.3 t-20 -98.44 138.65 35.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.201 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 80.7 mt -134.44 38.26 3.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.204 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -138.3 8.82 3.5 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 63.11 18.6 60.52 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.581 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 14.9 tt -136.13 139.56 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.713 0.292 . . . . 0.0 111.225 171.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -87.26 141.44 17.51 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -174.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.5 119.35 36.16 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 111.254 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.84 -19.53 9.67 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.716 1.611 . . . . 0.0 111.22 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.7 p -92.95 12.74 22.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.254 -168.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 84.8 m -75.95 109.86 9.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.221 -161.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.89 127.61 54.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.145 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.447 HG22 HG11 ' A' ' 462' ' ' VAL . 64.9 t -115.69 126.2 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.109 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -127.14 152.65 47.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.263 -172.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 80.6 t -129.12 131.87 67.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -119.79 145.93 46.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.157 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.433 HG12 HG12 ' A' ' 513' ' ' ILE . 77.0 mt -118.32 114.89 46.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 53.57 40.77 31.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.222 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.8 -19.07 55.74 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 171.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.0 m -97.65 137.4 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.741 0.305 . . . . 0.0 111.174 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.3 tp -68.78 121.81 17.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.171 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -96.78 -40.27 9.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . 0.409 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 48.7 tptt -164.75 158.22 17.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.205 -173.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -143.27 153.28 42.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.233 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . 0.409 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 27.4 m-90 -137.98 142.42 40.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 172.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.8 m -107.54 123.04 47.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 168.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.81 167.8 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 70.5 m -118.5 142.28 47.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 97.1 mt -126.79 130.31 50.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.182 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -86.84 -179.97 48.88 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.78 119.7 6.9 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.706 1.604 . . . . 0.0 111.183 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.3 mttt 55.54 35.61 25.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -101.04 144.41 30.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.229 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -122.36 140.5 52.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.228 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -127.67 147.58 50.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.201 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.4 119.23 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 54.5 mt -102.7 142.89 33.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.189 173.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' THR . . . . . 0.478 HG23 ' HG2' ' A' ' 459' ' ' GLU . 46.5 p -122.49 153.04 39.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -153.84 156.02 36.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 167.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.412 ' HB3' HD11 ' A' ' 455' ' ' LEU . 68.0 m -122.29 128.1 50.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.256 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -131.38 131.59 43.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.167 -169.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.6 m -114.08 105.43 54.25 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.212 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.81 118.9 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.732 1.621 . . . . 0.0 111.195 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 70.9 p -94.87 -12.41 26.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.249 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -117.35 138.06 52.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.272 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.442 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 35.7 tt0 -76.12 140.89 42.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.04 174.97 24.77 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.6 mmm -86.2 129.61 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 111.209 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -120.01 134.02 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.17 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -106.24 118.63 37.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.244 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.433 HG12 HG12 ' A' ' 479' ' ' ILE . 82.2 mt -105.35 123.23 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.244 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -118.5 145.43 45.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.08 140.04 52.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 172.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 66.6 p -131.9 153.2 50.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.25 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.1 p -123.38 141.98 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.203 170.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.7 t0 55.15 49.64 16.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.228 -173.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -56.87 -38.87 73.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.25 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.33 -5.19 46.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.154 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.1 t30 59.9 58.42 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.178 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 69.6 p -94.35 -20.87 19.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.277 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 96.4 t -121.24 133.83 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.167 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 84.5 t -89.16 122.71 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.227 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -102.64 170.5 7.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.266 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.63 -27.9 61.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.129 171.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -132.6 145.65 51.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.214 172.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -111.95 -20.78 11.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.195 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -93.85 -2.13 53.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.167 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -102.07 20.68 16.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.141 -174.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 441' ' ' THR . 50.4 p30 -132.81 25.36 4.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 90.8 t -129.53 143.06 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.182 173.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.4 131.8 50.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.7 m -117.15 126.37 52.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.23 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -132.62 129.96 39.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -100.22 129.02 46.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 90.7 t -120.97 135.64 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.25 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.7 t -106.86 123.13 47.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.225 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 94.4 t -102.98 127.09 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.236 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 452' ' ' VAL . 36.0 m -123.07 159.83 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.193 -177.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . 0.442 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 94.5 mt -82.57 11.11 6.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.208 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 C--O 1.199 -1.579 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 -176.092 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' MET . . . . . 0.748 ' HB2' ' HA ' ' A' ' 436' ' ' GLU . 48.0 mtp . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.777 0.322 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . 0.748 ' HA ' ' HB2' ' A' ' 435' ' ' MET . 16.7 pt-20 -109.12 -158.44 0.65 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.189 14.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -105.03 105.82 53.07 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.189 -158.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.422 ' HG3' HG22 ' A' ' 470' ' ' VAL . 68.3 Cg_endo -74.19 166.49 29.43 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.694 1.596 . . . . 0.0 111.236 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 62.2 t0 -124.0 76.11 1.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 172.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.45 131.04 35.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.242 -174.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.9 t -138.43 154.87 48.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.215 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 32.8 m -131.79 155.19 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 95.1 mt-10 -139.72 136.26 34.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.2 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.2 mt -106.28 127.14 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.178 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.02 147.88 48.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.235 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.04 -169.28 34.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.81 139.51 48.03 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.713 1.609 . . . . 0.0 111.196 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -87.55 -36.11 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 79.2 t -120.6 130.29 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.34 152.84 38.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.192 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.97 159.28 35.79 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.1 p -74.15 138.17 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.824 0.345 . . . . 0.0 111.145 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 62.49 24.31 14.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -115.32 151.92 33.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.404 HD11 ' HB3' ' A' ' 502' ' ' SER . 43.3 tp -88.89 128.4 35.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.23 -175.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.48 147.02 46.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.289 173.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.24 138.21 52.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.218 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -129.09 157.74 40.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 -178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -128.59 139.99 52.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.193 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.73 121.02 64.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.168 173.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.9 m-70 -102.6 108.0 19.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.467 HG11 HG22 ' A' ' 475' ' ' VAL . 2.1 m -118.63 130.44 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.25 -173.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.414 ' HD3' HD22 ' A' ' 465' ' ' LEU . 19.1 ptpt -143.65 154.05 43.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.222 -172.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 41.7 t-20 -107.0 142.22 36.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 171.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.414 HD22 ' HD3' ' A' ' 463' ' ' LYS . 55.3 mt -132.11 3.73 4.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.185 -170.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.59 1.25 71.78 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.79 17.67 76.92 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.526 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.7 tt -127.14 150.18 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 111.236 171.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -95.5 132.15 10.97 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.422 HG22 ' HG3' ' A' ' 438' ' ' PRO . 87.1 t -116.67 118.03 37.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.85 0.357 . . . . 0.0 111.176 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.06 -19.14 8.38 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 121.724 1.616 . . . . 0.0 111.194 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 95.4 p -93.92 13.56 22.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -165.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 94.1 m -77.44 112.82 14.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -161.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.61 126.56 55.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.187 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.467 HG22 HG11 ' A' ' 462' ' ' VAL . 59.9 t -118.57 127.42 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.189 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -134.89 156.58 48.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.199 -173.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.03 136.88 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -170.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -116.93 147.89 41.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.185 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.417 HG12 HG12 ' A' ' 513' ' ' ILE . 82.2 mt -119.7 116.09 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.221 167.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.28 41.35 32.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.249 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.65 -11.47 68.39 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.9 m -98.63 136.09 39.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.875 0.369 . . . . 0.0 111.18 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.35 120.58 15.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.21 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -98.2 -40.27 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.166 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -168.46 158.52 9.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 -173.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -143.74 153.89 42.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -136.95 143.04 42.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.209 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.6 m -106.38 125.16 50.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.214 169.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.42 168.47 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.201 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.7 m -120.02 142.22 49.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.18 172.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.0 mt -128.38 130.79 48.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.255 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -90.64 -171.06 43.63 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.83 113.3 1.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.602 1.535 . . . . 0.0 111.201 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 65.4 35.3 7.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.196 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -101.72 143.2 31.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.182 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.87 141.3 52.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.207 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -127.1 146.17 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 94.3 t -112.35 119.69 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.176 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 38.8 mt -102.88 142.17 34.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.223 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 66.2 p -122.25 152.52 39.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.199 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -155.21 157.2 36.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.263 169.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.404 ' HB3' HD11 ' A' ' 455' ' ' LEU . 73.6 m -120.26 128.67 53.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.183 -175.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -130.51 129.87 43.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.236 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.1 m -117.26 109.35 42.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.258 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.74 155.04 44.23 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.715 1.61 . . . . 0.0 111.221 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 73.3 p -125.48 -10.16 6.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.168 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -129.96 136.07 49.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.257 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -71.17 142.88 50.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.198 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.98 174.6 25.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -84.19 125.96 32.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -119.58 132.12 55.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.211 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -104.97 118.69 37.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.215 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.417 HG12 HG12 ' A' ' 479' ' ' ILE . 86.8 mt -104.47 124.25 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.187 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -118.33 144.16 46.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.65 139.24 54.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 172.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 64.0 p -130.91 150.1 52.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.242 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.1 p -124.72 140.54 47.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.292 168.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 24.5 t0 47.84 47.18 18.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.213 -172.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -57.38 -36.44 71.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.22 173.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -74.16 -5.8 43.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.23 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 63.91 46.26 3.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.182 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 43.5 p -88.83 -16.76 31.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.155 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.427 HG13 ' HE2' ' A' ' 435' ' ' MET . 85.0 t -121.66 132.1 71.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . 0.434 ' HB ' ' SD ' ' A' ' 435' ' ' MET . 67.9 t -90.79 121.2 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.214 174.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -102.91 176.39 5.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.239 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.92 -25.89 63.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.195 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -152.8 148.12 26.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.165 168.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -108.95 -11.4 14.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.198 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -94.69 -9.99 33.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.256 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -103.98 36.6 2.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.177 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -142.47 24.69 1.9 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.266 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 89.2 t -129.31 143.18 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.255 172.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.16 133.5 48.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.169 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 96.9 m -116.62 126.7 53.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -131.72 131.66 43.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.186 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -103.15 129.27 49.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.228 -173.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 92.8 t -121.29 137.3 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.3 t -108.01 125.15 51.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 96.0 t -103.27 129.37 55.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.183 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.76 164.1 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 93.8 mt -87.35 45.79 1.31 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--O 1.201 -1.48 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.284 174.042 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' MET . . . . . 0.4 ' SD ' HG21 ' A' ' 523' ' ' VAL . 22.5 mmt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.878 0.37 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -80.03 145.07 32.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.221 131.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . 0.403 ' HA ' ' HD2' ' A' ' 438' ' ' PRO . 92.0 m-85 -105.88 110.31 63.98 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.198 -146.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 525' ' ' GLU . 72.4 Cg_endo -70.32 168.14 23.15 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.651 1.567 . . . . 0.0 111.238 173.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -124.31 81.88 1.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.263 170.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.01 137.84 35.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.208 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 530' ' ' ASN . 7.7 t -144.53 154.6 43.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.203 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.59 155.34 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.299 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 97.0 mt-10 -139.95 137.9 35.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.24 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.4 mt -107.6 128.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -135.87 147.52 48.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.153 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.28 -171.18 35.73 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.79 128.78 18.5 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.756 1.637 . . . . 0.0 111.165 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -71.25 -40.32 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.184 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 67.9 t -121.61 131.65 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.181 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 30.0 m -129.88 152.34 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.259 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.26 159.75 43.42 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 176.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 540' ' ' VAL . 1.2 p -79.99 148.02 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.721 0.296 . . . . 0.0 111.215 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 20.8 m120 63.39 26.86 15.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -129.09 144.49 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.231 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' A' ' 502' ' ' SER . 30.8 tp -85.35 126.23 33.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.238 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -124.72 144.13 50.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -110.39 136.88 48.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -174.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -129.58 157.29 42.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -129.33 139.21 51.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.143 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.4 t -112.76 120.71 63.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.21 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.1 m-70 -103.35 107.29 18.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.229 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 475' ' ' VAL . 2.4 m -118.95 129.18 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.169 -172.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 46.4 pttt -143.41 155.0 44.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.246 -171.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 34.0 t30 -104.37 140.42 37.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.243 170.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 70.4 mt -128.47 6.52 5.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -95.64 -12.25 53.83 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 75.08 23.59 73.95 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.501 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 8.3 tt -128.96 139.77 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 0.0 111.219 165.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.58 134.33 13.96 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -173.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.38 116.23 39.48 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 111.28 172.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.46 -19.07 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.692 1.595 . . . . 0.0 111.18 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.7 p -95.05 13.43 25.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.205 -164.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 88.3 m -78.22 110.8 13.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 -163.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -111.27 127.39 55.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.46 HG22 HG11 ' A' ' 462' ' ' VAL . 68.8 t -115.09 126.93 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.282 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -127.89 153.44 46.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.139 -173.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 79.1 t -130.06 133.86 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -119.03 148.07 43.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.248 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.445 HG12 HG12 ' A' ' 513' ' ' ILE . 84.6 mt -118.73 115.55 48.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.253 169.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 53.74 41.17 32.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.267 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.97 -10.43 70.6 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.4 m -97.45 136.51 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 111.135 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.9 tp -69.05 120.79 15.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.147 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -98.26 -40.63 8.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.256 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -167.98 161.1 12.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.198 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -141.83 152.56 43.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -137.37 142.36 41.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.268 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.0 m -108.74 124.56 50.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.195 168.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.56 168.19 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.191 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 49.2 m -120.9 143.09 49.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.171 172.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.2 129.13 47.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.161 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.24 -173.86 48.64 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.6 112.4 1.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.701 1.601 . . . . 0.0 111.146 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.0 mttt 65.95 36.06 6.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.196 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -101.6 144.0 30.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.38 140.41 52.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -129.39 145.75 51.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 89.4 t -112.72 118.99 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.195 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 50.3 mt -103.41 142.71 33.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.212 173.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 63.3 p -124.51 153.3 42.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.257 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.93 156.73 38.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.255 168.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.493 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.8 m -120.46 128.66 53.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 -175.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -129.67 129.57 44.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.232 -170.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 95.3 m -115.9 109.7 44.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.16 141.43 29.32 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.724 1.616 . . . . 0.0 111.148 174.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 81.5 p -111.91 -21.58 11.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.216 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -120.14 139.58 52.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.249 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.404 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 32.5 tt0 -73.2 140.22 46.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.276 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.04 175.3 24.33 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.4 mmm -86.4 129.01 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 111.195 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -120.73 131.37 54.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.282 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.01 119.43 38.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.156 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.445 HG12 HG12 ' A' ' 479' ' ' ILE . 90.2 mt -101.71 122.24 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.161 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -120.67 145.97 46.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.161 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.25 142.06 51.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.5 p -131.04 149.76 52.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.245 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 13.8 p -125.45 149.29 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 168.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 22.6 t70 57.7 40.35 26.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 -171.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -58.85 -39.09 80.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.229 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -80.0 -2.95 46.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.201 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.2 t30 61.75 61.99 1.34 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.248 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 73.7 p -97.25 -30.32 13.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.24 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.4 HG21 ' SD ' ' A' ' 435' ' ' MET . 10.3 p -127.55 135.15 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.181 176.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 97.8 t -90.26 123.65 42.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.236 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 438' ' ' PRO . 12.8 pt-20 -119.85 170.09 9.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.211 -170.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.24 -28.84 60.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.168 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 54.9 t-20 -126.39 112.78 16.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 -168.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -105.49 2.12 28.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.217 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -91.6 -30.5 16.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.18 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.435 ' HB3' ' OG1' ' A' ' 441' ' ' THR . 99.8 m-20 -97.28 -12.79 22.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.174 -175.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -83.04 9.11 10.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.22 -174.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 93.4 t -131.66 141.99 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 165.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.12 133.17 46.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 83.7 m -114.48 124.05 50.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -133.13 131.07 40.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.172 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -104.07 130.31 51.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.169 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.51 136.94 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.157 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.1 t -104.84 124.95 50.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.268 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 95.8 t -101.89 127.32 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.189 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 452' ' ' VAL . 34.7 m -120.85 160.31 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . 0.404 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 92.7 mt -80.96 -0.02 37.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--O 1.201 -1.494 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.218 -177.638 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 99.3 mmm . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.816 0.341 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -109.61 133.92 52.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.284 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -123.53 118.6 27.42 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.203 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.9 165.02 33.95 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.674 1.582 . . . . 0.0 111.224 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -129.45 99.27 5.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.228 170.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.4 145.32 25.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.288 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.5 t -149.33 156.77 42.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.17 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.63 153.53 39.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.175 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 47.7 mt-10 -138.2 137.89 38.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.213 177.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 83.4 mt -107.52 126.12 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.181 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -136.96 148.93 47.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.184 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.61 -166.85 33.45 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -55.22 136.62 74.19 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.693 1.595 . . . . 0.0 111.239 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -87.68 -40.1 14.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.223 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.55 130.11 74.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.78 153.83 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.195 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.59 157.87 34.9 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.8 p -70.5 141.67 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.213 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 63.57 29.75 15.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.245 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -124.18 142.42 51.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.163 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 44.2 tp -82.36 126.24 31.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.308 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.27 144.28 49.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.248 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -101.16 134.31 44.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.163 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -128.39 157.19 41.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.242 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.4 ' HG2' HG23 ' A' ' 500' ' ' THR . 87.3 mt-10 -129.91 138.47 50.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.224 -175.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.46 119.9 59.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 95.9 m-70 -98.88 112.92 24.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.179 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.66 131.42 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.215 -174.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -123.04 152.68 40.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.265 -172.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 12.9 t-20 -106.71 129.89 54.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 152.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 75.8 mt -120.12 22.12 11.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.212 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 468' ' ' ILE . . . -112.89 136.7 13.67 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 466' ' ' GLY . . . -9.12 -46.55 0.0 OUTLIER Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 155.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 466' ' ' GLY . 12.6 tt -123.16 142.29 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.744 0.306 . . . . 0.0 111.261 -163.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -89.06 162.5 31.14 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 84.4 t -124.5 119.06 26.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.199 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.52 -19.22 7.74 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.69 1.593 . . . . 0.0 111.158 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 96.5 p -94.83 14.6 20.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -166.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.1 m -76.46 110.85 11.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 -158.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.42 125.99 53.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.186 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 96.3 t -117.29 129.95 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.117 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -125.36 152.58 44.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.168 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 51.8 t -126.89 134.58 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -121.08 148.11 44.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.134 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.33 115.56 47.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.183 171.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 54.35 41.25 32.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.36 -14.87 64.46 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 171.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.2 m -98.96 137.19 37.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.75 0.31 . . . . 0.0 111.254 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.3 tp -68.38 119.36 12.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -100.06 -40.61 7.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.23 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -153.85 160.59 42.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -142.98 149.75 38.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.293 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -137.64 142.13 41.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.1 m -109.45 123.55 49.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.24 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.41 168.08 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.252 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.9 m -116.31 141.48 48.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.166 171.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 83.5 mt -126.88 128.63 46.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -76.97 177.3 52.39 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 172.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . 0.415 ' HB3' ' O ' ' A' ' 467' ' ' GLY . 55.1 Cg_endo -65.75 117.55 4.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.739 1.626 . . . . 0.0 111.202 176.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 93.2 mttt 66.91 36.78 4.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.194 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -112.11 144.03 42.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.235 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -119.34 142.8 47.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.199 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -129.56 150.16 51.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 88.2 t -113.25 120.0 62.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 42.8 mt -103.12 144.45 31.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.246 172.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 459' ' ' GLU . 41.0 p -122.55 154.7 37.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.183 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.71 156.66 38.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.183 168.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.4 m -120.44 136.97 54.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.17 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -140.61 129.08 22.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.243 -167.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.4 m -119.55 111.9 35.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.23 152.89 40.24 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.663 1.575 . . . . 0.0 111.219 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 72.9 p -124.45 -12.44 7.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -123.03 141.21 52.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.202 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 508' ' ' GLU . 4.6 pt-20 -86.88 142.14 28.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.171 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.54 178.28 27.03 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -170.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.3 mmm -84.8 128.25 34.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.204 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -117.61 133.95 55.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 175.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -107.7 118.63 37.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 80.7 mt -105.03 124.98 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.271 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -117.78 147.08 43.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.275 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.93 139.11 53.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 66.0 p -131.92 153.96 49.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.0 p -125.75 141.62 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.26 171.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 32.0 t0 54.86 49.03 18.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.143 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -57.38 -38.87 74.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.415 ' HG2' HG21 ' A' ' 522' ' ' THR . 19.7 pm0 -75.73 -8.72 57.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.174 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.4 t30 63.37 64.0 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.21 171.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' THR . . . . . 0.415 HG21 ' HG2' ' A' ' 520' ' ' GLU . 69.0 p -96.69 -19.43 18.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.157 174.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 98.5 t -117.23 132.86 65.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.163 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 86.0 t -90.13 122.58 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -105.38 169.28 8.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.186 -170.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 98.4 mt -73.4 -28.36 61.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.194 167.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -136.22 127.87 28.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.187 173.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -109.03 -14.35 14.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.224 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -95.84 -10.02 30.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.267 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -103.41 26.28 8.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.141 -174.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -129.26 25.17 5.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.23 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 97.7 t -127.54 141.61 45.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.26 131.9 51.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.281 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.6 m -117.49 127.27 53.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.256 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -130.46 131.61 45.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.172 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -100.85 126.15 47.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.202 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.77 136.38 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.212 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -108.56 124.68 50.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 91.7 t -104.29 129.4 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.248 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.81 172.79 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.237 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 87.9 mt -95.43 39.28 1.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 . . . . . 0 C--O 1.2 -1.539 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.181 -175.437 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 94.2 mtp . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.816 0.341 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -112.86 147.07 37.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.198 148.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . 0.425 ' HA ' ' HD2' ' A' ' 438' ' ' PRO . 74.3 m-85 -116.13 102.66 53.71 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.16 -158.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.534 ' HG3' HG22 ' A' ' 470' ' ' VAL . 64.6 Cg_endo -70.45 173.63 11.31 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.679 1.586 . . . . 0.0 111.208 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -123.47 75.1 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.212 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 48.9 mt -81.47 126.01 31.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 15.4 t -143.22 157.38 44.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.55 154.89 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.25 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 50.4 mt-10 -137.46 136.84 38.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 81.5 mt -102.53 134.63 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.207 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -135.49 143.15 45.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 144.0 -176.34 23.35 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.44 165.92 26.7 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.644 1.562 . . . . 0.0 111.162 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 58.5 p-10 -123.86 10.4 8.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.19 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.56 116.48 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.122 167.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.3 154.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.223 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.64 160.44 28.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.3 p -72.91 135.42 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.744 0.307 . . . . 0.0 111.237 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 62.08 20.43 11.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.212 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -109.76 130.46 55.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.229 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.429 HD11 ' HB2' ' A' ' 502' ' ' SER . 32.0 tp -76.23 128.6 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.193 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.63 142.07 51.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.21 173.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -111.2 139.0 46.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.195 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -130.86 159.08 38.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.41 ' HG2' HG23 ' A' ' 500' ' ' THR . 91.2 mt-10 -129.6 140.14 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 60.7 t -114.33 120.51 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.202 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 85.1 m-70 -99.32 115.8 30.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.237 176.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 496' ' ' GLU . 2.8 m -118.74 131.84 70.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.205 -174.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -128.33 156.3 43.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 62.3 t-20 -118.7 116.18 26.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.219 159.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 57.4 mt -109.6 13.19 23.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.205 -170.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.57 -3.17 69.2 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.9 19.72 78.39 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.515 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 6.4 tt -130.77 148.0 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.731 0.301 . . . . 0.0 111.166 174.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -85.96 131.12 10.3 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.534 HG22 ' HG3' ' A' ' 438' ' ' PRO . 92.0 t -117.95 116.42 36.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.234 170.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.68 -19.64 6.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.753 1.635 . . . . 0.0 111.161 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 78.5 p -98.56 0.13 44.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.134 -158.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 473' ' ' THR . 13.1 t -85.53 124.71 32.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.21 -162.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -111.68 128.65 56.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.227 -172.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.13 125.89 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.231 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -130.33 155.05 46.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.256 -170.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.85 133.23 66.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.262 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -119.91 147.5 44.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.275 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.1 mt -120.59 118.51 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.253 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 54.64 41.01 32.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.195 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.34 -20.09 45.98 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 171.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.3 m -98.31 139.44 34.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.821 0.343 . . . . 0.0 111.189 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.6 tp -68.21 121.15 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.152 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . 0.425 ' OH ' ' O ' ' A' ' 502' ' ' SER . 29.9 t80 -96.48 -39.3 9.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.234 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -163.34 158.69 21.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.187 -173.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -140.19 149.97 43.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -175.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -138.68 141.91 38.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.156 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.8 m -104.79 127.42 52.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.0 m -138.1 166.34 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 53.5 m -121.73 142.25 50.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.194 170.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.5 mt -128.85 131.19 47.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.92 -178.03 46.26 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.82 117.76 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.773 1.649 . . . . 0.0 111.21 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.1 mttt 55.56 39.79 31.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.216 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -100.47 145.23 28.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.139 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 462' ' ' VAL . 85.3 tt0 -120.85 140.72 51.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.186 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -127.58 145.7 50.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 173.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.92 119.58 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.4 mt -104.89 142.09 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.147 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 459' ' ' GLU . 44.4 p -122.58 150.86 42.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.192 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.85 156.57 36.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 171.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.429 ' HB2' HD11 ' A' ' 455' ' ' LEU . 95.6 p -122.93 133.72 54.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -140.79 129.71 23.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.2 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.0 m -116.51 112.34 41.28 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.214 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -71.47 153.33 60.73 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.748 1.632 . . . . 0.0 111.176 172.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 65.0 p -122.81 -5.21 8.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.061 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -133.47 137.19 45.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.152 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.09 141.43 52.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.288 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.24 176.91 26.25 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.3 mmm -84.85 128.05 34.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 111.173 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -120.25 132.83 55.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.17 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -104.23 119.58 39.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 94.2 mt -103.68 124.46 57.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.187 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -119.67 146.17 45.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.09 143.74 50.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.205 172.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 77.4 p -130.73 150.04 52.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.202 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . 0.716 ' O ' ' CB ' ' A' ' 518' ' ' ASP . 7.2 p -125.16 120.64 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 167.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . 0.716 ' CB ' ' O ' ' A' ' 517' ' ' VAL . 30.5 t70 105.59 25.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.264 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -58.39 -39.4 79.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.261 -158.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -79.04 2.08 21.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.085 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.4 t30 66.37 66.02 0.48 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.182 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 58.4 p -97.26 -34.1 11.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 -172.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 10.3 p -138.46 140.28 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.199 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 85.2 t -90.16 125.21 43.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.196 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.452 ' HG3' ' HG2' ' A' ' 438' ' ' PRO . 54.1 mp0 -103.95 176.47 5.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.269 -170.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 93.3 mt -71.07 -29.99 66.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.158 176.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -125.9 148.22 49.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.212 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -110.74 -5.77 14.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.265 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -93.64 -22.0 19.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.16 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -98.41 13.76 30.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.156 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -82.66 -2.76 54.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 58.7 t -128.22 142.0 44.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.237 -171.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.03 134.72 47.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 173.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.9 m -116.74 126.47 53.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.262 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -134.27 123.28 23.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.187 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -102.46 128.11 49.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.163 -172.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 90.6 t -122.79 137.19 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.26 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 71.4 m -98.95 124.9 44.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 86.4 t -102.85 129.37 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.199 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.96 165.84 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.152 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.0 -2.01 46.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.269 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 C--O 1.199 -1.562 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.241 -176.712 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 99.5 mtp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.775 0.322 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -105.21 136.02 45.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.261 135.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . 0.452 ' HB3' ' HG ' ' A' ' 526' ' ' LEU . 9.6 m-30 -107.29 117.22 56.65 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.181 -160.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 525' ' ' GLU . 30.3 Cg_exo -57.08 168.91 2.26 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 121.794 1.663 . . . . 0.0 111.141 171.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 12.1 t0 -129.98 71.97 1.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.208 166.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.404 ' HB2' ' OE1' ' A' ' 525' ' ' GLU . 85.2 mt -78.81 139.51 38.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.214 -173.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 12.3 t -146.15 157.7 43.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.208 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.5 155.69 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.187 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.4 mt-10 -139.86 136.05 33.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.236 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 95.3 mt -108.82 126.52 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.154 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.71 148.5 47.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.272 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.69 -168.65 34.39 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.82 116.16 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.642 1.562 . . . . 0.0 111.241 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -75.47 -18.22 59.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.205 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 96.7 t -125.96 129.32 72.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.169 169.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.07 154.05 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.188 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.55 149.86 32.39 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.419 HG11 HD21 ' A' ' 541' ' ' LEU . 5.9 p -71.05 136.54 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 111.187 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 61.85 27.36 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.216 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -123.59 148.21 46.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 502' ' ' SER . 29.4 tp -85.58 128.07 34.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -172.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.79 145.85 48.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.195 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -109.09 133.97 52.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.188 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -127.91 157.2 41.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.429 ' HG2' HG23 ' A' ' 500' ' ' THR . 96.8 mt-10 -130.5 141.1 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.179 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 49.7 t -112.88 120.08 62.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.207 170.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.6 m-70 -101.8 111.3 23.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.15 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.444 HG11 HG22 ' A' ' 475' ' ' VAL . 8.9 m -116.05 132.05 66.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.281 -170.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -127.21 155.13 43.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.217 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 61.2 t-20 -116.75 120.84 39.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.206 159.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 63.0 mt -115.0 8.19 15.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -168.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.03 -0.24 74.76 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.68 20.05 75.42 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.525 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.0 tt -131.03 145.68 35.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.786 0.327 . . . . 0.0 111.185 173.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -84.85 134.54 12.73 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.81 116.49 31.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.252 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.66 -18.49 9.27 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.675 1.583 . . . . 0.0 111.14 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.4 p -92.01 10.65 28.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.225 -165.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 99.0 m -80.27 112.91 18.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.142 -162.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -110.48 127.52 55.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.213 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.444 HG22 HG11 ' A' ' 462' ' ' VAL . 93.8 t -115.83 127.1 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -127.09 155.2 43.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.169 -172.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 69.2 t -128.67 132.96 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.279 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -120.17 147.03 45.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.225 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.419 HG12 HG12 ' A' ' 513' ' ' ILE . 83.6 mt -118.72 117.05 53.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.246 172.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 54.08 41.02 32.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.242 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.23 -10.44 66.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.5 m -97.51 138.45 34.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 111.222 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.6 tp -69.8 120.81 16.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.187 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -98.93 -40.69 7.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.262 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -166.57 159.03 13.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 -173.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -140.95 151.82 44.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.212 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 25.9 m-90 -138.16 141.9 40.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.23 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.6 m -109.65 126.02 53.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.252 168.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.04 167.83 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.199 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 30.4 t -118.79 140.93 49.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 170.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 83.9 mt -128.99 126.01 38.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.163 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.78 -173.39 48.32 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.23 111.7 1.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.772 1.648 . . . . 0.0 111.241 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.0 mttt 58.65 41.45 22.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -101.32 143.96 30.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.221 173.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -121.08 139.95 52.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.158 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -128.45 147.85 50.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.248 175.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 96.9 t -112.2 118.95 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.169 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 48.3 mt -102.24 142.19 33.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.222 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 459' ' ' GLU . 36.1 p -122.85 151.92 41.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.248 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -154.41 156.38 36.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.167 166.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.46 ' HB3' HD11 ' A' ' 455' ' ' LEU . 69.9 m -119.73 128.63 53.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.191 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -125.74 129.27 49.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 -171.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.409 ' HA ' ' HD2' ' A' ' 505' ' ' PRO . 96.2 m -117.8 108.76 42.3 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 172.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 504' ' ' THR . 71.7 Cg_endo -71.85 157.65 54.61 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.741 1.627 . . . . 0.0 111.25 174.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 75.5 p -124.9 -21.95 4.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.206 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.97 138.77 52.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -73.74 139.71 45.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.5 174.76 24.11 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.5 mmm -85.59 128.46 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.844 0.354 . . . . 0.0 111.142 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -120.77 130.31 53.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -103.27 119.81 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.19 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.419 HG12 HG12 ' A' ' 479' ' ' ILE . 80.8 mt -102.11 120.22 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.271 176.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -122.35 146.41 47.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.226 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.15 140.25 53.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.9 p -131.79 152.78 50.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.249 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.66 146.47 31.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 24.8 t70 59.06 39.89 22.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.176 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -58.16 -39.88 79.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.222 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -79.36 -2.71 42.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.197 -175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.4 t30 61.14 60.72 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.199 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 72.2 p -89.75 -29.77 18.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.254 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.8 p -132.54 136.76 55.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.221 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . 0.444 ' O ' ' CD1' ' A' ' 437' ' ' PHE . 95.2 t -90.07 125.19 42.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.191 176.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 438' ' ' PRO . 22.8 pt-20 -130.65 171.03 13.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 -166.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.452 ' HG ' ' HB3' ' A' ' 437' ' ' PHE . 54.7 mt -73.87 -27.73 61.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.192 174.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -110.08 67.23 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.168 -171.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -97.39 -8.52 29.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.209 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -104.4 -29.93 10.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.211 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -105.15 34.95 2.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.2 -174.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -124.61 23.14 8.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.247 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 93.3 t -129.46 144.93 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.58 133.56 49.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.195 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.1 m -115.43 124.2 50.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.266 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -128.31 128.51 44.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -101.1 126.94 47.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.243 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.5 t -121.43 136.18 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.8 t -101.41 127.5 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.9 t -99.78 126.69 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.42 150.72 24.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.183 -173.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . 0.419 HD21 HG11 ' A' ' 452' ' ' VAL . 86.0 mt -78.97 51.95 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.193 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 . . . . . 0 C--O 1.199 -1.586 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 -177.313 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.795 0.331 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -115.44 131.11 57.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.17 -173.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . 0.406 ' N ' HD11 ' A' ' 468' ' ' ILE . 39.1 m-85 -126.48 104.53 24.6 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.181 172.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 437' ' ' PHE . 37.5 Cg_endo -67.44 168.52 17.78 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.604 1.536 . . . . 0.0 111.21 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -129.7 81.06 1.99 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.182 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 8.9 mt -89.42 130.66 35.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 -175.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.0 t -146.16 163.1 36.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.228 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.09 154.58 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 93.9 mt-10 -135.63 137.94 42.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.208 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 89.3 mt -104.35 132.0 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.67 142.98 45.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.222 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.45 32.79 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.19 141.26 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.743 1.629 . . . . 0.0 111.232 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -97.26 -18.81 18.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.228 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 87.9 t -126.12 125.94 68.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.259 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.57 154.27 39.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.195 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.27 158.1 43.49 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 1.8 p -79.15 142.57 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.799 0.333 . . . . 0.0 111.232 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 63.11 29.41 16.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.22 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -125.93 145.11 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.432 HD11 ' HB3' ' A' ' 502' ' ' SER . 33.0 tp -78.53 126.79 31.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.08 143.42 49.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -109.88 135.53 50.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.298 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -129.66 157.87 40.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.216 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.4 ' HG2' HG23 ' A' ' 500' ' ' THR . 80.2 mt-10 -130.09 139.57 50.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.268 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 45.0 t -113.22 120.24 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.175 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 94.2 m-70 -99.59 114.29 27.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 462' ' ' VAL . 2.9 m -117.21 127.0 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.153 -173.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.439 ' HD2' HD22 ' A' ' 465' ' ' LEU . 25.1 pttt -138.18 151.94 48.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 -171.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 52.9 t-20 -111.2 127.59 55.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.276 167.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.439 HD22 ' HD2' ' A' ' 463' ' ' LYS . 68.9 mt -115.61 7.5 14.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.28 -169.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -93.98 -5.2 62.72 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -169.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.02 23.15 76.89 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -171.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.508 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 1.3 mt -130.04 155.18 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 111.168 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . 0.487 ' N ' ' CG2' ' A' ' 468' ' ' ILE . . . -117.08 120.47 4.82 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -172.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 491' ' ' LEU . 74.9 t -119.63 118.22 32.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.185 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -84.29 -17.62 5.4 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.714 1.609 . . . . 0.0 111.152 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 79.3 p -99.0 4.17 47.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -163.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 473' ' ' THR . 3.5 t -83.67 125.34 31.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.176 -163.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.58 130.35 55.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 -170.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 76.6 t -113.11 128.29 69.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.269 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.51 154.26 45.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.2 -173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 78.0 t -127.7 132.89 68.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.201 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -120.31 147.05 45.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.3 mt -120.85 116.22 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.194 172.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 54.38 40.97 32.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.269 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 93.49 -18.79 55.68 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 171.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.4 m -100.08 138.11 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.353 . . . . 0.0 111.149 -175.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.33 121.53 15.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.248 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -93.31 -39.93 10.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.287 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -168.91 159.52 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.233 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -132.08 152.34 51.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.189 -175.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 32.8 m-90 -136.3 141.44 43.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.7 m -109.95 124.72 51.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 166.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 25.9 m -138.74 167.54 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.6 p -114.44 141.08 48.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.24 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 470' ' ' VAL . 82.4 mt -129.82 129.76 44.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.201 174.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -93.76 -173.43 39.56 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.99 111.36 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.656 1.571 . . . . 0.0 111.203 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.4 mttt 63.62 43.64 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.191 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -104.52 142.96 33.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -121.36 139.51 53.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.223 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -128.79 147.25 50.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.199 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 83.2 t -111.62 119.13 59.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -176.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 66.6 mt -104.85 143.93 32.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.179 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' THR . . . . . 0.4 HG23 ' HG2' ' A' ' 459' ' ' GLU . 61.0 p -124.77 153.65 42.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.143 175.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -154.3 157.0 37.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.208 170.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.432 ' HB3' HD11 ' A' ' 455' ' ' LEU . 60.9 m -122.27 134.77 54.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.199 -175.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -140.33 129.49 23.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.215 -168.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.0 m -118.88 112.42 36.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.182 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.74 151.55 41.02 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.769 1.646 . . . . 0.0 111.286 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 70.1 p -122.02 -15.13 7.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.177 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -120.59 139.46 52.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.233 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -75.79 140.16 42.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.211 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.67 177.13 26.84 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.7 mmm -86.36 129.42 34.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.781 0.324 . . . . 0.0 111.222 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.84 132.62 55.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.263 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -104.74 118.19 35.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 89.1 mt -105.91 122.95 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -122.41 150.23 42.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.146 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.74 141.05 52.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.259 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 59.5 p -130.82 155.08 47.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.23 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.2 p -132.16 144.43 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.16 172.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.83 16.55 6.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.241 166.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -61.15 -45.22 95.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.235 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -97.95 -23.82 15.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.178 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -77.82 68.9 3.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 80.9 p -74.88 69.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.218 -163.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 4.3 p -100.99 140.74 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 167.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 95.2 t -82.84 125.51 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.248 -162.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -100.31 173.95 6.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.184 -172.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 92.7 mt -71.98 -28.55 63.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.142 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -155.78 114.63 3.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.195 175.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -104.67 5.74 33.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.152 -170.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -93.88 -25.24 17.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -103.45 34.42 2.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.188 -173.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -120.18 24.54 10.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.219 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.42 141.65 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 171.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -124.38 131.71 53.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.176 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.5 m -116.98 126.55 53.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.195 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -131.95 130.28 41.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.258 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -101.32 129.27 47.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.239 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 93.6 t -121.14 136.4 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.207 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 40.2 t -104.96 124.75 50.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.185 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.6 t -101.7 127.04 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.173 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 31.8 m -124.71 165.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.249 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 69.4 mt -90.42 10.72 24.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.24 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 . . . . . 0 C--O 1.199 -1.581 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 -177.342 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' MET . . . . . 0.682 ' CB ' ' CA ' ' A' ' 436' ' ' GLU . 42.4 mmm . . . . . 0 CA--C 1.523 -0.08 0 CA-C-O 120.861 0.362 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . 0.682 ' CA ' ' CB ' ' A' ' 435' ' ' MET . 12.4 pt-20 -115.09 176.35 5.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.082 31.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -98.55 108.47 48.23 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.183 -147.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.496 ' HG3' HG22 ' A' ' 470' ' ' VAL . 84.7 Cg_endo -72.35 172.06 15.71 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.772 1.648 . . . . 0.0 111.263 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 62.0 t0 -122.49 73.91 1.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.278 167.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.48 137.09 36.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 8.2 t -144.19 154.33 43.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.185 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.3 m -128.46 153.65 38.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.153 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.481 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.4 mt-10 -141.01 137.82 33.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.66 127.25 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.207 174.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.13 145.2 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.117 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.5 -166.5 38.47 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.1 143.36 64.96 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.694 1.596 . . . . 0.0 111.249 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -90.35 -39.17 12.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.193 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 70.2 t -121.15 130.15 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.253 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.63 153.31 38.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.205 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -82.78 157.27 35.62 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.5 138.07 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.215 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 62.63 25.19 14.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.258 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -114.78 150.97 34.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.197 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 42.5 tp -87.41 127.21 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 -175.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.32 144.57 48.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.232 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.08 138.15 46.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.03 156.65 44.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -129.49 139.36 51.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 47.5 t -111.15 120.81 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.235 173.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.481 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 95.4 m-70 -102.42 107.72 18.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.184 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.3 m -118.48 129.95 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.166 -173.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -143.72 154.72 43.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.192 -171.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 39.7 t-20 -108.26 143.67 36.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.223 170.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.53 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 43.6 mt -133.01 3.37 3.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.204 -172.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -96.97 4.63 63.1 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -170.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.07 17.57 75.76 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 174.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.55 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 2.2 tt -125.87 149.72 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.733 0.301 . . . . 0.0 111.181 167.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -95.91 131.76 10.79 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.496 HG22 ' HG3' ' A' ' 438' ' ' PRO . 99.5 t -119.33 119.63 31.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 111.218 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.17 -19.2 6.94 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.632 1.555 . . . . 0.0 111.189 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 91.2 p -94.12 16.51 14.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.185 -164.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 94.7 m -82.36 111.71 18.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.262 -165.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -111.57 127.24 55.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 85.3 t -118.14 128.8 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.159 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -125.05 154.69 40.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 -173.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.71 134.37 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.23 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -122.04 149.17 43.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.211 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 81.6 mt -120.54 115.69 47.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.198 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.26 41.44 31.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.236 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.94 -8.66 79.2 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.0 m -97.97 135.92 38.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.788 0.328 . . . . 0.0 111.298 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 68.2 tp -68.76 118.79 12.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -99.78 -40.42 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.262 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -166.99 158.85 12.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -140.5 151.97 45.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.21 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -137.36 142.23 41.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.168 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.9 m -109.5 124.38 50.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 166.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.93 168.09 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.125 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.1 m -118.79 142.0 48.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.182 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.31 131.08 48.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.39 -175.48 48.72 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.46 113.32 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.7 1.6 . . . . 0.0 111.159 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.7 mttt 65.9 35.32 6.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.173 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -102.97 143.63 32.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.237 176.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.9 141.08 51.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.189 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -128.18 146.76 50.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.28 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.69 119.58 60.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.225 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.3 mt -101.82 143.35 31.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.136 173.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 59.5 p -122.21 151.85 40.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.184 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.72 156.21 35.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.218 167.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.2 m -123.01 133.98 54.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.179 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 45.5 t90 -140.21 130.0 24.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.195 -167.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 95.2 m -118.17 111.78 38.4 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.296 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.12 155.53 56.65 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.596 1.53 . . . . 0.0 111.247 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 76.9 p -125.25 -13.02 6.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.271 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.39 137.57 49.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.17 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.97 142.17 52.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.42 175.59 24.96 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.2 mmm -85.62 126.86 34.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 111.259 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -119.79 126.94 52.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.206 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -103.31 119.24 38.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.252 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.41 124.12 56.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.218 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -116.86 145.14 43.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.151 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.24 139.55 53.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 173.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 76.8 p -131.05 151.51 51.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.235 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.5 p -126.47 144.6 36.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 169.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 30.1 t70 65.12 41.3 4.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.236 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -59.17 -39.85 83.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -81.01 -3.82 53.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.173 -173.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 60.5 t30 63.1 59.74 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.264 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 77.3 p -90.13 -30.26 17.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.211 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.511 HG21 ' HE3' ' A' ' 435' ' ' MET . 8.1 p -137.76 133.13 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.191 174.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 91.8 t -91.12 118.17 35.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.247 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.5 167.09 10.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.181 -171.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.02 -28.57 60.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -119.04 120.81 38.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 -169.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -107.43 2.36 24.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.238 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -90.1 -28.23 19.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.286 -175.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -100.16 5.92 44.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.209 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -63.08 -26.34 68.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.216 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.22 143.28 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.178 -174.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.79 132.37 51.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 88.0 m -116.32 125.63 52.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -131.14 130.39 43.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -102.34 129.98 48.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.23 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 92.3 t -120.52 136.54 57.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.168 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.8 t -105.84 124.82 50.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.172 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.9 t -102.85 129.22 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.196 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.92 164.45 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.14 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.9 mt -89.44 11.2 19.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.248 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 . . . . . 0 C--O 1.199 -1.567 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.222 -176.222 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 28.7 ttt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.761 0.315 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . 0.414 ' HB2' HD13 ' A' ' 468' ' ' ILE . 74.6 mm-40 -104.85 172.64 6.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 157.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -113.02 106.67 54.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.164 -170.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.49 164.15 9.55 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.665 1.577 . . . . 0.0 111.254 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 49.7 t0 -130.28 58.37 1.67 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.285 166.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.08 134.67 53.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 -175.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 10.0 t -142.08 153.3 44.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.207 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.9 m -131.63 154.07 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.237 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.1 mt-10 -139.2 137.08 35.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 91.3 mt -107.16 127.4 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.244 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.93 148.76 48.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.205 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 152.5 -163.57 30.36 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.96 144.45 94.29 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.755 1.637 . . . . 0.0 111.196 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -98.55 -37.01 9.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.183 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 84.9 t -122.15 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.228 172.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.81 151.1 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.108 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -77.09 155.86 44.81 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.93 135.76 27.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.788 0.328 . . . . 0.0 111.21 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 63.02 26.57 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -114.0 154.92 26.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 40.2 tp -94.4 128.09 40.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.261 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.29 143.45 50.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.172 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -105.64 136.5 45.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.25 174.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.33 156.57 44.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.183 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.429 ' HG2' HG23 ' A' ' 500' ' ' THR . 92.9 mt-10 -130.19 140.99 50.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 -177.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 53.1 t -113.14 121.39 65.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.239 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 87.5 m-70 -96.57 111.47 23.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.241 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.503 HG11 HG22 ' A' ' 475' ' ' VAL . 2.6 m -119.91 129.18 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.272 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -145.35 155.29 43.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 36.7 t-20 -106.61 142.22 36.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.225 171.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 65.0 mt -134.08 5.06 3.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.231 -172.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -89.14 2.45 83.72 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -175.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.22 16.3 77.0 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.54 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 6.4 tt -126.45 146.06 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.25 171.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -87.11 132.56 11.24 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 173.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 80.7 t -116.17 115.5 40.44 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.841 0.353 . . . . 0.0 111.263 171.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.02 -18.25 8.94 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.591 1.528 . . . . 0.0 111.162 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.9 p -93.33 11.52 27.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.212 -166.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 86.9 m -75.76 114.38 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.161 -158.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.71 128.18 55.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.503 HG22 HG11 ' A' ' 462' ' ' VAL . 63.4 t -116.76 128.75 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.231 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -125.43 154.25 42.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.21 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 76.6 t -128.41 134.01 65.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.238 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.58 147.41 45.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.7 mt -120.7 116.81 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.204 171.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 54.41 41.48 31.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 90.73 -14.27 63.51 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.3 m -97.28 137.43 36.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 111.26 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 67.5 tp -69.52 120.69 15.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.154 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -97.61 -40.19 8.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.258 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -165.7 158.79 15.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -140.05 152.34 46.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.23 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -138.49 142.87 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.178 172.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.8 m -107.27 125.71 51.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 168.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.65 168.06 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.144 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 62.7 m -119.58 141.77 48.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.209 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 87.9 mt -129.39 130.19 45.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.202 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.03 -172.86 47.45 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.16 112.65 1.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.655 1.57 . . . . 0.0 111.212 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.5 mttt 65.7 35.34 6.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -101.91 142.55 33.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.256 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -120.74 141.47 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -127.35 146.27 50.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.264 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.7 t -111.55 119.5 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.146 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.54 143.02 32.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 459' ' ' GLU . 41.6 p -120.84 151.5 39.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.225 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -154.44 156.65 37.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 167.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 67.3 m -122.05 132.5 54.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 46.6 t90 -138.39 129.04 26.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.164 -168.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 88.3 m -116.48 110.29 42.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.192 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.99 144.6 58.68 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.638 1.559 . . . . 0.0 111.151 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 76.2 p -117.36 -14.89 10.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.24 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -118.97 137.31 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.129 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 508' ' ' GLU . 22.0 pm0 -77.04 145.47 37.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.137 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 147.18 178.16 22.26 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -85.33 129.6 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.749 0.309 . . . . 0.0 111.257 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -119.43 133.38 55.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.165 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -106.05 119.16 38.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.257 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 83.1 mt -104.28 124.1 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.252 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -117.62 145.93 44.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.55 138.8 53.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.3 p -131.6 151.03 51.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.22 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.0 p -127.73 147.52 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.2 172.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 8.7 t70 69.04 25.38 5.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.205 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -61.67 -45.01 95.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.204 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -94.02 -18.79 21.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.261 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . 0.714 ' O ' ' N ' ' A' ' 523' ' ' VAL . 70.5 m-80 -82.97 13.44 3.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.26 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' THR . . . . . 0.644 ' C ' ' O ' ' A' ' 521' ' ' ASN . 30.9 p -11.66 75.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.288 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.714 ' N ' ' O ' ' A' ' 521' ' ' ASN . 14.0 p -107.94 143.45 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.199 169.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 86.4 t -81.78 125.0 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.224 -173.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -114.06 177.17 4.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.329 -168.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.33 -26.85 62.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.202 171.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -159.27 111.17 2.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.274 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 53.1 mp0 -94.05 -1.44 54.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.218 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -86.29 -15.45 40.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.279 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -101.81 1.71 37.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.182 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -92.6 17.25 10.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.2 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 79.8 t -128.99 142.31 44.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.227 171.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.76 132.01 49.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.189 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.0 m -116.68 125.83 52.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.175 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -130.86 131.35 44.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.321 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -101.06 125.88 47.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -173.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 85.4 t -120.15 135.62 59.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -106.94 125.56 51.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.221 171.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 95.5 t -100.77 126.17 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.156 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.83 170.41 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.158 -174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 97.0 mt -87.96 14.03 9.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.204 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 C--O 1.2 -1.509 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.194 -176.958 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 98.5 mmm . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.876 0.369 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . 0.423 ' HB3' HD13 ' A' ' 468' ' ' ILE . 88.0 tt0 -88.67 149.81 23.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.175 156.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -109.91 112.25 58.12 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.228 -157.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.48 ' HG3' HG22 ' A' ' 470' ' ' VAL . 72.8 Cg_endo -74.09 169.74 21.73 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.649 1.566 . . . . 0.0 111.231 175.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 56.7 t0 -116.56 62.1 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 169.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.84 137.13 57.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.222 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 530' ' ' ASN . 13.1 t -146.66 156.97 43.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.204 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.09 155.21 39.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 47.5 mt-10 -138.75 135.71 34.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.126 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 513' ' ' ILE . 89.6 mt -107.57 125.52 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.156 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -136.86 147.19 46.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.2 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.73 -165.75 34.17 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -56.96 136.67 78.04 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.712 1.608 . . . . 0.0 111.178 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -86.39 -38.63 17.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 538' ' ' SER . 92.2 t -124.84 133.91 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.8 m -130.45 152.65 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -82.4 160.42 39.91 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 540' ' ' VAL . 4.9 p -76.45 139.25 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 0.0 111.144 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 62.57 27.3 16.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.273 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -123.95 142.39 51.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.163 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 502' ' ' SER . 36.7 tp -85.76 127.29 34.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.237 -174.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.58 144.17 49.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.221 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -110.1 135.14 51.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.156 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -129.09 157.64 41.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.476 ' HG2' HG23 ' A' ' 500' ' ' THR . 81.7 mt-10 -130.45 139.23 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.223 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 59.4 t -112.09 120.63 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 172.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.438 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 88.3 m-70 -97.86 118.38 34.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.506 HG11 HG22 ' A' ' 475' ' ' VAL . 11.8 m -117.97 131.86 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -127.04 155.22 43.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.229 -175.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 54.8 t-20 -117.06 131.26 56.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.245 157.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 50.8 mt -127.25 4.7 6.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.171 -167.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -91.8 3.73 78.14 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -175.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.8 20.24 75.78 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.579 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.1 tt -131.81 144.34 37.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.754 0.312 . . . . 0.0 111.231 175.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -85.8 133.18 11.6 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.48 HG22 ' HG3' ' A' ' 438' ' ' PRO . 85.9 t -119.61 118.11 32.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 0.0 111.209 170.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.2 -19.08 8.24 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 121.679 1.586 . . . . 0.0 111.133 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 91.5 p -93.07 10.14 32.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.177 -163.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.6 m -78.28 111.58 14.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.269 -161.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -110.4 127.28 55.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.167 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.506 HG22 HG11 ' A' ' 462' ' ' VAL . 88.8 t -115.78 128.75 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.236 -178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -123.6 151.7 42.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -174.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 87.8 t -130.12 134.77 62.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.205 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -118.41 145.77 44.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.74 117.93 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.202 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 50.7 t30 54.41 41.79 31.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.215 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 96.66 -22.91 37.7 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 172.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.1 m -100.27 139.43 35.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 111.174 -175.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 67.1 tp -68.77 121.64 16.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.231 175.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -98.18 -41.02 8.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.217 -173.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -167.45 162.53 14.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -172.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -141.81 153.44 44.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.26 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -137.49 142.08 41.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.234 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.1 m -108.14 127.58 53.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.248 169.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.97 167.6 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.205 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 49.8 m -121.15 142.22 50.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.215 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 82.4 mt -130.47 128.1 40.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.245 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.37 -170.85 46.87 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.57 112.55 1.64 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.702 1.601 . . . . 0.0 111.205 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.3 mttt 62.08 35.67 15.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.268 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -99.55 144.32 28.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.138 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -120.52 141.69 50.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -126.54 146.76 50.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.188 173.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.7 t -112.44 119.34 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.082 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . 0.424 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 43.7 mt -103.17 141.1 36.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.2 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' THR . . . . . 0.476 HG23 ' HG2' ' A' ' 459' ' ' GLU . 60.7 p -124.76 152.07 44.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.207 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -154.62 157.12 37.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.285 170.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.513 ' HB3' HD11 ' A' ' 455' ' ' LEU . 71.5 m -119.43 131.42 55.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.208 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 42.2 t90 -140.71 129.72 23.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 -169.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 88.9 m -115.94 109.28 45.21 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.279 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.84 118.86 5.61 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.743 1.629 . . . . 0.0 111.104 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 68.2 p -99.02 1.1 45.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.25 137.03 49.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.432 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 37.7 tt0 -73.79 138.49 44.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.184 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.34 174.48 23.69 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.1 mmm -85.22 129.24 34.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.806 0.336 . . . . 0.0 111.185 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -119.48 128.48 54.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.173 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -106.04 119.38 39.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 444' ' ' ILE . 79.7 mt -102.96 122.25 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.1 -176.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -119.97 144.74 47.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.91 140.16 52.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.4 p -131.63 151.17 51.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.9 p -118.64 143.72 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 23.9 t0 46.59 56.49 6.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.206 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -58.17 -38.01 75.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.246 172.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -73.77 -8.36 55.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -174.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.7 t30 58.7 58.32 3.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.175 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 70.7 p -93.07 -21.85 19.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.208 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 12.7 p -135.38 133.82 52.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 99.3 t -93.26 127.29 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.204 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 40.6 mp0 -100.3 164.13 12.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.297 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 93.3 mt -74.48 -29.69 61.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.209 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -111.85 156.18 22.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.238 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -117.69 -10.31 10.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.239 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -90.97 -8.82 48.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.189 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.436 ' O ' ' HA ' ' A' ' 441' ' ' THR . 95.6 m-20 -96.73 -6.03 37.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -76.48 -19.84 57.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.167 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 63.5 t -128.09 141.07 47.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.158 -174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.88 133.43 45.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.179 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 96.9 m -115.98 126.31 53.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.211 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -131.25 130.13 42.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.151 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -100.32 129.14 46.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.181 -172.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.6 t -121.22 135.56 61.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.207 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' SER . . . . . 0.4 ' HB3' HG23 ' A' ' 449' ' ' VAL . 36.3 t -104.82 126.0 51.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.189 174.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.37 127.76 55.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.177 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 452' ' ' VAL . 35.7 m -122.23 159.23 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.131 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . 0.576 ' O ' ' HB3' ' A' ' 542' ' ' GLU . 83.6 mt -81.23 57.74 3.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.109 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . 0.576 ' HB3' ' O ' ' A' ' 541' ' ' LEU . 24.9 pt-20 . . . . . 0 C--O 1.2 -1.511 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.256 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 95.9 mtp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.838 0.351 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -113.67 132.56 55.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.185 -166.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . 0.432 ' HB2' ' HG ' ' A' ' 526' ' ' LEU . 34.4 m-85 -130.06 132.88 24.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 175.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -69.97 166.45 27.8 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.685 1.59 . . . . 0.0 111.188 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -138.26 89.68 2.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.6 133.21 37.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.165 -169.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 10.0 t -146.36 155.31 42.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.207 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 517' ' ' VAL . 28.6 m -129.31 153.75 39.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.177 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -135.59 133.69 38.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.251 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 77.6 mt -104.48 124.99 59.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.98 146.55 47.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.182 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.55 -167.44 33.04 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -56.16 133.89 60.8 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.636 1.558 . . . . 0.0 111.181 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -82.66 -40.42 20.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 172.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 64.1 t -122.94 130.88 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.171 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.04 154.43 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.05 152.35 36.41 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.68 137.25 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.797 0.332 . . . . 0.0 111.222 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 64.15 30.78 13.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.213 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -125.02 143.42 50.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.218 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 44.0 tp -81.18 127.2 32.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.259 -175.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.9 144.88 48.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.151 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -103.97 136.43 43.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.18 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -130.04 156.66 44.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.195 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -130.65 140.4 50.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.223 -175.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.69 121.26 64.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.175 172.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -100.46 117.52 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.175 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.52 131.38 71.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.156 -174.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -125.5 154.93 41.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.204 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.49 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 61.8 t-20 -117.85 121.7 41.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.222 157.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 61.4 mt -113.75 14.71 18.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.191 -170.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -98.42 -4.83 57.18 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -174.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.9 23.07 78.34 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.49 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.3 tt -134.54 146.92 30.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 111.188 172.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -82.55 135.44 14.09 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 86.0 t -121.88 119.96 28.72 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.741 0.305 . . . . 0.0 111.225 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -84.24 -17.46 5.53 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.668 1.579 . . . . 0.0 111.199 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 84.4 p -91.75 7.98 39.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -162.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 88.4 m -81.23 108.29 14.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.226 -162.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -110.58 124.4 51.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 98.8 t -111.19 126.98 68.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 -173.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -125.53 151.92 45.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 -172.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 73.5 t -126.88 132.8 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.213 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -120.1 147.41 44.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.87 115.07 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.233 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 54.49 40.91 32.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.185 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 95.01 -17.63 58.93 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 171.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.7 m -99.5 135.97 40.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 111.146 -175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.9 tp -67.99 120.54 14.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -96.41 -40.35 9.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.238 -175.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -167.05 158.28 12.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -137.41 152.03 49.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.187 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 -136.73 142.68 43.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.194 174.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.5 m -108.91 124.8 51.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.253 168.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.5 m -139.12 166.81 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 86.8 p -118.02 144.56 45.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 169.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.9 mt -126.72 130.93 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -92.43 -177.34 41.59 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.21 121.04 9.2 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.68 1.586 . . . . 0.0 111.222 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.8 mttt 55.03 41.9 31.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 175.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.91 143.62 34.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.217 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -117.71 140.42 49.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.228 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -126.95 145.85 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 174.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 79.3 t -111.74 119.47 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.178 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 45.4 mt -103.45 143.11 33.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.196 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 52.9 p -122.82 153.23 39.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.25 156.14 36.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.198 166.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 57.6 m -122.18 133.63 54.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.223 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 47.7 t90 -139.86 129.68 24.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 -165.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.5 m -117.8 114.21 37.66 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.221 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -71.32 154.85 61.12 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.706 1.604 . . . . 0.0 111.203 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 74.1 p -124.64 -14.53 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.182 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -122.91 136.51 54.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.254 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 508' ' ' GLU . 21.7 pm0 -76.51 145.76 38.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.58 179.57 22.81 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -173.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.04 129.96 34.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.741 0.305 . . . . 0.0 111.189 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.45 133.49 55.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.226 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -105.21 119.36 38.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.186 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 94.5 mt -103.86 124.88 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -118.73 145.76 45.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.154 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.23 143.28 51.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.215 173.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 68.1 p -130.89 151.26 51.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.194 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . 0.477 ' HB ' HG13 ' A' ' 442' ' ' VAL . 12.4 p -116.81 143.8 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.224 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.6 t0 37.98 60.99 1.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.196 -167.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -56.75 -37.51 71.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -170.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -74.56 -5.29 42.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.204 -173.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 60.1 t30 63.1 60.17 1.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.223 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 73.0 p -112.7 12.35 19.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.226 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.66 137.11 51.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 84.7 t -91.54 116.27 32.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.208 169.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -126.75 172.22 10.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.209 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . 0.432 ' HG ' ' HB2' ' A' ' 437' ' ' PHE . 69.1 mt -76.12 -26.4 56.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 177.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -111.12 124.08 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 -162.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -117.91 -4.67 11.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.235 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -93.54 -35.18 13.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 -171.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -98.79 7.78 45.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.124 -171.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -65.77 -22.67 66.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.204 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.56 139.76 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.219 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.35 133.02 50.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.9 m -116.67 127.15 54.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.24 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -132.55 129.86 39.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.196 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -100.1 128.5 46.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.206 -172.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 96.6 t -121.26 136.22 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 40.2 t -105.52 124.43 49.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.195 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.16 125.45 55.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.213 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.96 161.4 28.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.197 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.68 56.84 4.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.175 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 . . . . . 0 C--O 1.2 -1.518 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.225 -179.093 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 98.7 mmm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.768 0.318 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -108.82 147.9 31.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.232 167.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . 0.411 ' CD1' ' O ' ' A' ' 524' ' ' VAL . 17.8 m-30 -109.65 104.6 55.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.159 -163.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.407 ' HB3' HD22 ' A' ' 464' ' ' ASN . 69.5 Cg_endo -72.97 163.0 39.57 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.694 1.596 . . . . 0.0 111.223 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -111.47 90.32 3.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 166.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 78.1 mt -85.28 145.69 27.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.0 t -144.28 154.77 43.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.275 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 32.6 m -130.62 156.43 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 460' ' ' VAL . 96.9 mt-10 -140.11 137.43 34.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.204 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 92.7 mt -107.62 127.16 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.249 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.83 149.04 47.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.23 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 153.46 -165.1 31.3 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.72 120.66 7.57 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.708 1.605 . . . . 0.0 111.256 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -83.33 -8.68 59.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.181 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.24 128.45 64.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 169.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 25.4 m -131.08 155.59 42.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -93.67 154.5 21.7 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.89 137.91 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 62.89 27.44 15.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.23 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 454' ' ' LYS . 28.0 mmmt -125.36 142.08 51.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.199 178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 502' ' ' SER . 37.2 tp -91.07 127.82 36.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.224 -174.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.71 145.55 48.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -106.93 138.02 43.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.184 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -129.09 157.04 42.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.207 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -129.96 139.6 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.267 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 47.7 t -112.33 121.22 64.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.196 172.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.465 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.5 m-70 -101.39 105.91 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.284 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.42 HG11 HG22 ' A' ' 475' ' ' VAL . 3.2 m -118.51 130.78 72.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -173.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -142.38 152.82 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.222 -171.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.63 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.9 t-20 -98.53 140.8 32.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.259 170.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 72.6 mt -130.55 5.4 4.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.221 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -101.37 -1.39 53.79 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.2 27.02 74.15 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.632 HG13 ' O ' ' A' ' 468' ' ' ILE . 0.6 OUTLIER -120.69 141.74 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.747 0.308 . . . . 0.0 111.201 175.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . 0.504 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -81.39 99.61 1.97 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.685 ' CG1' ' O ' ' A' ' 470' ' ' VAL . 0.4 OUTLIER -103.16 110.53 63.82 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 470' ' ' VAL . 74.4 Cg_endo -72.71 -15.33 27.05 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.721 1.614 . . . . 0.0 111.271 177.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.6 p -89.75 11.18 20.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.195 -157.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' THR . . . . . 0.453 ' OG1' ' CG1' ' A' ' 470' ' ' VAL . 97.3 m -77.16 109.59 11.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 -166.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -110.55 125.75 53.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.266 172.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.42 HG22 HG11 ' A' ' 462' ' ' VAL . 86.3 t -117.35 128.17 74.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.192 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -127.46 154.35 45.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.232 -173.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.2 t -128.16 134.56 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.19 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -122.01 148.0 45.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.297 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 89.6 mt -119.98 117.26 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 172.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 54.16 41.48 31.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.183 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.65 -8.65 74.41 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.9 m -97.55 137.51 36.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 111.288 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 68.5 tp -70.69 120.77 16.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.148 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -98.45 -40.51 8.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.245 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . 0.411 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 51.1 tptt -165.95 159.17 15.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.189 -172.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -141.26 152.8 44.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.233 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . 0.411 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 24.1 m-90 -138.16 142.4 40.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.2 171.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.9 m -106.79 124.33 49.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.227 169.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.73 167.44 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.263 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 70.7 m -121.21 144.16 48.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.14 172.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 94.6 mt -127.07 129.32 47.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.264 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . 0.504 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -83.91 -173.99 50.09 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 174.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.93 111.03 0.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.734 1.623 . . . . 0.0 111.27 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 64.48 34.61 10.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.162 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -99.19 143.31 29.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.236 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.2 140.87 52.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.243 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.46 147.36 49.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.164 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 96.3 t -112.45 119.55 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 54.2 mt -103.51 142.72 33.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.25 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 53.3 p -122.24 153.17 39.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.24 156.15 36.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 167.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.434 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.3 m -121.29 128.28 52.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -128.25 129.8 46.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -171.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.9 m -117.84 109.04 41.81 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.26 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.77 152.19 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.697 1.598 . . . . 0.0 111.247 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.7 p -124.74 -0.77 7.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.25 136.21 48.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.202 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -79.85 143.94 33.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.247 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.28 175.92 22.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -82.25 126.6 32.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.776 0.322 . . . . 0.0 111.13 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -119.84 130.82 55.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.161 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -105.79 118.93 37.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.193 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 84.1 mt -104.22 123.19 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.292 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -119.44 145.7 46.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.249 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.35 142.0 51.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.8 p -130.76 151.38 51.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.1 p -124.88 145.8 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.216 169.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 19.7 t70 65.3 34.61 8.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.44 -39.66 80.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.192 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -79.13 -4.15 48.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.9 t30 63.29 64.54 0.82 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.282 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 76.3 p -98.6 -31.48 11.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.219 -176.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.96 138.89 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.147 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . 0.411 ' O ' ' CD1' ' A' ' 437' ' ' PHE . 86.0 t -89.04 124.85 42.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.178 174.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -110.9 165.13 12.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 -166.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 86.2 mt -78.02 -25.54 47.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -145.76 111.1 5.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.084 -172.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -101.5 4.42 41.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -80.97 -22.54 39.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.184 -173.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -101.3 2.1 39.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.194 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -73.5 -5.5 40.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.168 -174.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.3 141.31 46.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.167 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.65 135.62 48.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.3 m -114.86 125.58 53.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.219 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -131.46 129.85 41.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.165 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -99.61 124.59 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -173.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 97.0 t -121.28 135.58 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.186 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 36.3 t -104.78 129.33 53.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.224 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 86.3 t -102.41 126.71 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.245 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' A' ' 542' ' ' GLU . 27.6 m -127.32 157.65 38.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.187 -177.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . 0.497 ' O ' ' O ' ' A' ' 542' ' ' GLU . 79.8 mt -68.14 -17.64 64.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.174 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 541' ' ' LEU . 88.7 tt0 . . . . . 0 C--O 1.2 -1.532 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' MET . . . . . 0.46 ' HA ' ' HA ' ' A' ' 436' ' ' GLU . 96.0 mtp . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.87 0.367 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 435' ' ' MET . 25.1 pt-20 -84.68 -179.24 7.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.216 -2.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -111.51 117.14 49.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 -154.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.418 ' HG3' HG22 ' A' ' 470' ' ' VAL . 72.2 Cg_endo -78.86 168.01 21.44 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.681 1.587 . . . . 0.0 111.203 -173.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -118.74 82.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.146 163.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 87.3 mt -81.1 127.4 32.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.122 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.1 t -148.45 160.92 42.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.196 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.07 155.75 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.276 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -135.99 139.69 43.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.243 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 61.9 mt -108.05 137.27 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.33 142.45 45.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 179.97 179.45 48.8 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.581 ' O ' ' HB2' ' A' ' 448' ' ' ASP . 33.8 Cg_endo -70.98 -31.49 15.04 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.679 1.586 . . . . 0.0 111.224 -172.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . 0.581 ' HB2' ' O ' ' A' ' 447' ' ' PRO . 82.7 m-20 75.59 -11.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.271 -175.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' A' ' 447' ' ' PRO . 47.9 t -139.13 117.15 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 175.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.68 152.54 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.229 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.51 157.74 44.52 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.5 p -76.43 140.22 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.127 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 63.13 29.6 16.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -124.73 139.0 54.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 37.3 tp -76.5 126.39 30.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.87 145.05 48.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.19 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -103.03 136.15 43.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -129.16 156.68 43.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -128.22 139.24 52.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.234 -171.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 57.0 t -115.85 120.3 64.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 173.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -99.56 113.31 25.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.295 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.43 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -116.14 127.33 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.458 ' HD2' HD22 ' A' ' 465' ' ' LEU . 11.3 pttt -131.83 150.49 52.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.224 -170.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.5 t-20 -105.24 137.99 42.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.241 162.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.458 HD22 ' HD2' ' A' ' 463' ' ' LYS . 56.5 mt -123.61 0.07 8.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 -169.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -95.53 -15.4 43.73 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.49 31.19 63.42 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.519 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 0.1 OUTLIER -132.95 130.08 58.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 111.182 177.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.23 131.34 10.81 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -170.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.435 HG11 HG22 ' A' ' 523' ' ' VAL . 97.9 t -123.3 120.11 27.29 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.734 0.302 . . . . 0.0 111.148 170.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.62 -19.01 6.48 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.654 1.57 . . . . 0.0 111.12 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.8 p -95.95 12.93 28.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.256 -163.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.9 m -77.32 117.66 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.192 -162.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -109.95 128.26 55.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.285 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.42 128.15 73.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.198 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -125.9 152.8 45.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -171.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 72.9 t -127.95 132.72 68.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.214 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -120.0 148.76 43.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.234 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.8 mt -120.96 115.91 48.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.261 170.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 54.52 41.35 32.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.2 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 95.42 -19.94 51.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 171.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -98.13 137.03 37.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 0.0 111.223 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.03 120.62 14.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.257 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -97.3 -39.89 9.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -176.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -166.11 157.95 13.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -141.73 154.63 45.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.175 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -135.29 142.3 45.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.238 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.9 m -102.31 122.51 44.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.201 165.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.56 166.92 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.204 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 67.4 m -120.12 142.28 49.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 96.9 mt -128.9 131.45 47.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.251 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -92.42 -165.68 38.82 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.37 114.2 2.77 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.676 1.584 . . . . 0.0 111.205 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 61.7 41.05 12.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.266 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -102.49 141.32 35.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -120.76 137.95 54.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -123.42 145.59 48.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.203 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.66 117.85 55.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 19.0 mt -109.46 136.14 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.24 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 44.6 p -120.09 155.24 33.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -172.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -153.52 156.57 38.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.215 171.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.8 m -121.1 133.35 55.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 41.2 t90 -140.19 130.1 24.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.188 -166.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.6 m -116.33 112.34 41.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.216 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.52 152.37 48.61 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.712 1.608 . . . . 0.0 111.142 172.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 71.1 p -122.37 -15.07 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.228 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -120.07 139.74 52.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -77.24 139.98 39.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.22 178.38 25.97 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.1 131.14 34.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.781 0.324 . . . . 0.0 111.153 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -117.34 137.51 52.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.245 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -104.85 118.69 37.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.152 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 86.2 mt -104.14 125.24 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.205 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -116.74 146.92 42.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.93 142.31 51.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.283 169.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 36.8 p -131.28 151.05 51.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.257 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.75 140.39 46.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.26 171.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 22.1 t0 51.81 51.14 17.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 -173.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -58.22 -38.26 76.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.196 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -77.3 -8.54 57.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.174 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 59.5 t30 64.74 59.83 0.9 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.193 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 69.3 p -101.75 -9.78 20.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.265 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . 0.435 HG22 HG11 ' A' ' 470' ' ' VAL . 87.5 t -112.3 131.95 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.264 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 80.1 t -90.61 116.93 32.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.259 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -120.37 177.46 5.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.187 -170.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.19 -24.44 57.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.134 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -147.9 117.32 6.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.211 -175.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -95.49 -3.5 46.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.17 -173.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -94.51 -0.75 54.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.22 176.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -102.55 23.26 12.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.174 -173.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -97.27 -19.2 18.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.194 -169.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.8 t -123.34 140.0 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.21 -166.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -129.74 136.09 49.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.257 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.5 m -114.99 128.44 56.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.186 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -133.21 127.93 34.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.08 -171.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -102.38 128.28 49.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.21 -170.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 86.8 t -122.33 137.15 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 41.2 t -103.91 124.67 49.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.158 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 93.0 t -102.73 126.27 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.162 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.96 159.61 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.167 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 59.1 mt -84.8 57.04 4.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.163 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 C--O 1.199 -1.585 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.179 -179.359 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.814 0.34 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . 0.407 ' HB3' HD13 ' A' ' 468' ' ' ILE . 88.3 tt0 -101.73 150.94 22.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.246 156.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . 0.4 ' HA ' ' HD2' ' A' ' 438' ' ' PRO . 15.4 m-30 -106.43 108.65 62.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.199 -158.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.487 ' HB3' HG23 ' A' ' 468' ' ' ILE . 73.5 Cg_endo -72.8 162.51 40.96 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.717 1.611 . . . . 0.0 111.257 177.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -111.01 76.09 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.243 164.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.4 mt -74.84 137.9 42.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 531' ' ' ASN . 11.3 t -144.34 155.1 43.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.112 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.02 155.74 41.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.304 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 97.8 mt-10 -137.32 139.64 40.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.161 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 87.6 mt -107.85 132.07 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.225 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -136.27 142.8 43.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.229 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 162.18 -173.49 38.5 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.58 134.86 34.23 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.727 1.618 . . . . 0.0 111.229 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -75.9 -40.7 53.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.191 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.4 t -122.31 132.4 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.179 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.05 152.13 36.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.5 159.9 46.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.52 149.2 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 111.174 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 19.0 m120 63.38 26.47 14.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.147 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.408 ' O ' ' HD2' ' A' ' 505' ' ' PRO . 28.0 mmmt -128.31 143.3 51.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.082 -177.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 37.3 tp -86.38 127.83 34.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.191 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.35 144.19 49.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.218 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -102.46 135.15 44.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 87.2 m-85 -129.16 157.12 42.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.193 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . 0.43 ' HG2' HG23 ' A' ' 500' ' ' THR . 90.6 mt-10 -129.82 141.11 50.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.195 -174.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.9 t -113.24 121.03 64.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 172.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 94.6 m-70 -99.42 111.1 23.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.156 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.27 130.91 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.425 ' HD3' HD22 ' A' ' 465' ' ' LEU . 19.2 ptpt -143.78 154.1 43.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -175.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.58 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.4 t-20 -104.77 141.46 36.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.208 172.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.425 HD22 ' HD3' ' A' ' 463' ' ' LYS . 63.8 mt -131.69 4.3 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.203 -169.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -91.78 0.06 72.84 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.28 19.04 75.59 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.58 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 5.5 tt -126.72 143.84 38.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.765 0.317 . . . . 0.0 111.289 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -84.9 132.11 10.86 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . 0.461 HG22 ' HG3' ' A' ' 438' ' ' PRO . 85.6 t -118.89 116.01 34.6 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 111.21 173.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.29 -18.19 9.91 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.689 1.592 . . . . 0.0 111.209 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.3 p -91.53 12.56 20.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.259 -167.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 89.8 m -79.64 111.26 15.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.22 -163.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -113.84 125.62 54.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.0 131.02 67.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.198 -173.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . 0.481 ' HD2' ' HG3' ' A' ' 519' ' ' GLU . 92.5 mtt-85 -120.42 154.2 35.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.173 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.1 t -128.93 134.81 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.195 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.73 147.28 45.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 93.3 mt -124.24 117.5 50.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.21 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 45.4 t30 54.8 42.18 31.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.195 172.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 96.07 -19.99 52.05 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 174.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.2 m -101.53 138.99 37.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.764 0.316 . . . . 0.0 111.251 -174.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.7 tp -69.96 121.75 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.166 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -97.71 -40.43 8.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.219 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -165.56 158.9 16.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.185 -171.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -140.0 152.77 46.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.221 -177.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -138.49 142.61 39.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.6 m -106.34 126.01 51.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.224 170.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.66 167.85 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.21 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.6 m -120.47 143.34 48.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 170.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.5 mt -129.03 129.21 45.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.259 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -86.44 -173.44 49.1 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.96 112.06 1.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.681 1.587 . . . . 0.0 111.196 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.0 mttt 64.68 33.69 10.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.21 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -101.15 144.96 29.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.167 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -123.5 141.3 52.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.176 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.78 147.22 50.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.182 174.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.9 t -111.87 119.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 43.3 mt -103.81 142.03 35.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.213 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' THR . . . . . 0.43 HG23 ' HG2' ' A' ' 459' ' ' GLU . 47.4 p -122.99 152.95 40.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.226 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.1 p90 -153.97 156.58 37.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.147 168.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 67.1 m -121.28 131.61 54.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.184 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . 0.466 ' CH2' ' HB3' ' A' ' 505' ' ' PRO . 41.1 t90 -140.11 129.92 24.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 -169.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' THR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 505' ' ' PRO . 82.1 m -111.47 110.84 55.32 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.256 179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . 0.466 ' HB3' ' CH2' ' A' ' 503' ' ' TRP . 74.0 Cg_endo -70.96 111.57 3.08 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.726 1.618 . . . . 0.0 111.165 174.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 80.8 p -83.61 -20.31 33.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.195 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -121.75 140.9 51.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.189 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.451 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 31.7 tt0 -72.26 141.0 48.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.05 174.58 23.58 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -176.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -85.48 127.83 34.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.783 0.325 . . . . 0.0 111.157 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -120.38 132.04 55.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.295 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -105.53 119.58 39.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.256 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 92.8 mt -100.73 122.74 53.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -120.75 147.06 45.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.57 140.17 52.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 174.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.2 p -130.91 150.64 51.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.113 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . 0.485 ' CG1' ' HB2' ' A' ' 531' ' ' ASN . 12.0 p -123.42 149.75 27.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.199 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 23.8 t0 46.0 48.96 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.162 -165.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . 0.481 ' HG3' ' HD2' ' A' ' 476' ' ' ARG . 9.5 tm-20 -57.37 -37.22 72.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.289 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.91 -6.37 46.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.24 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.4 t30 57.84 60.12 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.22 175.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 69.7 p -99.86 -20.74 16.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 9.9 p -130.29 136.41 58.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.188 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 88.9 t -89.59 126.78 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.186 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.42 ' HG2' ' HG2' ' A' ' 438' ' ' PRO . 52.9 mt-10 -99.81 171.63 7.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 -171.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.36 -26.49 61.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.236 173.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -139.36 147.77 41.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.232 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -111.97 -17.19 12.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.216 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -95.24 -6.56 41.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -99.26 0.75 43.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.2 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . 0.485 ' HB2' ' CG1' ' A' ' 517' ' ' VAL . 49.5 p-10 -111.75 24.44 12.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 -175.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 89.5 t -132.12 145.45 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.155 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.37 134.11 48.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.273 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.7 m -116.03 126.38 53.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.156 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -132.68 130.69 40.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.332 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.5 129.42 47.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.164 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.9 t -121.59 136.22 59.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.8 t -106.29 126.8 52.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.211 173.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.9 t -102.3 128.63 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.203 176.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.96 159.94 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . 0.451 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 93.2 mt -83.48 0.89 44.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 . . . . . 0 C--O 1.201 -1.498 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.143 -177.595 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 CA--C 1.522 -0.099 0 CA-C-O 120.824 0.345 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -106.02 125.53 51.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.185 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -127.22 140.97 39.36 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.083 -175.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.76 162.6 40.61 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.715 1.61 . . . . 0.0 111.125 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -133.38 83.47 2.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 13.9 mt -91.7 127.08 37.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.253 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 9.0 t -145.77 157.82 43.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.55 154.75 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.199 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 94.9 mt-10 -135.62 137.48 41.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.204 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.6 mt -103.65 131.58 51.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.202 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -135.98 142.24 44.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.186 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.9 -176.02 33.51 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.79 141.19 44.47 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.666 1.577 . . . . 0.0 111.323 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -95.82 -17.24 21.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.204 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.6 t -126.61 124.97 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.8 m -130.03 154.24 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.124 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.44 150.84 27.5 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.79 140.01 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 0.0 111.16 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 63.69 30.11 14.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.161 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 454' ' ' LYS . 29.2 mmmt -126.02 142.93 51.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 36.7 tp -83.48 126.67 33.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.196 -176.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.79 144.98 48.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -102.78 135.87 43.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.133 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.94 157.2 42.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -130.01 139.51 51.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.157 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.83 120.09 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.1 m-70 -100.68 116.08 31.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.429 HG11 HG22 ' A' ' 475' ' ' VAL . 1.4 m -117.41 128.09 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 -175.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.449 ' HD2' HD22 ' A' ' 465' ' ' LEU . 13.4 pttt -133.69 150.76 51.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.176 -174.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 57.8 t-20 -111.51 123.97 51.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.214 167.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.449 HD22 ' HD2' ' A' ' 463' ' ' LYS . 56.0 mt -110.52 5.63 21.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.272 -170.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.77 -14.96 54.34 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -174.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.23 21.88 78.4 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.463 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.0 tt -129.49 139.9 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.88 0.371 . . . . 0.0 111.12 167.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -83.09 134.1 12.53 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -169.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 84.8 t -122.16 119.0 28.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.758 0.314 . . . . 0.0 111.263 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -86.15 -18.16 3.54 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.652 1.568 . . . . 0.0 111.137 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.6 p -97.11 4.0 51.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.178 -160.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' THR . . . . . 0.469 HG21 ' O ' ' A' ' 473' ' ' THR . 10.2 t -85.31 123.52 30.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.22 -166.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -113.34 128.93 56.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.22 -174.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.429 HG22 HG11 ' A' ' 462' ' ' VAL . 88.4 t -112.02 125.79 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 -174.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.02 155.77 44.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.214 -171.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.31 133.31 69.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -120.5 148.26 44.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.219 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 70.5 mt -120.24 114.73 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.226 169.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 53.96 40.97 32.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 91.64 -11.79 71.17 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.6 m -98.29 134.3 41.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 111.195 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.5 tp -68.54 119.18 12.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.278 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -99.08 -40.58 7.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.231 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -167.33 157.51 11.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.168 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -140.4 151.97 45.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.229 -175.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -136.46 142.15 43.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.2 m -103.26 125.0 49.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.21 163.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.43 166.05 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.4 m -121.95 142.43 50.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.169 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . 0.429 HD22 ' HB2' ' A' ' 497' ' ' LYS . 87.3 mt -129.64 131.44 46.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.167 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -89.76 -167.08 42.14 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 172.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.47 117.53 4.79 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.708 1.605 . . . . 0.0 111.224 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.1 mttt 59.69 41.78 18.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.172 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -103.83 144.56 31.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.256 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -120.32 143.25 48.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.163 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.429 ' HB2' HD22 ' A' ' 491' ' ' LEU . 1.8 tttp -137.46 130.75 30.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.217 -173.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 69.4 t -106.37 118.53 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.161 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 37.2 mt -107.07 144.02 34.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.196 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 41.7 p -122.35 152.68 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.175 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.9 156.4 37.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 168.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 68.8 m -120.41 134.02 55.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.286 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -130.31 129.37 43.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.236 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 96.6 m -118.49 110.55 38.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 170.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.61 152.26 47.98 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.74 1.627 . . . . 0.0 111.168 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 59.4 p -123.88 -15.07 7.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -119.26 135.16 54.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.639 ' CD ' ' H ' ' A' ' 508' ' ' GLU . 2.9 pm0 -80.08 124.82 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.168 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 174.47 -179.99 45.45 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.3 mmm -84.39 127.21 33.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 111.253 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -122.1 133.03 54.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.154 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -105.31 119.17 38.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.289 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.0 123.73 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 -176.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -115.19 146.51 41.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.46 142.74 51.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.237 168.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 77.2 p -130.8 150.39 51.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.22 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.79 147.43 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.278 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 35.5 t70 22.62 85.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.22 -156.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -61.2 -40.56 94.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.237 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -81.21 -7.29 59.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.268 -165.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 63.86 46.37 3.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.146 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 72.0 p -90.13 -14.9 32.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.248 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 92.4 t -107.41 131.47 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.222 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 87.7 t -89.52 120.15 37.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.19 173.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -117.33 170.03 9.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.163 -167.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.36 -26.66 61.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.124 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 42.0 p30 -96.74 164.03 12.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.203 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -130.04 -30.04 2.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.174 169.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -100.83 -8.39 22.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -99.0 21.24 11.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 -170.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -99.99 -2.06 35.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.203 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 79.4 t -128.81 139.17 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.235 178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.86 133.15 45.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.288 174.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.5 m -117.51 127.03 53.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.193 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -133.6 129.34 36.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.245 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -100.22 126.46 46.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.195 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 82.1 t -121.0 135.83 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.188 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -105.17 127.75 53.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.239 173.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.03 127.73 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.183 173.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.51 150.88 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 -172.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . 0.715 ' O ' ' HG ' ' A' ' 541' ' ' LEU . 39.8 tp -111.03 55.83 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.178 -174.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--O 1.199 -1.573 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 178.185 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.758 0.313 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -126.55 133.06 51.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.197 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -127.21 145.1 52.97 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.83 165.71 31.31 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.653 1.569 . . . . 0.0 111.227 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -147.78 98.91 3.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.193 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 60.3 mt -96.18 142.64 28.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.192 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.5 t -148.53 159.17 44.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.227 174.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.05 154.91 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.184 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -135.79 138.72 42.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.231 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 82.5 mt -106.19 128.23 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -135.75 149.04 49.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.231 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.84 -173.53 35.15 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.16 145.47 60.74 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.718 1.612 . . . . 0.0 111.117 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -90.07 -41.78 11.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 74.9 t -118.25 126.18 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.267 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.5 m -129.73 152.23 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.232 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.79 158.71 45.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 3.1 p -79.42 146.02 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.839 0.352 . . . . 0.0 111.133 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 63.65 29.06 15.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.25 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.91 141.87 51.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 35.0 tp -81.57 127.55 32.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.205 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.16 144.5 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.202 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -103.01 135.78 44.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.191 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -129.34 157.08 42.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.237 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -129.68 139.63 51.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.218 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.5 t -112.01 120.44 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.186 170.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -101.54 113.17 26.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.411 HG11 HG22 ' A' ' 475' ' ' VAL . 1.5 m -119.66 130.72 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.23 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -142.73 154.97 44.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -172.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 41.2 t30 -106.71 140.12 40.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.208 170.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 65.1 mt -125.88 4.76 7.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.182 -174.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -89.42 -15.33 58.77 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.53 24.28 73.18 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.469 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.3 tt -137.67 136.39 45.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 111.174 171.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -74.45 136.54 21.31 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -168.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.64 118.15 30.95 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.802 0.334 . . . . 0.0 111.216 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.74 -18.5 5.54 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.649 1.566 . . . . 0.0 111.266 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.6 p -94.11 13.06 24.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 -163.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 100.0 m -78.83 111.62 15.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.16 -161.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -109.83 125.89 53.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.411 HG22 HG11 ' A' ' 462' ' ' VAL . 60.1 t -119.9 127.0 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.177 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -135.28 157.24 47.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.178 -172.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 69.4 t -127.68 134.38 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.244 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -116.85 146.73 42.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.174 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 80.2 mt -120.1 115.05 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.171 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 53.68 41.29 32.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.178 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 93.01 -15.4 62.95 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 172.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -99.64 133.71 43.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.803 0.335 . . . . 0.0 111.25 -174.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 56.0 tp -68.79 120.23 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.222 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -97.36 -40.96 8.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.211 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -168.31 157.44 9.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.193 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -140.5 155.17 46.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.228 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -135.21 142.38 46.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.252 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.4 m -109.67 123.32 49.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.206 166.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.11 167.74 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.277 -175.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 82.9 p -116.75 143.89 45.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.143 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 96.4 mt -129.16 131.23 47.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.201 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -90.15 -179.19 44.27 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 172.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.49 120.24 7.72 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.686 1.591 . . . . 0.0 111.255 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.9 mttt 57.08 36.62 27.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.249 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -103.24 144.08 31.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.162 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -122.95 140.67 52.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.243 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -126.81 147.68 50.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.185 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 90.0 t -110.89 119.16 58.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 35.7 mt -104.16 141.65 35.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.199 173.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 46.3 p -124.55 153.86 41.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.23 156.28 36.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.211 166.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 52.7 m -122.47 134.37 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 41.3 t90 -140.17 129.77 24.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.211 -166.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.3 m -117.15 112.88 39.55 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.28 150.32 36.83 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.703 1.602 . . . . 0.0 111.237 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 66.9 p -122.68 -11.71 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.194 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -120.03 139.19 52.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.173 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -80.74 143.6 32.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.135 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.93 177.84 25.18 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.7 mmm -86.31 130.75 34.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 111.184 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -118.71 134.93 54.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.225 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -106.95 119.6 39.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.158 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 85.2 mt -103.5 124.9 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.193 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -117.71 145.7 44.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.228 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.75 141.4 51.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.192 170.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 68.0 p -131.05 150.56 52.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.169 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.3 p -125.73 143.19 40.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 169.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.9 t70 59.41 36.04 23.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.167 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -58.76 -37.64 76.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.196 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.87 -4.59 50.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.208 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 59.6 t30 65.18 59.63 0.82 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.209 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 66.9 p -92.53 -29.12 16.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.314 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 14.4 p -130.89 138.69 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.275 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.01 121.68 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.18 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -120.08 178.24 4.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.148 -174.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 87.9 mt -69.83 -27.28 64.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.21 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -157.36 121.55 4.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.208 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -103.24 1.73 33.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.212 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -97.93 -9.64 25.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 168.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . 0.682 ' O ' ' HB3' ' A' ' 531' ' ' ASN . 63.4 t30 -98.08 65.66 1.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.14 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . 0.682 ' HB3' ' O ' ' A' ' 530' ' ' ASN . 25.7 p-10 164.68 25.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.112 -157.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 71.5 t -130.96 138.47 53.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 161.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.03 130.61 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -172.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.2 m -117.29 127.05 53.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.247 176.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -130.65 130.2 43.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.206 -175.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -99.08 125.59 44.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -173.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.54 135.58 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.166 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.5 t -105.79 122.41 46.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.221 171.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 98.2 t -102.76 127.08 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.15 165.06 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.84 -47.09 82.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.287 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 C--O 1.2 -1.509 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.113 173.777 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 94.7 mtp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.824 0.345 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -100.77 147.57 25.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.225 161.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -115.16 113.72 43.62 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.258 -162.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.94 166.94 7.84 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.713 1.609 . . . . 0.0 111.118 174.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -141.16 73.52 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.204 165.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.01 143.36 34.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.141 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 44.7 p -127.8 162.39 26.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.183 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 29.1 m -131.82 152.08 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.26 163.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' A' ' 460' ' ' VAL . 86.2 mt-10 -139.96 135.69 33.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 175.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 84.5 mt -109.66 124.18 66.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.211 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.0 148.66 47.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.227 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.22 -163.92 32.17 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -56.25 136.77 77.07 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.674 1.582 . . . . 0.0 111.247 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -86.99 -37.63 17.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.203 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 93.1 t -124.85 132.87 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.203 174.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.84 151.85 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.24 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.61 158.78 43.62 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.8 136.17 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 111.22 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 62.56 21.99 13.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.19 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -110.3 130.98 55.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.17 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 35.3 tp -74.73 126.81 31.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.156 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.56 146.47 48.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -108.66 132.26 54.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -128.18 157.2 41.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.172 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -130.35 140.36 50.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.211 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 48.8 t -111.77 120.39 62.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 170.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.473 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.1 m-70 -105.98 109.09 20.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.195 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 14.6 m -116.42 132.61 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -119.77 159.16 25.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 44.5 t-20 -111.82 121.75 45.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 156.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 48.5 mt -117.16 1.0 12.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 -177.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.72 -19.29 41.17 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 75.28 28.87 61.14 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 15.2 tt -128.14 136.03 61.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 111.193 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.7 122.24 13.76 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.09 112.07 31.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 111.169 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.23 -17.42 11.7 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.738 1.625 . . . . 0.0 111.206 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 58.5 m -87.98 10.73 17.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -162.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.9 m -79.97 108.54 13.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -162.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -109.54 127.44 54.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.194 175.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 80.4 t -113.45 126.16 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.303 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -127.87 153.84 46.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.243 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.75 134.38 64.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -120.99 147.55 45.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.219 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.44 HG12 HG12 ' A' ' 513' ' ' ILE . 86.3 mt -120.39 117.41 53.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 170.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 54.31 41.43 31.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.268 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.95 -9.51 71.94 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.1 m -98.14 137.81 36.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.745 0.307 . . . . 0.0 111.208 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -69.76 120.31 15.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -98.09 -40.39 8.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -165.15 158.07 16.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.213 -173.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -142.23 152.04 42.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.234 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.3 m-90 -137.79 142.66 40.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.288 170.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.7 m -105.97 125.12 50.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.231 170.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.0 m -138.98 167.21 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.5 m -122.79 143.31 49.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.161 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 90.8 mt -128.57 128.81 44.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.268 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.37 -167.79 43.59 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.79 112.84 1.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.658 1.572 . . . . 0.0 111.205 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.0 mttt 66.86 36.19 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -96.61 143.81 27.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.235 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -125.37 141.48 52.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.233 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . 0.445 ' HB3' ' HE3' ' A' ' 497' ' ' LYS . 26.4 mmmt -129.8 144.82 51.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.189 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.3 119.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.128 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 64.6 mt -104.03 143.3 33.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 47.1 p -122.36 152.77 39.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.211 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -153.82 156.61 37.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.236 168.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.2 m -121.1 129.25 53.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.189 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -127.27 129.5 47.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 -172.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.9 m -113.89 110.47 49.02 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.192 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.29 150.99 53.9 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.691 1.594 . . . . 0.0 111.179 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 79.9 p -123.41 -13.53 7.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.223 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -125.76 137.12 53.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.192 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.435 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 30.9 tt0 -77.02 140.05 40.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.242 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.8 175.12 23.95 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.7 mmm -85.67 129.91 34.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.191 176.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -119.63 130.32 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -104.01 119.39 38.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.195 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.44 HG12 HG12 ' A' ' 479' ' ' ILE . 82.5 mt -104.05 123.76 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.201 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -119.76 145.14 46.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.208 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.04 143.09 50.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.192 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 82.7 p -131.17 153.2 49.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.289 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 9.1 p -126.78 140.85 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.238 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 3.3 t0 64.09 38.84 8.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.19 167.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -58.76 -44.14 90.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.226 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -90.33 -22.53 21.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.187 -169.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -85.14 78.03 9.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.225 171.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 56.6 p -70.44 65.32 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.199 -174.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.2 p -101.87 146.26 10.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 -175.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 86.9 t -83.21 125.08 40.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.281 -175.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -114.23 175.89 5.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.265 -171.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.91 -26.18 62.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.112 170.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -155.52 108.65 2.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.221 175.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -100.67 1.32 40.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.165 -175.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -87.78 -10.66 50.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.195 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -101.53 12.74 36.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.184 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -84.27 0.99 46.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.86 140.4 48.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.228 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.18 137.18 49.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.0 m -115.21 126.52 54.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -134.71 129.75 35.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.181 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -100.19 128.71 46.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.226 -173.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 91.9 t -121.13 135.99 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.242 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.6 t -105.66 124.42 49.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.145 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.6 t -102.03 126.61 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.73 155.23 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . 0.435 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 83.4 mt -80.93 52.83 1.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.238 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 . . . . . 0 C--O 1.2 -1.5 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.209 -177.446 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 98.2 mtp . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.782 0.325 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -119.24 157.42 28.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.267 158.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -112.62 95.48 32.7 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.265 -163.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.28 168.68 22.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.723 1.615 . . . . 0.0 111.243 173.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 64.2 t0 -127.62 81.57 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.267 172.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.6 136.01 33.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 -174.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 8.0 t -141.0 153.14 45.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.324 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 26.2 m -131.62 154.9 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.131 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.7 mt-10 -139.4 135.69 33.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.2 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 87.7 mt -107.34 126.86 63.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.192 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.9 147.93 48.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.243 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.89 -169.66 34.67 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.42 114.46 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.693 1.595 . . . . 0.0 111.163 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -69.04 -26.96 65.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 97.5 t -123.69 130.96 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.221 172.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.2 152.01 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.187 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.58 158.91 41.9 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.53 137.91 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 111.248 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 62.21 25.5 15.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.299 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -116.56 150.2 38.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.176 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 37.9 tp -88.87 127.61 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.279 -175.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.41 143.99 49.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.228 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -107.71 137.32 45.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.187 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.86 157.67 41.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.27 141.2 51.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.155 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 47.1 t -113.13 120.95 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.162 170.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.7 m-70 -103.29 108.17 19.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.442 HG11 HG22 ' A' ' 475' ' ' VAL . 2.3 m -118.42 130.55 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.224 -171.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -144.99 151.72 39.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.167 -173.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 44.6 t-20 -106.81 139.58 41.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.163 173.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 73.7 mt -129.37 4.09 5.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.214 -171.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -88.0 -2.04 81.42 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.94 21.4 78.23 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.437 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.8 tt -126.55 148.85 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.773 0.32 . . . . 0.0 111.186 175.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -94.06 115.69 5.06 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 94.3 t -104.76 114.48 63.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.757 0.313 . . . . 0.0 111.194 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.7 -17.98 10.79 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.698 1.598 . . . . 0.0 111.201 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.7 p -91.42 12.08 21.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.164 -164.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 91.1 m -78.75 108.17 11.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.229 -162.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -111.07 128.26 55.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.218 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . 0.442 HG22 HG11 ' A' ' 462' ' ' VAL . 67.1 t -115.05 128.46 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 -176.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -123.67 152.61 41.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 79.7 t -127.7 133.71 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.284 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.22 147.51 44.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.169 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 513' ' ' ILE . 84.1 mt -119.86 117.19 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.292 171.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 54.55 41.16 32.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.176 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.56 -11.82 67.12 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 173.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.2 m -97.71 137.64 36.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 111.224 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 66.5 tp -69.3 120.69 15.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.263 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -98.11 -40.47 8.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 -176.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 486' ' ' ASN . 51.5 tptt -166.16 159.91 15.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 -173.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . 0.405 ' N ' ' HG3' ' A' ' 485' ' ' LYS . 16.5 p30 -141.17 153.13 45.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.182 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -139.17 142.79 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.196 171.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.8 m -107.55 125.09 50.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.204 169.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.61 168.07 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 59.4 m -121.98 143.09 49.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.173 170.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.4 mt -127.38 129.53 47.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.216 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.38 -179.74 48.15 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.06 113.87 1.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.647 1.565 . . . . 0.0 111.211 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.5 mttt 64.73 34.14 9.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -101.5 143.47 31.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.28 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -122.81 140.3 53.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.208 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -128.29 146.43 50.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.206 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.9 t -112.34 119.45 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 49.5 mt -102.86 142.25 34.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.239 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 45.7 p -123.82 152.78 41.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.23 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.95 156.84 38.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.314 167.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 70.5 m -120.12 129.81 54.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.206 -176.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -130.69 129.57 42.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.219 -170.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.1 m -117.34 107.3 45.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.222 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.35 143.48 31.47 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.713 1.608 . . . . 0.0 111.202 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 67.4 p -115.41 -14.85 11.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.169 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -119.94 138.02 53.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . 0.402 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 33.2 tt0 -75.0 140.11 43.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.197 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.87 174.44 24.05 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -176.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.6 mmm -85.17 127.82 34.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.842 0.353 . . . . 0.0 111.111 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -120.89 131.96 54.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.18 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -104.17 118.07 35.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.165 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 479' ' ' ILE . 83.9 mt -104.52 120.22 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -123.02 149.4 44.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.239 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.4 140.81 52.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.233 175.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 60.1 p -131.75 151.75 51.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.163 174.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.1 p -124.83 145.05 32.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.216 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 5.7 t0 70.85 16.56 6.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.136 170.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -61.78 -43.06 99.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.196 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -90.16 -16.59 29.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 -175.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -117.27 57.93 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.192 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 69.5 p -58.13 97.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.25 -163.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.49 140.66 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.159 172.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 85.0 t -82.78 123.45 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.32 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -110.85 170.49 8.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.283 -164.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.34 -26.44 60.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.143 171.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -150.09 106.15 3.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.295 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -98.3 5.95 47.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.18 -172.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -89.12 -16.32 31.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.201 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -99.24 -13.47 19.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.162 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -80.87 11.86 3.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.2 -174.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 88.6 t -130.29 141.48 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.157 167.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.87 133.98 46.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.239 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 85.8 m -116.19 125.89 52.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -131.21 129.09 41.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.191 176.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -101.14 125.65 47.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.249 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 85.3 t -121.25 136.26 58.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.9 t -104.61 127.34 52.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.179 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 85.2 t -101.24 126.85 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.144 173.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 32.2 m -122.87 159.77 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.12 -175.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . 0.402 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 94.3 mt -85.29 0.42 52.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.153 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 . . . . . 0 C--O 1.2 -1.537 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.219 -176.848 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 82.9 mmm . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.847 0.356 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -145.19 129.47 17.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 165.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . 0.422 ' HA ' ' HD2' ' A' ' 438' ' ' PRO . 95.8 m-85 -128.56 104.95 19.18 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 174.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 437' ' ' PHE . 69.0 Cg_endo -66.24 162.95 33.76 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.73 1.62 . . . . 0.0 111.233 170.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -143.17 78.07 1.59 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.232 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 14.7 mt -80.28 125.86 30.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.198 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 14.5 t -138.74 157.15 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.37 155.48 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.308 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 91.5 mt-10 -137.05 133.75 35.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.193 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 92.6 mt -104.56 127.28 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -135.48 146.48 48.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.226 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.61 -171.17 34.19 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.96 140.39 45.58 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.71 1.607 . . . . 0.0 111.205 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -86.03 -36.52 19.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.237 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.2 t -120.03 129.57 75.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.231 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.09 153.18 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.232 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.37 156.54 43.3 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.1 p -76.19 140.29 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.201 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 63.46 28.65 15.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.239 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -121.73 148.04 45.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.82 127.06 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.28 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.25 143.38 49.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.177 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -103.99 135.17 46.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.121 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -130.27 157.22 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -129.81 139.83 51.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.221 -175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 47.7 t -113.45 121.9 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 173.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.471 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.5 m-70 -101.71 112.05 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.15 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.408 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -117.89 128.83 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.256 -171.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . 0.454 ' HD2' HD22 ' A' ' 465' ' ' LEU . 45.7 pttt -145.07 154.97 43.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.202 -172.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 63.4 t-20 -113.77 120.88 42.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.156 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . 0.454 HD22 ' HD2' ' A' ' 463' ' ' LYS . 82.6 mt -112.16 15.36 20.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.176 -170.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.28 -9.62 61.7 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -177.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.96 16.79 76.65 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.474 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.7 tt -127.03 146.21 33.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.701 0.286 . . . . 0.0 111.264 170.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -83.6 132.06 10.82 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.7 114.55 32.66 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.222 168.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -84.71 -19.17 4.27 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.811 1.674 . . . . 0.0 111.242 -174.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 99.1 p -97.92 5.32 49.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.233 -160.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' THR . . . . . 0.409 HG21 ' O ' ' A' ' 473' ' ' THR . 8.9 t -84.99 127.03 34.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.212 -160.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.94 130.92 55.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.249 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.89 130.21 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.268 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -129.49 155.09 46.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.176 -170.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 41.4 t -125.55 135.02 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.228 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -124.04 150.15 45.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.218 -174.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 86.3 mt -124.03 116.45 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.221 172.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 54.49 41.19 32.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.19 -13.52 66.87 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 170.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.6 m -99.76 138.53 36.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 111.257 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.7 tp -67.85 120.44 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -99.01 -40.28 8.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.156 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt -158.26 162.9 37.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -138.12 148.32 44.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.157 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -138.48 142.03 39.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.135 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 93.2 m -109.75 126.68 54.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.286 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.5 m -138.19 167.1 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.242 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.7 m -117.32 140.28 49.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.184 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.9 mt -129.44 130.24 45.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.136 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -91.15 -167.21 41.04 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 173.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.2 111.73 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.731 1.62 . . . . 0.0 111.239 175.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.1 mttt 60.01 43.69 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.181 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.06 142.67 31.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.238 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -122.14 137.92 54.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.145 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -127.97 148.61 50.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.188 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 85.9 t -111.2 118.53 57.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.186 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 48.1 mt -104.84 145.65 30.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.259 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 55.5 p -120.51 154.0 35.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.218 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -152.93 155.04 36.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 165.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 65.2 m -124.25 131.59 53.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -131.42 131.53 43.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.201 -170.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.4 m -118.02 110.3 40.02 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.221 174.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.85 154.44 43.28 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.806 1.671 . . . . 0.0 111.107 172.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 74.3 p -124.19 -19.16 5.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.242 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -120.13 138.92 53.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.22 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.21 140.44 46.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.46 176.61 26.1 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.64 128.94 35.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.17 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -121.92 136.55 54.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.209 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -104.68 119.09 38.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.243 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 93.0 mt -103.73 124.05 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.175 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -121.37 151.16 40.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.27 143.18 51.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.163 173.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 64.6 p -131.07 154.1 48.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.215 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.7 138.33 54.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.235 165.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 25.0 t0 54.97 61.24 3.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.19 -171.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -57.05 -38.77 73.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.18 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 521' ' ' ASN . 11.4 pt-20 -81.15 20.01 0.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.158 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . 0.535 ' C ' ' O ' ' A' ' 520' ' ' GLU . 55.7 t30 -29.81 107.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.198 -159.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 70.5 p -101.06 11.72 39.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.206 168.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 94.7 t -116.14 136.17 53.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.156 -170.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 90.8 t -88.62 121.38 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.287 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -108.88 -178.4 3.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.232 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.42 -30.52 70.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -115.34 -121.99 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.181 166.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -163.49 -45.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.168 166.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -98.57 5.99 47.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 -162.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -94.92 11.3 32.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.213 -171.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -101.41 20.26 16.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.173 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.57 142.01 44.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.203 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.4 131.74 48.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 80.1 m -115.25 125.34 53.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.171 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -132.58 130.83 40.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.149 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -104.05 129.63 51.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.224 -174.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.0 t -121.27 137.19 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.257 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.6 t -103.97 124.13 48.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.199 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 83.9 t -102.17 126.47 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.242 175.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.07 160.54 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.26 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 76.0 mt -84.5 -4.63 59.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.185 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 . . . . . 0 C--O 1.2 -1.506 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.114 -175.801 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 28.7 ttt . . . . . 0 CA--C 1.523 -0.084 0 CA-C-O 120.884 0.373 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -91.55 144.83 25.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.249 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -120.23 121.01 29.68 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.165 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.24 165.37 26.97 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.74 1.627 . . . . 0.0 111.064 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -143.36 89.72 2.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 15.4 mt -90.14 128.3 36.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.187 -176.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.4 t -143.76 157.59 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.199 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.63 154.59 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.25 -177.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' GLU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 50.3 mt-10 -135.95 139.82 43.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.233 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 85.4 mt -105.38 132.17 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.24 142.52 44.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.189 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 160.41 -174.97 37.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.15 142.72 42.53 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.762 1.642 . . . . 0.0 111.208 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -75.24 -46.36 34.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.251 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.18 130.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.192 -176.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.37 153.09 38.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.249 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -85.65 159.81 33.62 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 4.7 p -72.41 139.96 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 0.0 111.242 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 63.31 29.95 15.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.22 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -124.52 138.64 54.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.22 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 502' ' ' SER . 34.4 tp -81.49 126.9 32.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.24 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.81 144.47 48.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.223 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -101.88 134.19 45.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.213 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -129.42 156.88 43.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.106 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -130.1 139.94 50.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.124 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.9 t -111.54 120.1 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' HIS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.0 m-70 -99.63 114.17 27.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.225 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' VAL . . . . . 0.4 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -117.42 129.43 73.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.224 -175.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -144.26 153.07 41.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.23 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 31.0 t30 -111.72 130.05 55.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.185 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 78.9 mt -114.61 4.03 15.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.204 -173.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -88.7 -20.54 47.04 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.91 24.37 72.16 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' ILE . . . . . 0.421 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.6 tt -134.44 138.97 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 111.173 169.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -76.07 131.68 12.06 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -166.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.38 117.63 30.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 111.251 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -86.72 -17.74 3.24 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.639 1.559 . . . . 0.0 111.175 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 98.5 p -95.59 4.36 53.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.259 -160.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' THR . . . . . 0.45 HG21 ' O ' ' A' ' 473' ' ' THR . 9.6 t -86.57 124.33 32.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.265 -164.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -113.6 129.13 56.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.191 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 97.0 t -112.22 127.54 69.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.234 -174.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.69 157.65 41.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.27 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.3 t -126.33 133.63 68.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.145 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -120.85 148.53 43.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 77.5 mt -119.77 115.71 48.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.232 169.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 54.23 41.0 32.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.187 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.18 -16.0 61.96 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 171.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -97.88 136.18 38.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.352 . . . . 0.0 111.207 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.5 tp -68.49 120.0 13.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.099 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -98.37 -40.06 8.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -166.36 157.41 12.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.268 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -139.96 151.18 45.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.181 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 30.0 m-90 -136.82 142.05 42.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.178 170.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.7 m -102.82 125.03 49.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.24 164.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.74 166.0 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.234 -172.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.8 m -122.48 143.53 49.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 171.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.9 mt -128.54 130.26 47.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -91.32 -165.09 39.61 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.49 112.35 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.723 1.616 . . . . 0.0 111.182 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 59.94 48.31 8.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.209 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -104.56 142.98 33.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.146 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -117.59 141.76 47.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.269 172.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -139.25 130.13 26.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.227 -172.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 73.7 t -105.58 118.41 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 -170.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 36.0 mt -105.73 143.6 33.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 173.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 50.7 p -122.87 152.67 40.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -153.81 156.41 37.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.189 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' SER . . . . . 0.406 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.7 m -121.07 133.57 55.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.234 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -133.46 131.21 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.165 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.6 m -116.58 109.74 43.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.278 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.54 153.53 34.73 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.714 1.609 . . . . 0.0 111.19 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 69.9 p -128.52 -2.3 5.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.203 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -133.95 135.31 43.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.206 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -72.24 141.79 48.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.4 175.22 25.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.2 mmm -86.03 127.17 34.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 111.188 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -119.98 137.45 54.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.311 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -106.79 119.2 38.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.205 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 83.7 mt -102.98 123.8 56.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.214 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -116.46 144.98 43.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.184 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.45 141.41 52.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.252 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 73.0 p -131.0 150.55 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.272 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . 0.615 ' O ' ' C ' ' A' ' 518' ' ' ASP . 14.6 p -123.54 150.65 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.261 174.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . 0.615 ' C ' ' O ' ' A' ' 517' ' ' VAL . 30.6 t0 2.83 85.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.242 -166.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.87 -41.81 87.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.213 -175.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -80.24 -24.91 39.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.167 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 76.98 -65.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.264 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 69.6 p 36.63 35.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.199 -162.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.3 p -153.55 138.86 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.225 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 91.9 t -87.7 117.6 31.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.191 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -115.45 170.84 8.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.255 -169.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.69 -27.01 61.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -154.94 121.41 5.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.186 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -101.86 0.47 35.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.225 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -89.73 -12.83 38.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.158 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -101.45 15.11 29.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.221 -175.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -69.27 -17.12 63.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.218 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.49 140.09 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -171.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -129.49 134.01 47.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.1 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 83.0 m -116.85 127.97 54.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.227 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -132.23 131.65 42.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.31 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -99.34 128.94 45.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.166 -172.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.5 t -121.27 136.79 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.175 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.2 t -106.38 123.99 48.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.187 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.3 t -103.1 128.31 56.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.138 175.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.24 165.02 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.25 58.9 4.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.157 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 C--O 1.2 -1.525 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.21 176.827 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.496 ' HB3' HG23 ' A' ' 468' ' ' ILE . 70.8 Cg_endo . . . . . 0 N--CA 1.458 -0.57 0 N-CA-C 111.227 -0.336 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -121.47 90.37 3.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.228 167.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 71.1 mt -83.03 138.27 33.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.193 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.3 t -140.05 153.77 46.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.173 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.2 m -132.89 156.31 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.212 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 95.8 mt-10 -139.74 136.68 34.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.27 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 94.5 mt -107.43 127.49 63.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.97 147.88 48.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.175 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.47 -167.85 34.65 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.51 142.19 58.33 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.689 1.593 . . . . 0.0 111.099 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -89.35 -38.26 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.235 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.2 t -120.42 130.08 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.207 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.41 151.73 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.204 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.47 159.98 43.23 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 540' ' ' VAL . 3.0 p -76.3 141.58 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.206 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 62.54 28.17 16.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.181 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -123.29 144.63 49.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.25 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.423 HD11 ' HB3' ' A' ' 502' ' ' SER . 37.2 tp -87.34 128.49 35.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.182 -173.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.97 145.01 48.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.163 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -103.39 135.26 45.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' TYR . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 94.7 m-85 -129.83 157.18 42.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.485 ' HG2' HG22 ' A' ' 500' ' ' THR . 93.6 mt-10 -130.47 141.07 50.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.185 -175.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 460' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 53.1 t -112.35 121.2 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.14 173.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.5 m-70 -103.16 107.85 18.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.158 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.448 HG11 HG21 ' A' ' 475' ' ' VAL . 2.5 m -118.85 130.52 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.217 -173.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -143.04 155.08 44.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 8.3 t-20 -98.44 138.65 35.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.201 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 80.7 mt -134.44 38.26 3.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.204 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -138.3 8.82 3.5 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 63.11 18.6 60.52 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.581 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 14.9 tt -136.13 139.56 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.713 0.292 . . . . 0.0 111.225 171.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -87.26 141.44 17.51 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -174.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.5 119.35 36.16 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 111.254 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.84 -19.53 9.67 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.716 1.611 . . . . 0.0 111.22 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.7 p -92.95 12.74 22.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.254 -168.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 84.8 m -75.95 109.86 9.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.221 -161.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.89 127.61 54.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.145 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.448 HG21 HG11 ' A' ' 462' ' ' VAL . 64.9 t -115.69 126.2 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.109 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -127.14 152.65 47.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.263 -172.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 80.6 t -129.12 131.87 67.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -119.79 145.93 46.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.157 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.442 HG12 HG12 ' A' ' 513' ' ' ILE . 77.0 mt -118.32 114.89 46.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 53.57 40.77 31.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.222 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.8 -19.07 55.74 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 171.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.0 m -97.65 137.4 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.741 0.305 . . . . 0.0 111.174 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.3 tp -68.78 121.81 17.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.171 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -96.78 -40.27 9.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 485' ' ' LYS . . . . . 0.426 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 48.7 tptt -164.75 158.22 17.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.205 -173.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -143.27 153.28 42.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.233 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 487' ' ' TRP . . . . . 0.426 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 27.4 m-90 -137.98 142.42 40.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 172.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.8 m -107.54 123.04 47.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 168.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.81 167.8 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 70.5 m -118.5 142.28 47.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 97.1 mt -126.79 130.31 50.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.182 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -86.84 -179.97 48.88 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.78 119.7 6.9 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.706 1.604 . . . . 0.0 111.183 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.3 mttt 55.54 35.61 25.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -101.04 144.41 30.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.229 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -122.36 140.5 52.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.228 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -127.67 147.58 50.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.201 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.4 119.23 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 54.5 mt -102.7 142.89 33.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.189 173.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.485 HG22 ' HG2' ' A' ' 459' ' ' GLU . 46.5 p -122.49 153.04 39.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 501' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.0 p90 -153.84 156.02 36.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 167.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.423 ' HB3' HD11 ' A' ' 455' ' ' LEU . 68.0 m -122.29 128.1 50.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.256 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -131.38 131.59 43.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.167 -169.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.6 m -114.08 105.43 54.25 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.212 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.81 118.9 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.732 1.621 . . . . 0.0 111.195 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 70.9 p -94.87 -12.41 26.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.249 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -117.35 138.06 52.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.272 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.471 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 35.7 tt0 -76.12 140.89 42.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.04 174.97 24.77 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.6 mmm -86.2 129.61 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 111.209 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -120.01 134.02 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.17 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -106.24 118.63 37.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.244 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.442 HG12 HG12 ' A' ' 479' ' ' ILE . 82.2 mt -105.35 123.23 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.244 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -118.5 145.43 45.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.08 140.04 52.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 172.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 66.6 p -131.9 153.2 50.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.25 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.203 170.727 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 90.8 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.702 0.286 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.4 131.8 50.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.7 m -117.15 126.37 52.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.23 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -132.62 129.96 39.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -100.22 129.02 46.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 90.7 t -120.97 135.64 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.25 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.7 t -106.86 123.13 47.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.225 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 94.4 t -102.98 127.09 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.236 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 452' ' ' VAL . 36.0 m -123.07 159.83 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.193 -177.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 541' ' ' LEU . . . . . 0.471 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 94.5 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.208 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.415 ' HG3' HG21 ' A' ' 470' ' ' VAL . 68.3 Cg_endo . . . . . 0 N--CA 1.457 -0.63 0 N-CA-C 111.236 -0.332 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -124.0 76.11 1.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.45 131.04 35.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.242 -174.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.9 t -138.43 154.87 48.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.215 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 32.8 m -131.79 155.19 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 95.1 mt-10 -139.72 136.26 34.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.2 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.2 mt -106.28 127.14 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.178 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.02 147.88 48.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.235 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.04 -169.28 34.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.81 139.51 48.03 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.713 1.609 . . . . 0.0 111.196 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -87.55 -36.11 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 79.2 t -120.6 130.29 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.34 152.84 38.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.192 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.97 159.28 35.79 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.1 p -74.15 138.17 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.824 0.345 . . . . 0.0 111.145 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 62.49 24.31 14.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -115.32 151.92 33.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 502' ' ' SER . 43.3 tp -88.89 128.4 35.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.23 -175.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.48 147.02 46.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.289 173.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.24 138.21 52.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.218 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' TYR . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 90.3 m-85 -129.09 157.74 40.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -128.59 139.99 52.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.193 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.73 121.02 64.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.168 173.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.9 m-70 -102.6 108.0 19.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.468 HG11 HG21 ' A' ' 475' ' ' VAL . 2.1 m -118.63 130.44 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.25 -173.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.43 ' HD3' HD21 ' A' ' 465' ' ' LEU . 19.1 ptpt -143.65 154.05 43.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.222 -172.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 41.7 t-20 -107.0 142.22 36.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 171.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.43 HD21 ' HD3' ' A' ' 463' ' ' LYS . 55.3 mt -132.11 3.73 4.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.185 -170.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.59 1.25 71.78 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.79 17.67 76.92 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.526 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.7 tt -127.14 150.18 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 111.236 171.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -95.5 132.15 10.97 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.415 HG21 ' HG3' ' A' ' 438' ' ' PRO . 87.1 t -116.67 118.03 37.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.85 0.357 . . . . 0.0 111.176 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.06 -19.14 8.38 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 121.724 1.616 . . . . 0.0 111.194 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 95.4 p -93.92 13.56 22.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -165.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 94.1 m -77.44 112.82 14.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -161.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.61 126.56 55.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.187 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.468 HG21 HG11 ' A' ' 462' ' ' VAL . 59.9 t -118.57 127.42 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.189 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -134.89 156.58 48.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.199 -173.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.03 136.88 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -170.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -116.93 147.89 41.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.185 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.415 HG12 HG12 ' A' ' 513' ' ' ILE . 82.2 mt -119.7 116.09 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.221 167.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.28 41.35 32.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.249 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.65 -11.47 68.39 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.9 m -98.63 136.09 39.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.875 0.369 . . . . 0.0 111.18 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.35 120.58 15.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.21 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -98.2 -40.27 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.166 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -168.46 158.52 9.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 -173.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -143.74 153.89 42.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -136.95 143.04 42.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.209 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.6 m -106.38 125.16 50.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.214 169.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.42 168.47 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.201 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.7 m -120.02 142.22 49.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.18 172.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.0 mt -128.38 130.79 48.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.255 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -90.64 -171.06 43.63 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.83 113.3 1.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.602 1.535 . . . . 0.0 111.201 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.0 mttt 65.4 35.3 7.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.196 177.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -101.72 143.2 31.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.182 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.87 141.3 52.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.207 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -127.1 146.17 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 94.3 t -112.35 119.69 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.176 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 38.8 mt -102.88 142.17 34.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.223 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 66.2 p -122.25 152.52 39.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.199 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 501' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.9 p90 -155.21 157.2 36.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.263 169.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.412 ' HB3' HD11 ' A' ' 455' ' ' LEU . 73.6 m -120.26 128.67 53.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.183 -175.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -130.51 129.87 43.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.236 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.1 m -117.26 109.35 42.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.258 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.74 155.04 44.23 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.715 1.61 . . . . 0.0 111.221 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 73.3 p -125.48 -10.16 6.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.168 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -129.96 136.07 49.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.257 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -71.17 142.88 50.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.198 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.98 174.6 25.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -84.19 125.96 32.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -119.58 132.12 55.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.211 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -104.97 118.69 37.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.215 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.415 HG12 HG12 ' A' ' 479' ' ' ILE . 86.8 mt -104.47 124.25 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.187 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -118.33 144.16 46.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.65 139.24 54.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 172.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 64.0 p -130.91 150.1 52.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.242 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.292 168.021 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 89.2 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.827 0.346 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.16 133.5 48.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.169 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 96.9 m -116.62 126.7 53.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -131.72 131.66 43.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.186 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -103.15 129.27 49.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.228 -173.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 92.8 t -121.29 137.3 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.3 t -108.01 125.15 51.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 96.0 t -103.27 129.37 55.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.183 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.76 164.1 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 93.8 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 179.79 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.458 -0.61 0 N-CA-C 111.238 -0.331 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -124.31 81.88 1.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.263 170.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.01 137.84 35.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.208 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 7.7 t -144.53 154.6 43.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.203 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.59 155.34 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.299 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 97.0 mt-10 -139.95 137.9 35.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.24 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.4 mt -107.6 128.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -135.87 147.52 48.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.153 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.28 -171.18 35.73 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.79 128.78 18.5 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.756 1.637 . . . . 0.0 111.165 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -71.25 -40.32 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.184 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 67.9 t -121.61 131.65 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.181 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 30.0 m -129.88 152.34 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.259 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.26 159.75 43.42 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 176.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 540' ' ' VAL . 1.2 p -79.99 148.02 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.721 0.296 . . . . 0.0 111.215 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 63.39 26.86 15.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 454' ' ' LYS . 27.8 mmmt -129.09 144.49 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.231 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 502' ' ' SER . 30.8 tp -85.35 126.23 33.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.238 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -124.72 144.13 50.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -110.39 136.88 48.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -174.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -129.58 157.29 42.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -129.33 139.21 51.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.143 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.4 t -112.76 120.71 63.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.21 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.1 m-70 -103.35 107.29 18.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.229 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.459 HG11 HG21 ' A' ' 475' ' ' VAL . 2.4 m -118.95 129.18 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.169 -172.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 46.4 pttt -143.41 155.0 44.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.246 -171.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 34.0 t30 -104.37 140.42 37.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.243 170.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 70.4 mt -128.47 6.52 5.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -95.64 -12.25 53.83 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 75.08 23.59 73.95 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.501 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 8.3 tt -128.96 139.77 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 0.0 111.219 165.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.58 134.33 13.96 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -173.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.38 116.23 39.48 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 111.28 172.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.46 -19.07 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.692 1.595 . . . . 0.0 111.18 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.7 p -95.05 13.43 25.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.205 -164.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 88.3 m -78.22 110.8 13.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 -163.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -111.27 127.39 55.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.459 HG21 HG11 ' A' ' 462' ' ' VAL . 68.8 t -115.09 126.93 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.282 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -127.89 153.44 46.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.139 -173.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 79.1 t -130.06 133.86 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -119.03 148.07 43.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.248 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 513' ' ' ILE . 84.6 mt -118.73 115.55 48.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.253 169.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 53.74 41.17 32.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.267 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.97 -10.43 70.6 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.4 m -97.45 136.51 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 111.135 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.9 tp -69.05 120.79 15.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.147 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -98.26 -40.63 8.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.256 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -167.98 161.1 12.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.198 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -141.83 152.56 43.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -137.37 142.36 41.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.268 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.0 m -108.74 124.56 50.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.195 168.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.56 168.19 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.191 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 49.2 m -120.9 143.09 49.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.171 172.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.2 129.13 47.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.161 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.24 -173.86 48.64 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.6 112.4 1.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.701 1.601 . . . . 0.0 111.146 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.0 mttt 65.95 36.06 6.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.196 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -101.6 144.0 30.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.38 140.41 52.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -129.39 145.75 51.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 89.4 t -112.72 118.99 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.195 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 50.3 mt -103.41 142.71 33.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.212 173.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 63.3 p -124.51 153.3 42.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.257 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.93 156.73 38.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.255 168.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.504 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.8 m -120.46 128.66 53.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 -175.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -129.67 129.57 44.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.232 -170.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 95.3 m -115.9 109.7 44.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.16 141.43 29.32 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.724 1.616 . . . . 0.0 111.148 174.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 81.5 p -111.91 -21.58 11.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.216 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -120.14 139.58 52.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.249 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.438 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 32.5 tt0 -73.2 140.22 46.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.276 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.04 175.3 24.33 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.4 mmm -86.4 129.01 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 111.195 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -120.73 131.37 54.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.282 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.01 119.43 38.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.156 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 479' ' ' ILE . 90.2 mt -101.71 122.24 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.161 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -120.67 145.97 46.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.161 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.25 142.06 51.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.5 p -131.04 149.76 52.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.245 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 168.833 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 93.4 t . . . . . 0 CA--C 1.523 -0.068 0 CA-C-O 120.805 0.336 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.12 133.17 46.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 83.7 m -114.48 124.05 50.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -133.13 131.07 40.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.172 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -104.07 130.31 51.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.169 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.51 136.94 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.157 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.1 t -104.84 124.95 50.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.268 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 95.8 t -101.89 127.32 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.189 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 452' ' ' VAL . 34.7 m -120.85 160.31 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 541' ' ' LEU . . . . . 0.438 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 92.7 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 N--CA 1.458 -0.56 0 N-CA-C 111.224 -0.337 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -129.45 99.27 5.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.228 170.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.4 145.32 25.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.288 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.5 t -149.33 156.77 42.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.17 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.63 153.53 39.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.175 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 47.7 mt-10 -138.2 137.89 38.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.213 177.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 83.4 mt -107.52 126.12 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.181 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -136.96 148.93 47.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.184 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.61 -166.85 33.45 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -55.22 136.62 74.19 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.693 1.595 . . . . 0.0 111.239 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -87.68 -40.1 14.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.223 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.55 130.11 74.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.78 153.83 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.195 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.59 157.87 34.9 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.8 p -70.5 141.67 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.213 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 63.57 29.75 15.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.245 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -124.18 142.42 51.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.163 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 502' ' ' SER . 44.2 tp -82.36 126.24 31.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.308 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.27 144.28 49.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.248 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -101.16 134.31 44.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.163 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -128.39 157.19 41.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.242 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.428 ' HG2' HG22 ' A' ' 500' ' ' THR . 87.3 mt-10 -129.91 138.47 50.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.224 -175.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.46 119.9 59.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 95.9 m-70 -98.88 112.92 24.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.179 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.66 131.42 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.215 -174.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -123.04 152.68 40.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.265 -172.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 12.9 t-20 -106.71 129.89 54.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 152.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 75.8 mt -120.12 22.12 11.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.212 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 468' ' ' ILE . . . -112.89 136.7 13.67 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 467' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 466' ' ' GLY . . . -9.12 -46.55 0.0 OUTLIER Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 155.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 466' ' ' GLY . 12.6 tt -123.16 142.29 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.744 0.306 . . . . 0.0 111.261 -163.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -89.06 162.5 31.14 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 84.4 t -124.5 119.06 26.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.199 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.52 -19.22 7.74 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.69 1.593 . . . . 0.0 111.158 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 96.5 p -94.83 14.6 20.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -166.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.1 m -76.46 110.85 11.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 -158.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.42 125.99 53.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.186 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 96.3 t -117.29 129.95 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.117 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -125.36 152.58 44.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.168 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 51.8 t -126.89 134.58 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -121.08 148.11 44.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.134 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.33 115.56 47.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.183 171.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 54.35 41.25 32.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.36 -14.87 64.46 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 171.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.2 m -98.96 137.19 37.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.75 0.31 . . . . 0.0 111.254 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.3 tp -68.38 119.36 12.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -100.06 -40.61 7.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.23 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -153.85 160.59 42.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -142.98 149.75 38.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.293 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -137.64 142.13 41.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.1 m -109.45 123.55 49.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.24 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.41 168.08 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.252 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.9 m -116.31 141.48 48.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.166 171.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 83.5 mt -126.88 128.63 46.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -76.97 177.3 52.39 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 172.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 493' ' ' PRO . . . . . 0.412 ' HB3' ' O ' ' A' ' 467' ' ' GLY . 55.1 Cg_endo -65.75 117.55 4.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.739 1.626 . . . . 0.0 111.202 176.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 93.2 mttt 66.91 36.78 4.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.194 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -112.11 144.03 42.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.235 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -119.34 142.8 47.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.199 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -129.56 150.16 51.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 88.2 t -113.25 120.0 62.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 42.8 mt -103.12 144.45 31.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.246 172.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 459' ' ' GLU . 41.0 p -122.55 154.7 37.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.183 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.71 156.66 38.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.183 168.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.412 ' HB3' HD11 ' A' ' 455' ' ' LEU . 69.4 m -120.44 136.97 54.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.17 -177.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -140.61 129.08 22.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.243 -167.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.4 m -119.55 111.9 35.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.23 152.89 40.24 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.663 1.575 . . . . 0.0 111.219 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 72.9 p -124.45 -12.44 7.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -123.03 141.21 52.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.202 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -86.88 142.14 28.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.171 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.54 178.28 27.03 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -170.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.3 mmm -84.8 128.25 34.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.204 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -117.61 133.95 55.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -107.7 118.63 37.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 80.7 mt -105.03 124.98 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.271 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -117.78 147.08 43.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.275 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.93 139.11 53.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 66.0 p -131.92 153.96 49.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.26 171.895 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 97.7 t . . . . . 0 CA--C 1.524 -0.056 0 CA-C-O 120.847 0.356 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.26 131.9 51.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.281 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.6 m -117.49 127.27 53.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.256 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -130.46 131.61 45.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.172 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -100.85 126.15 47.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.202 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.77 136.38 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.212 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -108.56 124.68 50.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 91.7 t -104.29 129.4 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.248 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.81 172.79 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.237 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 179.25 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.529 ' HG3' HG21 ' A' ' 470' ' ' VAL . 64.6 Cg_endo . . . . . 0 N--CA 1.457 -0.618 0 N-CA-C 111.208 -0.343 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -123.47 75.1 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.212 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 48.9 mt -81.47 126.01 31.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 15.4 t -143.22 157.38 44.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.55 154.89 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.25 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 50.4 mt-10 -137.46 136.84 38.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 81.5 mt -102.53 134.63 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.207 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -135.49 143.15 45.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 144.0 -176.34 23.35 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.44 165.92 26.7 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.644 1.562 . . . . 0.0 111.162 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 58.5 p-10 -123.86 10.4 8.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.19 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.56 116.48 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.122 167.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.3 154.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.223 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.64 160.44 28.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.3 p -72.91 135.42 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.744 0.307 . . . . 0.0 111.237 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 62.08 20.43 11.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.212 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -109.76 130.46 55.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.229 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 502' ' ' SER . 32.0 tp -76.23 128.6 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.193 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.63 142.07 51.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.21 173.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -111.2 139.0 46.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.195 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -130.86 159.08 38.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.424 ' HG2' HG22 ' A' ' 500' ' ' THR . 91.2 mt-10 -129.6 140.14 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 60.7 t -114.33 120.51 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.202 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 85.1 m-70 -99.32 115.8 30.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.237 176.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.74 131.84 70.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.205 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -128.33 156.3 43.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 62.3 t-20 -118.7 116.18 26.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.219 159.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 57.4 mt -109.6 13.19 23.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.205 -170.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.57 -3.17 69.2 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.9 19.72 78.39 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.515 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 6.4 tt -130.77 148.0 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.731 0.301 . . . . 0.0 111.166 174.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -85.96 131.12 10.3 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.529 HG21 ' HG3' ' A' ' 438' ' ' PRO . 92.0 t -117.95 116.42 36.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.234 170.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.68 -19.64 6.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.753 1.635 . . . . 0.0 111.161 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 78.5 p -98.56 0.13 44.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.134 -158.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 473' ' ' THR . 13.1 t -85.53 124.71 32.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.21 -162.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -111.68 128.65 56.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.227 -172.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.13 125.89 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.231 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -130.33 155.05 46.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.256 -170.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.85 133.23 66.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.262 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -119.91 147.5 44.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.275 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.1 mt -120.59 118.51 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.253 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 54.64 41.01 32.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.195 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.34 -20.09 45.98 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 171.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.3 m -98.31 139.44 34.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.821 0.343 . . . . 0.0 111.189 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.6 tp -68.21 121.15 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.152 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 484' ' ' TYR . . . . . 0.411 ' OH ' ' O ' ' A' ' 502' ' ' SER . 29.9 t80 -96.48 -39.3 9.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.234 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -163.34 158.69 21.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.187 -173.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -140.19 149.97 43.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -138.68 141.91 38.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.156 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.8 m -104.79 127.42 52.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.0 m -138.1 166.34 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 53.5 m -121.73 142.25 50.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.194 170.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.5 mt -128.85 131.19 47.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.92 -178.03 46.26 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.82 117.76 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.773 1.649 . . . . 0.0 111.21 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.1 mttt 55.56 39.79 31.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.216 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -100.47 145.23 28.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.139 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -120.85 140.72 51.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.186 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -127.58 145.7 50.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 173.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.92 119.58 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.4 mt -104.89 142.09 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.147 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.424 HG22 ' HG2' ' A' ' 459' ' ' GLU . 44.4 p -122.58 150.86 42.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.192 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.85 156.57 36.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 171.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.412 ' HB2' HD11 ' A' ' 455' ' ' LEU . 95.6 p -122.93 133.72 54.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -140.79 129.71 23.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.2 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.0 m -116.51 112.34 41.28 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.214 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -71.47 153.33 60.73 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.748 1.632 . . . . 0.0 111.176 172.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 65.0 p -122.81 -5.21 8.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.061 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -133.47 137.19 45.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.152 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.09 141.43 52.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.288 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.24 176.91 26.25 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.3 mmm -84.85 128.05 34.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 111.173 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -120.25 132.83 55.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.17 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -104.23 119.58 39.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 94.2 mt -103.68 124.46 57.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.187 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -119.67 146.17 45.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.09 143.74 50.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.205 172.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 77.4 p -130.73 150.04 52.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.202 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 517' ' ' VAL . 7.2 p . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 167.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 58.7 t . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.822 0.344 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.03 134.72 47.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 173.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.9 m -116.74 126.47 53.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.262 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -134.27 123.28 23.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.187 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -102.46 128.11 49.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.163 -172.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 90.6 t -122.79 137.19 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.26 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 71.4 m -98.95 124.9 44.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 86.4 t -102.85 129.37 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.199 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.96 165.84 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.152 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.269 179.713 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo . . . . . 0 N--CA 1.458 -0.56 0 N-CA-C 111.141 -0.369 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -129.98 71.97 1.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.208 166.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 85.2 mt -78.81 139.51 38.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.214 -173.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 12.3 t -146.15 157.7 43.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.208 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.5 155.69 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.187 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.4 mt-10 -139.86 136.05 33.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.236 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 95.3 mt -108.82 126.52 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.154 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.71 148.5 47.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.272 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.69 -168.65 34.39 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.82 116.16 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.642 1.562 . . . . 0.0 111.241 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -75.47 -18.22 59.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.205 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 96.7 t -125.96 129.32 72.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.169 169.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.07 154.05 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.188 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.55 149.86 32.39 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.417 HG11 HD23 ' A' ' 541' ' ' LEU . 5.9 p -71.05 136.54 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 111.187 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 61.85 27.36 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.216 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -123.59 148.21 46.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 502' ' ' SER . 29.4 tp -85.58 128.07 34.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -172.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.79 145.85 48.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.195 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -109.09 133.97 52.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.188 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 458' ' ' TYR . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 90.1 m-85 -127.91 157.2 41.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.417 ' HG2' HG22 ' A' ' 500' ' ' THR . 96.8 mt-10 -130.5 141.1 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.179 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 49.7 t -112.88 120.08 62.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.207 170.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.6 m-70 -101.8 111.3 23.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.15 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 475' ' ' VAL . 8.9 m -116.05 132.05 66.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.281 -170.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -127.21 155.13 43.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.217 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 61.2 t-20 -116.75 120.84 39.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.206 159.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 63.0 mt -115.0 8.19 15.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -168.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.03 -0.24 74.76 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.68 20.05 75.42 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.525 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.0 tt -131.03 145.68 35.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.786 0.327 . . . . 0.0 111.185 173.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -84.85 134.54 12.73 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.81 116.49 31.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.252 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.66 -18.49 9.27 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.675 1.583 . . . . 0.0 111.14 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.4 p -92.01 10.65 28.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.225 -165.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 99.0 m -80.27 112.91 18.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.142 -162.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -110.48 127.52 55.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.213 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.444 HG21 HG11 ' A' ' 462' ' ' VAL . 93.8 t -115.83 127.1 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -127.09 155.2 43.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.169 -172.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 69.2 t -128.67 132.96 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.279 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -120.17 147.03 45.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.225 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.424 HG12 HG12 ' A' ' 513' ' ' ILE . 83.6 mt -118.72 117.05 53.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.246 172.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 54.08 41.02 32.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.242 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.23 -10.44 66.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.5 m -97.51 138.45 34.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 111.222 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.6 tp -69.8 120.81 16.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.187 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -98.93 -40.69 7.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.262 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -166.57 159.03 13.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 -173.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -140.95 151.82 44.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.212 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 25.9 m-90 -138.16 141.9 40.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.23 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.6 m -109.65 126.02 53.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.252 168.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.04 167.83 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.199 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 30.4 t -118.79 140.93 49.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 170.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 83.9 mt -128.99 126.01 38.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.163 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.78 -173.39 48.32 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.23 111.7 1.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.772 1.648 . . . . 0.0 111.241 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.0 mttt 58.65 41.45 22.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -101.32 143.96 30.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.221 173.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -121.08 139.95 52.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.158 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -128.45 147.85 50.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.248 175.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 96.9 t -112.2 118.95 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.169 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 48.3 mt -102.24 142.19 33.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.222 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.417 HG22 ' HG2' ' A' ' 459' ' ' GLU . 36.1 p -122.85 151.92 41.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.248 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 501' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 55.1 p90 -154.41 156.38 36.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.167 166.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.469 ' HB3' HD11 ' A' ' 455' ' ' LEU . 69.9 m -119.73 128.63 53.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.191 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -125.74 129.27 49.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 -171.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 96.2 m -117.8 108.76 42.3 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 172.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.85 157.65 54.61 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.741 1.627 . . . . 0.0 111.25 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 75.5 p -124.9 -21.95 4.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.206 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.97 138.77 52.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.423 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 34.7 tt0 -73.74 139.71 45.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.5 174.76 24.11 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.5 mmm -85.59 128.46 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.844 0.354 . . . . 0.0 111.142 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -120.77 130.31 53.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -103.27 119.81 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.19 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.424 HG12 HG12 ' A' ' 479' ' ' ILE . 80.8 mt -102.11 120.22 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.271 176.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -122.35 146.41 47.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.226 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.15 140.25 53.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.9 p -131.79 152.78 50.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.249 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 172.085 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 93.3 t . . . . . 0 CA--C 1.523 -0.076 0 CA-C-O 120.837 0.351 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.58 133.56 49.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.195 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.1 m -115.43 124.2 50.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.266 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -128.31 128.51 44.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -101.1 126.94 47.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.243 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.5 t -121.43 136.18 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.8 t -101.41 127.5 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.9 t -99.78 126.69 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.42 150.72 24.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.183 -173.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 541' ' ' LEU . . . . . 0.423 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 86.0 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.193 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 N--CA 1.458 -0.562 0 N-CA-C 111.21 -0.342 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -129.7 81.06 1.99 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.182 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 8.9 mt -89.42 130.66 35.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 -175.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.0 t -146.16 163.1 36.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.228 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.09 154.58 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 93.9 mt-10 -135.63 137.94 42.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.208 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 89.3 mt -104.35 132.0 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.67 142.98 45.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.222 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.45 32.79 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.19 141.26 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.743 1.629 . . . . 0.0 111.232 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -97.26 -18.81 18.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.228 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 87.9 t -126.12 125.94 68.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.259 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.57 154.27 39.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.195 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.27 158.1 43.49 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 1.8 p -79.15 142.57 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.799 0.333 . . . . 0.0 111.232 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 63.11 29.41 16.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.22 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -125.93 145.11 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 502' ' ' SER . 33.0 tp -78.53 126.79 31.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.08 143.42 49.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -109.88 135.53 50.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.298 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -129.66 157.87 40.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.216 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.432 ' HG2' HG22 ' A' ' 500' ' ' THR . 80.2 mt-10 -130.09 139.57 50.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.268 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 45.0 t -113.22 120.24 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.175 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 94.2 m-70 -99.59 114.29 27.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 462' ' ' VAL . 2.9 m -117.21 127.0 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.153 -173.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.441 ' HD2' HD21 ' A' ' 465' ' ' LEU . 25.1 pttt -138.18 151.94 48.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 -171.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 52.9 t-20 -111.2 127.59 55.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.276 167.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.441 HD21 ' HD2' ' A' ' 463' ' ' LYS . 68.9 mt -115.61 7.5 14.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.28 -169.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -93.98 -5.2 62.72 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -169.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.02 23.15 76.89 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -171.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.508 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 1.3 mt -130.04 155.18 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 111.168 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.487 ' N ' ' CG2' ' A' ' 468' ' ' ILE . . . -117.08 120.47 4.82 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -172.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 491' ' ' LEU . 74.9 t -119.63 118.22 32.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.185 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -84.29 -17.62 5.4 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.714 1.609 . . . . 0.0 111.152 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 79.3 p -99.0 4.17 47.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -163.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 473' ' ' THR . 3.5 t -83.67 125.34 31.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.176 -163.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.58 130.35 55.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 -170.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 76.6 t -113.11 128.29 69.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.269 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.51 154.26 45.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.2 -173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 78.0 t -127.7 132.89 68.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.201 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -120.31 147.05 45.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.3 mt -120.85 116.22 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.194 172.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 54.38 40.97 32.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.269 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 93.49 -18.79 55.68 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 171.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.4 m -100.08 138.11 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.353 . . . . 0.0 111.149 -175.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.33 121.53 15.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.248 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -93.31 -39.93 10.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.287 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -168.91 159.52 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.233 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -132.08 152.34 51.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.189 -175.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 32.8 m-90 -136.3 141.44 43.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.7 m -109.95 124.72 51.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 166.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 25.9 m -138.74 167.54 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.6 p -114.44 141.08 48.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.24 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 470' ' ' VAL . 82.4 mt -129.82 129.76 44.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.201 174.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -93.76 -173.43 39.56 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.99 111.36 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.656 1.571 . . . . 0.0 111.203 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.4 mttt 63.62 43.64 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.191 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -104.52 142.96 33.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -121.36 139.51 53.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.223 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -128.79 147.25 50.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.199 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 83.2 t -111.62 119.13 59.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -176.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 66.6 mt -104.85 143.93 32.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.179 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.432 HG22 ' HG2' ' A' ' 459' ' ' GLU . 61.0 p -124.77 153.65 42.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.143 175.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -154.3 157.0 37.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.208 170.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.443 ' HB3' HD11 ' A' ' 455' ' ' LEU . 60.9 m -122.27 134.77 54.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.199 -175.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -140.33 129.49 23.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.215 -168.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.0 m -118.88 112.42 36.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.182 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.74 151.55 41.02 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.769 1.646 . . . . 0.0 111.286 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 70.1 p -122.02 -15.13 7.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.177 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -120.59 139.46 52.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.233 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -75.79 140.16 42.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.211 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.67 177.13 26.84 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.7 mmm -86.36 129.42 34.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.781 0.324 . . . . 0.0 111.222 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.84 132.62 55.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.263 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -104.74 118.19 35.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 89.1 mt -105.91 122.95 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -122.41 150.23 42.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.146 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.74 141.05 52.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.259 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 59.5 p -130.82 155.08 47.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.23 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.16 172.336 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 92.3 t . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.786 0.327 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -124.38 131.71 53.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.176 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.5 m -116.98 126.55 53.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.195 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -131.95 130.28 41.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.258 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -101.32 129.27 47.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.239 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 93.6 t -121.14 136.4 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.207 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 40.2 t -104.96 124.75 50.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.185 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.6 t -101.7 127.04 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.173 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 31.8 m -124.71 165.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.249 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 69.4 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.24 -175.384 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.491 ' HG3' HG21 ' A' ' 470' ' ' VAL . 84.7 Cg_endo . . . . . 0 N--CA 1.457 -0.665 0 N-CA-C 111.263 -0.322 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' ASP . . . . . 0.456 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 62.0 t0 -122.49 73.91 1.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.278 167.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.48 137.09 36.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 8.2 t -144.19 154.33 43.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.185 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.3 m -128.46 153.65 38.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.153 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.4 mt-10 -141.01 137.82 33.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.66 127.25 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.207 174.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.13 145.2 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.117 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.5 -166.5 38.47 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.1 143.36 64.96 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.694 1.596 . . . . 0.0 111.249 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -90.35 -39.17 12.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.193 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 70.2 t -121.15 130.15 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.253 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.63 153.31 38.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.205 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -82.78 157.27 35.62 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.5 138.07 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.215 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 62.63 25.19 14.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.258 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -114.78 150.97 34.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.197 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 42.5 tp -87.41 127.21 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 -175.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.32 144.57 48.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.232 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.08 138.15 46.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.03 156.65 44.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -129.49 139.36 51.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.15 120.81 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.235 173.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 95.4 m-70 -102.42 107.72 18.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.184 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.3 m -118.48 129.95 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.166 -173.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.407 ' HD3' HD21 ' A' ' 465' ' ' LEU . 19.1 ptpt -143.72 154.72 43.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.192 -171.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 39.7 t-20 -108.26 143.67 36.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.223 170.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 43.6 mt -133.01 3.37 3.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.204 -172.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -96.97 4.63 63.1 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -170.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.07 17.57 75.76 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 174.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.55 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 2.2 tt -125.87 149.72 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.733 0.301 . . . . 0.0 111.181 167.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -95.91 131.76 10.79 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.491 HG21 ' HG3' ' A' ' 438' ' ' PRO . 99.5 t -119.33 119.63 31.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 111.218 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.17 -19.2 6.94 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.632 1.555 . . . . 0.0 111.189 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 91.2 p -94.12 16.51 14.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.185 -164.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 94.7 m -82.36 111.71 18.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.262 -165.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -111.57 127.24 55.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 85.3 t -118.14 128.8 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.159 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -125.05 154.69 40.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 -173.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.71 134.37 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.23 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -122.04 149.17 43.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.211 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 81.6 mt -120.54 115.69 47.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.198 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.26 41.44 31.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.236 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.94 -8.66 79.2 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.0 m -97.97 135.92 38.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.788 0.328 . . . . 0.0 111.298 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 68.2 tp -68.76 118.79 12.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -99.78 -40.42 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.262 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -166.99 158.85 12.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -140.5 151.97 45.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.21 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -137.36 142.23 41.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.168 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.9 m -109.5 124.38 50.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 166.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.93 168.09 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.125 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.1 m -118.79 142.0 48.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.182 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.31 131.08 48.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.39 -175.48 48.72 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.46 113.32 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.7 1.6 . . . . 0.0 111.159 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.7 mttt 65.9 35.32 6.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.173 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -102.97 143.63 32.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.237 176.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.9 141.08 51.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.189 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -128.18 146.76 50.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.28 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.69 119.58 60.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.225 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.3 mt -101.82 143.35 31.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.136 173.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 59.5 p -122.21 151.85 40.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.184 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.72 156.21 35.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.218 167.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.2 m -123.01 133.98 54.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.179 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 45.5 t90 -140.21 130.0 24.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.195 -167.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 95.2 m -118.17 111.78 38.4 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.296 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.12 155.53 56.65 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.596 1.53 . . . . 0.0 111.247 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 76.9 p -125.25 -13.02 6.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.271 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.39 137.57 49.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.17 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.97 142.17 52.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.42 175.59 24.96 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.2 mmm -85.62 126.86 34.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 111.259 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -119.79 126.94 52.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.206 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -103.31 119.24 38.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.252 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.41 124.12 56.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.218 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -116.86 145.14 43.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.151 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.24 139.55 53.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 173.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 76.8 p -131.05 151.51 51.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.235 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 169.732 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 49.4 t . . . . . 0 CA--C 1.523 -0.059 0 CA-C-O 120.835 0.35 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.79 132.37 51.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 88.0 m -116.32 125.63 52.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -131.14 130.39 43.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -102.34 129.98 48.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.23 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 92.3 t -120.52 136.54 57.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.168 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.8 t -105.84 124.82 50.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.172 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.9 t -102.85 129.22 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.196 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.92 164.45 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.14 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.248 -178.159 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo . . . . . 0 N--CA 1.459 -0.558 0 N-CA-C 111.254 -0.325 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -130.28 58.37 1.67 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.285 166.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.08 134.67 53.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 -175.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 10.0 t -142.08 153.3 44.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.207 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.9 m -131.63 154.07 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.237 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.1 mt-10 -139.2 137.08 35.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 91.3 mt -107.16 127.4 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.244 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.93 148.76 48.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.205 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 152.5 -163.57 30.36 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.96 144.45 94.29 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.755 1.637 . . . . 0.0 111.196 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -98.55 -37.01 9.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.183 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 84.9 t -122.15 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.228 172.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.81 151.1 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.108 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -77.09 155.86 44.81 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.93 135.76 27.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.788 0.328 . . . . 0.0 111.21 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 63.02 26.57 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -114.0 154.92 26.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 40.2 tp -94.4 128.09 40.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.261 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.29 143.45 50.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.172 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -105.64 136.5 45.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.25 174.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.33 156.57 44.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.183 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 500' ' ' THR . 92.9 mt-10 -130.19 140.99 50.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 -177.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 53.1 t -113.14 121.39 65.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.239 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 87.5 m-70 -96.57 111.47 23.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.241 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 475' ' ' VAL . 2.6 m -119.91 129.18 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.272 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -145.35 155.29 43.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 36.7 t-20 -106.61 142.22 36.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.225 171.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 65.0 mt -134.08 5.06 3.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.231 -172.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -89.14 2.45 83.72 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -175.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.22 16.3 77.0 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.54 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 6.4 tt -126.45 146.06 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.25 171.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -87.11 132.56 11.24 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 173.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 80.7 t -116.17 115.5 40.44 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.841 0.353 . . . . 0.0 111.263 171.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.02 -18.25 8.94 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.591 1.528 . . . . 0.0 111.162 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.9 p -93.33 11.52 27.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.212 -166.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 86.9 m -75.76 114.38 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.161 -158.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.71 128.18 55.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.504 HG21 HG11 ' A' ' 462' ' ' VAL . 63.4 t -116.76 128.75 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.231 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -125.43 154.25 42.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.21 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 76.6 t -128.41 134.01 65.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.238 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.58 147.41 45.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.7 mt -120.7 116.81 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.204 171.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 54.41 41.48 31.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 90.73 -14.27 63.51 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.3 m -97.28 137.43 36.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 111.26 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 67.5 tp -69.52 120.69 15.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.154 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -97.61 -40.19 8.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.258 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -165.7 158.79 15.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -140.05 152.34 46.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.23 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -138.49 142.87 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.178 172.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.8 m -107.27 125.71 51.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 168.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.65 168.06 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.144 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 62.7 m -119.58 141.77 48.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.209 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 87.9 mt -129.39 130.19 45.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.202 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.03 -172.86 47.45 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.16 112.65 1.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.655 1.57 . . . . 0.0 111.212 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.5 mttt 65.7 35.34 6.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -101.91 142.55 33.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.256 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -120.74 141.47 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -127.35 146.27 50.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.264 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.7 t -111.55 119.5 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.146 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.54 143.02 32.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.447 HG22 ' HG2' ' A' ' 459' ' ' GLU . 41.6 p -120.84 151.5 39.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.225 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -154.44 156.65 37.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 167.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 67.3 m -122.05 132.5 54.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 46.6 t90 -138.39 129.04 26.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.164 -168.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 88.3 m -116.48 110.29 42.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.192 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.99 144.6 58.68 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.638 1.559 . . . . 0.0 111.151 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 76.2 p -117.36 -14.89 10.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.24 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -118.97 137.31 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.129 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 22.0 pm0 -77.04 145.47 37.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.137 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 147.18 178.16 22.26 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -85.33 129.6 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.749 0.309 . . . . 0.0 111.257 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -119.43 133.38 55.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.165 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -106.05 119.16 38.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.257 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 83.1 mt -104.28 124.1 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.252 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -117.62 145.93 44.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.55 138.8 53.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.3 p -131.6 151.03 51.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.22 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.2 172.579 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.793 0.33 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.76 132.01 49.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.189 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.0 m -116.68 125.83 52.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.175 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -130.86 131.35 44.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.321 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -101.06 125.88 47.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -173.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 85.4 t -120.15 135.62 59.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -106.94 125.56 51.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.221 171.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 95.5 t -100.77 126.17 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.156 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.83 170.41 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.158 -174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.204 -177.612 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.469 ' HG3' HG21 ' A' ' 470' ' ' VAL . 72.8 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 N-CA-C 111.231 -0.334 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 56.7 t0 -116.56 62.1 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 169.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.84 137.13 57.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.222 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.1 t -146.66 156.97 43.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.204 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.09 155.21 39.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 47.5 mt-10 -138.75 135.71 34.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.126 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 444' ' ' ILE . . . . . 0.43 HD13 HG22 ' A' ' 513' ' ' ILE . 89.6 mt -107.57 125.52 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.156 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -136.86 147.19 46.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.2 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.73 -165.75 34.17 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -56.96 136.67 78.04 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.712 1.608 . . . . 0.0 111.178 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -86.39 -38.63 17.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.405 HG22 ' HB3' ' A' ' 538' ' ' SER . 92.2 t -124.84 133.91 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.8 m -130.45 152.65 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -82.4 160.42 39.91 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 540' ' ' VAL . 4.9 p -76.45 139.25 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 0.0 111.144 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 62.57 27.3 16.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.273 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -123.95 142.39 51.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.163 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.515 HD11 ' HB3' ' A' ' 502' ' ' SER . 36.7 tp -85.76 127.29 34.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.237 -174.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.58 144.17 49.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.221 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -110.1 135.14 51.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.156 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -129.09 157.64 41.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.501 ' HG2' HG22 ' A' ' 500' ' ' THR . 81.7 mt-10 -130.45 139.23 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.223 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 59.4 t -112.09 120.63 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 172.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 88.3 m-70 -97.86 118.38 34.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.505 HG11 HG21 ' A' ' 475' ' ' VAL . 11.8 m -117.97 131.86 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -127.04 155.22 43.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.229 -175.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 54.8 t-20 -117.06 131.26 56.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.245 157.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 50.8 mt -127.25 4.7 6.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.171 -167.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -91.8 3.73 78.14 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -175.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.8 20.24 75.78 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.579 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.1 tt -131.81 144.34 37.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.754 0.312 . . . . 0.0 111.231 175.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -85.8 133.18 11.6 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.469 HG21 ' HG3' ' A' ' 438' ' ' PRO . 85.9 t -119.61 118.11 32.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 0.0 111.209 170.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.2 -19.08 8.24 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 121.679 1.586 . . . . 0.0 111.133 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 91.5 p -93.07 10.14 32.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.177 -163.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.6 m -78.28 111.58 14.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.269 -161.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -110.4 127.28 55.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.167 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.505 HG21 HG11 ' A' ' 462' ' ' VAL . 88.8 t -115.78 128.75 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.236 -178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -123.6 151.7 42.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -174.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 87.8 t -130.12 134.77 62.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.205 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -118.41 145.77 44.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.74 117.93 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.202 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 50.7 t30 54.41 41.79 31.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.215 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 96.66 -22.91 37.7 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 172.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.1 m -100.27 139.43 35.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 111.174 -175.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 67.1 tp -68.77 121.64 16.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.231 175.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -98.18 -41.02 8.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.217 -173.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -167.45 162.53 14.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -172.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -141.81 153.44 44.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.26 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -137.49 142.08 41.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.234 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.1 m -108.14 127.58 53.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.248 169.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.97 167.6 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.205 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 49.8 m -121.15 142.22 50.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.215 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 82.4 mt -130.47 128.1 40.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.245 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.37 -170.85 46.87 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.57 112.55 1.64 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.702 1.601 . . . . 0.0 111.205 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.3 mttt 62.08 35.67 15.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.268 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -99.55 144.32 28.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.138 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -120.52 141.69 50.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -126.54 146.76 50.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.188 173.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.7 t -112.44 119.34 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.082 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 43.7 mt -103.17 141.1 36.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.2 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.501 HG22 ' HG2' ' A' ' 459' ' ' GLU . 60.7 p -124.76 152.07 44.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.207 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -154.62 157.12 37.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.285 170.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.515 ' HB3' HD11 ' A' ' 455' ' ' LEU . 71.5 m -119.43 131.42 55.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.208 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 42.2 t90 -140.71 129.72 23.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 -169.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 88.9 m -115.94 109.28 45.21 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.279 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.84 118.86 5.61 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.743 1.629 . . . . 0.0 111.104 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 68.2 p -99.02 1.1 45.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.25 137.03 49.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.462 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 37.7 tt0 -73.79 138.49 44.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.184 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.34 174.48 23.69 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.1 mmm -85.22 129.24 34.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.806 0.336 . . . . 0.0 111.185 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -119.48 128.48 54.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.173 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -106.04 119.38 39.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.43 HG22 HD13 ' A' ' 444' ' ' ILE . 79.7 mt -102.96 122.25 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.1 -176.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -119.97 144.74 47.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.91 140.16 52.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.4 p -131.63 151.17 51.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 174.834 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 63.5 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.731 0.301 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.88 133.43 45.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.179 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 96.9 m -115.98 126.31 53.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.211 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -131.25 130.13 42.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.151 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -100.32 129.14 46.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.181 -172.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.6 t -121.22 135.56 61.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.207 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 538' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 449' ' ' VAL . 36.3 t -104.82 126.0 51.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.189 174.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.37 127.76 55.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.177 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 452' ' ' VAL . 35.7 m -122.23 159.23 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.131 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 541' ' ' LEU . . . . . 0.462 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 83.6 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.109 176.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 N--CA 1.458 -0.6 0 N-CA-C 111.188 -0.351 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -138.26 89.68 2.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.6 133.21 37.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.165 -169.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 10.0 t -146.36 155.31 42.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.207 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 517' ' ' VAL . 28.6 m -129.31 153.75 39.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.177 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -135.59 133.69 38.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.251 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 77.6 mt -104.48 124.99 59.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.98 146.55 47.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.182 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.55 -167.44 33.04 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -56.16 133.89 60.8 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.636 1.558 . . . . 0.0 111.181 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -82.66 -40.42 20.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 172.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 64.1 t -122.94 130.88 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.171 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.04 154.43 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.05 152.35 36.41 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.68 137.25 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.797 0.332 . . . . 0.0 111.222 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 64.15 30.78 13.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.213 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -125.02 143.42 50.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.218 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 44.0 tp -81.18 127.2 32.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.259 -175.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.9 144.88 48.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.151 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -103.97 136.43 43.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.18 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -130.04 156.66 44.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.195 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.405 ' HG2' HG22 ' A' ' 500' ' ' THR . 91.3 mt-10 -130.65 140.4 50.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.223 -175.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.69 121.26 64.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.175 172.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -100.46 117.52 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.175 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.52 131.38 71.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.156 -174.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -125.5 154.93 41.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.204 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 61.8 t-20 -117.85 121.7 41.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.222 157.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 61.4 mt -113.75 14.71 18.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.191 -170.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -98.42 -4.83 57.18 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -174.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.9 23.07 78.34 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.49 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.3 tt -134.54 146.92 30.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 111.188 172.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -82.55 135.44 14.09 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 86.0 t -121.88 119.96 28.72 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.741 0.305 . . . . 0.0 111.225 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -84.24 -17.46 5.53 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.668 1.579 . . . . 0.0 111.199 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 84.4 p -91.75 7.98 39.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -162.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 88.4 m -81.23 108.29 14.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.226 -162.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -110.58 124.4 51.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 98.8 t -111.19 126.98 68.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 -173.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -125.53 151.92 45.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 -172.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 73.5 t -126.88 132.8 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.213 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -120.1 147.41 44.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.87 115.07 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.233 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 54.49 40.91 32.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.185 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 95.01 -17.63 58.93 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 171.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.7 m -99.5 135.97 40.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 111.146 -175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.9 tp -67.99 120.54 14.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -96.41 -40.35 9.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.238 -175.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -167.05 158.28 12.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -137.41 152.03 49.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.187 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 -136.73 142.68 43.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.194 174.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.5 m -108.91 124.8 51.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.253 168.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.5 m -139.12 166.81 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 86.8 p -118.02 144.56 45.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 169.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.9 mt -126.72 130.93 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -92.43 -177.34 41.59 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.21 121.04 9.2 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.68 1.586 . . . . 0.0 111.222 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.8 mttt 55.03 41.9 31.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 175.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.91 143.62 34.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.217 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -117.71 140.42 49.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.228 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -126.95 145.85 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 174.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 79.3 t -111.74 119.47 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.178 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 45.4 mt -103.45 143.11 33.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.196 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.405 HG22 ' HG2' ' A' ' 459' ' ' GLU . 52.9 p -122.82 153.23 39.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.25 156.14 36.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.198 166.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 57.6 m -122.18 133.63 54.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.223 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 47.7 t90 -139.86 129.68 24.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 -165.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.5 m -117.8 114.21 37.66 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.221 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -71.32 154.85 61.12 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.706 1.604 . . . . 0.0 111.203 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 74.1 p -124.64 -14.53 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.182 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -122.91 136.51 54.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.254 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 21.7 pm0 -76.51 145.76 38.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.58 179.57 22.81 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -173.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.04 129.96 34.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.741 0.305 . . . . 0.0 111.189 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.45 133.49 55.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.226 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -105.21 119.36 38.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.186 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 94.5 mt -103.86 124.88 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -118.73 145.76 45.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.154 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.23 143.28 51.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.215 173.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 68.1 p -130.89 151.26 51.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.194 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.477 ' HB ' HG13 ' A' ' 442' ' ' VAL . 12.4 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.224 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.809 0.338 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.35 133.02 50.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.9 m -116.67 127.15 54.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.24 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -132.55 129.86 39.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.196 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -100.1 128.5 46.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.206 -172.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 96.6 t -121.26 136.22 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 40.2 t -105.52 124.43 49.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.195 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.16 125.45 55.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.213 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.96 161.4 28.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.197 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.175 177.946 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo . . . . . 0 N--CA 1.458 -0.598 0 N-CA-C 111.223 -0.337 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -111.47 90.32 3.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 166.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 78.1 mt -85.28 145.69 27.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.0 t -144.28 154.77 43.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.275 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 32.6 m -130.62 156.43 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.9 mt-10 -140.11 137.43 34.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.204 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 92.7 mt -107.62 127.16 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.249 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.83 149.04 47.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.23 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 153.46 -165.1 31.3 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.72 120.66 7.57 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.708 1.605 . . . . 0.0 111.256 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -83.33 -8.68 59.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.181 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.24 128.45 64.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 169.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 25.4 m -131.08 155.59 42.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -93.67 154.5 21.7 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.89 137.91 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 62.89 27.44 15.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.23 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -125.36 142.08 51.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.199 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 502' ' ' SER . 37.2 tp -91.07 127.82 36.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.224 -174.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.71 145.55 48.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -106.93 138.02 43.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.184 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -129.09 157.04 42.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.207 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -129.96 139.6 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.267 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 460' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 47.7 t -112.33 121.22 64.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.196 172.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.5 m-70 -101.39 105.91 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.284 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.419 HG11 HG21 ' A' ' 475' ' ' VAL . 3.2 m -118.51 130.78 72.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -173.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -142.38 152.82 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.222 -171.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.63 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.9 t-20 -98.53 140.8 32.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.259 170.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 72.6 mt -130.55 5.4 4.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.221 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -101.37 -1.39 53.79 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.2 27.02 74.15 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.63 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 0.6 OUTLIER -120.69 141.74 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.747 0.308 . . . . 0.0 111.201 175.57 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 469' ' ' GLY . . . . . 0.505 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -81.39 99.61 1.97 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.685 ' CG1' ' O ' ' A' ' 470' ' ' VAL . 0.4 OUTLIER -103.16 110.53 63.82 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.71 -15.33 27.05 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.721 1.614 . . . . 0.0 111.271 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.6 p -89.75 11.18 20.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.195 -157.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' THR . . . . . 0.453 ' OG1' ' CG1' ' A' ' 470' ' ' VAL . 97.3 m -77.16 109.59 11.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 -166.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -110.55 125.75 53.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.266 172.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.419 HG21 HG11 ' A' ' 462' ' ' VAL . 86.3 t -117.35 128.17 74.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.192 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -127.46 154.35 45.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.232 -173.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.2 t -128.16 134.56 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.19 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -122.01 148.0 45.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.297 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 89.6 mt -119.98 117.26 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 172.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 54.16 41.48 31.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.183 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.65 -8.65 74.41 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.9 m -97.55 137.51 36.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 111.288 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 68.5 tp -70.69 120.77 16.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.148 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -98.45 -40.51 8.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.245 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 485' ' ' LYS . . . . . 0.423 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 51.1 tptt -165.95 159.17 15.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.189 -172.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -141.26 152.8 44.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.233 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 487' ' ' TRP . . . . . 0.423 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 24.1 m-90 -138.16 142.4 40.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.2 171.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.9 m -106.79 124.33 49.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.227 169.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.73 167.44 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.263 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 70.7 m -121.21 144.16 48.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.14 172.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 94.6 mt -127.07 129.32 47.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.264 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 492' ' ' GLY . . . . . 0.505 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -83.91 -173.99 50.09 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 174.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.93 111.03 0.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.734 1.623 . . . . 0.0 111.27 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 64.48 34.61 10.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.162 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -99.19 143.31 29.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.236 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.2 140.87 52.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.243 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.46 147.36 49.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.164 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 96.3 t -112.45 119.55 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 54.2 mt -103.51 142.72 33.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.25 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 53.3 p -122.24 153.17 39.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.24 156.15 36.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 167.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.444 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.3 m -121.29 128.28 52.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -128.25 129.8 46.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -171.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.9 m -117.84 109.04 41.81 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.26 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.77 152.19 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.697 1.598 . . . . 0.0 111.247 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.7 p -124.74 -0.77 7.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.25 136.21 48.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.202 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -79.85 143.94 33.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.247 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.28 175.92 22.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -82.25 126.6 32.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.776 0.322 . . . . 0.0 111.13 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -119.84 130.82 55.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.161 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -105.79 118.93 37.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.193 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 84.1 mt -104.22 123.19 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.292 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -119.44 145.7 46.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.249 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.35 142.0 51.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.8 p -130.76 151.38 51.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.216 169.148 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 62.3 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.864 0.364 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.65 135.62 48.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.3 m -114.86 125.58 53.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.219 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -131.46 129.85 41.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.165 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -99.61 124.59 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -173.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 97.0 t -121.28 135.58 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.186 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 36.3 t -104.78 129.33 53.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.224 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 86.3 t -102.41 126.71 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.245 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.32 157.65 38.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.187 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.174 179.861 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.41 ' HG3' HG21 ' A' ' 470' ' ' VAL . 72.2 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 N-CA-C 111.203 -0.345 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -118.74 82.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.146 163.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 87.3 mt -81.1 127.4 32.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.122 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.1 t -148.45 160.92 42.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.196 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.07 155.75 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.276 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -135.99 139.69 43.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.243 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 61.9 mt -108.05 137.27 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.33 142.45 45.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 179.97 179.45 48.8 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.681 ' O ' ' HB2' ' A' ' 448' ' ' ASP . 33.8 Cg_endo -70.98 -31.49 15.04 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.679 1.586 . . . . 0.0 111.224 -172.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 448' ' ' ASP . . . . . 0.681 ' HB2' ' O ' ' A' ' 447' ' ' PRO . 82.7 m-20 75.59 -11.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.271 -175.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.13 117.15 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.68 152.54 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.229 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.51 157.74 44.52 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.5 p -76.43 140.22 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.127 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 63.13 29.6 16.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -124.73 139.0 54.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 37.3 tp -76.5 126.39 30.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.87 145.05 48.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.19 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -103.03 136.15 43.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -129.16 156.68 43.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -128.22 139.24 52.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.234 -171.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 57.0 t -115.85 120.3 64.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 173.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -99.56 113.31 25.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.295 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.43 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -116.14 127.33 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.467 ' HD2' HD21 ' A' ' 465' ' ' LEU . 11.3 pttt -131.83 150.49 52.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.224 -170.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.5 t-20 -105.24 137.99 42.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.241 162.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.467 HD21 ' HD2' ' A' ' 463' ' ' LYS . 56.5 mt -123.61 0.07 8.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 -169.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -95.53 -15.4 43.73 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.49 31.19 63.42 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.519 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 0.1 OUTLIER -132.95 130.08 58.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 111.182 177.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.23 131.34 10.81 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -170.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.41 HG21 ' HG3' ' A' ' 438' ' ' PRO . 97.9 t -123.3 120.11 27.29 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.734 0.302 . . . . 0.0 111.148 170.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.62 -19.01 6.48 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.654 1.57 . . . . 0.0 111.12 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.8 p -95.95 12.93 28.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.256 -163.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.9 m -77.32 117.66 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.192 -162.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -109.95 128.26 55.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.285 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.42 128.15 73.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.198 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -125.9 152.8 45.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -171.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 72.9 t -127.95 132.72 68.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.214 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -120.0 148.76 43.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.234 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.8 mt -120.96 115.91 48.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.261 170.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 54.52 41.35 32.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.2 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 95.42 -19.94 51.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 171.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -98.13 137.03 37.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 0.0 111.223 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.03 120.62 14.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.257 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -97.3 -39.89 9.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -176.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -166.11 157.95 13.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -141.73 154.63 45.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.175 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -135.29 142.3 45.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.238 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.9 m -102.31 122.51 44.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.201 165.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.56 166.92 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.204 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 67.4 m -120.12 142.28 49.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 96.9 mt -128.9 131.45 47.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.251 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -92.42 -165.68 38.82 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.37 114.2 2.77 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.676 1.584 . . . . 0.0 111.205 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 61.7 41.05 12.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.266 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -102.49 141.32 35.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -120.76 137.95 54.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -123.42 145.59 48.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.203 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.66 117.85 55.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 19.0 mt -109.46 136.14 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.24 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 44.6 p -120.09 155.24 33.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -172.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -153.52 156.57 38.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.215 171.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.8 m -121.1 133.35 55.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 41.2 t90 -140.19 130.1 24.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.188 -166.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.6 m -116.33 112.34 41.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.216 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.52 152.37 48.61 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.712 1.608 . . . . 0.0 111.142 172.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 71.1 p -122.37 -15.07 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.228 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -120.07 139.74 52.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -77.24 139.98 39.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.22 178.38 25.97 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.1 131.14 34.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.781 0.324 . . . . 0.0 111.153 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -117.34 137.51 52.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.245 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -104.85 118.69 37.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.152 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 86.2 mt -104.14 125.24 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.205 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -116.74 146.92 42.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.93 142.31 51.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.283 169.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 36.8 p -131.28 151.05 51.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.257 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.26 171.251 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.74 0.305 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -129.74 136.09 49.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.257 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.5 m -114.99 128.44 56.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.186 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -133.21 127.93 34.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.08 -171.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -102.38 128.28 49.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.21 -170.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 86.8 t -122.33 137.15 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 41.2 t -103.91 124.67 49.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.158 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 93.0 t -102.73 126.27 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.162 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.96 159.61 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.167 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.163 178.043 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 438' ' ' PRO . . . . . 0.479 ' HB3' HG23 ' A' ' 468' ' ' ILE . 73.5 Cg_endo . . . . . 0 N--CA 1.458 -0.617 0 N-CA-C 111.257 -0.324 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -111.01 76.09 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.243 164.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.4 mt -74.84 137.9 42.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.3 t -144.34 155.1 43.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.112 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.02 155.74 41.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.304 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 97.8 mt-10 -137.32 139.64 40.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.161 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 87.6 mt -107.85 132.07 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.225 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -136.27 142.8 43.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.229 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 162.18 -173.49 38.5 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.58 134.86 34.23 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.727 1.618 . . . . 0.0 111.229 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -75.9 -40.7 53.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.191 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.4 t -122.31 132.4 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.179 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.05 152.13 36.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.5 159.9 46.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.52 149.2 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 111.174 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 63.38 26.47 14.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.147 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -128.31 143.3 51.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.082 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 37.3 tp -86.38 127.83 34.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.191 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.35 144.19 49.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.218 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -102.46 135.15 44.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' TYR . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 87.2 m-85 -129.16 157.12 42.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.193 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 459' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 500' ' ' THR . 90.6 mt-10 -129.82 141.11 50.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.195 -174.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.9 t -113.24 121.03 64.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 172.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.465 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 94.6 m-70 -99.42 111.1 23.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.156 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.27 130.91 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.435 ' HD3' HD21 ' A' ' 465' ' ' LEU . 19.2 ptpt -143.78 154.1 43.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -175.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.58 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.4 t-20 -104.77 141.46 36.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.208 172.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.435 HD21 ' HD3' ' A' ' 463' ' ' LYS . 63.8 mt -131.69 4.3 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.203 -169.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 466' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -91.78 0.06 72.84 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.28 19.04 75.59 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.58 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 5.5 tt -126.72 143.84 38.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.765 0.317 . . . . 0.0 111.289 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -84.9 132.11 10.86 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' VAL . . . . . 0.45 HG21 ' HG3' ' A' ' 438' ' ' PRO . 85.6 t -118.89 116.01 34.6 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 111.21 173.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.29 -18.19 9.91 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.689 1.592 . . . . 0.0 111.209 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.3 p -91.53 12.56 20.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.259 -167.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 89.8 m -79.64 111.26 15.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.22 -163.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -113.84 125.62 54.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.0 131.02 67.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.198 -173.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -120.42 154.2 35.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.173 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.1 t -128.93 134.81 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.195 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.73 147.28 45.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 93.3 mt -124.24 117.5 50.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.21 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 45.4 t30 54.8 42.18 31.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.195 172.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 96.07 -19.99 52.05 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 174.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.2 m -101.53 138.99 37.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.764 0.316 . . . . 0.0 111.251 -174.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.7 tp -69.96 121.75 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.166 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -97.71 -40.43 8.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.219 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -165.56 158.9 16.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.185 -171.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -140.0 152.77 46.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.221 -177.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -138.49 142.61 39.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.6 m -106.34 126.01 51.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.224 170.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.66 167.85 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.21 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.6 m -120.47 143.34 48.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 170.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.5 mt -129.03 129.21 45.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.259 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -86.44 -173.44 49.1 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.96 112.06 1.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.681 1.587 . . . . 0.0 111.196 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.0 mttt 64.68 33.69 10.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.21 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -101.15 144.96 29.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.167 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -123.5 141.3 52.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.176 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.78 147.22 50.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.182 174.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.9 t -111.87 119.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 43.3 mt -103.81 142.03 35.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.213 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 500' ' ' THR . . . . . 0.445 HG22 ' HG2' ' A' ' 459' ' ' GLU . 47.4 p -122.99 152.95 40.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.226 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 501' ' ' PHE . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.1 p90 -153.97 156.58 37.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.147 168.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 67.1 m -121.28 131.61 54.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.184 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 503' ' ' TRP . . . . . 0.456 ' CH2' ' HB3' ' A' ' 505' ' ' PRO . 41.1 t90 -140.11 129.92 24.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 -169.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 82.1 m -111.47 110.84 55.32 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.256 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 505' ' ' PRO . . . . . 0.456 ' HB3' ' CH2' ' A' ' 503' ' ' TRP . 74.0 Cg_endo -70.96 111.57 3.08 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.726 1.618 . . . . 0.0 111.165 174.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 80.8 p -83.61 -20.31 33.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.195 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -121.75 140.9 51.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.189 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.48 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 31.7 tt0 -72.26 141.0 48.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.05 174.58 23.58 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -176.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -85.48 127.83 34.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.783 0.325 . . . . 0.0 111.157 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -120.38 132.04 55.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.295 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -105.53 119.58 39.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.256 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 92.8 mt -100.73 122.74 53.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -120.75 147.06 45.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.57 140.17 52.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 174.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.2 p -130.91 150.64 51.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.113 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.199 176.68 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 89.5 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.861 0.362 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.37 134.11 48.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.273 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.7 m -116.03 126.38 53.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.156 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -132.68 130.69 40.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.332 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.5 129.42 47.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.164 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.9 t -121.59 136.22 59.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.8 t -106.29 126.8 52.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.211 173.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.9 t -102.3 128.63 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.203 176.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.96 159.94 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 541' ' ' LEU . . . . . 0.48 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 93.2 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 N--CA 1.459 -0.549 0 N-CA-C 111.125 -0.375 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -133.38 83.47 2.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 13.9 mt -91.7 127.08 37.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.253 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 9.0 t -145.77 157.82 43.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.55 154.75 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.199 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 94.9 mt-10 -135.62 137.48 41.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.204 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.6 mt -103.65 131.58 51.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.202 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -135.98 142.24 44.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.186 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.9 -176.02 33.51 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.79 141.19 44.47 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.666 1.577 . . . . 0.0 111.323 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -95.82 -17.24 21.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.204 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.6 t -126.61 124.97 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.8 m -130.03 154.24 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.124 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.44 150.84 27.5 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.79 140.01 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 0.0 111.16 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 63.69 30.11 14.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.161 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -126.02 142.93 51.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 502' ' ' SER . 36.7 tp -83.48 126.67 33.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.196 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.79 144.98 48.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -102.78 135.87 43.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.133 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.94 157.2 42.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -130.01 139.51 51.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.157 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.83 120.09 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.1 m-70 -100.68 116.08 31.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 475' ' ' VAL . 1.4 m -117.41 128.09 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 -175.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.452 ' HD2' HD21 ' A' ' 465' ' ' LEU . 13.4 pttt -133.69 150.76 51.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.176 -174.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 57.8 t-20 -111.51 123.97 51.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.214 167.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.452 HD21 ' HD2' ' A' ' 463' ' ' LYS . 56.0 mt -110.52 5.63 21.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.272 -170.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.77 -14.96 54.34 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -174.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.23 21.88 78.4 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.463 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.0 tt -129.49 139.9 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.88 0.371 . . . . 0.0 111.12 167.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -83.09 134.1 12.53 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -169.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 84.8 t -122.16 119.0 28.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.758 0.314 . . . . 0.0 111.263 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -86.15 -18.16 3.54 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.652 1.568 . . . . 0.0 111.137 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.6 p -97.11 4.0 51.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.178 -160.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 473' ' ' THR . 10.2 t -85.31 123.52 30.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.22 -166.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -113.34 128.93 56.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.22 -174.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.431 HG21 HG11 ' A' ' 462' ' ' VAL . 88.4 t -112.02 125.79 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 -174.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.02 155.77 44.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.214 -171.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.31 133.31 69.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -120.5 148.26 44.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.219 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 70.5 mt -120.24 114.73 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.226 169.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 53.96 40.97 32.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 91.64 -11.79 71.17 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.6 m -98.29 134.3 41.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 111.195 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.5 tp -68.54 119.18 12.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.278 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -99.08 -40.58 7.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.231 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -167.33 157.51 11.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.168 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -140.4 151.97 45.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.229 -175.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -136.46 142.15 43.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.2 m -103.26 125.0 49.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.21 163.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.43 166.05 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.4 m -121.95 142.43 50.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.169 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 491' ' ' LEU . . . . . 0.433 HD21 ' HB2' ' A' ' 497' ' ' LYS . 87.3 mt -129.64 131.44 46.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.167 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -89.76 -167.08 42.14 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 172.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.47 117.53 4.79 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.708 1.605 . . . . 0.0 111.224 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.1 mttt 59.69 41.78 18.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.172 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -103.83 144.56 31.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.256 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -120.32 143.25 48.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.163 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.433 ' HB2' HD21 ' A' ' 491' ' ' LEU . 1.8 tttp -137.46 130.75 30.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.217 -173.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 69.4 t -106.37 118.53 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.161 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 37.2 mt -107.07 144.02 34.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.196 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 41.7 p -122.35 152.68 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.175 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.9 156.4 37.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 168.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.406 ' HB3' HD11 ' A' ' 455' ' ' LEU . 68.8 m -120.41 134.02 55.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.286 -176.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -130.31 129.37 43.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.236 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 96.6 m -118.49 110.55 38.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 170.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.61 152.26 47.98 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.74 1.627 . . . . 0.0 111.168 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 59.4 p -123.88 -15.07 7.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -119.26 135.16 54.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.701 ' CD ' ' H ' ' A' ' 508' ' ' GLU . 2.9 pm0 -80.08 124.82 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.168 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 174.47 -179.99 45.45 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.3 mmm -84.39 127.21 33.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 111.253 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -122.1 133.03 54.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.154 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -105.31 119.17 38.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.289 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.0 123.73 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 -176.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -115.19 146.51 41.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.46 142.74 51.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.237 168.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 77.2 p -130.8 150.39 51.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.22 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.278 172.684 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 79.4 t . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.801 0.334 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.86 133.15 45.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.288 174.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.5 m -117.51 127.03 53.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.193 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -133.6 129.34 36.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.245 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -100.22 126.46 46.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.195 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 82.1 t -121.0 135.83 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.188 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -105.17 127.75 53.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.239 173.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.03 127.73 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.183 173.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.51 150.88 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 -172.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 541' ' ' LEU . . . . . 0.702 ' O ' ' HG ' ' A' ' 541' ' ' LEU . 39.8 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.178 -174.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 N--CA 1.458 -0.585 0 N-CA-C 111.227 -0.336 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -147.78 98.91 3.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.193 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 60.3 mt -96.18 142.64 28.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.192 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.5 t -148.53 159.17 44.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.227 174.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.05 154.91 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.184 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 93.7 mt-10 -135.79 138.72 42.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.231 176.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 82.5 mt -106.19 128.23 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -135.75 149.04 49.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.231 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.84 -173.53 35.15 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.16 145.47 60.74 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.718 1.612 . . . . 0.0 111.117 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -90.07 -41.78 11.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 74.9 t -118.25 126.18 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.267 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.5 m -129.73 152.23 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.232 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.79 158.71 45.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 3.1 p -79.42 146.02 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.839 0.352 . . . . 0.0 111.133 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 63.65 29.06 15.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.25 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.91 141.87 51.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 35.0 tp -81.57 127.55 32.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.205 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.16 144.5 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.202 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -103.01 135.78 44.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.191 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -129.34 157.08 42.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.237 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -129.68 139.63 51.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.218 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 460' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 44.5 t -112.01 120.44 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.186 170.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 96.8 m-70 -101.54 113.17 26.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.412 HG11 HG21 ' A' ' 475' ' ' VAL . 1.5 m -119.66 130.72 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.23 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -142.73 154.97 44.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -172.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 41.2 t30 -106.71 140.12 40.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.208 170.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 65.1 mt -125.88 4.76 7.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.182 -174.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -89.42 -15.33 58.77 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.53 24.28 73.18 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.469 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.3 tt -137.67 136.39 45.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 111.174 171.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -74.45 136.54 21.31 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -168.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.64 118.15 30.95 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.802 0.334 . . . . 0.0 111.216 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.74 -18.5 5.54 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.649 1.566 . . . . 0.0 111.266 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.6 p -94.11 13.06 24.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 -163.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 100.0 m -78.83 111.62 15.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.16 -161.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -109.83 125.89 53.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.412 HG21 HG11 ' A' ' 462' ' ' VAL . 60.1 t -119.9 127.0 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.177 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -135.28 157.24 47.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.178 -172.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 69.4 t -127.68 134.38 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.244 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -116.85 146.73 42.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.174 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 80.2 mt -120.1 115.05 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.171 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 53.68 41.29 32.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.178 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 93.01 -15.4 62.95 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 172.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -99.64 133.71 43.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.803 0.335 . . . . 0.0 111.25 -174.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 56.0 tp -68.79 120.23 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.222 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -97.36 -40.96 8.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.211 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -168.31 157.44 9.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.193 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -140.5 155.17 46.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.228 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -135.21 142.38 46.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.252 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.4 m -109.67 123.32 49.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.206 166.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.11 167.74 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.277 -175.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 82.9 p -116.75 143.89 45.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.143 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 96.4 mt -129.16 131.23 47.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.201 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -90.15 -179.19 44.27 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 172.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.49 120.24 7.72 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.686 1.591 . . . . 0.0 111.255 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.9 mttt 57.08 36.62 27.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.249 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -103.24 144.08 31.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.162 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -122.95 140.67 52.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.243 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -126.81 147.68 50.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.185 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 90.0 t -110.89 119.16 58.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 35.7 mt -104.16 141.65 35.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.199 173.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 46.3 p -124.55 153.86 41.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.23 156.28 36.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.211 166.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 52.7 m -122.47 134.37 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 41.3 t90 -140.17 129.77 24.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.211 -166.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.3 m -117.15 112.88 39.55 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.28 150.32 36.83 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.703 1.602 . . . . 0.0 111.237 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 66.9 p -122.68 -11.71 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.194 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -120.03 139.19 52.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.173 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -80.74 143.6 32.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.135 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.93 177.84 25.18 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.7 mmm -86.31 130.75 34.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 111.184 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -118.71 134.93 54.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.225 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -106.95 119.6 39.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.158 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 85.2 mt -103.5 124.9 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.193 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -117.71 145.7 44.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.228 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.75 141.4 51.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.192 170.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 68.0 p -131.05 150.56 52.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.169 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 169.99 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 71.5 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.828 0.347 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.03 130.61 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -172.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.2 m -117.29 127.05 53.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.247 176.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -130.65 130.2 43.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.206 -175.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -99.08 125.59 44.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -173.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.54 135.58 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.166 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.5 t -105.79 122.41 46.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.221 171.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 98.2 t -102.76 127.08 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.15 165.06 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.287 177.255 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.458 -0.581 0 N-CA-C 111.118 -0.378 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -141.16 73.52 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.204 165.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.01 143.36 34.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.141 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 44.7 p -127.8 162.39 26.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.183 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 442' ' ' VAL . . . . . 0.412 ' CG1' ' HB ' ' A' ' 517' ' ' VAL . 29.1 m -131.82 152.08 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.26 163.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 86.2 mt-10 -139.96 135.69 33.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 175.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 84.5 mt -109.66 124.18 66.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.211 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.0 148.66 47.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.227 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.22 -163.92 32.17 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -56.25 136.77 77.07 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.674 1.582 . . . . 0.0 111.247 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -86.99 -37.63 17.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.203 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 93.1 t -124.85 132.87 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.203 174.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.84 151.85 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.24 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.61 158.78 43.62 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.8 136.17 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 111.22 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 62.56 21.99 13.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.19 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -110.3 130.98 55.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.17 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 35.3 tp -74.73 126.81 31.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.156 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.56 146.47 48.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -108.66 132.26 54.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -128.18 157.2 41.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.172 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -130.35 140.36 50.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.211 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 48.8 t -111.77 120.39 62.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 170.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.1 m-70 -105.98 109.09 20.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.195 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 14.6 m -116.42 132.61 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -119.77 159.16 25.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 44.5 t-20 -111.82 121.75 45.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 156.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 48.5 mt -117.16 1.0 12.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 -177.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.72 -19.29 41.17 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 75.28 28.87 61.14 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 15.2 tt -128.14 136.03 61.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 111.193 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.7 122.24 13.76 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.09 112.07 31.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 111.169 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.23 -17.42 11.7 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.738 1.625 . . . . 0.0 111.206 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 58.5 m -87.98 10.73 17.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -162.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.9 m -79.97 108.54 13.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -162.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -109.54 127.44 54.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.194 175.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 80.4 t -113.45 126.16 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.303 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -127.87 153.84 46.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.243 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.75 134.38 64.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -120.99 147.55 45.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.219 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.452 HG12 HG12 ' A' ' 513' ' ' ILE . 86.3 mt -120.39 117.41 53.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 170.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 54.31 41.43 31.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.268 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.95 -9.51 71.94 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.1 m -98.14 137.81 36.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.745 0.307 . . . . 0.0 111.208 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -69.76 120.31 15.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -98.09 -40.39 8.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -165.15 158.07 16.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.213 -173.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -142.23 152.04 42.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.234 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.3 m-90 -137.79 142.66 40.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.288 170.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.7 m -105.97 125.12 50.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.231 170.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.0 m -138.98 167.21 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.5 m -122.79 143.31 49.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.161 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 90.8 mt -128.57 128.81 44.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.268 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.37 -167.79 43.59 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.79 112.84 1.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.658 1.572 . . . . 0.0 111.205 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.0 mttt 66.86 36.19 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -96.61 143.81 27.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.235 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -125.37 141.48 52.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.233 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 497' ' ' LYS . . . . . 0.43 ' HB3' ' HE3' ' A' ' 497' ' ' LYS . 26.4 mmmt -129.8 144.82 51.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.189 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.3 119.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.128 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 64.6 mt -104.03 143.3 33.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 47.1 p -122.36 152.77 39.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.211 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -153.82 156.61 37.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.236 168.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.2 m -121.1 129.25 53.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.189 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -127.27 129.5 47.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 -172.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.9 m -113.89 110.47 49.02 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.192 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.29 150.99 53.9 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.691 1.594 . . . . 0.0 111.179 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 79.9 p -123.41 -13.53 7.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.223 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -125.76 137.12 53.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.192 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.462 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 30.9 tt0 -77.02 140.05 40.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.242 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.8 175.12 23.95 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.7 mmm -85.67 129.91 34.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.191 176.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -119.63 130.32 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -104.01 119.39 38.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.195 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.452 HG12 HG12 ' A' ' 479' ' ' ILE . 82.5 mt -104.05 123.76 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.201 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -119.76 145.14 46.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.208 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.04 143.09 50.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.192 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 82.7 p -131.17 153.2 49.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.289 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.412 ' HB ' ' CG1' ' A' ' 442' ' ' VAL . 9.1 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.238 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.803 0.335 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.18 137.18 49.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.0 m -115.21 126.52 54.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -134.71 129.75 35.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.181 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -100.19 128.71 46.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.226 -173.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 91.9 t -121.13 135.99 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.242 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.6 t -105.66 124.42 49.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.145 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.6 t -102.03 126.61 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.73 155.23 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 541' ' ' LEU . . . . . 0.462 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 83.4 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.238 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.458 -0.577 0 N-CA-C 111.243 -0.329 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -127.62 81.57 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.267 172.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.6 136.01 33.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 -174.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 8.0 t -141.0 153.14 45.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.324 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 26.2 m -131.62 154.9 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.131 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.7 mt-10 -139.4 135.69 33.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.2 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 87.7 mt -107.34 126.86 63.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.192 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.9 147.93 48.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.243 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.89 -169.66 34.67 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.42 114.46 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.693 1.595 . . . . 0.0 111.163 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -69.04 -26.96 65.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 97.5 t -123.69 130.96 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.221 172.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.2 152.01 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.187 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.58 158.91 41.9 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.53 137.91 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 111.248 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 62.21 25.5 15.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.299 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -116.56 150.2 38.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.176 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 502' ' ' SER . 37.9 tp -88.87 127.61 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.279 -175.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.41 143.99 49.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.228 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -107.71 137.32 45.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.187 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.86 157.67 41.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.27 141.2 51.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.155 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 460' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 47.1 t -113.13 120.95 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.162 170.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.7 m-70 -103.29 108.17 19.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 475' ' ' VAL . 2.3 m -118.42 130.55 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.224 -171.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -144.99 151.72 39.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.167 -173.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 44.6 t-20 -106.81 139.58 41.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.163 173.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 73.7 mt -129.37 4.09 5.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.214 -171.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -88.0 -2.04 81.42 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.94 21.4 78.23 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.437 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.8 tt -126.55 148.85 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.773 0.32 . . . . 0.0 111.186 175.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -94.06 115.69 5.06 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 94.3 t -104.76 114.48 63.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.757 0.313 . . . . 0.0 111.194 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.7 -17.98 10.79 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.698 1.598 . . . . 0.0 111.201 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.7 p -91.42 12.08 21.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.164 -164.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 91.1 m -78.75 108.17 11.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.229 -162.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -111.07 128.26 55.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.218 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 475' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 462' ' ' VAL . 67.1 t -115.05 128.46 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 -176.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -123.67 152.61 41.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 79.7 t -127.7 133.71 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.284 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.22 147.51 44.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.169 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 479' ' ' ILE . . . . . 0.466 HG12 HG12 ' A' ' 513' ' ' ILE . 84.1 mt -119.86 117.19 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.292 171.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 54.55 41.16 32.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.176 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.56 -11.82 67.12 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 173.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.2 m -97.71 137.64 36.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 111.224 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 66.5 tp -69.3 120.69 15.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.263 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -98.11 -40.47 8.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 -176.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -166.16 159.91 15.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 -173.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -141.17 153.13 45.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.182 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -139.17 142.79 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.196 171.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.8 m -107.55 125.09 50.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.204 169.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.61 168.07 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 59.4 m -121.98 143.09 49.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.173 170.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.4 mt -127.38 129.53 47.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.216 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.38 -179.74 48.15 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.06 113.87 1.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.647 1.565 . . . . 0.0 111.211 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.5 mttt 64.73 34.14 9.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -101.5 143.47 31.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.28 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -122.81 140.3 53.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.208 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -128.29 146.43 50.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.206 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.9 t -112.34 119.45 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 499' ' ' LEU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 49.5 mt -102.86 142.25 34.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.239 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 45.7 p -123.82 152.78 41.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.23 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.95 156.84 38.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.314 167.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.403 ' HB3' HD11 ' A' ' 455' ' ' LEU . 70.5 m -120.12 129.81 54.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.206 -176.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -130.69 129.57 42.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.219 -170.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.1 m -117.34 107.3 45.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.222 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.35 143.48 31.47 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.713 1.608 . . . . 0.0 111.202 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 67.4 p -115.41 -14.85 11.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.169 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -119.94 138.02 53.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 508' ' ' GLU . . . . . 0.437 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 33.2 tt0 -75.0 140.11 43.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.197 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.87 174.44 24.05 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -176.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.6 mmm -85.17 127.82 34.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.842 0.353 . . . . 0.0 111.111 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -120.89 131.96 54.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.18 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -104.17 118.07 35.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.165 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 513' ' ' ILE . . . . . 0.466 HG12 HG12 ' A' ' 479' ' ' ILE . 83.9 mt -104.52 120.22 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -123.02 149.4 44.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.239 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.4 140.81 52.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.233 175.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 60.1 p -131.75 151.75 51.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.163 174.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.216 173.659 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 88.6 t . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.847 0.356 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.87 133.98 46.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.239 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 85.8 m -116.19 125.89 52.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -131.21 129.09 41.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.191 176.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -101.14 125.65 47.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.249 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 85.3 t -121.25 136.26 58.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.9 t -104.61 127.34 52.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.179 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 85.2 t -101.24 126.85 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.144 173.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 32.2 m -122.87 159.77 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.12 -175.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 541' ' ' LEU . . . . . 0.437 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 94.3 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.153 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.459 -0.557 0 N-CA-C 111.233 -0.334 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -143.17 78.07 1.59 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.232 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 14.7 mt -80.28 125.86 30.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.198 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 14.5 t -138.74 157.15 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.37 155.48 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.308 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 91.5 mt-10 -137.05 133.75 35.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.193 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 92.6 mt -104.56 127.28 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -135.48 146.48 48.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.226 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.61 -171.17 34.19 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.96 140.39 45.58 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.71 1.607 . . . . 0.0 111.205 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -86.03 -36.52 19.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.237 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.2 t -120.03 129.57 75.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.231 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.09 153.18 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.232 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.37 156.54 43.3 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.1 p -76.19 140.29 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.201 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 63.46 28.65 15.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.239 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -121.73 148.04 45.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.82 127.06 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.28 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.25 143.38 49.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.177 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -103.99 135.17 46.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.121 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -130.27 157.22 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -129.81 139.83 51.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.221 -175.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.7 t -113.45 121.9 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 173.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.5 m-70 -101.71 112.05 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.15 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.408 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -117.89 128.83 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.256 -171.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 463' ' ' LYS . . . . . 0.449 ' HD2' HD21 ' A' ' 465' ' ' LEU . 45.7 pttt -145.07 154.97 43.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.202 -172.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 63.4 t-20 -113.77 120.88 42.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.156 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' LEU . . . . . 0.449 HD21 ' HD2' ' A' ' 463' ' ' LYS . 82.6 mt -112.16 15.36 20.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.176 -170.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.28 -9.62 61.7 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -177.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.96 16.79 76.65 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.474 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.7 tt -127.03 146.21 33.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.701 0.286 . . . . 0.0 111.264 170.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -83.6 132.06 10.82 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.7 114.55 32.66 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.222 168.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -84.71 -19.17 4.27 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.811 1.674 . . . . 0.0 111.242 -174.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 99.1 p -97.92 5.32 49.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.233 -160.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 473' ' ' THR . 8.9 t -84.99 127.03 34.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.212 -160.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.94 130.92 55.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.249 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.89 130.21 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.268 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -129.49 155.09 46.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.176 -170.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 41.4 t -125.55 135.02 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.228 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -124.04 150.15 45.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.218 -174.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 86.3 mt -124.03 116.45 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.221 172.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 54.49 41.19 32.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.19 -13.52 66.87 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 170.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.6 m -99.76 138.53 36.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 111.257 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.7 tp -67.85 120.44 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -99.01 -40.28 8.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.156 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt -158.26 162.9 37.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -138.12 148.32 44.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.157 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -138.48 142.03 39.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.135 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 93.2 m -109.75 126.68 54.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.286 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.5 m -138.19 167.1 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.242 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.7 m -117.32 140.28 49.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.184 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.9 mt -129.44 130.24 45.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.136 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -91.15 -167.21 41.04 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 173.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.2 111.73 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.731 1.62 . . . . 0.0 111.239 175.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 494' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.1 mttt 60.01 43.69 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.181 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.06 142.67 31.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.238 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -122.14 137.92 54.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.145 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -127.97 148.61 50.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.188 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 85.9 t -111.2 118.53 57.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.186 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 48.1 mt -104.84 145.65 30.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.259 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 55.5 p -120.51 154.0 35.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.218 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -152.93 155.04 36.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 165.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 65.2 m -124.25 131.59 53.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -131.42 131.53 43.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.201 -170.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.4 m -118.02 110.3 40.02 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.221 174.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.85 154.44 43.28 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.806 1.671 . . . . 0.0 111.107 172.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 74.3 p -124.19 -19.16 5.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.242 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -120.13 138.92 53.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.22 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.21 140.44 46.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.46 176.61 26.1 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.64 128.94 35.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.17 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -121.92 136.55 54.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.209 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -104.68 119.09 38.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.243 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 93.0 mt -103.73 124.05 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.175 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -121.37 151.16 40.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.27 143.18 51.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.163 173.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 64.6 p -131.07 154.1 48.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.215 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.235 165.989 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 92.9 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.857 0.361 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.4 131.74 48.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 80.1 m -115.25 125.34 53.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.171 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -132.58 130.83 40.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.149 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -104.05 129.63 51.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.224 -174.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.0 t -121.27 137.19 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.257 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.6 t -103.97 124.13 48.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.199 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 83.9 t -102.17 126.47 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.242 175.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.07 160.54 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.26 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 76.0 mt . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.185 -176.147 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.459 -0.54 0 N-CA-C 111.064 -0.398 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -143.36 89.72 2.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 15.4 mt -90.14 128.3 36.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.187 -176.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.4 t -143.76 157.59 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.199 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.63 154.59 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.25 -177.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 50.3 mt-10 -135.95 139.82 43.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.233 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 85.4 mt -105.38 132.17 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.24 142.52 44.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.189 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 160.41 -174.97 37.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.15 142.72 42.53 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.762 1.642 . . . . 0.0 111.208 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -75.24 -46.36 34.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.251 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.18 130.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.192 -176.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.37 153.09 38.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.249 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -85.65 159.81 33.62 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 4.7 p -72.41 139.96 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 0.0 111.242 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 63.31 29.95 15.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.22 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -124.52 138.64 54.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.22 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' LEU . . . . . 0.416 HD11 ' HB3' ' A' ' 502' ' ' SER . 34.4 tp -81.49 126.9 32.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.24 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.81 144.47 48.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.223 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -101.88 134.19 45.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.213 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -129.42 156.88 43.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.106 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -130.1 139.94 50.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.124 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.9 t -111.54 120.1 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' HIS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.0 m-70 -99.63 114.17 27.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.225 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 462' ' ' VAL . . . . . 0.4 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -117.42 129.43 73.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.224 -175.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -144.26 153.07 41.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.23 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 31.0 t30 -111.72 130.05 55.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.185 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 78.9 mt -114.61 4.03 15.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.204 -173.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -88.7 -20.54 47.04 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.91 24.37 72.16 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 468' ' ' ILE . . . . . 0.421 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.6 tt -134.44 138.97 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 111.173 169.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -76.07 131.68 12.06 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -166.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.38 117.63 30.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 111.251 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -86.72 -17.74 3.24 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.639 1.559 . . . . 0.0 111.175 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 98.5 p -95.59 4.36 53.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.259 -160.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 473' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 473' ' ' THR . 9.6 t -86.57 124.33 32.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.265 -164.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -113.6 129.13 56.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.191 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 97.0 t -112.22 127.54 69.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.234 -174.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.69 157.65 41.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.27 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.3 t -126.33 133.63 68.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.145 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -120.85 148.53 43.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 77.5 mt -119.77 115.71 48.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.232 169.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 54.23 41.0 32.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.187 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.18 -16.0 61.96 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 171.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -97.88 136.18 38.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.352 . . . . 0.0 111.207 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.5 tp -68.49 120.0 13.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.099 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -98.37 -40.06 8.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -166.36 157.41 12.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.268 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -139.96 151.18 45.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.181 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 30.0 m-90 -136.82 142.05 42.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.178 170.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.7 m -102.82 125.03 49.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.24 164.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.74 166.0 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.234 -172.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.8 m -122.48 143.53 49.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 171.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.9 mt -128.54 130.26 47.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -91.32 -165.09 39.61 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.49 112.35 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.723 1.616 . . . . 0.0 111.182 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 59.94 48.31 8.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.209 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -104.56 142.98 33.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.146 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -117.59 141.76 47.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.269 172.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -139.25 130.13 26.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.227 -172.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 73.7 t -105.58 118.41 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 -170.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 36.0 mt -105.73 143.6 33.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 173.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 50.7 p -122.87 152.67 40.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -153.81 156.41 37.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.189 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 502' ' ' SER . . . . . 0.416 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.7 m -121.07 133.57 55.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.234 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -133.46 131.21 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.165 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.6 m -116.58 109.74 43.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.278 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.54 153.53 34.73 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.714 1.609 . . . . 0.0 111.19 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 69.9 p -128.52 -2.3 5.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.203 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -133.95 135.31 43.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.206 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -72.24 141.79 48.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.4 175.22 25.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.2 mmm -86.03 127.17 34.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 111.188 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -119.98 137.45 54.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.311 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -106.79 119.2 38.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.205 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 83.7 mt -102.98 123.8 56.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.214 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -116.46 144.98 43.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.184 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.45 141.41 52.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.252 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 73.0 p -131.0 150.55 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.272 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.261 174.346 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.866 0.365 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -129.49 134.01 47.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.1 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 83.0 m -116.85 127.97 54.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.227 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -132.23 131.65 42.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.31 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -99.34 128.94 45.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.166 -172.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.5 t -121.27 136.79 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.175 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.2 t -106.38 123.99 48.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.187 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.3 t -103.1 128.31 56.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.138 175.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.24 165.02 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.157 176.19 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 435' ' ' MET . . . . . 0.694 ' HB2' ' HA ' ' A' ' 436' ' ' GLU . 99.5 mmm . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.871 0.367 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' GLU . . . . . 0.694 ' HA ' ' HB2' ' A' ' 435' ' ' MET . 88.5 tt0 -104.5 156.14 18.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.214 -25.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 435' ' ' MET . 16.6 m-30 -110.43 105.1 56.9 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.162 -164.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.496 ' HB3' HG23 ' A' ' 468' ' ' ILE . 70.8 Cg_endo -71.07 167.56 25.74 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.712 1.608 . . . . 0.0 111.227 173.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -121.47 90.37 3.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.228 167.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 71.1 mt -83.03 138.27 33.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.193 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 531' ' ' ASN . 13.3 t -140.05 153.77 46.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.173 177.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.2 m -132.89 156.31 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.212 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 95.8 mt-10 -139.74 136.68 34.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.27 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 94.5 mt -107.43 127.49 63.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.97 147.88 48.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.175 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.47 -167.85 34.65 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.51 142.19 58.33 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.689 1.593 . . . . 0.0 111.099 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -89.35 -38.26 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.235 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.2 t -120.42 130.08 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.207 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.41 151.73 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.204 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.47 159.98 43.23 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 540' ' ' VAL . 3.0 p -76.3 141.58 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.206 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 62.54 28.17 16.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.181 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -123.29 144.63 49.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.25 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.423 HD11 ' HB3' ' A' ' 502' ' ' SER . 37.2 tp -87.34 128.49 35.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.182 -173.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.97 145.01 48.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.163 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -103.39 135.26 45.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' TYR . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 94.7 m-85 -129.83 157.18 42.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.485 ' HG2' HG22 ' A' ' 500' ' ' THR . 93.6 mt-10 -130.47 141.07 50.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.185 -175.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 460' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 53.1 t -112.35 121.2 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.14 173.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.5 m-70 -103.16 107.85 18.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.158 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.448 HG11 HG21 ' A' ' 475' ' ' VAL . 2.5 m -118.85 130.52 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.217 -173.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -143.04 155.08 44.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 8.3 t-20 -98.44 138.65 35.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.201 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 80.7 mt -134.44 38.26 3.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.204 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -138.3 8.82 3.5 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 63.11 18.6 60.52 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.581 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 14.9 tt -136.13 139.56 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.713 0.292 . . . . 0.0 111.225 171.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -87.26 141.44 17.51 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -174.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.5 119.35 36.16 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 111.254 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.84 -19.53 9.67 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.716 1.611 . . . . 0.0 111.22 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.7 p -92.95 12.74 22.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.254 -168.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 84.8 m -75.95 109.86 9.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.221 -161.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.89 127.61 54.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.145 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.448 HG21 HG11 ' A' ' 462' ' ' VAL . 64.9 t -115.69 126.2 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.109 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -127.14 152.65 47.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.263 -172.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 80.6 t -129.12 131.87 67.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -119.79 145.93 46.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.157 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.442 HG12 HG12 ' A' ' 513' ' ' ILE . 77.0 mt -118.32 114.89 46.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 53.57 40.77 31.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.222 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.8 -19.07 55.74 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 171.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.0 m -97.65 137.4 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.741 0.305 . . . . 0.0 111.174 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.3 tp -68.78 121.81 17.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.171 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -96.78 -40.27 9.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.426 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 48.7 tptt -164.75 158.22 17.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.205 -173.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -143.27 153.28 42.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.233 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 487' ' ' TRP . . . . . 0.426 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 27.4 m-90 -137.98 142.42 40.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 172.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.8 m -107.54 123.04 47.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 168.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.81 167.8 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 70.5 m -118.5 142.28 47.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 97.1 mt -126.79 130.31 50.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.182 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -86.84 -179.97 48.88 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.78 119.7 6.9 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.706 1.604 . . . . 0.0 111.183 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.3 mttt 55.54 35.61 25.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -101.04 144.41 30.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.229 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -122.36 140.5 52.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.228 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -127.67 147.58 50.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.201 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.4 119.23 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 54.5 mt -102.7 142.89 33.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.189 173.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.485 HG22 ' HG2' ' A' ' 459' ' ' GLU . 46.5 p -122.49 153.04 39.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 501' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.0 p90 -153.84 156.02 36.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 167.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.423 ' HB3' HD11 ' A' ' 455' ' ' LEU . 68.0 m -122.29 128.1 50.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.256 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -131.38 131.59 43.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.167 -169.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.6 m -114.08 105.43 54.25 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.212 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.81 118.9 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.732 1.621 . . . . 0.0 111.195 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 70.9 p -94.87 -12.41 26.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.249 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -117.35 138.06 52.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.272 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.471 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 35.7 tt0 -76.12 140.89 42.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.04 174.97 24.77 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.6 mmm -86.2 129.61 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 111.209 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -120.01 134.02 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.17 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -106.24 118.63 37.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.244 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.442 HG12 HG12 ' A' ' 479' ' ' ILE . 82.2 mt -105.35 123.23 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.244 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -118.5 145.43 45.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.08 140.04 52.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 172.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 66.6 p -131.9 153.2 50.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.25 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 531' ' ' ASN . 8.1 p -123.38 141.98 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.203 170.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.7 t0 55.15 49.64 16.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.228 -173.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -56.87 -38.87 73.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.25 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.33 -5.19 46.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.154 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.1 t30 59.9 58.42 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.178 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 69.6 p -94.35 -20.87 19.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.277 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 96.4 t -121.24 133.83 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.167 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 84.5 t -89.16 122.71 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.227 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -102.64 170.5 7.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.266 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.63 -27.9 61.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.129 171.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -132.6 145.65 51.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.214 172.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -111.95 -20.78 11.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.195 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -93.85 -2.13 53.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.167 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -102.07 20.68 16.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.141 -174.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 531' ' ' ASN . . . . . 0.455 ' HB2' ' CG1' ' A' ' 517' ' ' VAL . 50.4 p30 -132.81 25.36 4.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 90.8 t -129.53 143.06 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.182 173.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.4 131.8 50.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.7 m -117.15 126.37 52.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.23 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -132.62 129.96 39.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -100.22 129.02 46.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 90.7 t -120.97 135.64 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.25 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.7 t -106.86 123.13 47.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.225 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 94.4 t -102.98 127.09 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.236 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 452' ' ' VAL . 36.0 m -123.07 159.83 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.193 -177.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 541' ' ' LEU . . . . . 0.471 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 94.5 mt -82.57 11.11 6.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.208 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 C--O 1.199 -1.579 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 -176.092 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 435' ' ' MET . . . . . 0.708 ' HB2' ' HA ' ' A' ' 436' ' ' GLU . 48.0 mtp . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.777 0.322 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' GLU . . . . . 0.708 ' HA ' ' HB2' ' A' ' 435' ' ' MET . 16.7 pt-20 -109.12 -158.44 0.65 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.189 14.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -105.03 105.82 53.07 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.189 -158.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.415 ' HG3' HG21 ' A' ' 470' ' ' VAL . 68.3 Cg_endo -74.19 166.49 29.43 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.694 1.596 . . . . 0.0 111.236 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -124.0 76.11 1.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.45 131.04 35.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.242 -174.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.9 t -138.43 154.87 48.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.215 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 32.8 m -131.79 155.19 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 95.1 mt-10 -139.72 136.26 34.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.2 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.2 mt -106.28 127.14 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.178 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.02 147.88 48.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.235 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.04 -169.28 34.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.81 139.51 48.03 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.713 1.609 . . . . 0.0 111.196 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -87.55 -36.11 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 79.2 t -120.6 130.29 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.34 152.84 38.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.192 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.97 159.28 35.79 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.1 p -74.15 138.17 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.824 0.345 . . . . 0.0 111.145 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 62.49 24.31 14.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -115.32 151.92 33.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 502' ' ' SER . 43.3 tp -88.89 128.4 35.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.23 -175.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.48 147.02 46.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.289 173.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.24 138.21 52.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.218 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' TYR . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 90.3 m-85 -129.09 157.74 40.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -128.59 139.99 52.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.193 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.73 121.02 64.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.168 173.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.9 m-70 -102.6 108.0 19.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.468 HG11 HG21 ' A' ' 475' ' ' VAL . 2.1 m -118.63 130.44 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.25 -173.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.43 ' HD3' HD21 ' A' ' 465' ' ' LEU . 19.1 ptpt -143.65 154.05 43.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.222 -172.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 41.7 t-20 -107.0 142.22 36.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 171.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.43 HD21 ' HD3' ' A' ' 463' ' ' LYS . 55.3 mt -132.11 3.73 4.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.185 -170.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.59 1.25 71.78 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.79 17.67 76.92 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.526 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.7 tt -127.14 150.18 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 111.236 171.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -95.5 132.15 10.97 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.415 HG21 ' HG3' ' A' ' 438' ' ' PRO . 87.1 t -116.67 118.03 37.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.85 0.357 . . . . 0.0 111.176 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.06 -19.14 8.38 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 121.724 1.616 . . . . 0.0 111.194 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 95.4 p -93.92 13.56 22.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -165.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 94.1 m -77.44 112.82 14.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -161.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.61 126.56 55.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.187 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.468 HG21 HG11 ' A' ' 462' ' ' VAL . 59.9 t -118.57 127.42 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.189 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -134.89 156.58 48.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.199 -173.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.03 136.88 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -170.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -116.93 147.89 41.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.185 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.415 HG12 HG12 ' A' ' 513' ' ' ILE . 82.2 mt -119.7 116.09 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.221 167.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.28 41.35 32.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.249 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.65 -11.47 68.39 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.9 m -98.63 136.09 39.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.875 0.369 . . . . 0.0 111.18 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.35 120.58 15.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.21 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -98.2 -40.27 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.166 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -168.46 158.52 9.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 -173.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -143.74 153.89 42.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -136.95 143.04 42.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.209 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.6 m -106.38 125.16 50.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.214 169.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.42 168.47 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.201 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.7 m -120.02 142.22 49.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.18 172.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.0 mt -128.38 130.79 48.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.255 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -90.64 -171.06 43.63 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.83 113.3 1.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.602 1.535 . . . . 0.0 111.201 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.0 mttt 65.4 35.3 7.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.196 177.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -101.72 143.2 31.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.182 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.87 141.3 52.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.207 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -127.1 146.17 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 94.3 t -112.35 119.69 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.176 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 38.8 mt -102.88 142.17 34.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.223 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 66.2 p -122.25 152.52 39.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.199 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.9 p90 -155.21 157.2 36.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.263 169.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.412 ' HB3' HD11 ' A' ' 455' ' ' LEU . 73.6 m -120.26 128.67 53.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.183 -175.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -130.51 129.87 43.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.236 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.1 m -117.26 109.35 42.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.258 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.74 155.04 44.23 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.715 1.61 . . . . 0.0 111.221 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 73.3 p -125.48 -10.16 6.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.168 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -129.96 136.07 49.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.257 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -71.17 142.88 50.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.198 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.98 174.6 25.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -84.19 125.96 32.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -119.58 132.12 55.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.211 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -104.97 118.69 37.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.215 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.415 HG12 HG12 ' A' ' 479' ' ' ILE . 86.8 mt -104.47 124.25 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.187 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -118.33 144.16 46.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.65 139.24 54.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 172.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 64.0 p -130.91 150.1 52.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.242 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.424 ' CG1' ' HB2' ' A' ' 531' ' ' ASN . 8.1 p -124.72 140.54 47.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.292 168.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 24.5 t0 47.84 47.18 18.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.213 -172.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -57.38 -36.44 71.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.22 173.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -74.16 -5.8 43.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.23 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 63.91 46.26 3.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.182 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 43.5 p -88.83 -16.76 31.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.155 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 85.0 t -121.66 132.1 71.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 524' ' ' VAL . . . . . 0.434 ' HB ' ' SD ' ' A' ' 435' ' ' MET . 67.9 t -90.79 121.2 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.214 174.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -102.91 176.39 5.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.239 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.92 -25.89 63.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.195 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -152.8 148.12 26.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.165 168.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -108.95 -11.4 14.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.198 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -94.69 -9.99 33.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.256 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -103.98 36.6 2.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.177 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 531' ' ' ASN . . . . . 0.424 ' HB2' ' CG1' ' A' ' 517' ' ' VAL . 49.8 p30 -142.47 24.69 1.9 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.266 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 89.2 t -129.31 143.18 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.255 172.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.16 133.5 48.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.169 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 96.9 m -116.62 126.7 53.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -131.72 131.66 43.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.186 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -103.15 129.27 49.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.228 -173.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 92.8 t -121.29 137.3 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.3 t -108.01 125.15 51.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 96.0 t -103.27 129.37 55.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.183 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.76 164.1 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 93.8 mt -87.35 45.79 1.31 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--O 1.201 -1.48 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.284 174.042 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 435' ' ' MET . . . . . 0.4 ' SD ' HG23 ' A' ' 523' ' ' VAL . 22.5 mmt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.878 0.37 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -80.03 145.07 32.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.221 131.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -105.88 110.31 63.98 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.198 -146.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 525' ' ' GLU . 72.4 Cg_endo -70.32 168.14 23.15 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.651 1.567 . . . . 0.0 111.238 173.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' ASP . . . . . 0.463 ' OD1' ' HB3' ' A' ' 527' ' ' ASN . 64.1 t0 -124.31 81.88 1.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.263 170.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.01 137.84 35.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.208 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.584 ' OG1' ' HB3' ' A' ' 530' ' ' ASN . 7.7 t -144.53 154.6 43.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.203 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.59 155.34 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.299 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 97.0 mt-10 -139.95 137.9 35.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.24 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.4 mt -107.6 128.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -135.87 147.52 48.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.153 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.28 -171.18 35.73 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.79 128.78 18.5 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.756 1.637 . . . . 0.0 111.165 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -71.25 -40.32 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.184 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 67.9 t -121.61 131.65 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.181 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 30.0 m -129.88 152.34 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.259 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.26 159.75 43.42 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 176.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 540' ' ' VAL . 1.2 p -79.99 148.02 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.721 0.296 . . . . 0.0 111.215 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 63.39 26.86 15.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 454' ' ' LYS . 27.8 mmmt -129.09 144.49 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.231 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 502' ' ' SER . 30.8 tp -85.35 126.23 33.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.238 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -124.72 144.13 50.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -110.39 136.88 48.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -174.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -129.58 157.29 42.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -129.33 139.21 51.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.143 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.4 t -112.76 120.71 63.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.21 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.1 m-70 -103.35 107.29 18.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.229 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.459 HG11 HG21 ' A' ' 475' ' ' VAL . 2.4 m -118.95 129.18 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.169 -172.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 46.4 pttt -143.41 155.0 44.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.246 -171.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 34.0 t30 -104.37 140.42 37.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.243 170.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 70.4 mt -128.47 6.52 5.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -95.64 -12.25 53.83 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 75.08 23.59 73.95 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.501 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 8.3 tt -128.96 139.77 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 0.0 111.219 165.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.58 134.33 13.96 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -173.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.38 116.23 39.48 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 111.28 172.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.46 -19.07 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.692 1.595 . . . . 0.0 111.18 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.7 p -95.05 13.43 25.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.205 -164.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 88.3 m -78.22 110.8 13.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 -163.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -111.27 127.39 55.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.459 HG21 HG11 ' A' ' 462' ' ' VAL . 68.8 t -115.09 126.93 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.282 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -127.89 153.44 46.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.139 -173.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 79.1 t -130.06 133.86 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -119.03 148.07 43.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.248 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 513' ' ' ILE . 84.6 mt -118.73 115.55 48.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.253 169.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 53.74 41.17 32.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.267 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.97 -10.43 70.6 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.4 m -97.45 136.51 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 111.135 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.9 tp -69.05 120.79 15.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.147 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -98.26 -40.63 8.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.256 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -167.98 161.1 12.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.198 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -141.83 152.56 43.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -137.37 142.36 41.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.268 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.0 m -108.74 124.56 50.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.195 168.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.56 168.19 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.191 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 49.2 m -120.9 143.09 49.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.171 172.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.2 129.13 47.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.161 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.24 -173.86 48.64 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.6 112.4 1.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.701 1.601 . . . . 0.0 111.146 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.0 mttt 65.95 36.06 6.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.196 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -101.6 144.0 30.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.38 140.41 52.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -129.39 145.75 51.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 89.4 t -112.72 118.99 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.195 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 50.3 mt -103.41 142.71 33.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.212 173.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 63.3 p -124.51 153.3 42.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.257 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.93 156.73 38.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.255 168.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.504 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.8 m -120.46 128.66 53.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 -175.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -129.67 129.57 44.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.232 -170.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 95.3 m -115.9 109.7 44.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.16 141.43 29.32 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.724 1.616 . . . . 0.0 111.148 174.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 81.5 p -111.91 -21.58 11.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.216 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -120.14 139.58 52.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.249 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.438 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 32.5 tt0 -73.2 140.22 46.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.276 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.04 175.3 24.33 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.4 mmm -86.4 129.01 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 111.195 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -120.73 131.37 54.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.282 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.01 119.43 38.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.156 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 479' ' ' ILE . 90.2 mt -101.71 122.24 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.161 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -120.67 145.97 46.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.161 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.25 142.06 51.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.5 p -131.04 149.76 52.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.245 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.447 ' CG1' ' HB2' ' A' ' 531' ' ' ASN . 13.8 p -125.45 149.29 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 168.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 22.6 t70 57.7 40.35 26.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 -171.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -58.85 -39.09 80.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.229 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -80.0 -2.95 46.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.201 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.2 t30 61.75 61.99 1.34 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.248 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 73.7 p -97.25 -30.32 13.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.24 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.4 HG23 ' SD ' ' A' ' 435' ' ' MET . 10.3 p -127.55 135.15 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.181 176.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 97.8 t -90.26 123.65 42.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.236 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 438' ' ' PRO . 12.8 pt-20 -119.85 170.09 9.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.211 -170.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.24 -28.84 60.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.168 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 527' ' ' ASN . . . . . 0.463 ' HB3' ' OD1' ' A' ' 439' ' ' ASP . 54.9 t-20 -126.39 112.78 16.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 -168.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -105.49 2.12 28.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.217 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -91.6 -30.5 16.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.18 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.584 ' HB3' ' OG1' ' A' ' 441' ' ' THR . 99.8 m-20 -97.28 -12.79 22.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.174 -175.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 531' ' ' ASN . . . . . 0.447 ' HB2' ' CG1' ' A' ' 517' ' ' VAL . 36.8 p-10 -83.04 9.11 10.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.22 -174.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 93.4 t -131.66 141.99 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 165.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.12 133.17 46.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 83.7 m -114.48 124.05 50.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -133.13 131.07 40.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.172 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -104.07 130.31 51.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.169 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.51 136.94 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.157 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.1 t -104.84 124.95 50.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.268 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 95.8 t -101.89 127.32 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.189 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 452' ' ' VAL . 34.7 m -120.85 160.31 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 541' ' ' LEU . . . . . 0.438 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 92.7 mt -80.96 -0.02 37.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--O 1.201 -1.494 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.218 -177.638 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 99.3 mmm . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.816 0.341 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -109.61 133.92 52.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.284 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -123.53 118.6 27.42 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.203 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.9 165.02 33.95 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.674 1.582 . . . . 0.0 111.224 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -129.45 99.27 5.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.228 170.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.4 145.32 25.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.288 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.5 t -149.33 156.77 42.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.17 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.63 153.53 39.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.175 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 47.7 mt-10 -138.2 137.89 38.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.213 177.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 83.4 mt -107.52 126.12 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.181 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -136.96 148.93 47.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.184 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.61 -166.85 33.45 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -55.22 136.62 74.19 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.693 1.595 . . . . 0.0 111.239 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -87.68 -40.1 14.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.223 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.55 130.11 74.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.78 153.83 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.195 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.59 157.87 34.9 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.8 p -70.5 141.67 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.213 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 63.57 29.75 15.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.245 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -124.18 142.42 51.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.163 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 502' ' ' SER . 44.2 tp -82.36 126.24 31.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.308 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.27 144.28 49.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.248 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -101.16 134.31 44.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.163 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -128.39 157.19 41.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.242 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.428 ' HG2' HG22 ' A' ' 500' ' ' THR . 87.3 mt-10 -129.91 138.47 50.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.224 -175.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.46 119.9 59.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 95.9 m-70 -98.88 112.92 24.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.179 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.66 131.42 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.215 -174.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -123.04 152.68 40.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.265 -172.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 12.9 t-20 -106.71 129.89 54.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 152.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 75.8 mt -120.12 22.12 11.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.212 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 468' ' ' ILE . . . -112.89 136.7 13.67 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 467' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 466' ' ' GLY . . . -9.12 -46.55 0.0 OUTLIER Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 155.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 466' ' ' GLY . 12.6 tt -123.16 142.29 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.744 0.306 . . . . 0.0 111.261 -163.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -89.06 162.5 31.14 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 84.4 t -124.5 119.06 26.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.199 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.52 -19.22 7.74 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.69 1.593 . . . . 0.0 111.158 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 96.5 p -94.83 14.6 20.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -166.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.1 m -76.46 110.85 11.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 -158.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.42 125.99 53.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.186 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 96.3 t -117.29 129.95 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.117 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -125.36 152.58 44.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.168 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 51.8 t -126.89 134.58 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -121.08 148.11 44.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.134 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.33 115.56 47.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.183 171.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 54.35 41.25 32.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.36 -14.87 64.46 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 171.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.2 m -98.96 137.19 37.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.75 0.31 . . . . 0.0 111.254 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.3 tp -68.38 119.36 12.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -100.06 -40.61 7.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.23 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -153.85 160.59 42.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -142.98 149.75 38.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.293 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -137.64 142.13 41.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.1 m -109.45 123.55 49.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.24 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.41 168.08 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.252 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.9 m -116.31 141.48 48.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.166 171.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 83.5 mt -126.88 128.63 46.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -76.97 177.3 52.39 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 172.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' PRO . . . . . 0.412 ' HB3' ' O ' ' A' ' 467' ' ' GLY . 55.1 Cg_endo -65.75 117.55 4.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.739 1.626 . . . . 0.0 111.202 176.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 93.2 mttt 66.91 36.78 4.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.194 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -112.11 144.03 42.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.235 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -119.34 142.8 47.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.199 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -129.56 150.16 51.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 88.2 t -113.25 120.0 62.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 42.8 mt -103.12 144.45 31.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.246 172.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 459' ' ' GLU . 41.0 p -122.55 154.7 37.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.183 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.71 156.66 38.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.183 168.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.412 ' HB3' HD11 ' A' ' 455' ' ' LEU . 69.4 m -120.44 136.97 54.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.17 -177.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -140.61 129.08 22.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.243 -167.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.4 m -119.55 111.9 35.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.23 152.89 40.24 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.663 1.575 . . . . 0.0 111.219 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 72.9 p -124.45 -12.44 7.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -123.03 141.21 52.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.202 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -86.88 142.14 28.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.171 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.54 178.28 27.03 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -170.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.3 mmm -84.8 128.25 34.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.204 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -117.61 133.95 55.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 175.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -107.7 118.63 37.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 80.7 mt -105.03 124.98 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.271 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -117.78 147.08 43.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.275 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.93 139.11 53.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 66.0 p -131.92 153.96 49.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.0 p -125.75 141.62 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.26 171.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 32.0 t0 54.86 49.03 18.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.143 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -57.38 -38.87 74.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 520' ' ' GLU . 19.7 pm0 -75.73 -8.72 57.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.174 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.4 t30 63.37 64.0 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.21 171.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 69.0 p -96.69 -19.43 18.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.157 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 98.5 t -117.23 132.86 65.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.163 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 86.0 t -90.13 122.58 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -105.38 169.28 8.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.186 -170.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 98.4 mt -73.4 -28.36 61.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.194 167.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -136.22 127.87 28.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.187 173.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -109.03 -14.35 14.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.224 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -95.84 -10.02 30.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.267 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -103.41 26.28 8.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.141 -174.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -129.26 25.17 5.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.23 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 97.7 t -127.54 141.61 45.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.26 131.9 51.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.281 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.6 m -117.49 127.27 53.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.256 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -130.46 131.61 45.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.172 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -100.85 126.15 47.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.202 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.77 136.38 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.212 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -108.56 124.68 50.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 91.7 t -104.29 129.4 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.248 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.81 172.79 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.237 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 87.9 mt -95.43 39.28 1.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 . . . . . 0 C--O 1.2 -1.539 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.181 -175.437 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 94.2 mtp . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.816 0.341 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -112.86 147.07 37.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.198 148.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -116.13 102.66 53.71 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.16 -158.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.529 ' HG3' HG21 ' A' ' 470' ' ' VAL . 64.6 Cg_endo -70.45 173.63 11.31 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.679 1.586 . . . . 0.0 111.208 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -123.47 75.1 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.212 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 48.9 mt -81.47 126.01 31.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 15.4 t -143.22 157.38 44.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.55 154.89 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.25 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 50.4 mt-10 -137.46 136.84 38.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 81.5 mt -102.53 134.63 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.207 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -135.49 143.15 45.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 144.0 -176.34 23.35 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.44 165.92 26.7 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.644 1.562 . . . . 0.0 111.162 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 58.5 p-10 -123.86 10.4 8.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.19 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.56 116.48 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.122 167.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.3 154.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.223 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.64 160.44 28.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.3 p -72.91 135.42 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.744 0.307 . . . . 0.0 111.237 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 62.08 20.43 11.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.212 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -109.76 130.46 55.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.229 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 502' ' ' SER . 32.0 tp -76.23 128.6 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.193 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.63 142.07 51.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.21 173.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -111.2 139.0 46.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.195 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -130.86 159.08 38.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.424 ' HG2' HG22 ' A' ' 500' ' ' THR . 91.2 mt-10 -129.6 140.14 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 60.7 t -114.33 120.51 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.202 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 85.1 m-70 -99.32 115.8 30.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.237 176.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.74 131.84 70.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.205 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -128.33 156.3 43.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 62.3 t-20 -118.7 116.18 26.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.219 159.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 57.4 mt -109.6 13.19 23.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.205 -170.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.57 -3.17 69.2 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.9 19.72 78.39 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.515 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 6.4 tt -130.77 148.0 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.731 0.301 . . . . 0.0 111.166 174.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -85.96 131.12 10.3 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.529 HG21 ' HG3' ' A' ' 438' ' ' PRO . 92.0 t -117.95 116.42 36.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.234 170.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.68 -19.64 6.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.753 1.635 . . . . 0.0 111.161 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 78.5 p -98.56 0.13 44.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.134 -158.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 473' ' ' THR . 13.1 t -85.53 124.71 32.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.21 -162.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -111.68 128.65 56.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.227 -172.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.13 125.89 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.231 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -130.33 155.05 46.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.256 -170.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.85 133.23 66.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.262 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -119.91 147.5 44.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.275 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.1 mt -120.59 118.51 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.253 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 54.64 41.01 32.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.195 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.34 -20.09 45.98 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 171.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.3 m -98.31 139.44 34.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.821 0.343 . . . . 0.0 111.189 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.6 tp -68.21 121.15 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.152 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' TYR . . . . . 0.411 ' OH ' ' O ' ' A' ' 502' ' ' SER . 29.9 t80 -96.48 -39.3 9.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.234 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -163.34 158.69 21.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.187 -173.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -140.19 149.97 43.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -175.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -138.68 141.91 38.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.156 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.8 m -104.79 127.42 52.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.0 m -138.1 166.34 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 53.5 m -121.73 142.25 50.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.194 170.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.5 mt -128.85 131.19 47.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.92 -178.03 46.26 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.82 117.76 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.773 1.649 . . . . 0.0 111.21 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.1 mttt 55.56 39.79 31.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.216 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -100.47 145.23 28.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.139 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -120.85 140.72 51.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.186 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -127.58 145.7 50.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 173.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.92 119.58 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.4 mt -104.89 142.09 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.147 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.424 HG22 ' HG2' ' A' ' 459' ' ' GLU . 44.4 p -122.58 150.86 42.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.192 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.85 156.57 36.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 171.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.412 ' HB2' HD11 ' A' ' 455' ' ' LEU . 95.6 p -122.93 133.72 54.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -140.79 129.71 23.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.2 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.0 m -116.51 112.34 41.28 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.214 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -71.47 153.33 60.73 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.748 1.632 . . . . 0.0 111.176 172.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 65.0 p -122.81 -5.21 8.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.061 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -133.47 137.19 45.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.152 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.09 141.43 52.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.288 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.24 176.91 26.25 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.3 mmm -84.85 128.05 34.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 111.173 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -120.25 132.83 55.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.17 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -104.23 119.58 39.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 94.2 mt -103.68 124.46 57.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.187 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -119.67 146.17 45.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.09 143.74 50.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.205 172.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 77.4 p -130.73 150.04 52.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.202 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.716 ' O ' ' CB ' ' A' ' 518' ' ' ASP . 7.2 p -125.16 120.64 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 167.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 518' ' ' ASP . . . . . 0.716 ' CB ' ' O ' ' A' ' 517' ' ' VAL . 30.5 t70 105.59 25.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.264 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -58.39 -39.4 79.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.261 -158.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -79.04 2.08 21.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.085 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.4 t30 66.37 66.02 0.48 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.182 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 58.4 p -97.26 -34.1 11.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 -172.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 10.3 p -138.46 140.28 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.199 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 85.2 t -90.16 125.21 43.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.196 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.496 ' HG3' ' HG2' ' A' ' 438' ' ' PRO . 54.1 mp0 -103.95 176.47 5.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.269 -170.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 93.3 mt -71.07 -29.99 66.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.158 176.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -125.9 148.22 49.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.212 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -110.74 -5.77 14.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.265 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -93.64 -22.0 19.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.16 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -98.41 13.76 30.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.156 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -82.66 -2.76 54.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 58.7 t -128.22 142.0 44.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.237 -171.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.03 134.72 47.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 173.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.9 m -116.74 126.47 53.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.262 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -134.27 123.28 23.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.187 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -102.46 128.11 49.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.163 -172.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 90.6 t -122.79 137.19 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.26 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 71.4 m -98.95 124.9 44.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 86.4 t -102.85 129.37 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.199 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.96 165.84 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.152 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.0 -2.01 46.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.269 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 C--O 1.199 -1.562 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.241 -176.712 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 99.5 mtp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.775 0.322 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -105.21 136.02 45.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.261 135.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' PHE . . . . . 0.454 ' HB3' ' HG ' ' A' ' 526' ' ' LEU . 9.6 m-30 -107.29 117.22 56.65 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.181 -160.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 525' ' ' GLU . 30.3 Cg_exo -57.08 168.91 2.26 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 121.794 1.663 . . . . 0.0 111.141 171.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -129.98 71.97 1.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.208 166.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 85.2 mt -78.81 139.51 38.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.214 -173.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 12.3 t -146.15 157.7 43.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.208 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.5 155.69 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.187 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.4 mt-10 -139.86 136.05 33.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.236 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 95.3 mt -108.82 126.52 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.154 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.71 148.5 47.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.272 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.69 -168.65 34.39 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.82 116.16 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.642 1.562 . . . . 0.0 111.241 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -75.47 -18.22 59.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.205 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 96.7 t -125.96 129.32 72.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.169 169.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.07 154.05 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.188 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.55 149.86 32.39 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.417 HG11 HD23 ' A' ' 541' ' ' LEU . 5.9 p -71.05 136.54 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 111.187 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 61.85 27.36 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.216 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -123.59 148.21 46.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 502' ' ' SER . 29.4 tp -85.58 128.07 34.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -172.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.79 145.85 48.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.195 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -109.09 133.97 52.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.188 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 458' ' ' TYR . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 90.1 m-85 -127.91 157.2 41.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.417 ' HG2' HG22 ' A' ' 500' ' ' THR . 96.8 mt-10 -130.5 141.1 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.179 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 49.7 t -112.88 120.08 62.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.207 170.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.6 m-70 -101.8 111.3 23.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.15 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 475' ' ' VAL . 8.9 m -116.05 132.05 66.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.281 -170.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -127.21 155.13 43.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.217 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 61.2 t-20 -116.75 120.84 39.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.206 159.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 63.0 mt -115.0 8.19 15.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -168.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.03 -0.24 74.76 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.68 20.05 75.42 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.525 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.0 tt -131.03 145.68 35.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.786 0.327 . . . . 0.0 111.185 173.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -84.85 134.54 12.73 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.81 116.49 31.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.252 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.66 -18.49 9.27 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.675 1.583 . . . . 0.0 111.14 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.4 p -92.01 10.65 28.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.225 -165.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 99.0 m -80.27 112.91 18.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.142 -162.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -110.48 127.52 55.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.213 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.444 HG21 HG11 ' A' ' 462' ' ' VAL . 93.8 t -115.83 127.1 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -127.09 155.2 43.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.169 -172.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 69.2 t -128.67 132.96 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.279 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -120.17 147.03 45.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.225 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.424 HG12 HG12 ' A' ' 513' ' ' ILE . 83.6 mt -118.72 117.05 53.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.246 172.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 54.08 41.02 32.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.242 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.23 -10.44 66.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.5 m -97.51 138.45 34.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 111.222 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.6 tp -69.8 120.81 16.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.187 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -98.93 -40.69 7.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.262 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -166.57 159.03 13.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 -173.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -140.95 151.82 44.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.212 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 25.9 m-90 -138.16 141.9 40.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.23 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.6 m -109.65 126.02 53.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.252 168.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.04 167.83 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.199 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 30.4 t -118.79 140.93 49.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 170.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 83.9 mt -128.99 126.01 38.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.163 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.78 -173.39 48.32 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.23 111.7 1.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.772 1.648 . . . . 0.0 111.241 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.0 mttt 58.65 41.45 22.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -101.32 143.96 30.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.221 173.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -121.08 139.95 52.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.158 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -128.45 147.85 50.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.248 175.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 96.9 t -112.2 118.95 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.169 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 48.3 mt -102.24 142.19 33.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.222 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.417 HG22 ' HG2' ' A' ' 459' ' ' GLU . 36.1 p -122.85 151.92 41.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.248 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 501' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 55.1 p90 -154.41 156.38 36.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.167 166.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.469 ' HB3' HD11 ' A' ' 455' ' ' LEU . 69.9 m -119.73 128.63 53.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.191 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -125.74 129.27 49.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 -171.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 96.2 m -117.8 108.76 42.3 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 172.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.85 157.65 54.61 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.741 1.627 . . . . 0.0 111.25 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 75.5 p -124.9 -21.95 4.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.206 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.97 138.77 52.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.423 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 34.7 tt0 -73.74 139.71 45.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.5 174.76 24.11 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.5 mmm -85.59 128.46 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.844 0.354 . . . . 0.0 111.142 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -120.77 130.31 53.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -103.27 119.81 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.19 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.424 HG12 HG12 ' A' ' 479' ' ' ILE . 80.8 mt -102.11 120.22 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.271 176.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -122.35 146.41 47.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.226 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.15 140.25 53.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.9 p -131.79 152.78 50.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.249 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.66 146.47 31.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 24.8 t70 59.06 39.89 22.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.176 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -58.16 -39.88 79.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.222 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -79.36 -2.71 42.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.197 -175.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.4 t30 61.14 60.72 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.199 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 72.2 p -89.75 -29.77 18.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.254 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.8 p -132.54 136.76 55.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.221 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 524' ' ' VAL . . . . . 0.444 ' O ' ' CD1' ' A' ' 437' ' ' PHE . 95.2 t -90.07 125.19 42.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.191 176.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 438' ' ' PRO . 22.8 pt-20 -130.65 171.03 13.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 -166.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.454 ' HG ' ' HB3' ' A' ' 437' ' ' PHE . 54.7 mt -73.87 -27.73 61.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.192 174.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -110.08 67.23 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.168 -171.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -97.39 -8.52 29.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.209 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -104.4 -29.93 10.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.211 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -105.15 34.95 2.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.2 -174.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -124.61 23.14 8.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.247 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 93.3 t -129.46 144.93 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.58 133.56 49.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.195 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.1 m -115.43 124.2 50.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.266 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -128.31 128.51 44.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -101.1 126.94 47.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.243 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.5 t -121.43 136.18 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.8 t -101.41 127.5 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.9 t -99.78 126.69 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.42 150.72 24.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.183 -173.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 541' ' ' LEU . . . . . 0.423 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 86.0 mt -78.97 51.95 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.193 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 . . . . . 0 C--O 1.199 -1.586 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 -177.313 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.795 0.331 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -115.44 131.11 57.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.17 -173.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' PHE . . . . . 0.405 ' N ' HD13 ' A' ' 468' ' ' ILE . 39.1 m-85 -126.48 104.53 24.6 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.181 172.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.44 168.52 17.78 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.604 1.536 . . . . 0.0 111.21 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -129.7 81.06 1.99 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.182 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 8.9 mt -89.42 130.66 35.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 -175.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.0 t -146.16 163.1 36.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.228 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.09 154.58 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 93.9 mt-10 -135.63 137.94 42.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.208 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 89.3 mt -104.35 132.0 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.67 142.98 45.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.222 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.45 32.79 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.19 141.26 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.743 1.629 . . . . 0.0 111.232 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -97.26 -18.81 18.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.228 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 87.9 t -126.12 125.94 68.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.259 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.57 154.27 39.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.195 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.27 158.1 43.49 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 1.8 p -79.15 142.57 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.799 0.333 . . . . 0.0 111.232 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 63.11 29.41 16.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.22 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -125.93 145.11 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 502' ' ' SER . 33.0 tp -78.53 126.79 31.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.08 143.42 49.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -109.88 135.53 50.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.298 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -129.66 157.87 40.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.216 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.432 ' HG2' HG22 ' A' ' 500' ' ' THR . 80.2 mt-10 -130.09 139.57 50.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.268 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 45.0 t -113.22 120.24 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.175 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 94.2 m-70 -99.59 114.29 27.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 462' ' ' VAL . 2.9 m -117.21 127.0 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.153 -173.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.441 ' HD2' HD21 ' A' ' 465' ' ' LEU . 25.1 pttt -138.18 151.94 48.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 -171.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 52.9 t-20 -111.2 127.59 55.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.276 167.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.441 HD21 ' HD2' ' A' ' 463' ' ' LYS . 68.9 mt -115.61 7.5 14.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.28 -169.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -93.98 -5.2 62.72 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -169.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.02 23.15 76.89 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -171.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.508 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 1.3 mt -130.04 155.18 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 111.168 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.487 ' N ' ' CG2' ' A' ' 468' ' ' ILE . . . -117.08 120.47 4.82 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -172.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 491' ' ' LEU . 74.9 t -119.63 118.22 32.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.185 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -84.29 -17.62 5.4 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.714 1.609 . . . . 0.0 111.152 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 79.3 p -99.0 4.17 47.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -163.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 473' ' ' THR . 3.5 t -83.67 125.34 31.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.176 -163.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.58 130.35 55.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 -170.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 76.6 t -113.11 128.29 69.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.269 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.51 154.26 45.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.2 -173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 78.0 t -127.7 132.89 68.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.201 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -120.31 147.05 45.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.3 mt -120.85 116.22 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.194 172.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 54.38 40.97 32.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.269 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 93.49 -18.79 55.68 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 171.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.4 m -100.08 138.11 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.353 . . . . 0.0 111.149 -175.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.33 121.53 15.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.248 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -93.31 -39.93 10.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.287 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -168.91 159.52 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.233 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -132.08 152.34 51.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.189 -175.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 32.8 m-90 -136.3 141.44 43.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.7 m -109.95 124.72 51.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 166.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 25.9 m -138.74 167.54 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.6 p -114.44 141.08 48.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.24 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 470' ' ' VAL . 82.4 mt -129.82 129.76 44.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.201 174.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -93.76 -173.43 39.56 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.99 111.36 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.656 1.571 . . . . 0.0 111.203 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.4 mttt 63.62 43.64 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.191 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -104.52 142.96 33.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -121.36 139.51 53.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.223 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -128.79 147.25 50.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.199 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 83.2 t -111.62 119.13 59.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -176.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 66.6 mt -104.85 143.93 32.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.179 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.432 HG22 ' HG2' ' A' ' 459' ' ' GLU . 61.0 p -124.77 153.65 42.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.143 175.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -154.3 157.0 37.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.208 170.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.443 ' HB3' HD11 ' A' ' 455' ' ' LEU . 60.9 m -122.27 134.77 54.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.199 -175.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -140.33 129.49 23.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.215 -168.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.0 m -118.88 112.42 36.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.182 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.74 151.55 41.02 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.769 1.646 . . . . 0.0 111.286 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 70.1 p -122.02 -15.13 7.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.177 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -120.59 139.46 52.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.233 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -75.79 140.16 42.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.211 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.67 177.13 26.84 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.7 mmm -86.36 129.42 34.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.781 0.324 . . . . 0.0 111.222 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.84 132.62 55.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.263 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -104.74 118.19 35.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 89.1 mt -105.91 122.95 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -122.41 150.23 42.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.146 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.74 141.05 52.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.259 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 59.5 p -130.82 155.08 47.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.23 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.2 p -132.16 144.43 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.16 172.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.83 16.55 6.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.241 166.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -61.15 -45.22 95.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.235 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -97.95 -23.82 15.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.178 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -77.82 68.9 3.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 80.9 p -74.88 69.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.218 -163.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 4.3 p -100.99 140.74 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 167.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 95.2 t -82.84 125.51 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.248 -162.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -100.31 173.95 6.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.184 -172.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 92.7 mt -71.98 -28.55 63.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.142 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -155.78 114.63 3.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.195 175.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -104.67 5.74 33.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.152 -170.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -93.88 -25.24 17.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -103.45 34.42 2.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.188 -173.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -120.18 24.54 10.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.219 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.42 141.65 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 171.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -124.38 131.71 53.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.176 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.5 m -116.98 126.55 53.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.195 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -131.95 130.28 41.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.258 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -101.32 129.27 47.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.239 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 93.6 t -121.14 136.4 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.207 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 40.2 t -104.96 124.75 50.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.185 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.6 t -101.7 127.04 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.173 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 31.8 m -124.71 165.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.249 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 69.4 mt -90.42 10.72 24.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.24 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 . . . . . 0 C--O 1.199 -1.581 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 -177.342 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 435' ' ' MET . . . . . 0.682 ' CB ' ' CA ' ' A' ' 436' ' ' GLU . 42.4 mmm . . . . . 0 CA--C 1.523 -0.08 0 CA-C-O 120.861 0.362 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' GLU . . . . . 0.682 ' CA ' ' CB ' ' A' ' 435' ' ' MET . 12.4 pt-20 -115.09 176.35 5.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.082 31.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -98.55 108.47 48.23 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.183 -147.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.491 ' HG3' HG21 ' A' ' 470' ' ' VAL . 84.7 Cg_endo -72.35 172.06 15.71 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.772 1.648 . . . . 0.0 111.263 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' ASP . . . . . 0.456 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 62.0 t0 -122.49 73.91 1.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.278 167.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.48 137.09 36.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' A' ' 530' ' ' ASN . 8.2 t -144.19 154.33 43.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.185 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.3 m -128.46 153.65 38.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.153 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.4 mt-10 -141.01 137.82 33.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.66 127.25 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.207 174.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.13 145.2 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.117 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.5 -166.5 38.47 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.1 143.36 64.96 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.694 1.596 . . . . 0.0 111.249 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -90.35 -39.17 12.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.193 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 70.2 t -121.15 130.15 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.253 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.63 153.31 38.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.205 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -82.78 157.27 35.62 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.5 138.07 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.215 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 62.63 25.19 14.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.258 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -114.78 150.97 34.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.197 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 42.5 tp -87.41 127.21 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 -175.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.32 144.57 48.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.232 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.08 138.15 46.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.03 156.65 44.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -129.49 139.36 51.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.15 120.81 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.235 173.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 95.4 m-70 -102.42 107.72 18.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.184 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.3 m -118.48 129.95 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.166 -173.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.407 ' HD3' HD21 ' A' ' 465' ' ' LEU . 19.1 ptpt -143.72 154.72 43.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.192 -171.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 39.7 t-20 -108.26 143.67 36.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.223 170.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 43.6 mt -133.01 3.37 3.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.204 -172.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -96.97 4.63 63.1 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -170.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.07 17.57 75.76 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 174.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.55 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 2.2 tt -125.87 149.72 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.733 0.301 . . . . 0.0 111.181 167.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -95.91 131.76 10.79 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.491 HG21 ' HG3' ' A' ' 438' ' ' PRO . 99.5 t -119.33 119.63 31.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 111.218 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.17 -19.2 6.94 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.632 1.555 . . . . 0.0 111.189 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 91.2 p -94.12 16.51 14.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.185 -164.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 94.7 m -82.36 111.71 18.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.262 -165.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -111.57 127.24 55.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 85.3 t -118.14 128.8 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.159 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -125.05 154.69 40.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 -173.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.71 134.37 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.23 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -122.04 149.17 43.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.211 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 81.6 mt -120.54 115.69 47.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.198 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.26 41.44 31.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.236 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.94 -8.66 79.2 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.0 m -97.97 135.92 38.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.788 0.328 . . . . 0.0 111.298 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 68.2 tp -68.76 118.79 12.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -99.78 -40.42 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.262 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -166.99 158.85 12.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -140.5 151.97 45.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.21 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -137.36 142.23 41.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.168 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.9 m -109.5 124.38 50.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 166.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.93 168.09 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.125 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.1 m -118.79 142.0 48.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.182 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.31 131.08 48.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.39 -175.48 48.72 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.46 113.32 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.7 1.6 . . . . 0.0 111.159 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.7 mttt 65.9 35.32 6.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.173 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -102.97 143.63 32.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.237 176.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.9 141.08 51.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.189 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -128.18 146.76 50.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.28 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.69 119.58 60.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.225 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.3 mt -101.82 143.35 31.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.136 173.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 59.5 p -122.21 151.85 40.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.184 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.72 156.21 35.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.218 167.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.2 m -123.01 133.98 54.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.179 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 45.5 t90 -140.21 130.0 24.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.195 -167.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 95.2 m -118.17 111.78 38.4 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.296 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.12 155.53 56.65 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.596 1.53 . . . . 0.0 111.247 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 76.9 p -125.25 -13.02 6.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.271 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.39 137.57 49.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.17 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.97 142.17 52.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.42 175.59 24.96 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.2 mmm -85.62 126.86 34.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 111.259 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -119.79 126.94 52.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.206 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -103.31 119.24 38.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.252 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.41 124.12 56.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.218 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -116.86 145.14 43.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.151 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.24 139.55 53.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 173.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 76.8 p -131.05 151.51 51.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.235 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.5 p -126.47 144.6 36.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 169.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 30.1 t70 65.12 41.3 4.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.236 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -59.17 -39.85 83.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -81.01 -3.82 53.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.173 -173.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 60.5 t30 63.1 59.74 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.264 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 77.3 p -90.13 -30.26 17.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.211 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.465 HG23 ' HE2' ' A' ' 435' ' ' MET . 8.1 p -137.76 133.13 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.191 174.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 91.8 t -91.12 118.17 35.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.247 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.5 167.09 10.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.181 -171.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.02 -28.57 60.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -119.04 120.81 38.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 -169.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -107.43 2.36 24.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.238 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -90.1 -28.23 19.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.286 -175.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.537 ' HB3' ' OG1' ' A' ' 441' ' ' THR . 92.6 m-20 -100.16 5.92 44.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.209 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -63.08 -26.34 68.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.216 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.22 143.28 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.178 -174.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.79 132.37 51.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 88.0 m -116.32 125.63 52.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -131.14 130.39 43.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -102.34 129.98 48.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.23 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 92.3 t -120.52 136.54 57.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.168 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.8 t -105.84 124.82 50.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.172 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.9 t -102.85 129.22 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.196 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.92 164.45 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.14 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.9 mt -89.44 11.2 19.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.248 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 . . . . . 0 C--O 1.199 -1.567 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.222 -176.222 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 28.7 ttt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.761 0.315 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 436' ' ' GLU . . . . . 0.404 ' HB2' HD12 ' A' ' 468' ' ' ILE . 74.6 mm-40 -104.85 172.64 6.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 157.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -113.02 106.67 54.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.164 -170.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.49 164.15 9.55 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.665 1.577 . . . . 0.0 111.254 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -130.28 58.37 1.67 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.285 166.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.08 134.67 53.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 -175.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 531' ' ' ASN . 10.0 t -142.08 153.3 44.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.207 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.9 m -131.63 154.07 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.237 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.1 mt-10 -139.2 137.08 35.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 91.3 mt -107.16 127.4 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.244 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.93 148.76 48.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.205 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 152.5 -163.57 30.36 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.96 144.45 94.29 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.755 1.637 . . . . 0.0 111.196 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -98.55 -37.01 9.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.183 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 84.9 t -122.15 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.228 172.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.81 151.1 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.108 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -77.09 155.86 44.81 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.93 135.76 27.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.788 0.328 . . . . 0.0 111.21 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 63.02 26.57 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -114.0 154.92 26.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 40.2 tp -94.4 128.09 40.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.261 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.29 143.45 50.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.172 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -105.64 136.5 45.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.25 174.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.33 156.57 44.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.183 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 500' ' ' THR . 92.9 mt-10 -130.19 140.99 50.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 -177.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 53.1 t -113.14 121.39 65.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.239 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 87.5 m-70 -96.57 111.47 23.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.241 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 475' ' ' VAL . 2.6 m -119.91 129.18 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.272 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -145.35 155.29 43.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 36.7 t-20 -106.61 142.22 36.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.225 171.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 65.0 mt -134.08 5.06 3.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.231 -172.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -89.14 2.45 83.72 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -175.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.22 16.3 77.0 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.54 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 6.4 tt -126.45 146.06 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.25 171.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -87.11 132.56 11.24 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 173.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 80.7 t -116.17 115.5 40.44 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.841 0.353 . . . . 0.0 111.263 171.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.02 -18.25 8.94 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.591 1.528 . . . . 0.0 111.162 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.9 p -93.33 11.52 27.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.212 -166.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 86.9 m -75.76 114.38 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.161 -158.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.71 128.18 55.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.504 HG21 HG11 ' A' ' 462' ' ' VAL . 63.4 t -116.76 128.75 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.231 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -125.43 154.25 42.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.21 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 76.6 t -128.41 134.01 65.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.238 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.58 147.41 45.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.7 mt -120.7 116.81 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.204 171.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 54.41 41.48 31.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 90.73 -14.27 63.51 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.3 m -97.28 137.43 36.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 111.26 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 67.5 tp -69.52 120.69 15.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.154 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -97.61 -40.19 8.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.258 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -165.7 158.79 15.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -140.05 152.34 46.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.23 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -138.49 142.87 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.178 172.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.8 m -107.27 125.71 51.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 168.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.65 168.06 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.144 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 62.7 m -119.58 141.77 48.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.209 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 87.9 mt -129.39 130.19 45.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.202 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.03 -172.86 47.45 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.16 112.65 1.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.655 1.57 . . . . 0.0 111.212 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.5 mttt 65.7 35.34 6.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -101.91 142.55 33.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.256 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -120.74 141.47 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -127.35 146.27 50.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.264 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.7 t -111.55 119.5 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.146 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.54 143.02 32.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.447 HG22 ' HG2' ' A' ' 459' ' ' GLU . 41.6 p -120.84 151.5 39.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.225 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -154.44 156.65 37.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 167.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 67.3 m -122.05 132.5 54.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 46.6 t90 -138.39 129.04 26.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.164 -168.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 88.3 m -116.48 110.29 42.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.192 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.99 144.6 58.68 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.638 1.559 . . . . 0.0 111.151 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 76.2 p -117.36 -14.89 10.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.24 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -118.97 137.31 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.129 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 22.0 pm0 -77.04 145.47 37.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.137 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 147.18 178.16 22.26 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -85.33 129.6 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.749 0.309 . . . . 0.0 111.257 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -119.43 133.38 55.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.165 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -106.05 119.16 38.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.257 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 83.1 mt -104.28 124.1 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.252 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -117.62 145.93 44.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.55 138.8 53.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.3 p -131.6 151.03 51.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.22 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.0 p -127.73 147.52 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.2 172.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 8.7 t70 69.04 25.38 5.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.205 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -61.67 -45.01 95.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.204 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -94.02 -18.79 21.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.261 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 521' ' ' ASN . . . . . 0.714 ' O ' ' N ' ' A' ' 523' ' ' VAL . 70.5 m-80 -82.97 13.44 3.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.26 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 522' ' ' THR . . . . . 0.644 ' C ' ' O ' ' A' ' 521' ' ' ASN . 30.9 p -11.66 75.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.288 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.714 ' N ' ' O ' ' A' ' 521' ' ' ASN . 14.0 p -107.94 143.45 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.199 169.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 86.4 t -81.78 125.0 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.224 -173.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -114.06 177.17 4.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.329 -168.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.33 -26.85 62.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.202 171.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -159.27 111.17 2.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.274 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 53.1 mp0 -94.05 -1.44 54.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.218 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -86.29 -15.45 40.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.279 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -101.81 1.71 37.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.182 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 531' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 441' ' ' THR . 44.1 p-10 -92.6 17.25 10.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.2 -177.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 79.8 t -128.99 142.31 44.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.227 171.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.76 132.01 49.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.189 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.0 m -116.68 125.83 52.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.175 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -130.86 131.35 44.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.321 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -101.06 125.88 47.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -173.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 85.4 t -120.15 135.62 59.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -106.94 125.56 51.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.221 171.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 95.5 t -100.77 126.17 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.156 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.83 170.41 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.158 -174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 97.0 mt -87.96 14.03 9.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.204 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 C--O 1.2 -1.509 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.194 -176.958 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 98.5 mmm . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.876 0.369 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 436' ' ' GLU . . . . . 0.438 ' HB3' HD12 ' A' ' 468' ' ' ILE . 88.0 tt0 -88.67 149.81 23.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.175 156.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -109.91 112.25 58.12 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.228 -157.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.469 ' HG3' HG21 ' A' ' 470' ' ' VAL . 72.8 Cg_endo -74.09 169.74 21.73 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.649 1.566 . . . . 0.0 111.231 175.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 56.7 t0 -116.56 62.1 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 169.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.84 137.13 57.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.222 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 530' ' ' ASN . 13.1 t -146.66 156.97 43.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.204 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.09 155.21 39.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 47.5 mt-10 -138.75 135.71 34.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.126 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 444' ' ' ILE . . . . . 0.43 HD13 HG22 ' A' ' 513' ' ' ILE . 89.6 mt -107.57 125.52 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.156 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -136.86 147.19 46.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.2 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.73 -165.75 34.17 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -56.96 136.67 78.04 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.712 1.608 . . . . 0.0 111.178 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -86.39 -38.63 17.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.405 HG22 ' HB3' ' A' ' 538' ' ' SER . 92.2 t -124.84 133.91 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.8 m -130.45 152.65 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -82.4 160.42 39.91 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 540' ' ' VAL . 4.9 p -76.45 139.25 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 0.0 111.144 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 62.57 27.3 16.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.273 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -123.95 142.39 51.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.163 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.515 HD11 ' HB3' ' A' ' 502' ' ' SER . 36.7 tp -85.76 127.29 34.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.237 -174.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.58 144.17 49.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.221 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -110.1 135.14 51.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.156 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -129.09 157.64 41.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.501 ' HG2' HG22 ' A' ' 500' ' ' THR . 81.7 mt-10 -130.45 139.23 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.223 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 59.4 t -112.09 120.63 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 172.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 88.3 m-70 -97.86 118.38 34.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.505 HG11 HG21 ' A' ' 475' ' ' VAL . 11.8 m -117.97 131.86 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -127.04 155.22 43.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.229 -175.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 54.8 t-20 -117.06 131.26 56.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.245 157.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 50.8 mt -127.25 4.7 6.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.171 -167.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -91.8 3.73 78.14 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -175.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.8 20.24 75.78 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.579 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.1 tt -131.81 144.34 37.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.754 0.312 . . . . 0.0 111.231 175.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -85.8 133.18 11.6 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.469 HG21 ' HG3' ' A' ' 438' ' ' PRO . 85.9 t -119.61 118.11 32.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 0.0 111.209 170.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.2 -19.08 8.24 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 121.679 1.586 . . . . 0.0 111.133 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 91.5 p -93.07 10.14 32.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.177 -163.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.6 m -78.28 111.58 14.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.269 -161.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -110.4 127.28 55.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.167 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.505 HG21 HG11 ' A' ' 462' ' ' VAL . 88.8 t -115.78 128.75 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.236 -178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -123.6 151.7 42.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -174.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 87.8 t -130.12 134.77 62.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.205 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -118.41 145.77 44.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.74 117.93 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.202 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 50.7 t30 54.41 41.79 31.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.215 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 96.66 -22.91 37.7 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 172.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.1 m -100.27 139.43 35.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 111.174 -175.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 67.1 tp -68.77 121.64 16.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.231 175.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -98.18 -41.02 8.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.217 -173.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -167.45 162.53 14.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -172.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -141.81 153.44 44.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.26 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -137.49 142.08 41.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.234 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.1 m -108.14 127.58 53.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.248 169.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.97 167.6 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.205 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 49.8 m -121.15 142.22 50.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.215 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 82.4 mt -130.47 128.1 40.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.245 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.37 -170.85 46.87 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.57 112.55 1.64 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.702 1.601 . . . . 0.0 111.205 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.3 mttt 62.08 35.67 15.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.268 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -99.55 144.32 28.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.138 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -120.52 141.69 50.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -126.54 146.76 50.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.188 173.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.7 t -112.44 119.34 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.082 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 43.7 mt -103.17 141.1 36.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.2 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.501 HG22 ' HG2' ' A' ' 459' ' ' GLU . 60.7 p -124.76 152.07 44.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.207 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -154.62 157.12 37.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.285 170.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.515 ' HB3' HD11 ' A' ' 455' ' ' LEU . 71.5 m -119.43 131.42 55.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.208 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 42.2 t90 -140.71 129.72 23.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 -169.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 88.9 m -115.94 109.28 45.21 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.279 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.84 118.86 5.61 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.743 1.629 . . . . 0.0 111.104 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 68.2 p -99.02 1.1 45.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.25 137.03 49.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.462 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 37.7 tt0 -73.79 138.49 44.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.184 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.34 174.48 23.69 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.1 mmm -85.22 129.24 34.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.806 0.336 . . . . 0.0 111.185 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -119.48 128.48 54.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.173 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -106.04 119.38 39.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.43 HG22 HD13 ' A' ' 444' ' ' ILE . 79.7 mt -102.96 122.25 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.1 -176.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -119.97 144.74 47.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.91 140.16 52.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.4 p -131.63 151.17 51.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.9 p -118.64 143.72 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 23.9 t0 46.59 56.49 6.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.206 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -58.17 -38.01 75.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.246 172.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -73.77 -8.36 55.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -174.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.7 t30 58.7 58.32 3.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.175 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 70.7 p -93.07 -21.85 19.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.208 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 12.7 p -135.38 133.82 52.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 99.3 t -93.26 127.29 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.204 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.424 ' HG3' ' HG2' ' A' ' 438' ' ' PRO . 40.6 mp0 -100.3 164.13 12.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.297 -176.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 93.3 mt -74.48 -29.69 61.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.209 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -111.85 156.18 22.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.238 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -117.69 -10.31 10.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.239 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -90.97 -8.82 48.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.189 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.484 ' HB3' ' HB ' ' A' ' 441' ' ' THR . 95.6 m-20 -96.73 -6.03 37.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -76.48 -19.84 57.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.167 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 63.5 t -128.09 141.07 47.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.158 -174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.88 133.43 45.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.179 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 96.9 m -115.98 126.31 53.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.211 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -131.25 130.13 42.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.151 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -100.32 129.14 46.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.181 -172.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.6 t -121.22 135.56 61.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.207 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 538' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 449' ' ' VAL . 36.3 t -104.82 126.0 51.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.189 174.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.37 127.76 55.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.177 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 452' ' ' VAL . 35.7 m -122.23 159.23 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.131 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 541' ' ' LEU . . . . . 0.549 ' O ' ' HB3' ' A' ' 542' ' ' GLU . 83.6 mt -81.23 57.74 3.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.109 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 542' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 541' ' ' LEU . 24.9 pt-20 . . . . . 0 C--O 1.2 -1.511 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.256 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 95.9 mtp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.838 0.351 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -113.67 132.56 55.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.185 -166.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' PHE . . . . . 0.485 ' HB2' ' HG ' ' A' ' 526' ' ' LEU . 34.4 m-85 -130.06 132.88 24.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 175.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -69.97 166.45 27.8 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.685 1.59 . . . . 0.0 111.188 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -138.26 89.68 2.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.6 133.21 37.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.165 -169.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.47 ' OG1' ' HB3' ' A' ' 530' ' ' ASN . 10.0 t -146.36 155.31 42.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.207 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 517' ' ' VAL . 28.6 m -129.31 153.75 39.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.177 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -135.59 133.69 38.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.251 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 77.6 mt -104.48 124.99 59.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.98 146.55 47.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.182 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.55 -167.44 33.04 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -56.16 133.89 60.8 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.636 1.558 . . . . 0.0 111.181 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -82.66 -40.42 20.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 172.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 64.1 t -122.94 130.88 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.171 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.04 154.43 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.05 152.35 36.41 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.68 137.25 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.797 0.332 . . . . 0.0 111.222 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 64.15 30.78 13.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.213 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -125.02 143.42 50.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.218 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 44.0 tp -81.18 127.2 32.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.259 -175.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.9 144.88 48.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.151 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -103.97 136.43 43.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.18 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -130.04 156.66 44.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.195 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.405 ' HG2' HG22 ' A' ' 500' ' ' THR . 91.3 mt-10 -130.65 140.4 50.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.223 -175.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.69 121.26 64.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.175 172.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -100.46 117.52 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.175 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.52 131.38 71.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.156 -174.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -125.5 154.93 41.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.204 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 61.8 t-20 -117.85 121.7 41.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.222 157.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 61.4 mt -113.75 14.71 18.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.191 -170.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -98.42 -4.83 57.18 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -174.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.9 23.07 78.34 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.49 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.3 tt -134.54 146.92 30.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 111.188 172.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -82.55 135.44 14.09 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 86.0 t -121.88 119.96 28.72 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.741 0.305 . . . . 0.0 111.225 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -84.24 -17.46 5.53 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.668 1.579 . . . . 0.0 111.199 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 84.4 p -91.75 7.98 39.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -162.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 88.4 m -81.23 108.29 14.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.226 -162.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -110.58 124.4 51.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 98.8 t -111.19 126.98 68.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 -173.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -125.53 151.92 45.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 -172.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 73.5 t -126.88 132.8 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.213 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -120.1 147.41 44.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.87 115.07 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.233 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 54.49 40.91 32.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.185 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 95.01 -17.63 58.93 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 171.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.7 m -99.5 135.97 40.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 111.146 -175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.9 tp -67.99 120.54 14.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -96.41 -40.35 9.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.238 -175.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -167.05 158.28 12.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -137.41 152.03 49.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.187 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 -136.73 142.68 43.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.194 174.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.5 m -108.91 124.8 51.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.253 168.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.5 m -139.12 166.81 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 86.8 p -118.02 144.56 45.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 169.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.9 mt -126.72 130.93 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -92.43 -177.34 41.59 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.21 121.04 9.2 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.68 1.586 . . . . 0.0 111.222 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.8 mttt 55.03 41.9 31.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 175.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.91 143.62 34.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.217 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -117.71 140.42 49.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.228 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -126.95 145.85 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 174.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 79.3 t -111.74 119.47 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.178 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 45.4 mt -103.45 143.11 33.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.196 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.405 HG22 ' HG2' ' A' ' 459' ' ' GLU . 52.9 p -122.82 153.23 39.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.25 156.14 36.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.198 166.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 57.6 m -122.18 133.63 54.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.223 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 47.7 t90 -139.86 129.68 24.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 -165.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.5 m -117.8 114.21 37.66 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.221 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -71.32 154.85 61.12 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.706 1.604 . . . . 0.0 111.203 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 74.1 p -124.64 -14.53 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.182 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -122.91 136.51 54.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.254 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 21.7 pm0 -76.51 145.76 38.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.58 179.57 22.81 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -173.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.04 129.96 34.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.741 0.305 . . . . 0.0 111.189 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.45 133.49 55.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.226 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -105.21 119.36 38.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.186 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 94.5 mt -103.86 124.88 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -118.73 145.76 45.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.154 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.23 143.28 51.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.215 173.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 68.1 p -130.89 151.26 51.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.194 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.477 ' HB ' HG13 ' A' ' 442' ' ' VAL . 12.4 p -116.81 143.8 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.224 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.6 t0 37.98 60.99 1.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.196 -167.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -56.75 -37.51 71.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -170.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -74.56 -5.29 42.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.204 -173.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 60.1 t30 63.1 60.17 1.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.223 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 73.0 p -112.7 12.35 19.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.226 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.66 137.11 51.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 84.7 t -91.54 116.27 32.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.208 169.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -126.75 172.22 10.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.209 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 526' ' ' LEU . . . . . 0.485 ' HG ' ' HB2' ' A' ' 437' ' ' PHE . 69.1 mt -76.12 -26.4 56.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 177.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -111.12 124.08 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 -162.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -117.91 -4.67 11.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.235 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -93.54 -35.18 13.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 -171.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.47 ' HB3' ' OG1' ' A' ' 441' ' ' THR . 9.7 m120 -98.79 7.78 45.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.124 -171.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -65.77 -22.67 66.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.204 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.56 139.76 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.219 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.35 133.02 50.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.9 m -116.67 127.15 54.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.24 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -132.55 129.86 39.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.196 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -100.1 128.5 46.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.206 -172.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 96.6 t -121.26 136.22 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 40.2 t -105.52 124.43 49.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.195 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.16 125.45 55.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.213 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.96 161.4 28.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.197 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.68 56.84 4.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.175 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 . . . . . 0 C--O 1.2 -1.518 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.225 -179.093 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 98.7 mmm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.768 0.318 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -108.82 147.9 31.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.232 167.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' PHE . . . . . 0.411 ' CD1' ' O ' ' A' ' 524' ' ' VAL . 17.8 m-30 -109.65 104.6 55.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.159 -163.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.97 163.0 39.57 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.694 1.596 . . . . 0.0 111.223 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -111.47 90.32 3.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 166.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 78.1 mt -85.28 145.69 27.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 530' ' ' ASN . 13.0 t -144.28 154.77 43.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.275 176.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 32.6 m -130.62 156.43 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.9 mt-10 -140.11 137.43 34.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.204 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 92.7 mt -107.62 127.16 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.249 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.83 149.04 47.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.23 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 153.46 -165.1 31.3 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.72 120.66 7.57 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.708 1.605 . . . . 0.0 111.256 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -83.33 -8.68 59.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.181 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.24 128.45 64.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 169.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 25.4 m -131.08 155.59 42.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -93.67 154.5 21.7 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.89 137.91 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 62.89 27.44 15.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.23 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -125.36 142.08 51.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.199 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 502' ' ' SER . 37.2 tp -91.07 127.82 36.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.224 -174.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.71 145.55 48.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -106.93 138.02 43.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.184 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -129.09 157.04 42.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.207 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -129.96 139.6 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.267 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 460' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 47.7 t -112.33 121.22 64.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.196 172.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.5 m-70 -101.39 105.91 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.284 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.419 HG11 HG21 ' A' ' 475' ' ' VAL . 3.2 m -118.51 130.78 72.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -173.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -142.38 152.82 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.222 -171.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.63 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.9 t-20 -98.53 140.8 32.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.259 170.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 72.6 mt -130.55 5.4 4.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.221 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -101.37 -1.39 53.79 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.2 27.02 74.15 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.63 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 0.6 OUTLIER -120.69 141.74 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.747 0.308 . . . . 0.0 111.201 175.57 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 469' ' ' GLY . . . . . 0.505 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -81.39 99.61 1.97 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.685 ' CG1' ' O ' ' A' ' 470' ' ' VAL . 0.4 OUTLIER -103.16 110.53 63.82 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.71 -15.33 27.05 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.721 1.614 . . . . 0.0 111.271 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.6 p -89.75 11.18 20.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.195 -157.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' THR . . . . . 0.453 ' OG1' ' CG1' ' A' ' 470' ' ' VAL . 97.3 m -77.16 109.59 11.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 -166.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -110.55 125.75 53.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.266 172.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.419 HG21 HG11 ' A' ' 462' ' ' VAL . 86.3 t -117.35 128.17 74.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.192 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -127.46 154.35 45.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.232 -173.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.2 t -128.16 134.56 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.19 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -122.01 148.0 45.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.297 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 89.6 mt -119.98 117.26 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 172.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 54.16 41.48 31.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.183 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.65 -8.65 74.41 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.9 m -97.55 137.51 36.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 111.288 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 68.5 tp -70.69 120.77 16.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.148 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -98.45 -40.51 8.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.245 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' LYS . . . . . 0.423 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 51.1 tptt -165.95 159.17 15.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.189 -172.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -141.26 152.8 44.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.233 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 487' ' ' TRP . . . . . 0.423 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 24.1 m-90 -138.16 142.4 40.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.2 171.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.9 m -106.79 124.33 49.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.227 169.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.73 167.44 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.263 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 70.7 m -121.21 144.16 48.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.14 172.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 94.6 mt -127.07 129.32 47.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.264 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 492' ' ' GLY . . . . . 0.505 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -83.91 -173.99 50.09 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 174.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.93 111.03 0.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.734 1.623 . . . . 0.0 111.27 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 64.48 34.61 10.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.162 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -99.19 143.31 29.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.236 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.2 140.87 52.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.243 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.46 147.36 49.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.164 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 96.3 t -112.45 119.55 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 54.2 mt -103.51 142.72 33.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.25 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 53.3 p -122.24 153.17 39.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.24 156.15 36.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 167.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.444 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.3 m -121.29 128.28 52.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -128.25 129.8 46.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -171.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.9 m -117.84 109.04 41.81 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.26 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.77 152.19 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.697 1.598 . . . . 0.0 111.247 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.7 p -124.74 -0.77 7.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.25 136.21 48.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.202 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -79.85 143.94 33.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.247 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.28 175.92 22.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -82.25 126.6 32.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.776 0.322 . . . . 0.0 111.13 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -119.84 130.82 55.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.161 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -105.79 118.93 37.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.193 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 84.1 mt -104.22 123.19 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.292 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -119.44 145.7 46.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.249 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.35 142.0 51.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.8 p -130.76 151.38 51.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.1 p -124.88 145.8 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.216 169.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 19.7 t70 65.3 34.61 8.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.44 -39.66 80.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.192 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -79.13 -4.15 48.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.9 t30 63.29 64.54 0.82 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.282 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 76.3 p -98.6 -31.48 11.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.219 -176.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.96 138.89 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.147 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 524' ' ' VAL . . . . . 0.411 ' O ' ' CD1' ' A' ' 437' ' ' PHE . 86.0 t -89.04 124.85 42.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.178 174.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -110.9 165.13 12.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 -166.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 86.2 mt -78.02 -25.54 47.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -145.76 111.1 5.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.084 -172.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -101.5 4.42 41.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -80.97 -22.54 39.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.184 -173.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.503 ' HB3' ' OG1' ' A' ' 441' ' ' THR . 95.2 m-20 -101.3 2.1 39.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.194 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -73.5 -5.5 40.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.168 -174.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.3 141.31 46.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.167 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.65 135.62 48.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.3 m -114.86 125.58 53.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.219 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -131.46 129.85 41.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.165 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -99.61 124.59 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -173.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 97.0 t -121.28 135.58 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.186 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 36.3 t -104.78 129.33 53.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.224 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 86.3 t -102.41 126.71 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.245 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.32 157.65 38.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.187 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 541' ' ' LEU . . . . . 0.497 ' O ' ' O ' ' A' ' 542' ' ' GLU . 79.8 mt -68.14 -17.64 64.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.174 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 542' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 541' ' ' LEU . 88.7 tt0 . . . . . 0 C--O 1.2 -1.532 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 436' ' ' GLU . 96.0 mtp . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.87 0.367 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 435' ' ' MET . 25.1 pt-20 -84.68 -179.24 7.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.216 -2.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -111.51 117.14 49.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 -154.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.41 ' HG3' HG21 ' A' ' 470' ' ' VAL . 72.2 Cg_endo -78.86 168.01 21.44 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.681 1.587 . . . . 0.0 111.203 -173.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -118.74 82.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.146 163.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 87.3 mt -81.1 127.4 32.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.122 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.1 t -148.45 160.92 42.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.196 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.07 155.75 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.276 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -135.99 139.69 43.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.243 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 61.9 mt -108.05 137.27 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.33 142.45 45.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 179.97 179.45 48.8 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.681 ' O ' ' HB2' ' A' ' 448' ' ' ASP . 33.8 Cg_endo -70.98 -31.49 15.04 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.679 1.586 . . . . 0.0 111.224 -172.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 448' ' ' ASP . . . . . 0.681 ' HB2' ' O ' ' A' ' 447' ' ' PRO . 82.7 m-20 75.59 -11.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.271 -175.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.13 117.15 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.68 152.54 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.229 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.51 157.74 44.52 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.5 p -76.43 140.22 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.127 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 63.13 29.6 16.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -124.73 139.0 54.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 37.3 tp -76.5 126.39 30.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.87 145.05 48.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.19 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -103.03 136.15 43.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -129.16 156.68 43.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -128.22 139.24 52.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.234 -171.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 57.0 t -115.85 120.3 64.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 173.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -99.56 113.31 25.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.295 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.43 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -116.14 127.33 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.467 ' HD2' HD21 ' A' ' 465' ' ' LEU . 11.3 pttt -131.83 150.49 52.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.224 -170.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.5 t-20 -105.24 137.99 42.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.241 162.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.467 HD21 ' HD2' ' A' ' 463' ' ' LYS . 56.5 mt -123.61 0.07 8.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 -169.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -95.53 -15.4 43.73 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.49 31.19 63.42 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.519 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 0.1 OUTLIER -132.95 130.08 58.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 111.182 177.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.23 131.34 10.81 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -170.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.435 HG11 HG21 ' A' ' 523' ' ' VAL . 97.9 t -123.3 120.11 27.29 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.734 0.302 . . . . 0.0 111.148 170.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.62 -19.01 6.48 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.654 1.57 . . . . 0.0 111.12 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.8 p -95.95 12.93 28.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.256 -163.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.9 m -77.32 117.66 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.192 -162.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -109.95 128.26 55.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.285 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.42 128.15 73.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.198 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -125.9 152.8 45.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -171.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 72.9 t -127.95 132.72 68.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.214 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -120.0 148.76 43.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.234 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.8 mt -120.96 115.91 48.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.261 170.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 54.52 41.35 32.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.2 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 95.42 -19.94 51.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 171.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -98.13 137.03 37.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 0.0 111.223 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.03 120.62 14.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.257 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -97.3 -39.89 9.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -176.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -166.11 157.95 13.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -141.73 154.63 45.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.175 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -135.29 142.3 45.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.238 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.9 m -102.31 122.51 44.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.201 165.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.56 166.92 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.204 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 67.4 m -120.12 142.28 49.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 96.9 mt -128.9 131.45 47.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.251 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -92.42 -165.68 38.82 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.37 114.2 2.77 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.676 1.584 . . . . 0.0 111.205 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 61.7 41.05 12.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.266 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -102.49 141.32 35.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -120.76 137.95 54.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -123.42 145.59 48.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.203 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.66 117.85 55.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 19.0 mt -109.46 136.14 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.24 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 44.6 p -120.09 155.24 33.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -172.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -153.52 156.57 38.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.215 171.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.8 m -121.1 133.35 55.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 41.2 t90 -140.19 130.1 24.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.188 -166.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.6 m -116.33 112.34 41.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.216 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.52 152.37 48.61 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.712 1.608 . . . . 0.0 111.142 172.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 71.1 p -122.37 -15.07 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.228 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -120.07 139.74 52.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -77.24 139.98 39.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.22 178.38 25.97 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.1 131.14 34.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.781 0.324 . . . . 0.0 111.153 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -117.34 137.51 52.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.245 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -104.85 118.69 37.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.152 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 86.2 mt -104.14 125.24 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.205 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 64.7 m-80 -116.74 146.92 42.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.93 142.31 51.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.283 169.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 36.8 p -131.28 151.05 51.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.257 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.75 140.39 46.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.26 171.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 22.1 t0 51.81 51.14 17.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 -173.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -58.22 -38.26 76.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.196 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -77.3 -8.54 57.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.174 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 59.5 t30 64.74 59.83 0.9 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.193 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 69.3 p -101.75 -9.78 20.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.265 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 523' ' ' VAL . . . . . 0.435 HG21 HG11 ' A' ' 470' ' ' VAL . 87.5 t -112.3 131.95 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.264 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 80.1 t -90.61 116.93 32.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.259 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -120.37 177.46 5.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.187 -170.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.19 -24.44 57.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.134 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -147.9 117.32 6.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.211 -175.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -95.49 -3.5 46.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.17 -173.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -94.51 -0.75 54.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.22 176.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -102.55 23.26 12.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.174 -173.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -97.27 -19.2 18.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.194 -169.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.8 t -123.34 140.0 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.21 -166.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -129.74 136.09 49.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.257 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.5 m -114.99 128.44 56.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.186 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -133.21 127.93 34.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.08 -171.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -102.38 128.28 49.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.21 -170.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 86.8 t -122.33 137.15 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 41.2 t -103.91 124.67 49.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.158 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 93.0 t -102.73 126.27 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.162 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.96 159.61 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.167 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 59.1 mt -84.8 57.04 4.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.163 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 C--O 1.199 -1.585 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.179 -179.359 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.814 0.34 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 436' ' ' GLU . . . . . 0.412 ' HB3' HD12 ' A' ' 468' ' ' ILE . 88.3 tt0 -101.73 150.94 22.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.246 156.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -106.43 108.65 62.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.199 -158.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' PRO . . . . . 0.479 ' HB3' HG23 ' A' ' 468' ' ' ILE . 73.5 Cg_endo -72.8 162.51 40.96 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.717 1.611 . . . . 0.0 111.257 177.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -111.01 76.09 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.243 164.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.4 mt -74.84 137.9 42.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 531' ' ' ASN . 11.3 t -144.34 155.1 43.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.112 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.02 155.74 41.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.304 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 97.8 mt-10 -137.32 139.64 40.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.161 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 87.6 mt -107.85 132.07 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.225 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -136.27 142.8 43.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.229 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 162.18 -173.49 38.5 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.58 134.86 34.23 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.727 1.618 . . . . 0.0 111.229 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -75.9 -40.7 53.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.191 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.4 t -122.31 132.4 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.179 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.05 152.13 36.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.5 159.9 46.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.52 149.2 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 111.174 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 63.38 26.47 14.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.147 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -128.31 143.3 51.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.082 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 37.3 tp -86.38 127.83 34.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.191 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.35 144.19 49.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.218 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -102.46 135.15 44.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' TYR . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 87.2 m-85 -129.16 157.12 42.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.193 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 459' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 500' ' ' THR . 90.6 mt-10 -129.82 141.11 50.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.195 -174.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.9 t -113.24 121.03 64.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 172.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.465 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 94.6 m-70 -99.42 111.1 23.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.156 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.27 130.91 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.435 ' HD3' HD21 ' A' ' 465' ' ' LEU . 19.2 ptpt -143.78 154.1 43.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -175.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.58 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.4 t-20 -104.77 141.46 36.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.208 172.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.435 HD21 ' HD3' ' A' ' 463' ' ' LYS . 63.8 mt -131.69 4.3 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.203 -169.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 466' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -91.78 0.06 72.84 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.28 19.04 75.59 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.58 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 5.5 tt -126.72 143.84 38.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.765 0.317 . . . . 0.0 111.289 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -84.9 132.11 10.86 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' VAL . . . . . 0.45 HG21 ' HG3' ' A' ' 438' ' ' PRO . 85.6 t -118.89 116.01 34.6 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 111.21 173.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.29 -18.19 9.91 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.689 1.592 . . . . 0.0 111.209 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.3 p -91.53 12.56 20.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.259 -167.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 89.8 m -79.64 111.26 15.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.22 -163.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -113.84 125.62 54.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.0 131.02 67.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.198 -173.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -120.42 154.2 35.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.173 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.1 t -128.93 134.81 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.195 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.73 147.28 45.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 93.3 mt -124.24 117.5 50.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.21 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 45.4 t30 54.8 42.18 31.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.195 172.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 96.07 -19.99 52.05 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 174.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.2 m -101.53 138.99 37.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.764 0.316 . . . . 0.0 111.251 -174.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.7 tp -69.96 121.75 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.166 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -97.71 -40.43 8.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.219 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -165.56 158.9 16.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.185 -171.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -140.0 152.77 46.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.221 -177.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -138.49 142.61 39.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.6 m -106.34 126.01 51.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.224 170.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.66 167.85 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.21 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.6 m -120.47 143.34 48.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 170.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.5 mt -129.03 129.21 45.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.259 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -86.44 -173.44 49.1 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.96 112.06 1.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.681 1.587 . . . . 0.0 111.196 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.0 mttt 64.68 33.69 10.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.21 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -101.15 144.96 29.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.167 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -123.5 141.3 52.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.176 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.78 147.22 50.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.182 174.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.9 t -111.87 119.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 43.3 mt -103.81 142.03 35.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.213 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 500' ' ' THR . . . . . 0.445 HG22 ' HG2' ' A' ' 459' ' ' GLU . 47.4 p -122.99 152.95 40.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.226 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 501' ' ' PHE . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.1 p90 -153.97 156.58 37.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.147 168.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 67.1 m -121.28 131.61 54.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.184 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 503' ' ' TRP . . . . . 0.456 ' CH2' ' HB3' ' A' ' 505' ' ' PRO . 41.1 t90 -140.11 129.92 24.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 -169.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 82.1 m -111.47 110.84 55.32 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.256 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 505' ' ' PRO . . . . . 0.456 ' HB3' ' CH2' ' A' ' 503' ' ' TRP . 74.0 Cg_endo -70.96 111.57 3.08 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.726 1.618 . . . . 0.0 111.165 174.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 80.8 p -83.61 -20.31 33.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.195 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -121.75 140.9 51.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.189 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.48 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 31.7 tt0 -72.26 141.0 48.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.05 174.58 23.58 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -176.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -85.48 127.83 34.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.783 0.325 . . . . 0.0 111.157 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -120.38 132.04 55.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.295 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -105.53 119.58 39.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.256 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 92.8 mt -100.73 122.74 53.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -120.75 147.06 45.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.57 140.17 52.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 174.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.2 p -130.91 150.64 51.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.113 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.565 ' CG1' ' HB2' ' A' ' 531' ' ' ASN . 12.0 p -123.42 149.75 27.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.199 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 23.8 t0 46.0 48.96 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.162 -165.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -57.37 -37.22 72.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.289 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.91 -6.37 46.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.24 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.4 t30 57.84 60.12 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.22 175.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 69.7 p -99.86 -20.74 16.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 9.9 p -130.29 136.41 58.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.188 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 88.9 t -89.59 126.78 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.186 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -99.81 171.63 7.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 -171.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.36 -26.49 61.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.236 173.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -139.36 147.77 41.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.232 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -111.97 -17.19 12.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.216 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -95.24 -6.56 41.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -99.26 0.75 43.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.2 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 531' ' ' ASN . . . . . 0.565 ' HB2' ' CG1' ' A' ' 517' ' ' VAL . 49.5 p-10 -111.75 24.44 12.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 -175.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 89.5 t -132.12 145.45 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.155 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.37 134.11 48.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.273 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.7 m -116.03 126.38 53.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.156 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -132.68 130.69 40.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.332 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.5 129.42 47.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.164 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.9 t -121.59 136.22 59.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.8 t -106.29 126.8 52.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.211 173.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.9 t -102.3 128.63 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.203 176.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.96 159.94 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 541' ' ' LEU . . . . . 0.48 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 93.2 mt -83.48 0.89 44.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 . . . . . 0 C--O 1.201 -1.498 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.143 -177.595 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 CA--C 1.522 -0.099 0 CA-C-O 120.824 0.345 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -106.02 125.53 51.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.185 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -127.22 140.97 39.36 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.083 -175.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.76 162.6 40.61 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.715 1.61 . . . . 0.0 111.125 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -133.38 83.47 2.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 13.9 mt -91.7 127.08 37.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.253 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 9.0 t -145.77 157.82 43.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.55 154.75 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.199 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 94.9 mt-10 -135.62 137.48 41.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.204 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.6 mt -103.65 131.58 51.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.202 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -135.98 142.24 44.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.186 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.9 -176.02 33.51 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.79 141.19 44.47 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.666 1.577 . . . . 0.0 111.323 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -95.82 -17.24 21.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.204 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.6 t -126.61 124.97 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.8 m -130.03 154.24 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.124 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.44 150.84 27.5 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.79 140.01 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 0.0 111.16 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 63.69 30.11 14.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.161 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -126.02 142.93 51.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 502' ' ' SER . 36.7 tp -83.48 126.67 33.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.196 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.79 144.98 48.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -102.78 135.87 43.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.133 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.94 157.2 42.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -130.01 139.51 51.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.157 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.83 120.09 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.1 m-70 -100.68 116.08 31.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 475' ' ' VAL . 1.4 m -117.41 128.09 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 -175.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.452 ' HD2' HD21 ' A' ' 465' ' ' LEU . 13.4 pttt -133.69 150.76 51.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.176 -174.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 57.8 t-20 -111.51 123.97 51.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.214 167.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.452 HD21 ' HD2' ' A' ' 463' ' ' LYS . 56.0 mt -110.52 5.63 21.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.272 -170.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.77 -14.96 54.34 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -174.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.23 21.88 78.4 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.463 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.0 tt -129.49 139.9 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.88 0.371 . . . . 0.0 111.12 167.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -83.09 134.1 12.53 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -169.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 84.8 t -122.16 119.0 28.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.758 0.314 . . . . 0.0 111.263 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -86.15 -18.16 3.54 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.652 1.568 . . . . 0.0 111.137 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.6 p -97.11 4.0 51.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.178 -160.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 473' ' ' THR . 10.2 t -85.31 123.52 30.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.22 -166.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -113.34 128.93 56.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.22 -174.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.431 HG21 HG11 ' A' ' 462' ' ' VAL . 88.4 t -112.02 125.79 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 -174.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.02 155.77 44.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.214 -171.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.31 133.31 69.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -120.5 148.26 44.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.219 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 70.5 mt -120.24 114.73 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.226 169.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 53.96 40.97 32.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 91.64 -11.79 71.17 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.6 m -98.29 134.3 41.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 111.195 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.5 tp -68.54 119.18 12.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.278 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -99.08 -40.58 7.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.231 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -167.33 157.51 11.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.168 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -140.4 151.97 45.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.229 -175.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -136.46 142.15 43.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.2 m -103.26 125.0 49.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.21 163.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.43 166.05 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.4 m -121.95 142.43 50.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.169 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 491' ' ' LEU . . . . . 0.433 HD21 ' HB2' ' A' ' 497' ' ' LYS . 87.3 mt -129.64 131.44 46.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.167 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -89.76 -167.08 42.14 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 172.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.47 117.53 4.79 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.708 1.605 . . . . 0.0 111.224 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.1 mttt 59.69 41.78 18.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.172 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -103.83 144.56 31.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.256 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -120.32 143.25 48.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.163 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.433 ' HB2' HD21 ' A' ' 491' ' ' LEU . 1.8 tttp -137.46 130.75 30.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.217 -173.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 69.4 t -106.37 118.53 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.161 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 37.2 mt -107.07 144.02 34.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.196 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 41.7 p -122.35 152.68 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.175 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.9 156.4 37.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 168.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.406 ' HB3' HD11 ' A' ' 455' ' ' LEU . 68.8 m -120.41 134.02 55.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.286 -176.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -130.31 129.37 43.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.236 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 96.6 m -118.49 110.55 38.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 170.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.61 152.26 47.98 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.74 1.627 . . . . 0.0 111.168 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 59.4 p -123.88 -15.07 7.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -119.26 135.16 54.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.701 ' CD ' ' H ' ' A' ' 508' ' ' GLU . 2.9 pm0 -80.08 124.82 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.168 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 174.47 -179.99 45.45 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.3 mmm -84.39 127.21 33.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 111.253 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -122.1 133.03 54.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.154 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -105.31 119.17 38.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.289 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.0 123.73 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 -176.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -115.19 146.51 41.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.46 142.74 51.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.237 168.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 77.2 p -130.8 150.39 51.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.22 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.79 147.43 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.278 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 35.5 t70 22.62 85.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.22 -156.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -61.2 -40.56 94.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.237 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -81.21 -7.29 59.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.268 -165.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 63.86 46.37 3.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.146 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 72.0 p -90.13 -14.9 32.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.248 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 92.4 t -107.41 131.47 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.222 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 87.7 t -89.52 120.15 37.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.19 173.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -117.33 170.03 9.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.163 -167.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.36 -26.66 61.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.124 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 42.0 p30 -96.74 164.03 12.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.203 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -130.04 -30.04 2.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.174 169.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -100.83 -8.39 22.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -99.0 21.24 11.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 -170.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -99.99 -2.06 35.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.203 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 79.4 t -128.81 139.17 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.235 178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.86 133.15 45.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.288 174.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.5 m -117.51 127.03 53.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.193 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -133.6 129.34 36.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.245 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -100.22 126.46 46.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.195 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 82.1 t -121.0 135.83 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.188 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -105.17 127.75 53.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.239 173.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.03 127.73 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.183 173.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.51 150.88 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 -172.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 541' ' ' LEU . . . . . 0.702 ' O ' ' HG ' ' A' ' 541' ' ' LEU . 39.8 tp -111.03 55.83 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.178 -174.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--O 1.199 -1.573 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 178.185 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.758 0.313 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -126.55 133.06 51.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.197 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -127.21 145.1 52.97 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.83 165.71 31.31 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.653 1.569 . . . . 0.0 111.227 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -147.78 98.91 3.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.193 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 531' ' ' ASN . 60.3 mt -96.18 142.64 28.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.192 -176.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.5 t -148.53 159.17 44.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.227 174.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.05 154.91 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.184 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 93.7 mt-10 -135.79 138.72 42.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.231 176.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 82.5 mt -106.19 128.23 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -135.75 149.04 49.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.231 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.84 -173.53 35.15 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.16 145.47 60.74 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.718 1.612 . . . . 0.0 111.117 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -90.07 -41.78 11.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 74.9 t -118.25 126.18 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.267 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.5 m -129.73 152.23 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.232 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.79 158.71 45.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 3.1 p -79.42 146.02 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.839 0.352 . . . . 0.0 111.133 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 63.65 29.06 15.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.25 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.91 141.87 51.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 35.0 tp -81.57 127.55 32.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.205 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.16 144.5 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.202 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -103.01 135.78 44.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.191 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -129.34 157.08 42.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.237 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -129.68 139.63 51.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.218 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 460' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 44.5 t -112.01 120.44 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.186 170.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 96.8 m-70 -101.54 113.17 26.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.412 HG11 HG21 ' A' ' 475' ' ' VAL . 1.5 m -119.66 130.72 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.23 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -142.73 154.97 44.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -172.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 41.2 t30 -106.71 140.12 40.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.208 170.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 65.1 mt -125.88 4.76 7.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.182 -174.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -89.42 -15.33 58.77 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.53 24.28 73.18 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.469 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.3 tt -137.67 136.39 45.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 111.174 171.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -74.45 136.54 21.31 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -168.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.64 118.15 30.95 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.802 0.334 . . . . 0.0 111.216 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.74 -18.5 5.54 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.649 1.566 . . . . 0.0 111.266 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.6 p -94.11 13.06 24.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 -163.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 100.0 m -78.83 111.62 15.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.16 -161.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -109.83 125.89 53.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.412 HG21 HG11 ' A' ' 462' ' ' VAL . 60.1 t -119.9 127.0 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.177 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -135.28 157.24 47.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.178 -172.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 69.4 t -127.68 134.38 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.244 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -116.85 146.73 42.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.174 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 80.2 mt -120.1 115.05 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.171 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 53.68 41.29 32.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.178 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 93.01 -15.4 62.95 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 172.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -99.64 133.71 43.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.803 0.335 . . . . 0.0 111.25 -174.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 56.0 tp -68.79 120.23 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.222 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -97.36 -40.96 8.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.211 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -168.31 157.44 9.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.193 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -140.5 155.17 46.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.228 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -135.21 142.38 46.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.252 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.4 m -109.67 123.32 49.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.206 166.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.11 167.74 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.277 -175.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 82.9 p -116.75 143.89 45.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.143 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 96.4 mt -129.16 131.23 47.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.201 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -90.15 -179.19 44.27 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 172.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.49 120.24 7.72 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.686 1.591 . . . . 0.0 111.255 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.9 mttt 57.08 36.62 27.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.249 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -103.24 144.08 31.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.162 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -122.95 140.67 52.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.243 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -126.81 147.68 50.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.185 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 90.0 t -110.89 119.16 58.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 35.7 mt -104.16 141.65 35.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.199 173.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 46.3 p -124.55 153.86 41.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.23 156.28 36.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.211 166.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 52.7 m -122.47 134.37 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 41.3 t90 -140.17 129.77 24.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.211 -166.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.3 m -117.15 112.88 39.55 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.28 150.32 36.83 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.703 1.602 . . . . 0.0 111.237 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 66.9 p -122.68 -11.71 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.194 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -120.03 139.19 52.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.173 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -80.74 143.6 32.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.135 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.93 177.84 25.18 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.7 mmm -86.31 130.75 34.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 111.184 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -118.71 134.93 54.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.225 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -106.95 119.6 39.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.158 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 85.2 mt -103.5 124.9 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.193 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -117.71 145.7 44.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.228 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.75 141.4 51.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.192 170.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 68.0 p -131.05 150.56 52.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.169 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 531' ' ' ASN . 7.3 p -125.73 143.19 40.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 169.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.9 t70 59.41 36.04 23.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.167 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -58.76 -37.64 76.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.196 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.87 -4.59 50.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.208 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 59.6 t30 65.18 59.63 0.82 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.209 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 66.9 p -92.53 -29.12 16.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.314 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 14.4 p -130.89 138.69 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.275 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.01 121.68 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.18 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -120.08 178.24 4.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.148 -174.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 87.9 mt -69.83 -27.28 64.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.21 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -157.36 121.55 4.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.208 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -103.24 1.73 33.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.212 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -97.93 -9.64 25.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 168.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' A' ' 531' ' ' ASN . 63.4 t30 -98.08 65.66 1.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.14 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 531' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 530' ' ' ASN . 25.7 p-10 164.68 25.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.112 -157.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 532' ' ' VAL . . . . . 0.403 ' H ' ' H ' ' A' ' 531' ' ' ASN . 71.5 t -130.96 138.47 53.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 161.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.03 130.61 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -172.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.2 m -117.29 127.05 53.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.247 176.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -130.65 130.2 43.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.206 -175.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -99.08 125.59 44.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -173.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.54 135.58 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.166 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.5 t -105.79 122.41 46.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.221 171.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 98.2 t -102.76 127.08 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.15 165.06 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.84 -47.09 82.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.287 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 C--O 1.2 -1.509 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.113 173.777 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 94.7 mtp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.824 0.345 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -100.77 147.57 25.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.225 161.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -115.16 113.72 43.62 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.258 -162.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.94 166.94 7.84 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.713 1.609 . . . . 0.0 111.118 174.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -141.16 73.52 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.204 165.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.01 143.36 34.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.141 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 44.7 p -127.8 162.39 26.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.183 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' VAL . . . . . 0.412 ' CG1' ' HB ' ' A' ' 517' ' ' VAL . 29.1 m -131.82 152.08 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.26 163.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 86.2 mt-10 -139.96 135.69 33.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 175.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 84.5 mt -109.66 124.18 66.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.211 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.0 148.66 47.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.227 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.22 -163.92 32.17 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -56.25 136.77 77.07 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.674 1.582 . . . . 0.0 111.247 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -86.99 -37.63 17.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.203 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 93.1 t -124.85 132.87 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.203 174.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.84 151.85 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.24 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.61 158.78 43.62 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.8 136.17 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 111.22 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 62.56 21.99 13.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.19 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -110.3 130.98 55.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.17 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 35.3 tp -74.73 126.81 31.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.156 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.56 146.47 48.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -108.66 132.26 54.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -128.18 157.2 41.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.172 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -130.35 140.36 50.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.211 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 48.8 t -111.77 120.39 62.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 170.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.1 m-70 -105.98 109.09 20.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.195 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 14.6 m -116.42 132.61 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -119.77 159.16 25.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 44.5 t-20 -111.82 121.75 45.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 156.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 48.5 mt -117.16 1.0 12.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 -177.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.72 -19.29 41.17 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 75.28 28.87 61.14 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 15.2 tt -128.14 136.03 61.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 111.193 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.7 122.24 13.76 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.09 112.07 31.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 111.169 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.23 -17.42 11.7 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.738 1.625 . . . . 0.0 111.206 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 58.5 m -87.98 10.73 17.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -162.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.9 m -79.97 108.54 13.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -162.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -109.54 127.44 54.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.194 175.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 80.4 t -113.45 126.16 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.303 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -127.87 153.84 46.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.243 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.75 134.38 64.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -120.99 147.55 45.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.219 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.452 HG12 HG12 ' A' ' 513' ' ' ILE . 86.3 mt -120.39 117.41 53.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 170.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 54.31 41.43 31.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.268 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.95 -9.51 71.94 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.1 m -98.14 137.81 36.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.745 0.307 . . . . 0.0 111.208 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -69.76 120.31 15.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -98.09 -40.39 8.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -165.15 158.07 16.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.213 -173.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -142.23 152.04 42.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.234 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.3 m-90 -137.79 142.66 40.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.288 170.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.7 m -105.97 125.12 50.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.231 170.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.0 m -138.98 167.21 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.5 m -122.79 143.31 49.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.161 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 90.8 mt -128.57 128.81 44.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.268 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.37 -167.79 43.59 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.79 112.84 1.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.658 1.572 . . . . 0.0 111.205 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.0 mttt 66.86 36.19 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -96.61 143.81 27.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.235 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -125.37 141.48 52.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.233 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 497' ' ' LYS . . . . . 0.43 ' HB3' ' HE3' ' A' ' 497' ' ' LYS . 26.4 mmmt -129.8 144.82 51.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.189 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.3 119.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.128 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 64.6 mt -104.03 143.3 33.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 47.1 p -122.36 152.77 39.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.211 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -153.82 156.61 37.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.236 168.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.2 m -121.1 129.25 53.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.189 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -127.27 129.5 47.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 -172.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.9 m -113.89 110.47 49.02 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.192 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.29 150.99 53.9 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.691 1.594 . . . . 0.0 111.179 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 79.9 p -123.41 -13.53 7.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.223 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -125.76 137.12 53.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.192 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.462 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 30.9 tt0 -77.02 140.05 40.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.242 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.8 175.12 23.95 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.7 mmm -85.67 129.91 34.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.191 176.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -119.63 130.32 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -104.01 119.39 38.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.195 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.452 HG12 HG12 ' A' ' 479' ' ' ILE . 82.5 mt -104.05 123.76 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.201 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -119.76 145.14 46.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.208 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.04 143.09 50.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.192 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 82.7 p -131.17 153.2 49.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.289 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.43 HG22 ' HB2' ' A' ' 518' ' ' ASP . 9.1 p -126.78 140.85 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.238 173.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 518' ' ' ASP . . . . . 0.58 ' OD1' ' HB3' ' A' ' 521' ' ' ASN . 3.3 t0 64.09 38.84 8.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.19 167.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -58.76 -44.14 90.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.226 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -90.33 -22.53 21.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.187 -169.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 521' ' ' ASN . . . . . 0.58 ' HB3' ' OD1' ' A' ' 518' ' ' ASP . 55.2 t30 -85.14 78.03 9.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.225 171.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 56.6 p -70.44 65.32 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.199 -174.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.2 p -101.87 146.26 10.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 -175.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 86.9 t -83.21 125.08 40.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.281 -175.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.463 ' HB2' ' HG3' ' A' ' 528' ' ' GLU . 58.8 mt-10 -114.23 175.89 5.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.265 -171.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.91 -26.18 62.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.112 170.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -155.52 108.65 2.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.221 175.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 528' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 525' ' ' GLU . 36.4 mt-10 -100.67 1.32 40.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.165 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -87.78 -10.66 50.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.195 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -101.53 12.74 36.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.184 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -84.27 0.99 46.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.86 140.4 48.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.228 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.18 137.18 49.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.0 m -115.21 126.52 54.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -134.71 129.75 35.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.181 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -100.19 128.71 46.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.226 -173.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 91.9 t -121.13 135.99 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.242 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.6 t -105.66 124.42 49.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.145 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.6 t -102.03 126.61 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.73 155.23 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 541' ' ' LEU . . . . . 0.462 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 83.4 mt -80.93 52.83 1.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.238 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 . . . . . 0 C--O 1.2 -1.5 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.209 -177.446 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 98.2 mtp . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.782 0.325 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -119.24 157.42 28.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.267 158.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -112.62 95.48 32.7 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.265 -163.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.28 168.68 22.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.723 1.615 . . . . 0.0 111.243 173.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -127.62 81.57 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.267 172.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.6 136.01 33.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 -174.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 530' ' ' ASN . 8.0 t -141.0 153.14 45.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.324 176.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 26.2 m -131.62 154.9 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.131 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.7 mt-10 -139.4 135.69 33.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.2 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 87.7 mt -107.34 126.86 63.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.192 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.9 147.93 48.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.243 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.89 -169.66 34.67 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.42 114.46 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.693 1.595 . . . . 0.0 111.163 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -69.04 -26.96 65.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 97.5 t -123.69 130.96 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.221 172.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.2 152.01 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.187 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.58 158.91 41.9 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.53 137.91 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 111.248 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 62.21 25.5 15.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.299 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -116.56 150.2 38.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.176 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 502' ' ' SER . 37.9 tp -88.87 127.61 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.279 -175.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.41 143.99 49.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.228 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -107.71 137.32 45.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.187 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.86 157.67 41.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.27 141.2 51.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.155 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 460' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 47.1 t -113.13 120.95 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.162 170.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.7 m-70 -103.29 108.17 19.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 475' ' ' VAL . 2.3 m -118.42 130.55 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.224 -171.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -144.99 151.72 39.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.167 -173.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 44.6 t-20 -106.81 139.58 41.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.163 173.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 73.7 mt -129.37 4.09 5.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.214 -171.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -88.0 -2.04 81.42 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.94 21.4 78.23 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.437 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.8 tt -126.55 148.85 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.773 0.32 . . . . 0.0 111.186 175.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -94.06 115.69 5.06 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 94.3 t -104.76 114.48 63.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.757 0.313 . . . . 0.0 111.194 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.7 -17.98 10.79 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.698 1.598 . . . . 0.0 111.201 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.7 p -91.42 12.08 21.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.164 -164.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 91.1 m -78.75 108.17 11.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.229 -162.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -111.07 128.26 55.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.218 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 462' ' ' VAL . 67.1 t -115.05 128.46 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 -176.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -123.67 152.61 41.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 79.7 t -127.7 133.71 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.284 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.22 147.51 44.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.169 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' ILE . . . . . 0.466 HG12 HG12 ' A' ' 513' ' ' ILE . 84.1 mt -119.86 117.19 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.292 171.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 54.55 41.16 32.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.176 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.56 -11.82 67.12 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 173.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.2 m -97.71 137.64 36.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 111.224 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 66.5 tp -69.3 120.69 15.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.263 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -98.11 -40.47 8.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 -176.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -166.16 159.91 15.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 -173.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -141.17 153.13 45.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.182 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -139.17 142.79 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.196 171.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.8 m -107.55 125.09 50.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.204 169.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.61 168.07 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 59.4 m -121.98 143.09 49.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.173 170.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.4 mt -127.38 129.53 47.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.216 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.38 -179.74 48.15 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.06 113.87 1.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.647 1.565 . . . . 0.0 111.211 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.5 mttt 64.73 34.14 9.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -101.5 143.47 31.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.28 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -122.81 140.3 53.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.208 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -128.29 146.43 50.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.206 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.9 t -112.34 119.45 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 499' ' ' LEU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 49.5 mt -102.86 142.25 34.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.239 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 45.7 p -123.82 152.78 41.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.23 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.95 156.84 38.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.314 167.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.403 ' HB3' HD11 ' A' ' 455' ' ' LEU . 70.5 m -120.12 129.81 54.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.206 -176.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -130.69 129.57 42.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.219 -170.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.1 m -117.34 107.3 45.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.222 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.35 143.48 31.47 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.713 1.608 . . . . 0.0 111.202 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 67.4 p -115.41 -14.85 11.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.169 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -119.94 138.02 53.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 508' ' ' GLU . . . . . 0.437 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 33.2 tt0 -75.0 140.11 43.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.197 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.87 174.44 24.05 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -176.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.6 mmm -85.17 127.82 34.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.842 0.353 . . . . 0.0 111.111 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -120.89 131.96 54.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.18 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -104.17 118.07 35.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.165 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 513' ' ' ILE . . . . . 0.466 HG12 HG12 ' A' ' 479' ' ' ILE . 83.9 mt -104.52 120.22 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -123.02 149.4 44.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.239 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.4 140.81 52.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.233 175.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 60.1 p -131.75 151.75 51.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.163 174.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.498 ' CG1' ' HB2' ' A' ' 531' ' ' ASN . 8.1 p -124.83 145.05 32.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.216 173.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 5.7 t0 70.85 16.56 6.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.136 170.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -61.78 -43.06 99.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.196 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -90.16 -16.59 29.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 -175.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -117.27 57.93 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.192 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 69.5 p -58.13 97.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.25 -163.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.49 140.66 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.159 172.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 85.0 t -82.78 123.45 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.32 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -110.85 170.49 8.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.283 -164.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.34 -26.44 60.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.143 171.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -150.09 106.15 3.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.295 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -98.3 5.95 47.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.18 -172.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -89.12 -16.32 31.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.201 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 530' ' ' ASN . . . . . 0.473 ' HB3' ' OG1' ' A' ' 441' ' ' THR . 94.5 m-20 -99.24 -13.47 19.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.162 -175.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 531' ' ' ASN . . . . . 0.498 ' HB2' ' CG1' ' A' ' 517' ' ' VAL . 36.6 p30 -80.87 11.86 3.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.2 -174.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 88.6 t -130.29 141.48 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.157 167.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.87 133.98 46.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.239 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 85.8 m -116.19 125.89 52.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -131.21 129.09 41.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.191 176.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -101.14 125.65 47.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.249 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 85.3 t -121.25 136.26 58.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.9 t -104.61 127.34 52.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.179 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 85.2 t -101.24 126.85 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.144 173.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 32.2 m -122.87 159.77 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.12 -175.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 541' ' ' LEU . . . . . 0.437 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 94.3 mt -85.29 0.42 52.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.153 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 . . . . . 0 C--O 1.2 -1.537 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.219 -176.848 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 82.9 mmm . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.847 0.356 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -145.19 129.47 17.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 165.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -128.56 104.95 19.18 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 174.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -66.24 162.95 33.76 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.73 1.62 . . . . 0.0 111.233 170.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -143.17 78.07 1.59 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.232 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 14.7 mt -80.28 125.86 30.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.198 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 14.5 t -138.74 157.15 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.37 155.48 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.308 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 91.5 mt-10 -137.05 133.75 35.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.193 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 92.6 mt -104.56 127.28 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -135.48 146.48 48.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.226 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.61 -171.17 34.19 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.96 140.39 45.58 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.71 1.607 . . . . 0.0 111.205 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -86.03 -36.52 19.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.237 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.2 t -120.03 129.57 75.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.231 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.09 153.18 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.232 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.37 156.54 43.3 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.1 p -76.19 140.29 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.201 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 63.46 28.65 15.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.239 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -121.73 148.04 45.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.82 127.06 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.28 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.25 143.38 49.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.177 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -103.99 135.17 46.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.121 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -130.27 157.22 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -129.81 139.83 51.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.221 -175.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.7 t -113.45 121.9 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 173.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.5 m-70 -101.71 112.05 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.15 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.408 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -117.89 128.83 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.256 -171.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' LYS . . . . . 0.449 ' HD2' HD21 ' A' ' 465' ' ' LEU . 45.7 pttt -145.07 154.97 43.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.202 -172.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 63.4 t-20 -113.77 120.88 42.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.156 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' LEU . . . . . 0.449 HD21 ' HD2' ' A' ' 463' ' ' LYS . 82.6 mt -112.16 15.36 20.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.176 -170.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.28 -9.62 61.7 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -177.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.96 16.79 76.65 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.474 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.7 tt -127.03 146.21 33.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.701 0.286 . . . . 0.0 111.264 170.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -83.6 132.06 10.82 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.7 114.55 32.66 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.222 168.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -84.71 -19.17 4.27 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.811 1.674 . . . . 0.0 111.242 -174.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 99.1 p -97.92 5.32 49.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.233 -160.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 473' ' ' THR . 8.9 t -84.99 127.03 34.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.212 -160.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.94 130.92 55.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.249 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.89 130.21 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.268 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -129.49 155.09 46.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.176 -170.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 41.4 t -125.55 135.02 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.228 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -124.04 150.15 45.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.218 -174.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 86.3 mt -124.03 116.45 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.221 172.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 54.49 41.19 32.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.19 -13.52 66.87 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 170.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.6 m -99.76 138.53 36.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 111.257 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.7 tp -67.85 120.44 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -99.01 -40.28 8.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.156 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt -158.26 162.9 37.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -138.12 148.32 44.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.157 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -138.48 142.03 39.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.135 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 93.2 m -109.75 126.68 54.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.286 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.5 m -138.19 167.1 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.242 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.7 m -117.32 140.28 49.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.184 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.9 mt -129.44 130.24 45.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.136 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -91.15 -167.21 41.04 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 173.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.2 111.73 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.731 1.62 . . . . 0.0 111.239 175.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 494' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.1 mttt 60.01 43.69 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.181 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.06 142.67 31.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.238 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -122.14 137.92 54.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.145 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -127.97 148.61 50.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.188 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 85.9 t -111.2 118.53 57.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.186 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 48.1 mt -104.84 145.65 30.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.259 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 55.5 p -120.51 154.0 35.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.218 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -152.93 155.04 36.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 165.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 65.2 m -124.25 131.59 53.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -131.42 131.53 43.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.201 -170.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.4 m -118.02 110.3 40.02 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.221 174.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.85 154.44 43.28 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.806 1.671 . . . . 0.0 111.107 172.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 74.3 p -124.19 -19.16 5.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.242 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -120.13 138.92 53.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.22 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.21 140.44 46.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.46 176.61 26.1 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.64 128.94 35.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.17 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -121.92 136.55 54.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.209 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -104.68 119.09 38.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.243 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 93.0 mt -103.73 124.05 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.175 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -121.37 151.16 40.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.27 143.18 51.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.163 173.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 64.6 p -131.07 154.1 48.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.215 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.7 138.33 54.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.235 165.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 25.0 t0 54.97 61.24 3.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.19 -171.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -57.05 -38.77 73.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.18 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 521' ' ' ASN . 11.4 pt-20 -81.15 20.01 0.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.158 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 521' ' ' ASN . . . . . 0.535 ' C ' ' O ' ' A' ' 520' ' ' GLU . 55.7 t30 -29.81 107.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.198 -159.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 70.5 p -101.06 11.72 39.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.206 168.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 94.7 t -116.14 136.17 53.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.156 -170.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 90.8 t -88.62 121.38 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.287 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -108.88 -178.4 3.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.232 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.42 -30.52 70.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -115.34 -121.99 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.181 166.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -163.49 -45.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.168 166.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -98.57 5.99 47.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 -162.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -94.92 11.3 32.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.213 -171.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -101.41 20.26 16.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.173 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.57 142.01 44.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.203 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.4 131.74 48.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 80.1 m -115.25 125.34 53.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.171 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -132.58 130.83 40.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.149 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -104.05 129.63 51.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.224 -174.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.0 t -121.27 137.19 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.257 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.6 t -103.97 124.13 48.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.199 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 83.9 t -102.17 126.47 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.242 175.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.07 160.54 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.26 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 76.0 mt -84.5 -4.63 59.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.185 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 . . . . . 0 C--O 1.2 -1.506 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.114 -175.801 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 28.7 ttt . . . . . 0 CA--C 1.523 -0.084 0 CA-C-O 120.884 0.373 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -91.55 144.83 25.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.249 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -120.23 121.01 29.68 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.165 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.24 165.37 26.97 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.74 1.627 . . . . 0.0 111.064 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -143.36 89.72 2.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 15.4 mt -90.14 128.3 36.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.187 -176.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.4 t -143.76 157.59 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.199 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.63 154.59 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.25 -177.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 50.3 mt-10 -135.95 139.82 43.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.233 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 85.4 mt -105.38 132.17 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.24 142.52 44.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.189 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 160.41 -174.97 37.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.15 142.72 42.53 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.762 1.642 . . . . 0.0 111.208 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -75.24 -46.36 34.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.251 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.18 130.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.192 -176.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.37 153.09 38.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.249 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -85.65 159.81 33.62 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 4.7 p -72.41 139.96 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 0.0 111.242 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 63.31 29.95 15.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.22 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -124.52 138.64 54.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.22 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' LEU . . . . . 0.416 HD11 ' HB3' ' A' ' 502' ' ' SER . 34.4 tp -81.49 126.9 32.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.24 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.81 144.47 48.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.223 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -101.88 134.19 45.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.213 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -129.42 156.88 43.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.106 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -130.1 139.94 50.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.124 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.9 t -111.54 120.1 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' HIS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.0 m-70 -99.63 114.17 27.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.225 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 462' ' ' VAL . . . . . 0.4 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -117.42 129.43 73.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.224 -175.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -144.26 153.07 41.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.23 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 31.0 t30 -111.72 130.05 55.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.185 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 78.9 mt -114.61 4.03 15.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.204 -173.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -88.7 -20.54 47.04 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.91 24.37 72.16 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' ILE . . . . . 0.421 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.6 tt -134.44 138.97 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 111.173 169.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -76.07 131.68 12.06 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -166.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.38 117.63 30.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 111.251 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -86.72 -17.74 3.24 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.639 1.559 . . . . 0.0 111.175 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 98.5 p -95.59 4.36 53.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.259 -160.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 473' ' ' THR . 9.6 t -86.57 124.33 32.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.265 -164.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -113.6 129.13 56.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.191 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 97.0 t -112.22 127.54 69.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.234 -174.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.69 157.65 41.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.27 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.3 t -126.33 133.63 68.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.145 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -120.85 148.53 43.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 77.5 mt -119.77 115.71 48.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.232 169.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 54.23 41.0 32.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.187 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.18 -16.0 61.96 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 171.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -97.88 136.18 38.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.352 . . . . 0.0 111.207 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.5 tp -68.49 120.0 13.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.099 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -98.37 -40.06 8.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -166.36 157.41 12.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.268 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -139.96 151.18 45.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.181 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 30.0 m-90 -136.82 142.05 42.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.178 170.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.7 m -102.82 125.03 49.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.24 164.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.74 166.0 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.234 -172.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.8 m -122.48 143.53 49.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 171.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.9 mt -128.54 130.26 47.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -91.32 -165.09 39.61 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.49 112.35 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.723 1.616 . . . . 0.0 111.182 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 59.94 48.31 8.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.209 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -104.56 142.98 33.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.146 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -117.59 141.76 47.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.269 172.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -139.25 130.13 26.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.227 -172.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 73.7 t -105.58 118.41 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 -170.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 36.0 mt -105.73 143.6 33.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 173.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 50.7 p -122.87 152.67 40.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -153.81 156.41 37.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.189 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 502' ' ' SER . . . . . 0.416 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.7 m -121.07 133.57 55.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.234 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -133.46 131.21 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.165 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.6 m -116.58 109.74 43.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.278 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.54 153.53 34.73 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.714 1.609 . . . . 0.0 111.19 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 69.9 p -128.52 -2.3 5.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.203 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -133.95 135.31 43.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.206 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -72.24 141.79 48.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.4 175.22 25.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.2 mmm -86.03 127.17 34.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 111.188 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -119.98 137.45 54.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.311 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -106.79 119.2 38.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.205 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 83.7 mt -102.98 123.8 56.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.214 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -116.46 144.98 43.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.184 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.45 141.41 52.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.252 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 73.0 p -131.0 150.55 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.272 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.615 ' O ' ' C ' ' A' ' 518' ' ' ASP . 14.6 p -123.54 150.65 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.261 174.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 518' ' ' ASP . . . . . 0.615 ' C ' ' O ' ' A' ' 517' ' ' VAL . 30.6 t0 2.83 85.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.242 -166.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.87 -41.81 87.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.213 -175.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 520' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 521' ' ' ASN . 74.5 mm-40 -80.24 -24.91 39.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.167 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 521' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 520' ' ' GLU . 77.4 m-20 76.98 -65.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.264 176.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 69.6 p 36.63 35.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.199 -162.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.3 p -153.55 138.86 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.225 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 91.9 t -87.7 117.6 31.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.191 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -115.45 170.84 8.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.255 -169.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.69 -27.01 61.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -154.94 121.41 5.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.186 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -101.86 0.47 35.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.225 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -89.73 -12.83 38.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.158 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -101.45 15.11 29.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.221 -175.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -69.27 -17.12 63.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.218 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.49 140.09 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -171.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -129.49 134.01 47.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.1 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 83.0 m -116.85 127.97 54.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.227 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -132.23 131.65 42.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.31 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -99.34 128.94 45.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.166 -172.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.5 t -121.27 136.79 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.175 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.2 t -106.38 123.99 48.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.187 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.3 t -103.1 128.31 56.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.138 175.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.24 165.02 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.25 58.9 4.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.157 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 C--O 1.2 -1.525 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.21 176.827 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.496 ' HB3' HG23 ' A' ' 468' ' ' ILE . 70.8 Cg_endo . . . . . 0 N--CA 1.458 -0.57 0 N-CA-C 111.227 -0.336 . . . . 0.0 111.227 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -121.47 90.37 3.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.228 167.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 71.1 mt -83.03 138.27 33.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.193 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.3 t -140.05 153.77 46.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.173 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.2 m -132.89 156.31 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.212 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 95.8 mt-10 -139.74 136.68 34.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.27 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 94.5 mt -107.43 127.49 63.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.97 147.88 48.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.175 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.47 -167.85 34.65 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.51 142.19 58.33 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.689 1.593 . . . . 0.0 111.099 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -89.35 -38.26 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.235 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.2 t -120.42 130.08 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.207 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.41 151.73 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.204 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.47 159.98 43.23 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 540' ' ' VAL . 3.0 p -76.3 141.58 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.206 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 62.54 28.17 16.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.181 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -123.29 144.63 49.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.25 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.423 HD11 ' HB3' ' A' ' 502' ' ' SER . 37.2 tp -87.34 128.49 35.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.182 -173.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.97 145.01 48.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.163 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -103.39 135.26 45.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 94.7 m-85 -129.83 157.18 42.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.485 ' HG2' HG22 ' A' ' 500' ' ' THR . 93.6 mt-10 -130.47 141.07 50.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.185 -175.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 53.1 t -112.35 121.2 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.14 173.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.5 m-70 -103.16 107.85 18.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.158 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.448 HG11 HG21 ' A' ' 475' ' ' VAL . 2.5 m -118.85 130.52 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.217 -173.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -143.04 155.08 44.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 8.3 t-20 -98.44 138.65 35.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.201 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 80.7 mt -134.44 38.26 3.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.204 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -138.3 8.82 3.5 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 63.11 18.6 60.52 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.581 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 14.9 tt -136.13 139.56 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.713 0.292 . . . . 0.0 111.225 171.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -87.26 141.44 17.51 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -174.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.5 119.35 36.16 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 111.254 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.84 -19.53 9.67 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.716 1.611 . . . . 0.0 111.22 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.7 p -92.95 12.74 22.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.254 -168.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 84.8 m -75.95 109.86 9.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.221 -161.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.89 127.61 54.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.145 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.448 HG21 HG11 ' A' ' 462' ' ' VAL . 64.9 t -115.69 126.2 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.109 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -127.14 152.65 47.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.263 -172.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 80.6 t -129.12 131.87 67.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -119.79 145.93 46.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.157 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.442 HG12 HG12 ' A' ' 513' ' ' ILE . 77.0 mt -118.32 114.89 46.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 53.57 40.77 31.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.222 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.8 -19.07 55.74 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 171.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.0 m -97.65 137.4 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.741 0.305 . . . . 0.0 111.174 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.3 tp -68.78 121.81 17.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.171 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -96.78 -40.27 9.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . 0.426 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 48.7 tptt -164.75 158.22 17.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.205 -173.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -143.27 153.28 42.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.233 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . 0.426 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 27.4 m-90 -137.98 142.42 40.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 172.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.8 m -107.54 123.04 47.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 168.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.81 167.8 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 70.5 m -118.5 142.28 47.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 97.1 mt -126.79 130.31 50.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.182 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -86.84 -179.97 48.88 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.78 119.7 6.9 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.706 1.604 . . . . 0.0 111.183 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.3 mttt 55.54 35.61 25.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -101.04 144.41 30.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.229 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -122.36 140.5 52.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.228 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -127.67 147.58 50.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.201 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.4 119.23 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 54.5 mt -102.7 142.89 33.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.189 173.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.485 HG22 ' HG2' ' A' ' 459' ' ' GLU . 46.5 p -122.49 153.04 39.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.0 p90 -153.84 156.02 36.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 167.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.423 ' HB3' HD11 ' A' ' 455' ' ' LEU . 68.0 m -122.29 128.1 50.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.256 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -131.38 131.59 43.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.167 -169.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.6 m -114.08 105.43 54.25 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.212 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.81 118.9 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.732 1.621 . . . . 0.0 111.195 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 70.9 p -94.87 -12.41 26.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.249 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -117.35 138.06 52.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.272 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.471 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 35.7 tt0 -76.12 140.89 42.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.04 174.97 24.77 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.6 mmm -86.2 129.61 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 111.209 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -120.01 134.02 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.17 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -106.24 118.63 37.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.244 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.442 HG12 HG12 ' A' ' 479' ' ' ILE . 82.2 mt -105.35 123.23 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.244 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -118.5 145.43 45.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.08 140.04 52.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 172.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 66.6 p -131.9 153.2 50.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.25 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.203 170.727 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 90.8 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.702 0.286 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.4 131.8 50.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.7 m -117.15 126.37 52.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.23 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -132.62 129.96 39.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -100.22 129.02 46.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 90.7 t -120.97 135.64 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.25 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.7 t -106.86 123.13 47.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.225 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 94.4 t -102.98 127.09 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.236 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 452' ' ' VAL . 36.0 m -123.07 159.83 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.193 -177.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . 0.471 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 94.5 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.208 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.415 ' HG3' HG21 ' A' ' 470' ' ' VAL . 68.3 Cg_endo . . . . . 0 N--CA 1.457 -0.63 0 N-CA-C 111.236 -0.332 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -124.0 76.11 1.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.45 131.04 35.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.242 -174.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.9 t -138.43 154.87 48.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.215 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 32.8 m -131.79 155.19 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 95.1 mt-10 -139.72 136.26 34.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.2 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.2 mt -106.28 127.14 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.178 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.02 147.88 48.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.235 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.04 -169.28 34.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.81 139.51 48.03 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.713 1.609 . . . . 0.0 111.196 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -87.55 -36.11 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 79.2 t -120.6 130.29 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.34 152.84 38.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.192 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.97 159.28 35.79 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.1 p -74.15 138.17 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.824 0.345 . . . . 0.0 111.145 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 62.49 24.31 14.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -115.32 151.92 33.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 502' ' ' SER . 43.3 tp -88.89 128.4 35.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.23 -175.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.48 147.02 46.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.289 173.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.24 138.21 52.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.218 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 90.3 m-85 -129.09 157.74 40.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -128.59 139.99 52.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.193 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.73 121.02 64.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.168 173.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.9 m-70 -102.6 108.0 19.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.468 HG11 HG21 ' A' ' 475' ' ' VAL . 2.1 m -118.63 130.44 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.25 -173.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.43 ' HD3' HD21 ' A' ' 465' ' ' LEU . 19.1 ptpt -143.65 154.05 43.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.222 -172.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 41.7 t-20 -107.0 142.22 36.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 171.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.43 HD21 ' HD3' ' A' ' 463' ' ' LYS . 55.3 mt -132.11 3.73 4.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.185 -170.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.59 1.25 71.78 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.79 17.67 76.92 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.526 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.7 tt -127.14 150.18 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 111.236 171.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -95.5 132.15 10.97 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.415 HG21 ' HG3' ' A' ' 438' ' ' PRO . 87.1 t -116.67 118.03 37.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.85 0.357 . . . . 0.0 111.176 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.06 -19.14 8.38 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 121.724 1.616 . . . . 0.0 111.194 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 95.4 p -93.92 13.56 22.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -165.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 94.1 m -77.44 112.82 14.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -161.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.61 126.56 55.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.187 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.468 HG21 HG11 ' A' ' 462' ' ' VAL . 59.9 t -118.57 127.42 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.189 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -134.89 156.58 48.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.199 -173.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.03 136.88 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -170.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -116.93 147.89 41.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.185 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.415 HG12 HG12 ' A' ' 513' ' ' ILE . 82.2 mt -119.7 116.09 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.221 167.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.28 41.35 32.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.249 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.65 -11.47 68.39 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.9 m -98.63 136.09 39.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.875 0.369 . . . . 0.0 111.18 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.35 120.58 15.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.21 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -98.2 -40.27 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.166 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -168.46 158.52 9.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 -173.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -143.74 153.89 42.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -136.95 143.04 42.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.209 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.6 m -106.38 125.16 50.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.214 169.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.42 168.47 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.201 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.7 m -120.02 142.22 49.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.18 172.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.0 mt -128.38 130.79 48.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.255 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -90.64 -171.06 43.63 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.83 113.3 1.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.602 1.535 . . . . 0.0 111.201 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.0 mttt 65.4 35.3 7.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.196 177.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -101.72 143.2 31.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.182 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.87 141.3 52.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.207 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -127.1 146.17 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 94.3 t -112.35 119.69 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.176 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 38.8 mt -102.88 142.17 34.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.223 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 66.2 p -122.25 152.52 39.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.199 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.9 p90 -155.21 157.2 36.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.263 169.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.412 ' HB3' HD11 ' A' ' 455' ' ' LEU . 73.6 m -120.26 128.67 53.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.183 -175.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -130.51 129.87 43.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.236 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.1 m -117.26 109.35 42.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.258 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.74 155.04 44.23 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.715 1.61 . . . . 0.0 111.221 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 73.3 p -125.48 -10.16 6.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.168 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -129.96 136.07 49.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.257 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -71.17 142.88 50.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.198 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.98 174.6 25.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -84.19 125.96 32.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -119.58 132.12 55.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.211 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -104.97 118.69 37.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.215 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.415 HG12 HG12 ' A' ' 479' ' ' ILE . 86.8 mt -104.47 124.25 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.187 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -118.33 144.16 46.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.65 139.24 54.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 172.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 64.0 p -130.91 150.1 52.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.242 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.292 168.021 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 89.2 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.827 0.346 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.16 133.5 48.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.169 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 96.9 m -116.62 126.7 53.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -131.72 131.66 43.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.186 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -103.15 129.27 49.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.228 -173.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 92.8 t -121.29 137.3 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.3 t -108.01 125.15 51.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 96.0 t -103.27 129.37 55.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.183 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.76 164.1 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 93.8 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 179.79 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.458 -0.61 0 N-CA-C 111.238 -0.331 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -124.31 81.88 1.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.263 170.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.01 137.84 35.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.208 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 7.7 t -144.53 154.6 43.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.203 176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.59 155.34 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.299 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 97.0 mt-10 -139.95 137.9 35.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.24 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.4 mt -107.6 128.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -135.87 147.52 48.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.153 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.28 -171.18 35.73 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.79 128.78 18.5 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.756 1.637 . . . . 0.0 111.165 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -71.25 -40.32 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.184 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 67.9 t -121.61 131.65 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.181 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 30.0 m -129.88 152.34 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.259 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.26 159.75 43.42 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 176.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 540' ' ' VAL . 1.2 p -79.99 148.02 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.721 0.296 . . . . 0.0 111.215 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 20.8 m120 63.39 26.86 15.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 454' ' ' LYS . 27.8 mmmt -129.09 144.49 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.231 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 502' ' ' SER . 30.8 tp -85.35 126.23 33.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.238 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -124.72 144.13 50.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -110.39 136.88 48.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -174.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -129.58 157.29 42.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -129.33 139.21 51.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.143 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.4 t -112.76 120.71 63.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.21 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.1 m-70 -103.35 107.29 18.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.229 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.459 HG11 HG21 ' A' ' 475' ' ' VAL . 2.4 m -118.95 129.18 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.169 -172.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 46.4 pttt -143.41 155.0 44.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.246 -171.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 34.0 t30 -104.37 140.42 37.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.243 170.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 70.4 mt -128.47 6.52 5.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -95.64 -12.25 53.83 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 75.08 23.59 73.95 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.501 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 8.3 tt -128.96 139.77 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 0.0 111.219 165.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.58 134.33 13.96 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -173.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.38 116.23 39.48 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 111.28 172.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.46 -19.07 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.692 1.595 . . . . 0.0 111.18 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.7 p -95.05 13.43 25.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.205 -164.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 88.3 m -78.22 110.8 13.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 -163.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -111.27 127.39 55.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.459 HG21 HG11 ' A' ' 462' ' ' VAL . 68.8 t -115.09 126.93 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.282 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -127.89 153.44 46.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.139 -173.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 79.1 t -130.06 133.86 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -119.03 148.07 43.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.248 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 513' ' ' ILE . 84.6 mt -118.73 115.55 48.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.253 169.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 53.74 41.17 32.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.267 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.97 -10.43 70.6 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.4 m -97.45 136.51 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 111.135 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.9 tp -69.05 120.79 15.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.147 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -98.26 -40.63 8.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.256 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -167.98 161.1 12.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.198 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -141.83 152.56 43.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -137.37 142.36 41.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.268 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.0 m -108.74 124.56 50.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.195 168.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.56 168.19 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.191 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 49.2 m -120.9 143.09 49.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.171 172.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.2 129.13 47.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.161 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.24 -173.86 48.64 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.6 112.4 1.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.701 1.601 . . . . 0.0 111.146 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.0 mttt 65.95 36.06 6.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.196 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -101.6 144.0 30.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.38 140.41 52.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -129.39 145.75 51.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 89.4 t -112.72 118.99 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.195 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 50.3 mt -103.41 142.71 33.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.212 173.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 63.3 p -124.51 153.3 42.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.257 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.93 156.73 38.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.255 168.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.504 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.8 m -120.46 128.66 53.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 -175.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -129.67 129.57 44.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.232 -170.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 95.3 m -115.9 109.7 44.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.16 141.43 29.32 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.724 1.616 . . . . 0.0 111.148 174.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 81.5 p -111.91 -21.58 11.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.216 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -120.14 139.58 52.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.249 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.438 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 32.5 tt0 -73.2 140.22 46.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.276 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.04 175.3 24.33 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.4 mmm -86.4 129.01 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 111.195 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -120.73 131.37 54.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.282 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.01 119.43 38.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.156 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 479' ' ' ILE . 90.2 mt -101.71 122.24 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.161 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -120.67 145.97 46.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.161 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.25 142.06 51.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.5 p -131.04 149.76 52.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.245 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 13.8 p . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 168.833 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 93.4 t . . . . . 0 CA--C 1.523 -0.068 0 CA-C-O 120.805 0.336 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.12 133.17 46.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 83.7 m -114.48 124.05 50.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -133.13 131.07 40.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.172 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -104.07 130.31 51.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.169 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.51 136.94 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.157 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.1 t -104.84 124.95 50.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.268 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 95.8 t -101.89 127.32 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.189 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 452' ' ' VAL . 34.7 m -120.85 160.31 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . 0.438 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 92.7 mt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo . . . . . 0 N--CA 1.458 -0.56 0 N-CA-C 111.224 -0.337 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -129.45 99.27 5.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.228 170.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.4 145.32 25.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.288 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.5 t -149.33 156.77 42.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.17 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.63 153.53 39.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.175 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 47.7 mt-10 -138.2 137.89 38.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.213 177.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 83.4 mt -107.52 126.12 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.181 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -136.96 148.93 47.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.184 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.61 -166.85 33.45 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -55.22 136.62 74.19 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.693 1.595 . . . . 0.0 111.239 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -87.68 -40.1 14.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.223 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.55 130.11 74.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.78 153.83 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.195 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.59 157.87 34.9 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.8 p -70.5 141.67 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.213 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 63.57 29.75 15.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.245 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -124.18 142.42 51.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.163 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 502' ' ' SER . 44.2 tp -82.36 126.24 31.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.308 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.27 144.28 49.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.248 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -101.16 134.31 44.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.163 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -128.39 157.19 41.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.242 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.428 ' HG2' HG22 ' A' ' 500' ' ' THR . 87.3 mt-10 -129.91 138.47 50.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.224 -175.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.46 119.9 59.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 95.9 m-70 -98.88 112.92 24.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.179 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.66 131.42 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.215 -174.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -123.04 152.68 40.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.265 -172.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 12.9 t-20 -106.71 129.89 54.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 152.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 75.8 mt -120.12 22.12 11.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.212 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 468' ' ' ILE . . . -112.89 136.7 13.67 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 466' ' ' GLY . . . -9.12 -46.55 0.0 OUTLIER Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 155.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 466' ' ' GLY . 12.6 tt -123.16 142.29 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.744 0.306 . . . . 0.0 111.261 -163.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -89.06 162.5 31.14 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 84.4 t -124.5 119.06 26.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.199 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.52 -19.22 7.74 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.69 1.593 . . . . 0.0 111.158 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 96.5 p -94.83 14.6 20.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -166.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.1 m -76.46 110.85 11.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 -158.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.42 125.99 53.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.186 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 96.3 t -117.29 129.95 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.117 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -125.36 152.58 44.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.168 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 51.8 t -126.89 134.58 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -121.08 148.11 44.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.134 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.33 115.56 47.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.183 171.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 54.35 41.25 32.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.36 -14.87 64.46 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 171.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.2 m -98.96 137.19 37.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.75 0.31 . . . . 0.0 111.254 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.3 tp -68.38 119.36 12.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -100.06 -40.61 7.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.23 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -153.85 160.59 42.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -142.98 149.75 38.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.293 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -137.64 142.13 41.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.1 m -109.45 123.55 49.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.24 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.41 168.08 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.252 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.9 m -116.31 141.48 48.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.166 171.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 83.5 mt -126.88 128.63 46.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -76.97 177.3 52.39 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 172.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . 0.412 ' HB3' ' O ' ' A' ' 467' ' ' GLY . 55.1 Cg_endo -65.75 117.55 4.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.739 1.626 . . . . 0.0 111.202 176.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 93.2 mttt 66.91 36.78 4.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.194 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -112.11 144.03 42.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.235 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -119.34 142.8 47.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.199 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -129.56 150.16 51.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 88.2 t -113.25 120.0 62.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 42.8 mt -103.12 144.45 31.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.246 172.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 459' ' ' GLU . 41.0 p -122.55 154.7 37.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.183 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.71 156.66 38.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.183 168.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.412 ' HB3' HD11 ' A' ' 455' ' ' LEU . 69.4 m -120.44 136.97 54.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.17 -177.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -140.61 129.08 22.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.243 -167.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.4 m -119.55 111.9 35.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.23 152.89 40.24 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.663 1.575 . . . . 0.0 111.219 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 72.9 p -124.45 -12.44 7.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -123.03 141.21 52.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.202 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -86.88 142.14 28.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.171 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.54 178.28 27.03 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -170.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.3 mmm -84.8 128.25 34.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.204 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -117.61 133.95 55.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -107.7 118.63 37.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 80.7 mt -105.03 124.98 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.271 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -117.78 147.08 43.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.275 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.93 139.11 53.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 66.0 p -131.92 153.96 49.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.26 171.895 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 97.7 t . . . . . 0 CA--C 1.524 -0.056 0 CA-C-O 120.847 0.356 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.26 131.9 51.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.281 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.6 m -117.49 127.27 53.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.256 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -130.46 131.61 45.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.172 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -100.85 126.15 47.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.202 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.77 136.38 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.212 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -108.56 124.68 50.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 91.7 t -104.29 129.4 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.248 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.81 172.79 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.237 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 179.25 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.529 ' HG3' HG21 ' A' ' 470' ' ' VAL . 64.6 Cg_endo . . . . . 0 N--CA 1.457 -0.618 0 N-CA-C 111.208 -0.343 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -123.47 75.1 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.212 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 48.9 mt -81.47 126.01 31.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 15.4 t -143.22 157.38 44.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.55 154.89 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.25 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 50.4 mt-10 -137.46 136.84 38.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 81.5 mt -102.53 134.63 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.207 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -135.49 143.15 45.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 144.0 -176.34 23.35 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.44 165.92 26.7 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.644 1.562 . . . . 0.0 111.162 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 58.5 p-10 -123.86 10.4 8.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.19 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.56 116.48 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.122 167.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.3 154.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.223 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.64 160.44 28.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.3 p -72.91 135.42 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.744 0.307 . . . . 0.0 111.237 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 62.08 20.43 11.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.212 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -109.76 130.46 55.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.229 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 502' ' ' SER . 32.0 tp -76.23 128.6 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.193 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.63 142.07 51.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.21 173.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -111.2 139.0 46.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.195 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -130.86 159.08 38.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.424 ' HG2' HG22 ' A' ' 500' ' ' THR . 91.2 mt-10 -129.6 140.14 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 60.7 t -114.33 120.51 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.202 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 85.1 m-70 -99.32 115.8 30.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.237 176.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.74 131.84 70.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.205 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -128.33 156.3 43.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 62.3 t-20 -118.7 116.18 26.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.219 159.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 57.4 mt -109.6 13.19 23.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.205 -170.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.57 -3.17 69.2 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.9 19.72 78.39 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.515 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 6.4 tt -130.77 148.0 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.731 0.301 . . . . 0.0 111.166 174.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -85.96 131.12 10.3 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.529 HG21 ' HG3' ' A' ' 438' ' ' PRO . 92.0 t -117.95 116.42 36.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.234 170.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.68 -19.64 6.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.753 1.635 . . . . 0.0 111.161 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 78.5 p -98.56 0.13 44.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.134 -158.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 473' ' ' THR . 13.1 t -85.53 124.71 32.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.21 -162.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -111.68 128.65 56.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.227 -172.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.13 125.89 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.231 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -130.33 155.05 46.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.256 -170.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.85 133.23 66.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.262 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -119.91 147.5 44.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.275 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.1 mt -120.59 118.51 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.253 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 54.64 41.01 32.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.195 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.34 -20.09 45.98 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 171.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.3 m -98.31 139.44 34.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.821 0.343 . . . . 0.0 111.189 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.6 tp -68.21 121.15 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.152 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . 0.411 ' OH ' ' O ' ' A' ' 502' ' ' SER . 29.9 t80 -96.48 -39.3 9.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.234 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -163.34 158.69 21.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.187 -173.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -140.19 149.97 43.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -138.68 141.91 38.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.156 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.8 m -104.79 127.42 52.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.0 m -138.1 166.34 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 53.5 m -121.73 142.25 50.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.194 170.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.5 mt -128.85 131.19 47.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.92 -178.03 46.26 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.82 117.76 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.773 1.649 . . . . 0.0 111.21 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.1 mttt 55.56 39.79 31.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.216 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -100.47 145.23 28.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.139 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -120.85 140.72 51.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.186 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -127.58 145.7 50.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 173.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.92 119.58 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.4 mt -104.89 142.09 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.147 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.424 HG22 ' HG2' ' A' ' 459' ' ' GLU . 44.4 p -122.58 150.86 42.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.192 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.85 156.57 36.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 171.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.412 ' HB2' HD11 ' A' ' 455' ' ' LEU . 95.6 p -122.93 133.72 54.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -140.79 129.71 23.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.2 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.0 m -116.51 112.34 41.28 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.214 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -71.47 153.33 60.73 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.748 1.632 . . . . 0.0 111.176 172.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 65.0 p -122.81 -5.21 8.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.061 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -133.47 137.19 45.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.152 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.09 141.43 52.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.288 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.24 176.91 26.25 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.3 mmm -84.85 128.05 34.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 111.173 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -120.25 132.83 55.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.17 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -104.23 119.58 39.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 94.2 mt -103.68 124.46 57.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.187 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -119.67 146.17 45.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.09 143.74 50.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.205 172.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 77.4 p -130.73 150.04 52.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.202 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 517' ' ' VAL . 7.2 p . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 167.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 58.7 t . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.822 0.344 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.03 134.72 47.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 173.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.9 m -116.74 126.47 53.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.262 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -134.27 123.28 23.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.187 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -102.46 128.11 49.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.163 -172.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 90.6 t -122.79 137.19 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.26 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 71.4 m -98.95 124.9 44.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 86.4 t -102.85 129.37 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.199 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.96 165.84 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.152 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.269 179.713 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo . . . . . 0 N--CA 1.458 -0.56 0 N-CA-C 111.141 -0.369 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -129.98 71.97 1.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.208 166.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 85.2 mt -78.81 139.51 38.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.214 -173.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 12.3 t -146.15 157.7 43.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.208 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.5 155.69 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.187 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.4 mt-10 -139.86 136.05 33.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.236 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 95.3 mt -108.82 126.52 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.154 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.71 148.5 47.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.272 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.69 -168.65 34.39 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.82 116.16 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.642 1.562 . . . . 0.0 111.241 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -75.47 -18.22 59.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.205 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 96.7 t -125.96 129.32 72.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.169 169.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.07 154.05 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.188 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.55 149.86 32.39 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.417 HG11 HD23 ' A' ' 541' ' ' LEU . 5.9 p -71.05 136.54 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 111.187 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 61.85 27.36 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.216 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -123.59 148.21 46.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 502' ' ' SER . 29.4 tp -85.58 128.07 34.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -172.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.79 145.85 48.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.195 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -109.09 133.97 52.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.188 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 90.1 m-85 -127.91 157.2 41.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.417 ' HG2' HG22 ' A' ' 500' ' ' THR . 96.8 mt-10 -130.5 141.1 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.179 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 49.7 t -112.88 120.08 62.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.207 170.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.6 m-70 -101.8 111.3 23.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.15 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 475' ' ' VAL . 8.9 m -116.05 132.05 66.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.281 -170.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -127.21 155.13 43.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.217 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 61.2 t-20 -116.75 120.84 39.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.206 159.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 63.0 mt -115.0 8.19 15.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -168.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.03 -0.24 74.76 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.68 20.05 75.42 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.525 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.0 tt -131.03 145.68 35.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.786 0.327 . . . . 0.0 111.185 173.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -84.85 134.54 12.73 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.81 116.49 31.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.252 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.66 -18.49 9.27 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.675 1.583 . . . . 0.0 111.14 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.4 p -92.01 10.65 28.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.225 -165.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 99.0 m -80.27 112.91 18.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.142 -162.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -110.48 127.52 55.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.213 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.444 HG21 HG11 ' A' ' 462' ' ' VAL . 93.8 t -115.83 127.1 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -127.09 155.2 43.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.169 -172.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 69.2 t -128.67 132.96 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.279 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -120.17 147.03 45.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.225 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.424 HG12 HG12 ' A' ' 513' ' ' ILE . 83.6 mt -118.72 117.05 53.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.246 172.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 54.08 41.02 32.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.242 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.23 -10.44 66.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.5 m -97.51 138.45 34.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 111.222 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.6 tp -69.8 120.81 16.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.187 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -98.93 -40.69 7.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.262 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -166.57 159.03 13.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 -173.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -140.95 151.82 44.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.212 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 25.9 m-90 -138.16 141.9 40.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.23 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.6 m -109.65 126.02 53.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.252 168.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.04 167.83 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.199 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 30.4 t -118.79 140.93 49.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 170.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 83.9 mt -128.99 126.01 38.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.163 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.78 -173.39 48.32 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.23 111.7 1.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.772 1.648 . . . . 0.0 111.241 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.0 mttt 58.65 41.45 22.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -101.32 143.96 30.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.221 173.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -121.08 139.95 52.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.158 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -128.45 147.85 50.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.248 175.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 96.9 t -112.2 118.95 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.169 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 48.3 mt -102.24 142.19 33.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.222 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.417 HG22 ' HG2' ' A' ' 459' ' ' GLU . 36.1 p -122.85 151.92 41.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.248 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 55.1 p90 -154.41 156.38 36.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.167 166.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.469 ' HB3' HD11 ' A' ' 455' ' ' LEU . 69.9 m -119.73 128.63 53.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.191 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -125.74 129.27 49.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 -171.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 96.2 m -117.8 108.76 42.3 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 172.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.85 157.65 54.61 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.741 1.627 . . . . 0.0 111.25 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 75.5 p -124.9 -21.95 4.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.206 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.97 138.77 52.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.423 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 34.7 tt0 -73.74 139.71 45.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.5 174.76 24.11 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.5 mmm -85.59 128.46 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.844 0.354 . . . . 0.0 111.142 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -120.77 130.31 53.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -103.27 119.81 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.19 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.424 HG12 HG12 ' A' ' 479' ' ' ILE . 80.8 mt -102.11 120.22 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.271 176.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -122.35 146.41 47.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.226 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.15 140.25 53.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.9 p -131.79 152.78 50.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.249 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 172.085 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 93.3 t . . . . . 0 CA--C 1.523 -0.076 0 CA-C-O 120.837 0.351 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.58 133.56 49.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.195 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.1 m -115.43 124.2 50.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.266 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -128.31 128.51 44.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -101.1 126.94 47.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.243 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.5 t -121.43 136.18 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.8 t -101.41 127.5 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.9 t -99.78 126.69 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.42 150.72 24.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.183 -173.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . 0.423 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 86.0 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.193 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo . . . . . 0 N--CA 1.458 -0.562 0 N-CA-C 111.21 -0.342 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -129.7 81.06 1.99 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.182 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 8.9 mt -89.42 130.66 35.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 -175.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.0 t -146.16 163.1 36.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.228 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.09 154.58 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 93.9 mt-10 -135.63 137.94 42.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.208 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 89.3 mt -104.35 132.0 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.67 142.98 45.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.222 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.45 32.79 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.19 141.26 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.743 1.629 . . . . 0.0 111.232 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -97.26 -18.81 18.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.228 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 87.9 t -126.12 125.94 68.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.259 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.57 154.27 39.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.195 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.27 158.1 43.49 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 1.8 p -79.15 142.57 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.799 0.333 . . . . 0.0 111.232 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 63.11 29.41 16.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.22 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -125.93 145.11 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 502' ' ' SER . 33.0 tp -78.53 126.79 31.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.08 143.42 49.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -109.88 135.53 50.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.298 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -129.66 157.87 40.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.216 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.432 ' HG2' HG22 ' A' ' 500' ' ' THR . 80.2 mt-10 -130.09 139.57 50.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.268 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 45.0 t -113.22 120.24 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.175 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 94.2 m-70 -99.59 114.29 27.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 462' ' ' VAL . 2.9 m -117.21 127.0 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.153 -173.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.441 ' HD2' HD21 ' A' ' 465' ' ' LEU . 25.1 pttt -138.18 151.94 48.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 -171.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 52.9 t-20 -111.2 127.59 55.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.276 167.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.441 HD21 ' HD2' ' A' ' 463' ' ' LYS . 68.9 mt -115.61 7.5 14.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.28 -169.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -93.98 -5.2 62.72 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -169.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.02 23.15 76.89 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -171.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.508 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 1.3 mt -130.04 155.18 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 111.168 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.487 ' N ' ' CG2' ' A' ' 468' ' ' ILE . . . -117.08 120.47 4.82 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -172.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 491' ' ' LEU . 74.9 t -119.63 118.22 32.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.185 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -84.29 -17.62 5.4 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.714 1.609 . . . . 0.0 111.152 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 79.3 p -99.0 4.17 47.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -163.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 473' ' ' THR . 3.5 t -83.67 125.34 31.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.176 -163.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.58 130.35 55.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 -170.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 76.6 t -113.11 128.29 69.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.269 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.51 154.26 45.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.2 -173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 78.0 t -127.7 132.89 68.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.201 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -120.31 147.05 45.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.3 mt -120.85 116.22 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.194 172.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 54.38 40.97 32.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.269 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 93.49 -18.79 55.68 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 171.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.4 m -100.08 138.11 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.353 . . . . 0.0 111.149 -175.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.33 121.53 15.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.248 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -93.31 -39.93 10.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.287 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -168.91 159.52 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.233 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -132.08 152.34 51.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.189 -175.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 32.8 m-90 -136.3 141.44 43.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.7 m -109.95 124.72 51.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 166.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 25.9 m -138.74 167.54 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.6 p -114.44 141.08 48.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.24 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 470' ' ' VAL . 82.4 mt -129.82 129.76 44.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.201 174.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -93.76 -173.43 39.56 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.99 111.36 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.656 1.571 . . . . 0.0 111.203 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.4 mttt 63.62 43.64 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.191 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -104.52 142.96 33.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -121.36 139.51 53.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.223 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -128.79 147.25 50.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.199 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 83.2 t -111.62 119.13 59.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -176.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 66.6 mt -104.85 143.93 32.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.179 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.432 HG22 ' HG2' ' A' ' 459' ' ' GLU . 61.0 p -124.77 153.65 42.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.143 175.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -154.3 157.0 37.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.208 170.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.443 ' HB3' HD11 ' A' ' 455' ' ' LEU . 60.9 m -122.27 134.77 54.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.199 -175.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -140.33 129.49 23.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.215 -168.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.0 m -118.88 112.42 36.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.182 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.74 151.55 41.02 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.769 1.646 . . . . 0.0 111.286 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 70.1 p -122.02 -15.13 7.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.177 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -120.59 139.46 52.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.233 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -75.79 140.16 42.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.211 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.67 177.13 26.84 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.7 mmm -86.36 129.42 34.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.781 0.324 . . . . 0.0 111.222 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.84 132.62 55.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.263 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -104.74 118.19 35.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 89.1 mt -105.91 122.95 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -122.41 150.23 42.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.146 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.74 141.05 52.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.259 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 59.5 p -130.82 155.08 47.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.23 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.16 172.336 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 92.3 t . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.786 0.327 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -124.38 131.71 53.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.176 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.5 m -116.98 126.55 53.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.195 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -131.95 130.28 41.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.258 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -101.32 129.27 47.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.239 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 93.6 t -121.14 136.4 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.207 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 40.2 t -104.96 124.75 50.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.185 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.6 t -101.7 127.04 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.173 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 31.8 m -124.71 165.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.249 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 69.4 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.24 -175.384 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.491 ' HG3' HG21 ' A' ' 470' ' ' VAL . 84.7 Cg_endo . . . . . 0 N--CA 1.457 -0.665 0 N-CA-C 111.263 -0.322 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . 0.456 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 62.0 t0 -122.49 73.91 1.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.278 167.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.48 137.09 36.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 8.2 t -144.19 154.33 43.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.185 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.3 m -128.46 153.65 38.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.153 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.4 mt-10 -141.01 137.82 33.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.66 127.25 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.207 174.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.13 145.2 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.117 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.5 -166.5 38.47 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.1 143.36 64.96 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.694 1.596 . . . . 0.0 111.249 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -90.35 -39.17 12.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.193 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 70.2 t -121.15 130.15 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.253 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.63 153.31 38.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.205 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -82.78 157.27 35.62 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.5 138.07 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.215 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 62.63 25.19 14.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.258 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -114.78 150.97 34.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.197 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 42.5 tp -87.41 127.21 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 -175.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.32 144.57 48.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.232 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.08 138.15 46.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.03 156.65 44.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -129.49 139.36 51.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.15 120.81 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.235 173.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 95.4 m-70 -102.42 107.72 18.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.184 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.3 m -118.48 129.95 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.166 -173.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.407 ' HD3' HD21 ' A' ' 465' ' ' LEU . 19.1 ptpt -143.72 154.72 43.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.192 -171.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 39.7 t-20 -108.26 143.67 36.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.223 170.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 43.6 mt -133.01 3.37 3.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.204 -172.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -96.97 4.63 63.1 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -170.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.07 17.57 75.76 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 174.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.55 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 2.2 tt -125.87 149.72 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.733 0.301 . . . . 0.0 111.181 167.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -95.91 131.76 10.79 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.491 HG21 ' HG3' ' A' ' 438' ' ' PRO . 99.5 t -119.33 119.63 31.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 111.218 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.17 -19.2 6.94 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.632 1.555 . . . . 0.0 111.189 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 91.2 p -94.12 16.51 14.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.185 -164.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 94.7 m -82.36 111.71 18.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.262 -165.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -111.57 127.24 55.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 85.3 t -118.14 128.8 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.159 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -125.05 154.69 40.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 -173.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.71 134.37 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.23 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -122.04 149.17 43.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.211 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 81.6 mt -120.54 115.69 47.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.198 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.26 41.44 31.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.236 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.94 -8.66 79.2 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.0 m -97.97 135.92 38.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.788 0.328 . . . . 0.0 111.298 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 68.2 tp -68.76 118.79 12.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -99.78 -40.42 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.262 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -166.99 158.85 12.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -140.5 151.97 45.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.21 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -137.36 142.23 41.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.168 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.9 m -109.5 124.38 50.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 166.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.93 168.09 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.125 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.1 m -118.79 142.0 48.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.182 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.31 131.08 48.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.39 -175.48 48.72 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.46 113.32 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.7 1.6 . . . . 0.0 111.159 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.7 mttt 65.9 35.32 6.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.173 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -102.97 143.63 32.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.237 176.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.9 141.08 51.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.189 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -128.18 146.76 50.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.28 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.69 119.58 60.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.225 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.3 mt -101.82 143.35 31.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.136 173.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 59.5 p -122.21 151.85 40.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.184 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.72 156.21 35.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.218 167.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.2 m -123.01 133.98 54.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.179 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 45.5 t90 -140.21 130.0 24.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.195 -167.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 95.2 m -118.17 111.78 38.4 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.296 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.12 155.53 56.65 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.596 1.53 . . . . 0.0 111.247 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 76.9 p -125.25 -13.02 6.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.271 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.39 137.57 49.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.17 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.97 142.17 52.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.42 175.59 24.96 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.2 mmm -85.62 126.86 34.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 111.259 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -119.79 126.94 52.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.206 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -103.31 119.24 38.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.252 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.41 124.12 56.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.218 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -116.86 145.14 43.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.151 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.24 139.55 53.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 173.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 76.8 p -131.05 151.51 51.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.235 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.5 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 169.732 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 49.4 t . . . . . 0 CA--C 1.523 -0.059 0 CA-C-O 120.835 0.35 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.79 132.37 51.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 88.0 m -116.32 125.63 52.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -131.14 130.39 43.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -102.34 129.98 48.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.23 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 92.3 t -120.52 136.54 57.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.168 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.8 t -105.84 124.82 50.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.172 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.9 t -102.85 129.22 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.196 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.92 164.45 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.14 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.248 -178.159 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo . . . . . 0 N--CA 1.459 -0.558 0 N-CA-C 111.254 -0.325 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -130.28 58.37 1.67 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.285 166.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.08 134.67 53.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 -175.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 10.0 t -142.08 153.3 44.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.207 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.9 m -131.63 154.07 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.237 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.1 mt-10 -139.2 137.08 35.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 91.3 mt -107.16 127.4 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.244 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.93 148.76 48.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.205 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 152.5 -163.57 30.36 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.96 144.45 94.29 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.755 1.637 . . . . 0.0 111.196 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -98.55 -37.01 9.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.183 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 84.9 t -122.15 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.228 172.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.81 151.1 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.108 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -77.09 155.86 44.81 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.93 135.76 27.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.788 0.328 . . . . 0.0 111.21 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 63.02 26.57 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -114.0 154.92 26.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 40.2 tp -94.4 128.09 40.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.261 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.29 143.45 50.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.172 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -105.64 136.5 45.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.25 174.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.33 156.57 44.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.183 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 500' ' ' THR . 92.9 mt-10 -130.19 140.99 50.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 -177.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 53.1 t -113.14 121.39 65.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.239 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 87.5 m-70 -96.57 111.47 23.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.241 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 475' ' ' VAL . 2.6 m -119.91 129.18 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.272 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -145.35 155.29 43.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 36.7 t-20 -106.61 142.22 36.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.225 171.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 65.0 mt -134.08 5.06 3.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.231 -172.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -89.14 2.45 83.72 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -175.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.22 16.3 77.0 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.54 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 6.4 tt -126.45 146.06 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.25 171.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -87.11 132.56 11.24 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 173.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 80.7 t -116.17 115.5 40.44 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.841 0.353 . . . . 0.0 111.263 171.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.02 -18.25 8.94 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.591 1.528 . . . . 0.0 111.162 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.9 p -93.33 11.52 27.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.212 -166.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 86.9 m -75.76 114.38 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.161 -158.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.71 128.18 55.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.504 HG21 HG11 ' A' ' 462' ' ' VAL . 63.4 t -116.76 128.75 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.231 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -125.43 154.25 42.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.21 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 76.6 t -128.41 134.01 65.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.238 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.58 147.41 45.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.7 mt -120.7 116.81 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.204 171.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 54.41 41.48 31.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 90.73 -14.27 63.51 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.3 m -97.28 137.43 36.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 111.26 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 67.5 tp -69.52 120.69 15.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.154 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -97.61 -40.19 8.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.258 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -165.7 158.79 15.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -140.05 152.34 46.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.23 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -138.49 142.87 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.178 172.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.8 m -107.27 125.71 51.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 168.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.65 168.06 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.144 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 62.7 m -119.58 141.77 48.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.209 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 87.9 mt -129.39 130.19 45.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.202 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.03 -172.86 47.45 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.16 112.65 1.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.655 1.57 . . . . 0.0 111.212 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.5 mttt 65.7 35.34 6.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -101.91 142.55 33.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.256 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -120.74 141.47 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -127.35 146.27 50.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.264 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.7 t -111.55 119.5 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.146 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.54 143.02 32.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.447 HG22 ' HG2' ' A' ' 459' ' ' GLU . 41.6 p -120.84 151.5 39.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.225 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -154.44 156.65 37.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 167.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 67.3 m -122.05 132.5 54.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 46.6 t90 -138.39 129.04 26.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.164 -168.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 88.3 m -116.48 110.29 42.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.192 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.99 144.6 58.68 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.638 1.559 . . . . 0.0 111.151 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 76.2 p -117.36 -14.89 10.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.24 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -118.97 137.31 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.129 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 22.0 pm0 -77.04 145.47 37.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.137 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 147.18 178.16 22.26 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -85.33 129.6 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.749 0.309 . . . . 0.0 111.257 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -119.43 133.38 55.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.165 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -106.05 119.16 38.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.257 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 83.1 mt -104.28 124.1 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.252 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -117.62 145.93 44.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.55 138.8 53.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.3 p -131.6 151.03 51.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.22 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.0 p . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.2 172.579 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 79.8 t . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.793 0.33 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.76 132.01 49.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.189 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.0 m -116.68 125.83 52.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.175 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -130.86 131.35 44.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.321 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -101.06 125.88 47.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -173.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 85.4 t -120.15 135.62 59.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -106.94 125.56 51.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.221 171.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 95.5 t -100.77 126.17 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.156 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.83 170.41 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.158 -174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.204 -177.612 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.469 ' HG3' HG21 ' A' ' 470' ' ' VAL . 72.8 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 N-CA-C 111.231 -0.334 . . . . 0.0 111.231 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 56.7 t0 -116.56 62.1 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 169.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.84 137.13 57.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.222 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.1 t -146.66 156.97 43.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.204 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.09 155.21 39.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 47.5 mt-10 -138.75 135.71 34.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.126 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . 0.43 HD13 HG22 ' A' ' 513' ' ' ILE . 89.6 mt -107.57 125.52 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.156 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -136.86 147.19 46.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.2 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.73 -165.75 34.17 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -56.96 136.67 78.04 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.712 1.608 . . . . 0.0 111.178 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -86.39 -38.63 17.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.405 HG22 ' HB3' ' A' ' 538' ' ' SER . 92.2 t -124.84 133.91 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.8 m -130.45 152.65 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -82.4 160.42 39.91 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 540' ' ' VAL . 4.9 p -76.45 139.25 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 0.0 111.144 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 62.57 27.3 16.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.273 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -123.95 142.39 51.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.163 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.515 HD11 ' HB3' ' A' ' 502' ' ' SER . 36.7 tp -85.76 127.29 34.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.237 -174.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.58 144.17 49.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.221 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -110.1 135.14 51.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.156 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -129.09 157.64 41.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.501 ' HG2' HG22 ' A' ' 500' ' ' THR . 81.7 mt-10 -130.45 139.23 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.223 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 59.4 t -112.09 120.63 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 172.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 88.3 m-70 -97.86 118.38 34.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.505 HG11 HG21 ' A' ' 475' ' ' VAL . 11.8 m -117.97 131.86 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -127.04 155.22 43.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.229 -175.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 54.8 t-20 -117.06 131.26 56.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.245 157.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 50.8 mt -127.25 4.7 6.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.171 -167.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -91.8 3.73 78.14 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -175.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.8 20.24 75.78 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.579 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.1 tt -131.81 144.34 37.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.754 0.312 . . . . 0.0 111.231 175.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -85.8 133.18 11.6 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.469 HG21 ' HG3' ' A' ' 438' ' ' PRO . 85.9 t -119.61 118.11 32.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 0.0 111.209 170.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.2 -19.08 8.24 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 121.679 1.586 . . . . 0.0 111.133 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 91.5 p -93.07 10.14 32.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.177 -163.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.6 m -78.28 111.58 14.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.269 -161.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -110.4 127.28 55.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.167 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.505 HG21 HG11 ' A' ' 462' ' ' VAL . 88.8 t -115.78 128.75 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.236 -178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -123.6 151.7 42.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -174.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 87.8 t -130.12 134.77 62.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.205 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -118.41 145.77 44.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.74 117.93 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.202 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 50.7 t30 54.41 41.79 31.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.215 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 96.66 -22.91 37.7 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 172.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.1 m -100.27 139.43 35.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 111.174 -175.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 67.1 tp -68.77 121.64 16.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.231 175.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -98.18 -41.02 8.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.217 -173.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -167.45 162.53 14.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -172.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -141.81 153.44 44.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.26 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -137.49 142.08 41.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.234 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.1 m -108.14 127.58 53.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.248 169.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.97 167.6 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.205 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 49.8 m -121.15 142.22 50.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.215 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 82.4 mt -130.47 128.1 40.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.245 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.37 -170.85 46.87 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.57 112.55 1.64 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.702 1.601 . . . . 0.0 111.205 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.3 mttt 62.08 35.67 15.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.268 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -99.55 144.32 28.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.138 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -120.52 141.69 50.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -126.54 146.76 50.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.188 173.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.7 t -112.44 119.34 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.082 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 43.7 mt -103.17 141.1 36.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.2 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.501 HG22 ' HG2' ' A' ' 459' ' ' GLU . 60.7 p -124.76 152.07 44.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.207 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -154.62 157.12 37.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.285 170.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.515 ' HB3' HD11 ' A' ' 455' ' ' LEU . 71.5 m -119.43 131.42 55.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.208 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 42.2 t90 -140.71 129.72 23.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 -169.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 88.9 m -115.94 109.28 45.21 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.279 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.84 118.86 5.61 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.743 1.629 . . . . 0.0 111.104 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 68.2 p -99.02 1.1 45.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.25 137.03 49.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.462 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 37.7 tt0 -73.79 138.49 44.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.184 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.34 174.48 23.69 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.1 mmm -85.22 129.24 34.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.806 0.336 . . . . 0.0 111.185 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -119.48 128.48 54.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.173 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -106.04 119.38 39.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.43 HG22 HD13 ' A' ' 444' ' ' ILE . 79.7 mt -102.96 122.25 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.1 -176.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -119.97 144.74 47.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.91 140.16 52.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.4 p -131.63 151.17 51.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 174.834 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 63.5 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.731 0.301 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.88 133.43 45.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.179 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 96.9 m -115.98 126.31 53.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.211 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -131.25 130.13 42.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.151 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -100.32 129.14 46.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.181 -172.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.6 t -121.22 135.56 61.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.207 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 449' ' ' VAL . 36.3 t -104.82 126.0 51.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.189 174.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.37 127.76 55.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.177 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 452' ' ' VAL . 35.7 m -122.23 159.23 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.131 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . 0.462 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 83.6 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.109 176.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo . . . . . 0 N--CA 1.458 -0.6 0 N-CA-C 111.188 -0.351 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -138.26 89.68 2.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.6 133.21 37.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.165 -169.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 10.0 t -146.36 155.31 42.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.207 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 517' ' ' VAL . 28.6 m -129.31 153.75 39.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.177 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -135.59 133.69 38.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.251 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 77.6 mt -104.48 124.99 59.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.98 146.55 47.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.182 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.55 -167.44 33.04 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -56.16 133.89 60.8 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.636 1.558 . . . . 0.0 111.181 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -82.66 -40.42 20.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 172.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 64.1 t -122.94 130.88 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.171 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.04 154.43 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.05 152.35 36.41 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.68 137.25 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.797 0.332 . . . . 0.0 111.222 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 64.15 30.78 13.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.213 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -125.02 143.42 50.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.218 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 44.0 tp -81.18 127.2 32.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.259 -175.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.9 144.88 48.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.151 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -103.97 136.43 43.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.18 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -130.04 156.66 44.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.195 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.405 ' HG2' HG22 ' A' ' 500' ' ' THR . 91.3 mt-10 -130.65 140.4 50.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.223 -175.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.69 121.26 64.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.175 172.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -100.46 117.52 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.175 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.52 131.38 71.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.156 -174.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -125.5 154.93 41.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.204 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 61.8 t-20 -117.85 121.7 41.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.222 157.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 61.4 mt -113.75 14.71 18.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.191 -170.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -98.42 -4.83 57.18 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -174.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.9 23.07 78.34 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.49 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.3 tt -134.54 146.92 30.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 111.188 172.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -82.55 135.44 14.09 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 86.0 t -121.88 119.96 28.72 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.741 0.305 . . . . 0.0 111.225 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -84.24 -17.46 5.53 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.668 1.579 . . . . 0.0 111.199 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 84.4 p -91.75 7.98 39.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -162.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 88.4 m -81.23 108.29 14.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.226 -162.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -110.58 124.4 51.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 98.8 t -111.19 126.98 68.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 -173.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -125.53 151.92 45.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 -172.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 73.5 t -126.88 132.8 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.213 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -120.1 147.41 44.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.87 115.07 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.233 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 54.49 40.91 32.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.185 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 95.01 -17.63 58.93 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 171.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.7 m -99.5 135.97 40.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 111.146 -175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.9 tp -67.99 120.54 14.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -96.41 -40.35 9.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.238 -175.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -167.05 158.28 12.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -137.41 152.03 49.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.187 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 -136.73 142.68 43.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.194 174.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.5 m -108.91 124.8 51.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.253 168.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.5 m -139.12 166.81 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 86.8 p -118.02 144.56 45.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 169.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.9 mt -126.72 130.93 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -92.43 -177.34 41.59 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.21 121.04 9.2 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.68 1.586 . . . . 0.0 111.222 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.8 mttt 55.03 41.9 31.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 175.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.91 143.62 34.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.217 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -117.71 140.42 49.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.228 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -126.95 145.85 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 174.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 79.3 t -111.74 119.47 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.178 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 45.4 mt -103.45 143.11 33.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.196 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.405 HG22 ' HG2' ' A' ' 459' ' ' GLU . 52.9 p -122.82 153.23 39.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.25 156.14 36.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.198 166.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 57.6 m -122.18 133.63 54.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.223 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 47.7 t90 -139.86 129.68 24.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 -165.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.5 m -117.8 114.21 37.66 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.221 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -71.32 154.85 61.12 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.706 1.604 . . . . 0.0 111.203 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 74.1 p -124.64 -14.53 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.182 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -122.91 136.51 54.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.254 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 21.7 pm0 -76.51 145.76 38.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.58 179.57 22.81 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -173.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.04 129.96 34.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.741 0.305 . . . . 0.0 111.189 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.45 133.49 55.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.226 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -105.21 119.36 38.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.186 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 94.5 mt -103.86 124.88 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -118.73 145.76 45.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.154 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.23 143.28 51.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.215 173.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 68.1 p -130.89 151.26 51.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.194 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.477 ' HB ' HG13 ' A' ' 442' ' ' VAL . 12.4 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.224 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.809 0.338 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.35 133.02 50.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.9 m -116.67 127.15 54.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.24 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -132.55 129.86 39.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.196 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -100.1 128.5 46.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.206 -172.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 96.6 t -121.26 136.22 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 40.2 t -105.52 124.43 49.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.195 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.16 125.45 55.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.213 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.96 161.4 28.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.197 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.175 177.946 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo . . . . . 0 N--CA 1.458 -0.598 0 N-CA-C 111.223 -0.337 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -111.47 90.32 3.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 166.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 78.1 mt -85.28 145.69 27.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.0 t -144.28 154.77 43.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.275 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 32.6 m -130.62 156.43 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.9 mt-10 -140.11 137.43 34.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.204 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 92.7 mt -107.62 127.16 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.249 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.83 149.04 47.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.23 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 153.46 -165.1 31.3 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.72 120.66 7.57 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.708 1.605 . . . . 0.0 111.256 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -83.33 -8.68 59.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.181 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.24 128.45 64.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 169.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 25.4 m -131.08 155.59 42.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -93.67 154.5 21.7 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.89 137.91 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 62.89 27.44 15.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.23 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -125.36 142.08 51.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.199 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 502' ' ' SER . 37.2 tp -91.07 127.82 36.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.224 -174.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.71 145.55 48.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -106.93 138.02 43.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.184 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -129.09 157.04 42.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.207 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -129.96 139.6 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.267 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 47.7 t -112.33 121.22 64.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.196 172.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.5 m-70 -101.39 105.91 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.284 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.419 HG11 HG21 ' A' ' 475' ' ' VAL . 3.2 m -118.51 130.78 72.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -173.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -142.38 152.82 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.222 -171.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.63 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.9 t-20 -98.53 140.8 32.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.259 170.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 72.6 mt -130.55 5.4 4.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.221 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -101.37 -1.39 53.79 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.2 27.02 74.15 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.63 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 0.6 OUTLIER -120.69 141.74 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.747 0.308 . . . . 0.0 111.201 175.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . 0.505 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -81.39 99.61 1.97 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.685 ' O ' ' CG1' ' A' ' 470' ' ' VAL . 0.4 OUTLIER -103.16 110.53 63.82 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.71 -15.33 27.05 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.721 1.614 . . . . 0.0 111.271 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.6 p -89.75 11.18 20.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.195 -157.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . 0.453 ' OG1' ' CG1' ' A' ' 470' ' ' VAL . 97.3 m -77.16 109.59 11.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 -166.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -110.55 125.75 53.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.266 172.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.419 HG21 HG11 ' A' ' 462' ' ' VAL . 86.3 t -117.35 128.17 74.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.192 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -127.46 154.35 45.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.232 -173.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.2 t -128.16 134.56 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.19 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -122.01 148.0 45.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.297 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 89.6 mt -119.98 117.26 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 172.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 54.16 41.48 31.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.183 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.65 -8.65 74.41 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.9 m -97.55 137.51 36.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 111.288 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 68.5 tp -70.69 120.77 16.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.148 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -98.45 -40.51 8.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.245 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . 0.423 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 51.1 tptt -165.95 159.17 15.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.189 -172.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -141.26 152.8 44.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.233 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . 0.423 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 24.1 m-90 -138.16 142.4 40.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.2 171.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.9 m -106.79 124.33 49.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.227 169.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.73 167.44 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.263 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 70.7 m -121.21 144.16 48.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.14 172.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 94.6 mt -127.07 129.32 47.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.264 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . 0.505 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -83.91 -173.99 50.09 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 174.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.93 111.03 0.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.734 1.623 . . . . 0.0 111.27 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 64.48 34.61 10.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.162 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -99.19 143.31 29.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.236 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.2 140.87 52.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.243 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.46 147.36 49.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.164 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 96.3 t -112.45 119.55 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 54.2 mt -103.51 142.72 33.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.25 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 53.3 p -122.24 153.17 39.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.24 156.15 36.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 167.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.444 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.3 m -121.29 128.28 52.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -128.25 129.8 46.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -171.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.9 m -117.84 109.04 41.81 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.26 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.77 152.19 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.697 1.598 . . . . 0.0 111.247 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.7 p -124.74 -0.77 7.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.25 136.21 48.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.202 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -79.85 143.94 33.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.247 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.28 175.92 22.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -82.25 126.6 32.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.776 0.322 . . . . 0.0 111.13 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -119.84 130.82 55.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.161 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -105.79 118.93 37.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.193 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 84.1 mt -104.22 123.19 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.292 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -119.44 145.7 46.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.249 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.35 142.0 51.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.8 p -130.76 151.38 51.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.216 169.148 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 62.3 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.864 0.364 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.65 135.62 48.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.3 m -114.86 125.58 53.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.219 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -131.46 129.85 41.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.165 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -99.61 124.59 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -173.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 97.0 t -121.28 135.58 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.186 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 36.3 t -104.78 129.33 53.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.224 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 86.3 t -102.41 126.71 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.245 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.32 157.65 38.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.187 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.174 179.861 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.41 ' HG3' HG21 ' A' ' 470' ' ' VAL . 72.2 Cg_endo . . . . . 0 N--CA 1.459 -0.531 0 N-CA-C 111.203 -0.345 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -118.74 82.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.146 163.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 87.3 mt -81.1 127.4 32.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.122 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.1 t -148.45 160.92 42.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.196 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.07 155.75 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.276 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -135.99 139.69 43.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.243 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 61.9 mt -108.05 137.27 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.33 142.45 45.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 179.97 179.45 48.8 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.681 ' O ' ' HB2' ' A' ' 448' ' ' ASP . 33.8 Cg_endo -70.98 -31.49 15.04 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.679 1.586 . . . . 0.0 111.224 -172.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . 0.681 ' HB2' ' O ' ' A' ' 447' ' ' PRO . 82.7 m-20 75.59 -11.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.271 -175.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.13 117.15 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.68 152.54 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.229 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.51 157.74 44.52 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.5 p -76.43 140.22 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.127 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 63.13 29.6 16.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -124.73 139.0 54.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 37.3 tp -76.5 126.39 30.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.87 145.05 48.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.19 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -103.03 136.15 43.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -129.16 156.68 43.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -128.22 139.24 52.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.234 -171.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 57.0 t -115.85 120.3 64.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 173.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -99.56 113.31 25.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.295 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.43 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -116.14 127.33 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.467 ' HD2' HD21 ' A' ' 465' ' ' LEU . 11.3 pttt -131.83 150.49 52.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.224 -170.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.5 t-20 -105.24 137.99 42.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.241 162.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.467 HD21 ' HD2' ' A' ' 463' ' ' LYS . 56.5 mt -123.61 0.07 8.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 -169.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -95.53 -15.4 43.73 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.49 31.19 63.42 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.519 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 0.1 OUTLIER -132.95 130.08 58.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 111.182 177.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.23 131.34 10.81 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -170.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.41 HG21 ' HG3' ' A' ' 438' ' ' PRO . 97.9 t -123.3 120.11 27.29 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.734 0.302 . . . . 0.0 111.148 170.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.62 -19.01 6.48 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.654 1.57 . . . . 0.0 111.12 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.8 p -95.95 12.93 28.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.256 -163.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.9 m -77.32 117.66 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.192 -162.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -109.95 128.26 55.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.285 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.42 128.15 73.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.198 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -125.9 152.8 45.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -171.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 72.9 t -127.95 132.72 68.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.214 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -120.0 148.76 43.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.234 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.8 mt -120.96 115.91 48.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.261 170.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 54.52 41.35 32.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.2 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 95.42 -19.94 51.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 171.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -98.13 137.03 37.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 0.0 111.223 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.03 120.62 14.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.257 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -97.3 -39.89 9.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -176.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -166.11 157.95 13.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -141.73 154.63 45.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.175 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -135.29 142.3 45.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.238 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.9 m -102.31 122.51 44.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.201 165.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.56 166.92 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.204 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 67.4 m -120.12 142.28 49.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 96.9 mt -128.9 131.45 47.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.251 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -92.42 -165.68 38.82 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.37 114.2 2.77 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.676 1.584 . . . . 0.0 111.205 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 61.7 41.05 12.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.266 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -102.49 141.32 35.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -120.76 137.95 54.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -123.42 145.59 48.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.203 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.66 117.85 55.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 19.0 mt -109.46 136.14 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.24 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 44.6 p -120.09 155.24 33.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -172.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -153.52 156.57 38.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.215 171.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.8 m -121.1 133.35 55.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 41.2 t90 -140.19 130.1 24.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.188 -166.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.6 m -116.33 112.34 41.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.216 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.52 152.37 48.61 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.712 1.608 . . . . 0.0 111.142 172.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 71.1 p -122.37 -15.07 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.228 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -120.07 139.74 52.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -77.24 139.98 39.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.22 178.38 25.97 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.1 131.14 34.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.781 0.324 . . . . 0.0 111.153 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -117.34 137.51 52.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.245 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -104.85 118.69 37.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.152 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 86.2 mt -104.14 125.24 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.205 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -116.74 146.92 42.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.93 142.31 51.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.283 169.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 36.8 p -131.28 151.05 51.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.257 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.26 171.251 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.74 0.305 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -129.74 136.09 49.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.257 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.5 m -114.99 128.44 56.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.186 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -133.21 127.93 34.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.08 -171.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -102.38 128.28 49.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.21 -170.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 86.8 t -122.33 137.15 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 41.2 t -103.91 124.67 49.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.158 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 93.0 t -102.73 126.27 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.162 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.96 159.61 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.167 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.163 178.043 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . 0.479 ' HB3' HG23 ' A' ' 468' ' ' ILE . 73.5 Cg_endo . . . . . 0 N--CA 1.458 -0.617 0 N-CA-C 111.257 -0.324 . . . . 0.0 111.257 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -111.01 76.09 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.243 164.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.4 mt -74.84 137.9 42.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.3 t -144.34 155.1 43.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.112 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.02 155.74 41.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.304 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 97.8 mt-10 -137.32 139.64 40.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.161 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 87.6 mt -107.85 132.07 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.225 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -136.27 142.8 43.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.229 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 162.18 -173.49 38.5 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.58 134.86 34.23 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.727 1.618 . . . . 0.0 111.229 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -75.9 -40.7 53.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.191 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.4 t -122.31 132.4 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.179 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.05 152.13 36.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.5 159.9 46.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.52 149.2 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 111.174 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 19.0 m120 63.38 26.47 14.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.147 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -128.31 143.3 51.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.082 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 37.3 tp -86.38 127.83 34.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.191 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.35 144.19 49.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.218 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -102.46 135.15 44.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 87.2 m-85 -129.16 157.12 42.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.193 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 500' ' ' THR . 90.6 mt-10 -129.82 141.11 50.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.195 -174.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.9 t -113.24 121.03 64.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 172.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.465 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 94.6 m-70 -99.42 111.1 23.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.156 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.27 130.91 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.435 ' HD3' HD21 ' A' ' 465' ' ' LEU . 19.2 ptpt -143.78 154.1 43.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -175.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.58 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.4 t-20 -104.77 141.46 36.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.208 172.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.435 HD21 ' HD3' ' A' ' 463' ' ' LYS . 63.8 mt -131.69 4.3 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.203 -169.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -91.78 0.06 72.84 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.28 19.04 75.59 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.58 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 5.5 tt -126.72 143.84 38.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.765 0.317 . . . . 0.0 111.289 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -84.9 132.11 10.86 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . 0.45 HG21 ' HG3' ' A' ' 438' ' ' PRO . 85.6 t -118.89 116.01 34.6 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 111.21 173.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.29 -18.19 9.91 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.689 1.592 . . . . 0.0 111.209 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.3 p -91.53 12.56 20.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.259 -167.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 89.8 m -79.64 111.26 15.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.22 -163.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -113.84 125.62 54.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.0 131.02 67.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.198 -173.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -120.42 154.2 35.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.173 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.1 t -128.93 134.81 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.195 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.73 147.28 45.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 93.3 mt -124.24 117.5 50.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.21 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 45.4 t30 54.8 42.18 31.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.195 172.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 96.07 -19.99 52.05 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 174.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.2 m -101.53 138.99 37.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.764 0.316 . . . . 0.0 111.251 -174.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.7 tp -69.96 121.75 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.166 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -97.71 -40.43 8.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.219 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -165.56 158.9 16.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.185 -171.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -140.0 152.77 46.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.221 -177.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -138.49 142.61 39.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.6 m -106.34 126.01 51.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.224 170.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.66 167.85 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.21 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.6 m -120.47 143.34 48.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 170.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.5 mt -129.03 129.21 45.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.259 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -86.44 -173.44 49.1 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.96 112.06 1.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.681 1.587 . . . . 0.0 111.196 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.0 mttt 64.68 33.69 10.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.21 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -101.15 144.96 29.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.167 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -123.5 141.3 52.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.176 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.78 147.22 50.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.182 174.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.9 t -111.87 119.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 43.3 mt -103.81 142.03 35.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.213 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . 0.445 HG22 ' HG2' ' A' ' 459' ' ' GLU . 47.4 p -122.99 152.95 40.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.226 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.1 p90 -153.97 156.58 37.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.147 168.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 67.1 m -121.28 131.61 54.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.184 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . 0.456 ' CH2' ' HB3' ' A' ' 505' ' ' PRO . 41.1 t90 -140.11 129.92 24.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 -169.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 82.1 m -111.47 110.84 55.32 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.256 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . 0.456 ' HB3' ' CH2' ' A' ' 503' ' ' TRP . 74.0 Cg_endo -70.96 111.57 3.08 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.726 1.618 . . . . 0.0 111.165 174.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 80.8 p -83.61 -20.31 33.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.195 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -121.75 140.9 51.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.189 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.48 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 31.7 tt0 -72.26 141.0 48.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.05 174.58 23.58 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -176.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -85.48 127.83 34.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.783 0.325 . . . . 0.0 111.157 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -120.38 132.04 55.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.295 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -105.53 119.58 39.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.256 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 92.8 mt -100.73 122.74 53.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -120.75 147.06 45.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.57 140.17 52.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 174.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.2 p -130.91 150.64 51.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.113 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.199 176.68 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 89.5 t . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.861 0.362 . . . . 0.0 111.155 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.37 134.11 48.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.273 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.7 m -116.03 126.38 53.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.156 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -132.68 130.69 40.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.332 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.5 129.42 47.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.164 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.9 t -121.59 136.22 59.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.8 t -106.29 126.8 52.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.211 173.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.9 t -102.3 128.63 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.203 176.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.96 159.94 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . 0.48 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 93.2 mt . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 N--CA 1.459 -0.549 0 N-CA-C 111.125 -0.375 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -133.38 83.47 2.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 13.9 mt -91.7 127.08 37.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.253 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 9.0 t -145.77 157.82 43.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.55 154.75 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.199 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 94.9 mt-10 -135.62 137.48 41.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.204 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.6 mt -103.65 131.58 51.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.202 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -135.98 142.24 44.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.186 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.9 -176.02 33.51 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.79 141.19 44.47 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.666 1.577 . . . . 0.0 111.323 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -95.82 -17.24 21.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.204 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.6 t -126.61 124.97 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.8 m -130.03 154.24 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.124 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.44 150.84 27.5 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.79 140.01 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 0.0 111.16 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 63.69 30.11 14.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.161 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -126.02 142.93 51.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 502' ' ' SER . 36.7 tp -83.48 126.67 33.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.196 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.79 144.98 48.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -102.78 135.87 43.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.133 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.94 157.2 42.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -130.01 139.51 51.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.157 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.83 120.09 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.1 m-70 -100.68 116.08 31.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 475' ' ' VAL . 1.4 m -117.41 128.09 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 -175.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.452 ' HD2' HD21 ' A' ' 465' ' ' LEU . 13.4 pttt -133.69 150.76 51.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.176 -174.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 57.8 t-20 -111.51 123.97 51.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.214 167.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.452 HD21 ' HD2' ' A' ' 463' ' ' LYS . 56.0 mt -110.52 5.63 21.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.272 -170.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.77 -14.96 54.34 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -174.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.23 21.88 78.4 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.463 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.0 tt -129.49 139.9 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.88 0.371 . . . . 0.0 111.12 167.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -83.09 134.1 12.53 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -169.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 84.8 t -122.16 119.0 28.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.758 0.314 . . . . 0.0 111.263 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -86.15 -18.16 3.54 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.652 1.568 . . . . 0.0 111.137 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.6 p -97.11 4.0 51.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.178 -160.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 473' ' ' THR . 10.2 t -85.31 123.52 30.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.22 -166.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -113.34 128.93 56.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.22 -174.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.431 HG21 HG11 ' A' ' 462' ' ' VAL . 88.4 t -112.02 125.79 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 -174.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.02 155.77 44.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.214 -171.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.31 133.31 69.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -120.5 148.26 44.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.219 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 70.5 mt -120.24 114.73 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.226 169.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 53.96 40.97 32.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 91.64 -11.79 71.17 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.6 m -98.29 134.3 41.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 111.195 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.5 tp -68.54 119.18 12.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.278 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -99.08 -40.58 7.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.231 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -167.33 157.51 11.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.168 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -140.4 151.97 45.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.229 -175.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -136.46 142.15 43.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.2 m -103.26 125.0 49.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.21 163.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.43 166.05 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.4 m -121.95 142.43 50.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.169 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . 0.433 HD21 ' HB2' ' A' ' 497' ' ' LYS . 87.3 mt -129.64 131.44 46.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.167 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -89.76 -167.08 42.14 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 172.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.47 117.53 4.79 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.708 1.605 . . . . 0.0 111.224 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.1 mttt 59.69 41.78 18.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.172 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -103.83 144.56 31.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.256 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -120.32 143.25 48.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.163 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.433 ' HB2' HD21 ' A' ' 491' ' ' LEU . 1.8 tttp -137.46 130.75 30.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.217 -173.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 69.4 t -106.37 118.53 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.161 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 37.2 mt -107.07 144.02 34.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.196 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 41.7 p -122.35 152.68 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.175 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.9 156.4 37.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 168.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.406 ' HB3' HD11 ' A' ' 455' ' ' LEU . 68.8 m -120.41 134.02 55.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.286 -176.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -130.31 129.37 43.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.236 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 96.6 m -118.49 110.55 38.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 170.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.61 152.26 47.98 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.74 1.627 . . . . 0.0 111.168 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 59.4 p -123.88 -15.07 7.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -119.26 135.16 54.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.701 ' CD ' ' H ' ' A' ' 508' ' ' GLU . 2.9 pm0 -80.08 124.82 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.168 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 174.47 -179.99 45.45 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.3 mmm -84.39 127.21 33.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 111.253 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -122.1 133.03 54.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.154 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -105.31 119.17 38.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.289 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.0 123.73 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 -176.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -115.19 146.51 41.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.46 142.74 51.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.237 168.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 77.2 p -130.8 150.39 51.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.22 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.278 172.684 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 79.4 t . . . . . 0 N--CA 1.458 -0.074 0 CA-C-O 120.801 0.334 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.86 133.15 45.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.288 174.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.5 m -117.51 127.03 53.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.193 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -133.6 129.34 36.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.245 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -100.22 126.46 46.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.195 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 82.1 t -121.0 135.83 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.188 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -105.17 127.75 53.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.239 173.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.03 127.73 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.183 173.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.51 150.88 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 -172.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 541' ' ' LEU . 39.8 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.178 -174.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 N--CA 1.458 -0.585 0 N-CA-C 111.227 -0.336 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -147.78 98.91 3.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.193 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 60.3 mt -96.18 142.64 28.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.192 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.5 t -148.53 159.17 44.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.227 174.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.05 154.91 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.184 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 93.7 mt-10 -135.79 138.72 42.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.231 176.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 82.5 mt -106.19 128.23 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -135.75 149.04 49.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.231 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.84 -173.53 35.15 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.16 145.47 60.74 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.718 1.612 . . . . 0.0 111.117 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -90.07 -41.78 11.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 74.9 t -118.25 126.18 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.267 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.5 m -129.73 152.23 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.232 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.79 158.71 45.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 3.1 p -79.42 146.02 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.839 0.352 . . . . 0.0 111.133 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 63.65 29.06 15.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.25 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.91 141.87 51.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 35.0 tp -81.57 127.55 32.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.205 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.16 144.5 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.202 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -103.01 135.78 44.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.191 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -129.34 157.08 42.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.237 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -129.68 139.63 51.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.218 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 44.5 t -112.01 120.44 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.186 170.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 96.8 m-70 -101.54 113.17 26.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.412 HG11 HG21 ' A' ' 475' ' ' VAL . 1.5 m -119.66 130.72 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.23 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -142.73 154.97 44.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -172.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 41.2 t30 -106.71 140.12 40.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.208 170.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 65.1 mt -125.88 4.76 7.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.182 -174.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -89.42 -15.33 58.77 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.53 24.28 73.18 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.469 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.3 tt -137.67 136.39 45.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 111.174 171.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -74.45 136.54 21.31 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -168.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.64 118.15 30.95 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.802 0.334 . . . . 0.0 111.216 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.74 -18.5 5.54 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.649 1.566 . . . . 0.0 111.266 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.6 p -94.11 13.06 24.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 -163.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 100.0 m -78.83 111.62 15.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.16 -161.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -109.83 125.89 53.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.412 HG21 HG11 ' A' ' 462' ' ' VAL . 60.1 t -119.9 127.0 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.177 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -135.28 157.24 47.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.178 -172.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 69.4 t -127.68 134.38 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.244 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -116.85 146.73 42.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.174 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 80.2 mt -120.1 115.05 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.171 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 53.68 41.29 32.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.178 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 93.01 -15.4 62.95 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 172.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -99.64 133.71 43.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.803 0.335 . . . . 0.0 111.25 -174.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 56.0 tp -68.79 120.23 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.222 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -97.36 -40.96 8.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.211 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -168.31 157.44 9.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.193 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -140.5 155.17 46.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.228 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -135.21 142.38 46.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.252 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.4 m -109.67 123.32 49.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.206 166.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.11 167.74 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.277 -175.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 82.9 p -116.75 143.89 45.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.143 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 96.4 mt -129.16 131.23 47.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.201 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -90.15 -179.19 44.27 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 172.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.49 120.24 7.72 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.686 1.591 . . . . 0.0 111.255 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.9 mttt 57.08 36.62 27.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.249 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -103.24 144.08 31.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.162 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -122.95 140.67 52.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.243 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -126.81 147.68 50.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.185 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 90.0 t -110.89 119.16 58.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 35.7 mt -104.16 141.65 35.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.199 173.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 46.3 p -124.55 153.86 41.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.23 156.28 36.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.211 166.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 52.7 m -122.47 134.37 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 41.3 t90 -140.17 129.77 24.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.211 -166.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.3 m -117.15 112.88 39.55 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.28 150.32 36.83 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.703 1.602 . . . . 0.0 111.237 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 66.9 p -122.68 -11.71 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.194 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -120.03 139.19 52.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.173 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -80.74 143.6 32.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.135 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.93 177.84 25.18 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.7 mmm -86.31 130.75 34.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 111.184 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -118.71 134.93 54.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.225 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -106.95 119.6 39.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.158 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 85.2 mt -103.5 124.9 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.193 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -117.71 145.7 44.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.228 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.75 141.4 51.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.192 170.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 68.0 p -131.05 150.56 52.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.169 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 169.99 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 71.5 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.828 0.347 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.03 130.61 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -172.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.2 m -117.29 127.05 53.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.247 176.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -130.65 130.2 43.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.206 -175.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -99.08 125.59 44.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -173.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.54 135.58 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.166 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.5 t -105.79 122.41 46.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.221 171.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 98.2 t -102.76 127.08 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.15 165.06 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.287 177.255 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 N--CA 1.458 -0.581 0 N-CA-C 111.118 -0.378 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -141.16 73.52 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.204 165.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.01 143.36 34.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.141 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 44.7 p -127.8 162.39 26.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.183 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . 0.412 ' CG1' ' HB ' ' A' ' 517' ' ' VAL . 29.1 m -131.82 152.08 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.26 163.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 86.2 mt-10 -139.96 135.69 33.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 175.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 84.5 mt -109.66 124.18 66.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.211 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.0 148.66 47.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.227 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.22 -163.92 32.17 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -56.25 136.77 77.07 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.674 1.582 . . . . 0.0 111.247 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -86.99 -37.63 17.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.203 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 93.1 t -124.85 132.87 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.203 174.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.84 151.85 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.24 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.61 158.78 43.62 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.8 136.17 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 111.22 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 62.56 21.99 13.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.19 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -110.3 130.98 55.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.17 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 35.3 tp -74.73 126.81 31.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.156 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.56 146.47 48.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -108.66 132.26 54.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -128.18 157.2 41.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.172 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -130.35 140.36 50.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.211 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 48.8 t -111.77 120.39 62.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 170.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.1 m-70 -105.98 109.09 20.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.195 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 14.6 m -116.42 132.61 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -119.77 159.16 25.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 44.5 t-20 -111.82 121.75 45.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 156.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 48.5 mt -117.16 1.0 12.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 -177.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.72 -19.29 41.17 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 75.28 28.87 61.14 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 15.2 tt -128.14 136.03 61.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 111.193 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.7 122.24 13.76 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.09 112.07 31.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 111.169 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.23 -17.42 11.7 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.738 1.625 . . . . 0.0 111.206 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 58.5 m -87.98 10.73 17.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -162.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.9 m -79.97 108.54 13.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -162.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -109.54 127.44 54.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.194 175.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 80.4 t -113.45 126.16 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.303 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -127.87 153.84 46.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.243 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.75 134.38 64.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -120.99 147.55 45.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.219 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.452 HG12 HG12 ' A' ' 513' ' ' ILE . 86.3 mt -120.39 117.41 53.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 170.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 54.31 41.43 31.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.268 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.95 -9.51 71.94 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.1 m -98.14 137.81 36.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.745 0.307 . . . . 0.0 111.208 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -69.76 120.31 15.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -98.09 -40.39 8.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -165.15 158.07 16.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.213 -173.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -142.23 152.04 42.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.234 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.3 m-90 -137.79 142.66 40.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.288 170.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.7 m -105.97 125.12 50.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.231 170.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.0 m -138.98 167.21 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.5 m -122.79 143.31 49.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.161 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 90.8 mt -128.57 128.81 44.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.268 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.37 -167.79 43.59 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.79 112.84 1.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.658 1.572 . . . . 0.0 111.205 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.0 mttt 66.86 36.19 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -96.61 143.81 27.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.235 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -125.37 141.48 52.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.233 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . 0.43 ' HB3' ' HE3' ' A' ' 497' ' ' LYS . 26.4 mmmt -129.8 144.82 51.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.189 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.3 119.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.128 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 64.6 mt -104.03 143.3 33.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 47.1 p -122.36 152.77 39.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.211 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -153.82 156.61 37.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.236 168.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.2 m -121.1 129.25 53.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.189 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -127.27 129.5 47.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 -172.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.9 m -113.89 110.47 49.02 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.192 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.29 150.99 53.9 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.691 1.594 . . . . 0.0 111.179 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 79.9 p -123.41 -13.53 7.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.223 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -125.76 137.12 53.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.192 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.462 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 30.9 tt0 -77.02 140.05 40.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.242 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.8 175.12 23.95 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.7 mmm -85.67 129.91 34.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.191 176.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -119.63 130.32 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -104.01 119.39 38.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.195 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.452 HG12 HG12 ' A' ' 479' ' ' ILE . 82.5 mt -104.05 123.76 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.201 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -119.76 145.14 46.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.208 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.04 143.09 50.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.192 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 82.7 p -131.17 153.2 49.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.289 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.412 ' HB ' ' CG1' ' A' ' 442' ' ' VAL . 9.1 p . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.238 173.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.803 0.335 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.18 137.18 49.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.0 m -115.21 126.52 54.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -134.71 129.75 35.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.181 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -100.19 128.71 46.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.226 -173.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 91.9 t -121.13 135.99 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.242 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.6 t -105.66 124.42 49.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.145 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.6 t -102.03 126.61 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.73 155.23 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . 0.462 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 83.4 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.238 177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 N--CA 1.458 -0.577 0 N-CA-C 111.243 -0.329 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -127.62 81.57 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.267 172.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.6 136.01 33.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 -174.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 8.0 t -141.0 153.14 45.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.324 176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 26.2 m -131.62 154.9 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.131 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.7 mt-10 -139.4 135.69 33.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.2 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 87.7 mt -107.34 126.86 63.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.192 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.9 147.93 48.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.243 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.89 -169.66 34.67 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.42 114.46 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.693 1.595 . . . . 0.0 111.163 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -69.04 -26.96 65.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 97.5 t -123.69 130.96 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.221 172.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.2 152.01 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.187 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.58 158.91 41.9 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.53 137.91 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 111.248 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 62.21 25.5 15.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.299 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -116.56 150.2 38.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.176 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 502' ' ' SER . 37.9 tp -88.87 127.61 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.279 -175.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.41 143.99 49.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.228 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -107.71 137.32 45.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.187 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.86 157.67 41.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.27 141.2 51.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.155 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 47.1 t -113.13 120.95 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.162 170.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.7 m-70 -103.29 108.17 19.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 475' ' ' VAL . 2.3 m -118.42 130.55 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.224 -171.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -144.99 151.72 39.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.167 -173.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 44.6 t-20 -106.81 139.58 41.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.163 173.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 73.7 mt -129.37 4.09 5.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.214 -171.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -88.0 -2.04 81.42 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.94 21.4 78.23 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.437 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.8 tt -126.55 148.85 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.773 0.32 . . . . 0.0 111.186 175.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -94.06 115.69 5.06 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 94.3 t -104.76 114.48 63.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.757 0.313 . . . . 0.0 111.194 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.7 -17.98 10.79 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.698 1.598 . . . . 0.0 111.201 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.7 p -91.42 12.08 21.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.164 -164.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 91.1 m -78.75 108.17 11.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.229 -162.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -111.07 128.26 55.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.218 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 462' ' ' VAL . 67.1 t -115.05 128.46 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 -176.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -123.67 152.61 41.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 79.7 t -127.7 133.71 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.284 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.22 147.51 44.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.169 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . 0.466 HG12 HG12 ' A' ' 513' ' ' ILE . 84.1 mt -119.86 117.19 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.292 171.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 54.55 41.16 32.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.176 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.56 -11.82 67.12 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 173.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.2 m -97.71 137.64 36.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 111.224 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 66.5 tp -69.3 120.69 15.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.263 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -98.11 -40.47 8.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 -176.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -166.16 159.91 15.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 -173.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -141.17 153.13 45.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.182 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -139.17 142.79 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.196 171.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.8 m -107.55 125.09 50.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.204 169.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.61 168.07 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 59.4 m -121.98 143.09 49.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.173 170.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.4 mt -127.38 129.53 47.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.216 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.38 -179.74 48.15 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.06 113.87 1.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.647 1.565 . . . . 0.0 111.211 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.5 mttt 64.73 34.14 9.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -101.5 143.47 31.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.28 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -122.81 140.3 53.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.208 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -128.29 146.43 50.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.206 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.9 t -112.34 119.45 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 49.5 mt -102.86 142.25 34.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.239 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 45.7 p -123.82 152.78 41.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.23 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.95 156.84 38.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.314 167.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.403 ' HB3' HD11 ' A' ' 455' ' ' LEU . 70.5 m -120.12 129.81 54.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.206 -176.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -130.69 129.57 42.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.219 -170.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.1 m -117.34 107.3 45.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.222 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.35 143.48 31.47 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.713 1.608 . . . . 0.0 111.202 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 67.4 p -115.41 -14.85 11.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.169 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -119.94 138.02 53.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . 0.437 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 33.2 tt0 -75.0 140.11 43.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.197 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.87 174.44 24.05 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -176.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.6 mmm -85.17 127.82 34.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.842 0.353 . . . . 0.0 111.111 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -120.89 131.96 54.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.18 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -104.17 118.07 35.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.165 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . 0.466 HG12 HG12 ' A' ' 479' ' ' ILE . 83.9 mt -104.52 120.22 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -123.02 149.4 44.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.239 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.4 140.81 52.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.233 175.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 60.1 p -131.75 151.75 51.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.163 174.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.216 173.659 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 88.6 t . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.847 0.356 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.87 133.98 46.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.239 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 85.8 m -116.19 125.89 52.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -131.21 129.09 41.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.191 176.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -101.14 125.65 47.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.249 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 85.3 t -121.25 136.26 58.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.9 t -104.61 127.34 52.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.179 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 85.2 t -101.24 126.85 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.144 173.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 32.2 m -122.87 159.77 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.12 -175.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . 0.437 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 94.3 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.153 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.459 -0.557 0 N-CA-C 111.233 -0.334 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -143.17 78.07 1.59 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.232 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 14.7 mt -80.28 125.86 30.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.198 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 14.5 t -138.74 157.15 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.37 155.48 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.308 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 91.5 mt-10 -137.05 133.75 35.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.193 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 92.6 mt -104.56 127.28 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -135.48 146.48 48.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.226 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.61 -171.17 34.19 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.96 140.39 45.58 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.71 1.607 . . . . 0.0 111.205 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -86.03 -36.52 19.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.237 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.2 t -120.03 129.57 75.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.231 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.09 153.18 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.232 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.37 156.54 43.3 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.1 p -76.19 140.29 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.201 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 63.46 28.65 15.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.239 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -121.73 148.04 45.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.82 127.06 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.28 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.25 143.38 49.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.177 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -103.99 135.17 46.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.121 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -130.27 157.22 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -129.81 139.83 51.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.221 -175.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.7 t -113.45 121.9 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 173.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.5 m-70 -101.71 112.05 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.15 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.408 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -117.89 128.83 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.256 -171.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . 0.449 ' HD2' HD21 ' A' ' 465' ' ' LEU . 45.7 pttt -145.07 154.97 43.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.202 -172.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 63.4 t-20 -113.77 120.88 42.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.156 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . 0.449 HD21 ' HD2' ' A' ' 463' ' ' LYS . 82.6 mt -112.16 15.36 20.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.176 -170.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.28 -9.62 61.7 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -177.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.96 16.79 76.65 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.474 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.7 tt -127.03 146.21 33.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.701 0.286 . . . . 0.0 111.264 170.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -83.6 132.06 10.82 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.7 114.55 32.66 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.222 168.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -84.71 -19.17 4.27 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.811 1.674 . . . . 0.0 111.242 -174.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 99.1 p -97.92 5.32 49.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.233 -160.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 473' ' ' THR . 8.9 t -84.99 127.03 34.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.212 -160.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.94 130.92 55.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.249 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.89 130.21 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.268 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -129.49 155.09 46.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.176 -170.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 41.4 t -125.55 135.02 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.228 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -124.04 150.15 45.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.218 -174.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 86.3 mt -124.03 116.45 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.221 172.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 54.49 41.19 32.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.19 -13.52 66.87 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 170.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.6 m -99.76 138.53 36.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 111.257 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.7 tp -67.85 120.44 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -99.01 -40.28 8.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.156 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt -158.26 162.9 37.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -138.12 148.32 44.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.157 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -138.48 142.03 39.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.135 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 93.2 m -109.75 126.68 54.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.286 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.5 m -138.19 167.1 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.242 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.7 m -117.32 140.28 49.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.184 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.9 mt -129.44 130.24 45.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.136 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -91.15 -167.21 41.04 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 173.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.2 111.73 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.731 1.62 . . . . 0.0 111.239 175.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.1 mttt 60.01 43.69 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.181 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.06 142.67 31.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.238 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -122.14 137.92 54.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.145 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -127.97 148.61 50.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.188 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 85.9 t -111.2 118.53 57.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.186 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 48.1 mt -104.84 145.65 30.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.259 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 55.5 p -120.51 154.0 35.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.218 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -152.93 155.04 36.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 165.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 65.2 m -124.25 131.59 53.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -131.42 131.53 43.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.201 -170.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.4 m -118.02 110.3 40.02 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.221 174.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.85 154.44 43.28 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.806 1.671 . . . . 0.0 111.107 172.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 74.3 p -124.19 -19.16 5.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.242 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -120.13 138.92 53.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.22 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.21 140.44 46.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.46 176.61 26.1 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.64 128.94 35.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.17 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -121.92 136.55 54.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.209 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -104.68 119.09 38.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.243 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 93.0 mt -103.73 124.05 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.175 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -121.37 151.16 40.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.27 143.18 51.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.163 173.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 64.6 p -131.07 154.1 48.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.215 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.235 165.989 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 92.9 t . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.857 0.361 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.4 131.74 48.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 80.1 m -115.25 125.34 53.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.171 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -132.58 130.83 40.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.149 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -104.05 129.63 51.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.224 -174.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.0 t -121.27 137.19 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.257 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.6 t -103.97 124.13 48.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.199 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 83.9 t -102.17 126.47 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.242 175.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.07 160.54 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.26 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 76.0 mt . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.185 -176.147 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 N--CA 1.459 -0.54 0 N-CA-C 111.064 -0.398 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -143.36 89.72 2.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 15.4 mt -90.14 128.3 36.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.187 -176.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.4 t -143.76 157.59 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.199 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.63 154.59 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.25 -177.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 50.3 mt-10 -135.95 139.82 43.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.233 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 85.4 mt -105.38 132.17 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.24 142.52 44.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.189 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 160.41 -174.97 37.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.15 142.72 42.53 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.762 1.642 . . . . 0.0 111.208 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -75.24 -46.36 34.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.251 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.18 130.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.192 -176.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.37 153.09 38.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.249 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -85.65 159.81 33.62 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 4.7 p -72.41 139.96 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 0.0 111.242 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 63.31 29.95 15.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.22 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -124.52 138.64 54.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.22 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' LEU . . . . . 0.416 HD11 ' HB3' ' A' ' 502' ' ' SER . 34.4 tp -81.49 126.9 32.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.24 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.81 144.47 48.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.223 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -101.88 134.19 45.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.213 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -129.42 156.88 43.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.106 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -130.1 139.94 50.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.124 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.9 t -111.54 120.1 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' HIS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.0 m-70 -99.63 114.17 27.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.225 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' VAL . . . . . 0.4 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -117.42 129.43 73.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.224 -175.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -144.26 153.07 41.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.23 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 31.0 t30 -111.72 130.05 55.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.185 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 78.9 mt -114.61 4.03 15.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.204 -173.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -88.7 -20.54 47.04 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.91 24.37 72.16 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' ILE . . . . . 0.421 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.6 tt -134.44 138.97 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 111.173 169.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -76.07 131.68 12.06 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -166.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.38 117.63 30.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 111.251 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -86.72 -17.74 3.24 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.639 1.559 . . . . 0.0 111.175 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 98.5 p -95.59 4.36 53.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.259 -160.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 473' ' ' THR . 9.6 t -86.57 124.33 32.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.265 -164.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -113.6 129.13 56.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.191 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 97.0 t -112.22 127.54 69.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.234 -174.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.69 157.65 41.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.27 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.3 t -126.33 133.63 68.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.145 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -120.85 148.53 43.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 77.5 mt -119.77 115.71 48.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.232 169.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 54.23 41.0 32.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.187 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.18 -16.0 61.96 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 171.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -97.88 136.18 38.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.352 . . . . 0.0 111.207 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.5 tp -68.49 120.0 13.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.099 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -98.37 -40.06 8.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -166.36 157.41 12.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.268 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -139.96 151.18 45.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.181 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 30.0 m-90 -136.82 142.05 42.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.178 170.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.7 m -102.82 125.03 49.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.24 164.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.74 166.0 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.234 -172.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.8 m -122.48 143.53 49.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 171.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.9 mt -128.54 130.26 47.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -91.32 -165.09 39.61 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.49 112.35 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.723 1.616 . . . . 0.0 111.182 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 59.94 48.31 8.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.209 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -104.56 142.98 33.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.146 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -117.59 141.76 47.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.269 172.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -139.25 130.13 26.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.227 -172.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 73.7 t -105.58 118.41 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 -170.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 36.0 mt -105.73 143.6 33.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 173.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 50.7 p -122.87 152.67 40.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -153.81 156.41 37.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.189 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 502' ' ' SER . . . . . 0.416 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.7 m -121.07 133.57 55.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.234 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -133.46 131.21 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.165 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.6 m -116.58 109.74 43.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.278 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.54 153.53 34.73 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.714 1.609 . . . . 0.0 111.19 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 69.9 p -128.52 -2.3 5.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.203 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -133.95 135.31 43.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.206 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -72.24 141.79 48.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.4 175.22 25.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.2 mmm -86.03 127.17 34.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 111.188 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -119.98 137.45 54.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.311 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -106.79 119.2 38.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.205 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 83.7 mt -102.98 123.8 56.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.214 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -116.46 144.98 43.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.184 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.45 141.41 52.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.252 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 73.0 p -131.0 150.55 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.272 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 14.6 p . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.261 174.346 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.866 0.365 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -129.49 134.01 47.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.1 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 83.0 m -116.85 127.97 54.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.227 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -132.23 131.65 42.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.31 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -99.34 128.94 45.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.166 -172.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.5 t -121.27 136.79 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.175 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.2 t -106.38 123.99 48.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.187 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.3 t -103.1 128.31 56.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.138 175.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.24 165.02 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.157 176.19 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . 0.694 ' HB2' ' HA ' ' A' ' 436' ' ' GLU . 99.5 mmm . . . . . 0 N--CA 1.457 -0.085 0 CA-C-O 120.871 0.367 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . 0.694 ' HA ' ' HB2' ' A' ' 435' ' ' MET . 88.5 tt0 -104.5 156.14 18.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.214 -25.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 435' ' ' MET . 16.6 m-30 -110.43 105.1 56.9 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.162 -164.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.496 ' HB3' HG23 ' A' ' 468' ' ' ILE . 70.8 Cg_endo -71.07 167.56 25.74 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.712 1.608 . . . . 0.0 111.227 173.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -121.47 90.37 3.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.228 167.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 71.1 mt -83.03 138.27 33.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.193 -179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 531' ' ' ASN . 13.3 t -140.05 153.77 46.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.173 177.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.2 m -132.89 156.31 42.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.212 -179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 95.8 mt-10 -139.74 136.68 34.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.27 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 94.5 mt -107.43 127.49 63.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -135.97 147.88 48.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.175 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.47 -167.85 34.65 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.51 142.19 58.33 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.689 1.593 . . . . 0.0 111.099 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -89.35 -38.26 14.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.235 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 76.2 t -120.42 130.08 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.207 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.2 m -129.41 151.73 36.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.204 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.47 159.98 43.23 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 540' ' ' VAL . 3.0 p -76.3 141.58 15.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.804 0.335 . . . . 0.0 111.206 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 62.54 28.17 16.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.181 -178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -123.29 144.63 49.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.25 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.423 HD11 ' HB3' ' A' ' 502' ' ' SER . 37.2 tp -87.34 128.49 35.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.182 -173.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.97 145.01 48.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.163 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -103.39 135.26 45.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.161 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 94.7 m-85 -129.83 157.18 42.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.172 176.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.485 ' HG2' HG22 ' A' ' 500' ' ' THR . 93.6 mt-10 -130.47 141.07 50.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.185 -175.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 53.1 t -112.35 121.2 64.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.14 173.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.5 m-70 -103.16 107.85 18.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.158 -178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.448 HG11 HG21 ' A' ' 475' ' ' VAL . 2.5 m -118.85 130.52 73.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.217 -173.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -143.04 155.08 44.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.224 -170.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 8.3 t-20 -98.44 138.65 35.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.201 174.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 80.7 mt -134.44 38.26 3.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.204 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -138.3 8.82 3.5 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 63.11 18.6 60.52 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.581 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 14.9 tt -136.13 139.56 45.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.713 0.292 . . . . 0.0 111.225 171.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -87.26 141.44 17.51 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -174.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 92.7 t -116.5 119.35 36.16 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 111.254 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.84 -19.53 9.67 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.716 1.611 . . . . 0.0 111.22 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.7 p -92.95 12.74 22.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.254 -168.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 84.8 m -75.95 109.86 9.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.221 -161.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -109.89 127.61 54.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.145 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.448 HG21 HG11 ' A' ' 462' ' ' VAL . 64.9 t -115.69 126.2 73.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.109 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -127.14 152.65 47.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.263 -172.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 80.6 t -129.12 131.87 67.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.156 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -119.79 145.93 46.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.157 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.442 HG12 HG12 ' A' ' 513' ' ' ILE . 77.0 mt -118.32 114.89 46.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.177 171.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 53.57 40.77 31.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.222 -178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.8 -19.07 55.74 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 171.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.0 m -97.65 137.4 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.741 0.305 . . . . 0.0 111.174 -175.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.3 tp -68.78 121.81 17.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.171 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -96.78 -40.27 9.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.204 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.426 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 48.7 tptt -164.75 158.22 17.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.205 -173.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -143.27 153.28 42.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.233 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . 0.426 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 27.4 m-90 -137.98 142.42 40.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 172.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.8 m -107.54 123.04 47.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.201 168.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.81 167.8 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.166 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 70.5 m -118.5 142.28 47.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 97.1 mt -126.79 130.31 50.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.182 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -86.84 -179.97 48.88 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 173.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.78 119.7 6.9 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.706 1.604 . . . . 0.0 111.183 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.3 mttt 55.54 35.61 25.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.163 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -101.04 144.41 30.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.229 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -122.36 140.5 52.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.228 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -127.67 147.58 50.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.201 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 91.7 t -111.4 119.23 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.412 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 54.5 mt -102.7 142.89 33.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.189 173.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.485 HG22 ' HG2' ' A' ' 459' ' ' GLU . 46.5 p -122.49 153.04 39.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.183 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.0 p90 -153.84 156.02 36.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.169 167.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.423 ' HB3' HD11 ' A' ' 455' ' ' LEU . 68.0 m -122.29 128.1 50.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.256 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -131.38 131.59 43.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.167 -169.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.6 m -114.08 105.43 54.25 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.212 172.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -74.81 118.9 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.732 1.621 . . . . 0.0 111.195 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 70.9 p -94.87 -12.41 26.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.249 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -117.35 138.06 52.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.272 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.471 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 35.7 tt0 -76.12 140.89 42.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.136 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.04 174.97 24.77 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.6 mmm -86.2 129.61 34.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 0.0 111.209 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -120.01 134.02 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.17 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -106.24 118.63 37.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.244 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.442 HG12 HG12 ' A' ' 479' ' ' ILE . 82.2 mt -105.35 123.23 59.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.244 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -118.5 145.43 45.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.08 140.04 52.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 172.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 66.6 p -131.9 153.2 50.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.25 176.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.455 ' CG1' ' HB2' ' A' ' 531' ' ' ASN . 8.1 p -123.38 141.98 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.203 170.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.7 t0 55.15 49.64 16.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.228 -173.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -56.87 -38.87 73.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.25 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.33 -5.19 46.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.154 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.1 t30 59.9 58.42 2.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.178 177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 69.6 p -94.35 -20.87 19.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.277 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 96.4 t -121.24 133.83 66.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.167 174.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 84.5 t -89.16 122.71 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.227 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -102.64 170.5 7.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.266 -170.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.63 -27.9 61.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.129 171.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -132.6 145.65 51.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.214 172.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -111.95 -20.78 11.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.195 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -93.85 -2.13 53.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.167 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -102.07 20.68 16.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.141 -174.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . 0.455 ' HB2' ' CG1' ' A' ' 517' ' ' VAL . 50.4 p30 -132.81 25.36 4.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.134 -177.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 90.8 t -129.53 143.06 42.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.182 173.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.4 131.8 50.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.163 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.7 m -117.15 126.37 52.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.23 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -132.62 129.96 39.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.13 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -100.22 129.02 46.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.172 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 90.7 t -120.97 135.64 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.25 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.7 t -106.86 123.13 47.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.225 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 94.4 t -102.98 127.09 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.236 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 452' ' ' VAL . 36.0 m -123.07 159.83 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.193 -177.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . 0.471 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 94.5 mt -82.57 11.11 6.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.208 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 C--O 1.199 -1.579 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 -176.092 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . 0.708 ' HB2' ' HA ' ' A' ' 436' ' ' GLU . 48.0 mtp . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.777 0.322 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . 0.708 ' HA ' ' HB2' ' A' ' 435' ' ' MET . 16.7 pt-20 -109.12 -158.44 0.65 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.189 14.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -105.03 105.82 53.07 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.189 -158.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.415 ' HG3' HG21 ' A' ' 470' ' ' VAL . 68.3 Cg_endo -74.19 166.49 29.43 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.694 1.596 . . . . 0.0 111.236 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -124.0 76.11 1.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 172.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 66.9 mt -81.45 131.04 35.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.242 -174.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.9 t -138.43 154.87 48.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.215 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 32.8 m -131.79 155.19 41.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.185 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 95.1 mt-10 -139.72 136.26 34.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.2 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.2 mt -106.28 127.14 61.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.178 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.02 147.88 48.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.235 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.04 -169.28 34.15 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.81 139.51 48.03 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.713 1.609 . . . . 0.0 111.196 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -87.55 -36.11 17.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 79.2 t -120.6 130.29 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.147 176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.3 m -130.34 152.84 38.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.192 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.97 159.28 35.79 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.1 p -74.15 138.17 21.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.824 0.345 . . . . 0.0 111.145 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 62.49 24.31 14.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.207 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -115.32 151.92 33.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.125 176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 502' ' ' SER . 43.3 tp -88.89 128.4 35.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.23 -175.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.48 147.02 46.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.289 173.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.24 138.21 52.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.218 177.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 90.3 m-85 -129.09 157.74 40.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.187 -178.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -128.59 139.99 52.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.193 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.73 121.02 64.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.168 173.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.9 m-70 -102.6 108.0 19.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.175 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.468 HG11 HG21 ' A' ' 475' ' ' VAL . 2.1 m -118.63 130.44 73.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.25 -173.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.43 ' HD3' HD21 ' A' ' 465' ' ' LEU . 19.1 ptpt -143.65 154.05 43.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.222 -172.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 41.7 t-20 -107.0 142.22 36.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 171.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.43 HD21 ' HD3' ' A' ' 463' ' ' LYS . 55.3 mt -132.11 3.73 4.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.185 -170.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.59 1.25 71.78 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.79 17.67 76.92 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.526 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.7 tt -127.14 150.18 32.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.777 0.322 . . . . 0.0 111.236 171.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -95.5 132.15 10.97 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.415 HG21 ' HG3' ' A' ' 438' ' ' PRO . 87.1 t -116.67 118.03 37.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.85 0.357 . . . . 0.0 111.176 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -81.06 -19.14 8.38 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 121.724 1.616 . . . . 0.0 111.194 -177.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 95.4 p -93.92 13.56 22.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.177 -165.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 94.1 m -77.44 112.82 14.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -161.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -111.61 126.56 55.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.187 -179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.468 HG21 HG11 ' A' ' 462' ' ' VAL . 59.9 t -118.57 127.42 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.189 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -134.89 156.58 48.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.199 -173.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 74.8 t -129.03 136.88 58.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -170.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -116.93 147.89 41.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.185 178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.415 HG12 HG12 ' A' ' 513' ' ' ILE . 82.2 mt -119.7 116.09 49.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.221 167.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.28 41.35 32.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.249 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.65 -11.47 68.39 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 172.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.9 m -98.63 136.09 39.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.875 0.369 . . . . 0.0 111.18 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.7 tp -69.35 120.58 15.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.21 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -98.2 -40.27 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.166 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 50.3 tptt -168.46 158.52 9.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 -173.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -143.74 153.89 42.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.124 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -136.95 143.04 42.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.209 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.6 m -106.38 125.16 50.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.214 169.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.42 168.47 18.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.201 -178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.7 m -120.02 142.22 49.01 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.18 172.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.0 mt -128.38 130.79 48.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.255 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -90.64 -171.06 43.63 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 174.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.83 113.3 1.93 Allowed 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.602 1.535 . . . . 0.0 111.201 176.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.0 mttt 65.4 35.3 7.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.196 177.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -101.72 143.2 31.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.182 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.87 141.3 52.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.207 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -127.1 146.17 50.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.148 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 94.3 t -112.35 119.69 60.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.176 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 38.8 mt -102.88 142.17 34.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.223 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 66.2 p -122.25 152.52 39.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.199 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.9 p90 -155.21 157.2 36.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.263 169.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.412 ' HB3' HD11 ' A' ' 455' ' ' LEU . 73.6 m -120.26 128.67 53.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.183 -175.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.8 t90 -130.51 129.87 43.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.236 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.1 m -117.26 109.35 42.44 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.258 172.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.74 155.04 44.23 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 121.715 1.61 . . . . 0.0 111.221 175.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 73.3 p -125.48 -10.16 6.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.168 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -129.96 136.07 49.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.257 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -71.17 142.88 50.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.198 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.98 174.6 25.09 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -84.19 125.96 32.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.828 0.347 . . . . 0.0 111.208 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -119.58 132.12 55.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.211 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -104.97 118.69 37.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.215 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.415 HG12 HG12 ' A' ' 479' ' ' ILE . 86.8 mt -104.47 124.25 58.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.187 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -118.33 144.16 46.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.65 139.24 54.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.206 172.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 64.0 p -130.91 150.1 52.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.242 177.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.424 ' CG1' ' HB2' ' A' ' 531' ' ' ASN . 8.1 p -124.72 140.54 47.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.292 168.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 24.5 t0 47.84 47.18 18.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.213 -172.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -57.38 -36.44 71.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.22 173.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -74.16 -5.8 43.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.23 -176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 63.91 46.26 3.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.182 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 43.5 p -88.83 -16.76 31.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.155 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 85.0 t -121.66 132.1 71.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.151 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . 0.434 ' HB ' ' SD ' ' A' ' 435' ' ' MET . 67.9 t -90.79 121.2 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.214 174.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -102.91 176.39 5.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.239 -171.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -69.92 -25.89 63.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.195 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -152.8 148.12 26.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.165 168.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -108.95 -11.4 14.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.198 -169.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -94.69 -9.99 33.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.256 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -103.98 36.6 2.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.177 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . 0.424 ' HB2' ' CG1' ' A' ' 517' ' ' VAL . 49.8 p30 -142.47 24.69 1.9 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.266 -178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 89.2 t -129.31 143.18 41.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.255 172.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.16 133.5 48.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.169 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 96.9 m -116.62 126.7 53.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.183 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -131.72 131.66 43.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.186 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -103.15 129.27 49.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.228 -173.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 92.8 t -121.29 137.3 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.151 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.3 t -108.01 125.15 51.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.119 170.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 96.0 t -103.27 129.37 55.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.183 175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.76 164.1 24.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 93.8 mt -87.35 45.79 1.31 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--O 1.201 -1.48 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.284 174.042 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . 0.4 ' SD ' HG23 ' A' ' 523' ' ' VAL . 22.5 mmt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.878 0.37 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -80.03 145.07 32.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.221 131.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -105.88 110.31 63.98 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.198 -146.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 525' ' ' GLU . 72.4 Cg_endo -70.32 168.14 23.15 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.651 1.567 . . . . 0.0 111.238 173.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . 0.463 ' OD1' ' HB3' ' A' ' 527' ' ' ASN . 64.1 t0 -124.31 81.88 1.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.263 170.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.01 137.84 35.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.208 -176.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.584 ' OG1' ' HB3' ' A' ' 530' ' ' ASN . 7.7 t -144.53 154.6 43.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.203 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 28.3 m -131.59 155.34 41.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.299 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 97.0 mt-10 -139.95 137.9 35.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.24 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.4 mt -107.6 128.11 63.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 174.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -135.87 147.52 48.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.153 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 159.28 -171.18 35.73 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.79 128.78 18.5 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 121.756 1.637 . . . . 0.0 111.165 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -71.25 -40.32 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.184 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 67.9 t -121.61 131.65 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.181 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 30.0 m -129.88 152.34 37.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.259 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.26 159.75 43.42 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 176.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 540' ' ' VAL . 1.2 p -79.99 148.02 6.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.721 0.296 . . . . 0.0 111.215 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 20.8 m120 63.39 26.86 15.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.146 -178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 454' ' ' LYS . 27.8 mmmt -129.09 144.49 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.231 -177.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' A' ' 502' ' ' SER . 30.8 tp -85.35 126.23 33.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.238 -176.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -124.72 144.13 50.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 174.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -110.39 136.88 48.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -174.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -129.58 157.29 42.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.147 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -129.33 139.21 51.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.143 -176.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.4 t -112.76 120.71 63.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.21 170.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.1 m-70 -103.35 107.29 18.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.229 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.459 HG11 HG21 ' A' ' 475' ' ' VAL . 2.4 m -118.95 129.18 75.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.169 -172.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 46.4 pttt -143.41 155.0 44.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.246 -171.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 34.0 t30 -104.37 140.42 37.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.243 170.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 70.4 mt -128.47 6.52 5.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.178 -175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -95.64 -12.25 53.83 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 75.08 23.59 73.95 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.501 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 8.3 tt -128.96 139.77 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.817 0.342 . . . . 0.0 111.219 165.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.58 134.33 13.96 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 -173.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.38 116.23 39.48 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.781 0.324 . . . . 0.0 111.28 172.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.46 -19.07 9.2 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.692 1.595 . . . . 0.0 111.18 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.7 p -95.05 13.43 25.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.205 -164.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 88.3 m -78.22 110.8 13.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.287 -163.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -111.27 127.39 55.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.188 -178.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.459 HG21 HG11 ' A' ' 462' ' ' VAL . 68.8 t -115.09 126.93 72.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.282 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -127.89 153.44 46.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.139 -173.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 79.1 t -130.06 133.86 63.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.243 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -119.03 148.07 43.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.248 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 513' ' ' ILE . 84.6 mt -118.73 115.55 48.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.253 169.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 53.74 41.17 32.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.267 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 87.97 -10.43 70.6 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.4 m -97.45 136.51 37.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.905 0.383 . . . . 0.0 111.135 -178.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 60.9 tp -69.05 120.79 15.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.147 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -98.26 -40.63 8.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.256 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -167.98 161.1 12.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.198 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -141.83 152.56 43.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.221 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -137.37 142.36 41.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.268 171.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.0 m -108.74 124.56 50.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.195 168.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.56 168.19 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.191 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 49.2 m -120.9 143.09 49.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.171 172.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 91.4 mt -127.2 129.13 47.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.161 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.24 -173.86 48.64 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 175.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.6 112.4 1.45 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.701 1.601 . . . . 0.0 111.146 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.0 mttt 65.95 36.06 6.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.196 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -101.6 144.0 30.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.38 140.41 52.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -129.39 145.75 51.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 89.4 t -112.72 118.99 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.195 -178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 50.3 mt -103.41 142.71 33.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.212 173.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 63.3 p -124.51 153.3 42.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.257 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.93 156.73 38.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.255 168.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.504 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.8 m -120.46 128.66 53.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.203 -175.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -129.67 129.57 44.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.232 -170.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 95.3 m -115.9 109.7 44.83 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.16 141.43 29.32 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.724 1.616 . . . . 0.0 111.148 174.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 81.5 p -111.91 -21.58 11.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.216 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -120.14 139.58 52.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.249 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.438 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 32.5 tt0 -73.2 140.22 46.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.276 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.04 175.3 24.33 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.159 -0.776 . . . . 0.0 111.159 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.4 mmm -86.4 129.01 35.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.327 . . . . 0.0 111.195 176.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -120.73 131.37 54.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.282 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -103.01 119.43 38.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.156 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.458 HG12 HG12 ' A' ' 479' ' ' ILE . 90.2 mt -101.71 122.24 53.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.161 176.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -120.67 145.97 46.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.161 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.25 142.06 51.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.5 p -131.04 149.76 52.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.245 177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.447 ' CG1' ' HB2' ' A' ' 531' ' ' ASN . 13.8 p -125.45 149.29 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 168.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 22.6 t70 57.7 40.35 26.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 -171.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -58.85 -39.09 80.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.229 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -80.0 -2.95 46.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.201 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.2 t30 61.75 61.99 1.34 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.248 -178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 73.7 p -97.25 -30.32 13.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.24 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.4 HG23 ' SD ' ' A' ' 435' ' ' MET . 10.3 p -127.55 135.15 63.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.181 176.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 97.8 t -90.26 123.65 42.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.236 177.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 438' ' ' PRO . 12.8 pt-20 -119.85 170.09 9.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.211 -170.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 78.8 mt -75.24 -28.84 60.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.168 -178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . 0.463 ' HB3' ' OD1' ' A' ' 439' ' ' ASP . 54.9 t-20 -126.39 112.78 16.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.169 -168.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -105.49 2.12 28.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.217 179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -91.6 -30.5 16.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.18 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.584 ' HB3' ' OG1' ' A' ' 441' ' ' THR . 99.8 m-20 -97.28 -12.79 22.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.174 -175.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . 0.447 ' HB2' ' CG1' ' A' ' 517' ' ' VAL . 36.8 p-10 -83.04 9.11 10.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.22 -174.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 93.4 t -131.66 141.99 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.185 165.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.12 133.17 46.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 83.7 m -114.48 124.05 50.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -133.13 131.07 40.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.172 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -104.07 130.31 51.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.169 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 84.0 t -120.51 136.94 55.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.157 176.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.1 t -104.84 124.95 50.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.268 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 95.8 t -101.89 127.32 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.189 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 452' ' ' VAL . 34.7 m -120.85 160.31 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.206 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . 0.438 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 92.7 mt -80.96 -0.02 37.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--O 1.201 -1.494 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.218 -177.638 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 99.3 mmm . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.816 0.341 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -109.61 133.92 52.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.284 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -123.53 118.6 27.42 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.203 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -72.9 165.02 33.95 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 121.674 1.582 . . . . 0.0 111.224 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -129.45 99.27 5.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.228 170.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 78.5 mt -89.4 145.32 25.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.288 177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.5 t -149.33 156.77 42.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.17 176.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.8 m -130.63 153.53 39.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.175 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 47.7 mt-10 -138.2 137.89 38.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.213 177.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 83.4 mt -107.52 126.12 63.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.181 176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -136.96 148.93 47.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.184 177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.61 -166.85 33.45 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -55.22 136.62 74.19 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.693 1.595 . . . . 0.0 111.239 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -87.68 -40.1 14.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.223 175.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.55 130.11 74.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 175.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.78 153.83 39.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.195 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.59 157.87 34.9 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 178.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.8 p -70.5 141.67 16.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 0.0 111.213 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 63.57 29.75 15.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.245 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -124.18 142.42 51.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.163 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.412 HD11 ' HB3' ' A' ' 502' ' ' SER . 44.2 tp -82.36 126.24 31.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.308 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.27 144.28 49.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.248 177.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -101.16 134.31 44.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.163 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -128.39 157.19 41.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.242 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.428 ' HG2' HG22 ' A' ' 500' ' ' THR . 87.3 mt-10 -129.91 138.47 50.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.224 -175.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.6 t -109.46 119.9 59.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.119 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 95.9 m-70 -98.88 112.92 24.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.179 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.66 131.42 69.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.215 -174.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -123.04 152.68 40.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.265 -172.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 12.9 t-20 -106.71 129.89 54.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.169 152.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 75.8 mt -120.12 22.12 11.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.212 -176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.558 ' O ' ' N ' ' A' ' 468' ' ' ILE . . . -112.89 136.7 13.67 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -175.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . 0.51 ' C ' ' O ' ' A' ' 466' ' ' GLY . . . -9.12 -46.55 0.0 OUTLIER Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 155.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 466' ' ' GLY . 12.6 tt -123.16 142.29 40.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.744 0.306 . . . . 0.0 111.261 -163.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -89.06 162.5 31.14 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 111.204 -0.759 . . . . 0.0 111.204 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 84.4 t -124.5 119.06 26.07 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 111.199 178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.52 -19.22 7.74 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.69 1.593 . . . . 0.0 111.158 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 96.5 p -94.83 14.6 20.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.201 -166.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.1 m -76.46 110.85 11.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.217 -158.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.42 125.99 53.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.186 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 96.3 t -117.29 129.95 72.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.117 -176.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -125.36 152.58 44.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.168 -173.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 51.8 t -126.89 134.58 65.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.221 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -121.08 148.11 44.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.134 -178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.4 mt -120.33 115.56 47.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.183 171.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 54.35 41.25 32.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.203 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.36 -14.87 64.46 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 171.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.2 m -98.96 137.19 37.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.75 0.31 . . . . 0.0 111.254 -176.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.3 tp -68.38 119.36 12.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.173 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -100.06 -40.61 7.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.23 -175.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -153.85 160.59 42.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.126 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -142.98 149.75 38.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.293 173.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -137.64 142.13 41.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.204 173.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.1 m -109.45 123.55 49.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.24 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.41 168.08 18.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.252 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.9 m -116.31 141.48 48.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.166 171.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 83.5 mt -126.88 128.63 46.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.21 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -76.97 177.3 52.39 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 172.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . 0.412 ' HB3' ' O ' ' A' ' 467' ' ' GLY . 55.1 Cg_endo -65.75 117.55 4.73 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.739 1.626 . . . . 0.0 111.202 176.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 93.2 mttt 66.91 36.78 4.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.194 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -112.11 144.03 42.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.235 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -119.34 142.8 47.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.199 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -129.56 150.16 51.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 88.2 t -113.25 120.0 62.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.135 -177.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 42.8 mt -103.12 144.45 31.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.246 172.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 459' ' ' GLU . 41.0 p -122.55 154.7 37.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.183 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.71 156.66 38.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.183 168.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.412 ' HB3' HD11 ' A' ' 455' ' ' LEU . 69.4 m -120.44 136.97 54.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.17 -177.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 39.4 t90 -140.61 129.08 22.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.243 -167.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.4 m -119.55 111.9 35.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.207 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -75.23 152.89 40.24 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 121.663 1.575 . . . . 0.0 111.219 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 72.9 p -124.45 -12.44 7.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 176.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -123.03 141.21 52.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.202 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -86.88 142.14 28.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.171 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.54 178.28 27.03 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -170.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.3 mmm -84.8 128.25 34.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 111.204 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -117.61 133.95 55.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.155 175.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -107.7 118.63 37.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.127 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 80.7 mt -105.03 124.98 60.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.271 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -117.78 147.08 43.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.275 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.93 139.11 53.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.157 172.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 66.0 p -131.92 153.96 49.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.174 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.0 p -125.75 141.62 44.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.26 171.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 32.0 t0 54.86 49.03 18.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.143 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -57.38 -38.87 74.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 520' ' ' GLU . 19.7 pm0 -75.73 -8.72 57.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.174 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.4 t30 63.37 64.0 0.85 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.21 171.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 69.0 p -96.69 -19.43 18.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.157 174.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 98.5 t -117.23 132.86 65.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.163 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 86.0 t -90.13 122.58 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.146 174.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -105.38 169.28 8.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.186 -170.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 98.4 mt -73.4 -28.36 61.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.194 167.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -136.22 127.87 28.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.187 173.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -109.03 -14.35 14.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.224 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -95.84 -10.02 30.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.267 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -103.41 26.28 8.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.141 -174.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 50.5 p30 -129.26 25.17 5.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.23 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 97.7 t -127.54 141.61 45.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.26 131.9 51.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.281 -176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.6 m -117.49 127.27 53.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.256 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -130.46 131.61 45.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.172 -175.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -100.85 126.15 47.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.202 -173.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.77 136.38 57.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.212 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -108.56 124.68 50.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.205 172.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 91.7 t -104.29 129.4 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.248 174.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.5 m -123.81 172.79 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.237 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 87.9 mt -95.43 39.28 1.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.163 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 . . . . . 0 C--O 1.2 -1.539 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.181 -175.437 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 94.2 mtp . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.816 0.341 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -112.86 147.07 37.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.198 148.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -116.13 102.66 53.71 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.16 -158.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.529 ' HG3' HG21 ' A' ' 470' ' ' VAL . 64.6 Cg_endo -70.45 173.63 11.31 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.679 1.586 . . . . 0.0 111.208 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -123.47 75.1 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.212 170.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 48.9 mt -81.47 126.01 31.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 15.4 t -143.22 157.38 44.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.55 154.89 40.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.25 -175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 50.4 mt-10 -137.46 136.84 38.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 177.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 81.5 mt -102.53 134.63 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.207 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -135.49 143.15 45.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.118 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 144.0 -176.34 23.35 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.44 165.92 26.7 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 121.644 1.562 . . . . 0.0 111.162 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 58.5 p-10 -123.86 10.4 8.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.19 175.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.56 116.48 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.122 167.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.3 m -131.3 154.83 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.223 178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -89.64 160.44 28.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.3 p -72.91 135.42 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.744 0.307 . . . . 0.0 111.237 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 62.08 20.43 11.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.212 -174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -109.76 130.46 55.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.229 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 502' ' ' SER . 32.0 tp -76.23 128.6 35.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.193 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.63 142.07 51.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.21 173.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -111.2 139.0 46.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.195 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -130.86 159.08 38.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.17 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.424 ' HG2' HG22 ' A' ' 500' ' ' THR . 91.2 mt-10 -129.6 140.14 51.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -173.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 60.7 t -114.33 120.51 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.202 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 85.1 m-70 -99.32 115.8 30.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.237 176.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.74 131.84 70.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.205 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -128.33 156.3 43.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.158 -175.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 62.3 t-20 -118.7 116.18 26.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.219 159.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 57.4 mt -109.6 13.19 23.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.205 -170.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.57 -3.17 69.2 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -174.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.9 19.72 78.39 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.515 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 6.4 tt -130.77 148.0 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.731 0.301 . . . . 0.0 111.166 174.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -85.96 131.12 10.3 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.529 HG21 ' HG3' ' A' ' 438' ' ' PRO . 92.0 t -117.95 116.42 36.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.814 0.34 . . . . 0.0 111.234 170.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -82.68 -19.64 6.04 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.753 1.635 . . . . 0.0 111.161 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 78.5 p -98.56 0.13 44.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.134 -158.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 473' ' ' THR . 13.1 t -85.53 124.71 32.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.21 -162.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -111.68 128.65 56.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.227 -172.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.13 125.89 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.231 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -130.33 155.05 46.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.256 -170.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.85 133.23 66.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.262 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -119.91 147.5 44.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.275 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.1 mt -120.59 118.51 56.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.253 171.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 54.64 41.01 32.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.195 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.34 -20.09 45.98 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 171.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.3 m -98.31 139.44 34.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.821 0.343 . . . . 0.0 111.189 -176.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.6 tp -68.21 121.15 15.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.152 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . 0.411 ' OH ' ' O ' ' A' ' 502' ' ' SER . 29.9 t80 -96.48 -39.3 9.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.234 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -163.34 158.69 21.6 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.187 -173.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -140.19 149.97 43.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.183 -175.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.5 m-90 -138.68 141.91 38.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.156 170.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.8 m -104.79 127.42 52.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.168 168.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.0 m -138.1 166.34 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.09 -176.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 53.5 m -121.73 142.25 50.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.194 170.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.5 mt -128.85 131.19 47.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.112 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.92 -178.03 46.26 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.82 117.76 4.44 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.773 1.649 . . . . 0.0 111.21 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.1 mttt 55.56 39.79 31.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.216 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -100.47 145.23 28.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.139 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -120.85 140.72 51.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.186 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -127.58 145.7 50.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 173.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.4 t -112.92 119.58 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.4 mt -104.89 142.09 35.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.147 174.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.424 HG22 ' HG2' ' A' ' 459' ' ' GLU . 44.4 p -122.58 150.86 42.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.192 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.85 156.57 36.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 171.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.412 ' HB2' HD11 ' A' ' 455' ' ' LEU . 95.6 p -122.93 133.72 54.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.214 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -140.79 129.71 23.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.2 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.0 m -116.51 112.34 41.28 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.214 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -71.47 153.33 60.73 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.748 1.632 . . . . 0.0 111.176 172.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 65.0 p -122.81 -5.21 8.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.061 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -133.47 137.19 45.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.152 177.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -70.09 141.43 52.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.288 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.24 176.91 26.25 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.3 mmm -84.85 128.05 34.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 111.173 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -120.25 132.83 55.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.17 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -104.23 119.58 39.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.17 -177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 94.2 mt -103.68 124.46 57.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.187 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -119.67 146.17 45.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.17 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.09 143.74 50.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.205 172.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 77.4 p -130.73 150.04 52.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.202 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.716 ' O ' ' CB ' ' A' ' 518' ' ' ASP . 7.2 p -125.16 120.64 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.132 167.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . 0.716 ' CB ' ' O ' ' A' ' 517' ' ' VAL . 30.5 t70 105.59 25.24 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.264 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -58.39 -39.4 79.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.261 -158.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -79.04 2.08 21.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.085 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.4 t30 66.37 66.02 0.48 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.182 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 58.4 p -97.26 -34.1 11.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 -172.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 10.3 p -138.46 140.28 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.199 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 85.2 t -90.16 125.21 43.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.196 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.496 ' HG3' ' HG2' ' A' ' 438' ' ' PRO . 54.1 mp0 -103.95 176.47 5.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.269 -170.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 93.3 mt -71.07 -29.99 66.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.158 176.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -125.9 148.22 49.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.212 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -110.74 -5.77 14.92 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.265 174.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -93.64 -22.0 19.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.16 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -98.41 13.76 30.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.156 -175.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -82.66 -2.76 54.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 176.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 58.7 t -128.22 142.0 44.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.237 -171.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.03 134.72 47.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.185 173.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.9 m -116.74 126.47 53.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.262 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -134.27 123.28 23.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.187 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -102.46 128.11 49.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.163 -172.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 90.6 t -122.79 137.19 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.26 -173.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 71.4 m -98.95 124.9 44.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.136 177.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 86.4 t -102.85 129.37 54.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.199 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.6 m -124.96 165.84 21.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.152 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.0 -2.01 46.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.269 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 C--O 1.199 -1.562 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.241 -176.712 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 99.5 mtp . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.775 0.322 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -105.21 136.02 45.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.261 135.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . 0.454 ' HB3' ' HG ' ' A' ' 526' ' ' LEU . 9.6 m-30 -107.29 117.22 56.65 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.181 -160.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 525' ' ' GLU . 30.3 Cg_exo -57.08 168.91 2.26 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 C-N-CA 121.794 1.663 . . . . 0.0 111.141 171.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -129.98 71.97 1.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.208 166.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 85.2 mt -78.81 139.51 38.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.214 -173.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 12.3 t -146.15 157.7 43.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.208 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.8 m -132.5 155.69 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.187 -176.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.4 mt-10 -139.86 136.05 33.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.236 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 95.3 mt -108.82 126.52 65.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.154 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -136.71 148.5 47.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.272 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.69 -168.65 34.39 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.82 116.16 4.14 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.642 1.562 . . . . 0.0 111.241 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -75.47 -18.22 59.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.205 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 96.7 t -125.96 129.32 72.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.169 169.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.07 154.05 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.188 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.55 149.86 32.39 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.417 HG11 HD23 ' A' ' 541' ' ' LEU . 5.9 p -71.05 136.54 25.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.751 0.31 . . . . 0.0 111.187 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 61.85 27.36 16.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.216 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -123.59 148.21 46.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.231 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 502' ' ' SER . 29.4 tp -85.58 128.07 34.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -172.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.79 145.85 48.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.195 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -109.09 133.97 52.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.188 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 90.1 m-85 -127.91 157.2 41.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.142 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.417 ' HG2' HG22 ' A' ' 500' ' ' THR . 96.8 mt-10 -130.5 141.1 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.179 -177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 49.7 t -112.88 120.08 62.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.207 170.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.6 m-70 -101.8 111.3 23.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.15 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.444 HG11 HG21 ' A' ' 475' ' ' VAL . 8.9 m -116.05 132.05 66.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.281 -170.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -127.21 155.13 43.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.217 -177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 61.2 t-20 -116.75 120.84 39.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.206 159.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 63.0 mt -115.0 8.19 15.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.241 -168.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.03 -0.24 74.76 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.68 20.05 75.42 Favored Glycine 0 CA--C 1.522 0.47 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.525 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.0 tt -131.03 145.68 35.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.786 0.327 . . . . 0.0 111.185 173.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -84.85 134.54 12.73 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 72.4 t -120.81 116.49 31.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.252 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.66 -18.49 9.27 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.675 1.583 . . . . 0.0 111.14 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.4 p -92.01 10.65 28.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.225 -165.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 99.0 m -80.27 112.91 18.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.142 -162.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -110.48 127.52 55.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.213 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.444 HG21 HG11 ' A' ' 462' ' ' VAL . 93.8 t -115.83 127.1 73.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -127.09 155.2 43.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.169 -172.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 69.2 t -128.67 132.96 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.279 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -120.17 147.03 45.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.225 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.424 HG12 HG12 ' A' ' 513' ' ' ILE . 83.6 mt -118.72 117.05 53.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.246 172.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 54.08 41.02 32.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.242 -177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.23 -10.44 66.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 175.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.5 m -97.51 138.45 34.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 111.222 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.6 tp -69.8 120.81 16.12 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.187 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -98.93 -40.69 7.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.262 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -166.57 159.03 13.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.21 -173.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -140.95 151.82 44.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.212 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 25.9 m-90 -138.16 141.9 40.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.23 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.6 m -109.65 126.02 53.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.252 168.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.8 m -139.04 167.83 19.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.199 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 30.4 t -118.79 140.93 49.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 170.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 83.9 mt -128.99 126.01 38.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.163 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -81.78 -173.39 48.32 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.23 111.7 1.18 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 121.772 1.648 . . . . 0.0 111.241 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 97.0 mttt 58.65 41.45 22.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.144 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -101.32 143.96 30.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.221 173.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -121.08 139.95 52.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.158 -178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -128.45 147.85 50.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.248 175.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 96.9 t -112.2 118.95 59.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.169 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 48.3 mt -102.24 142.19 33.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.222 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.417 HG22 ' HG2' ' A' ' 459' ' ' GLU . 36.1 p -122.85 151.92 41.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.248 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 55.1 p90 -154.41 156.38 36.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.167 166.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.469 ' HB3' HD11 ' A' ' 455' ' ' LEU . 69.9 m -119.73 128.63 53.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.191 -177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.9 t90 -125.74 129.27 49.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.153 -171.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 96.2 m -117.8 108.76 42.3 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.211 172.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.85 157.65 54.61 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.741 1.627 . . . . 0.0 111.25 174.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 75.5 p -124.9 -21.95 4.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.206 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -118.97 138.77 52.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.423 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 34.7 tt0 -73.74 139.71 45.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.139 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.5 174.76 24.11 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -175.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.5 mmm -85.59 128.46 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.844 0.354 . . . . 0.0 111.142 177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -120.77 130.31 53.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.142 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -103.27 119.81 39.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.19 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.424 HG12 HG12 ' A' ' 479' ' ' ILE . 80.8 mt -102.11 120.22 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.271 176.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -122.35 146.41 47.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.226 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.15 140.25 53.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.9 p -131.79 152.78 50.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.249 177.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.66 146.47 31.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 172.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 24.8 t70 59.06 39.89 22.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.176 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -58.16 -39.88 79.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.222 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -79.36 -2.71 42.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.197 -175.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.4 t30 61.14 60.72 1.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.199 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 72.2 p -89.75 -29.77 18.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.254 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.8 p -132.54 136.76 55.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.221 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . 0.444 ' O ' ' CD1' ' A' ' 437' ' ' PHE . 95.2 t -90.07 125.19 42.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.191 176.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 438' ' ' PRO . 22.8 pt-20 -130.65 171.03 13.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 -166.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.454 ' HG ' ' HB3' ' A' ' 437' ' ' PHE . 54.7 mt -73.87 -27.73 61.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.192 174.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -110.08 67.23 0.64 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.168 -171.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -97.39 -8.52 29.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.209 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -104.4 -29.93 10.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.211 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -105.15 34.95 2.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.2 -174.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -124.61 23.14 8.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.247 -172.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 93.3 t -129.46 144.93 36.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 175.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.58 133.56 49.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.195 -175.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.1 m -115.43 124.2 50.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.266 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -128.31 128.51 44.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.181 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -101.1 126.94 47.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.243 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.5 t -121.43 136.18 59.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.129 177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.8 t -101.41 127.5 48.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 175.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.9 t -99.78 126.69 53.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.205 173.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.3 m -121.42 150.72 24.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.183 -173.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . 0.423 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 86.0 mt -78.97 51.95 1.2 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.193 177.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 . . . . . 0 C--O 1.199 -1.586 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.182 -177.313 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 97.1 mmm . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.795 0.331 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -115.44 131.11 57.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.17 -173.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . 0.405 ' N ' HD13 ' A' ' 468' ' ' ILE . 39.1 m-85 -126.48 104.53 24.6 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.181 172.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.44 168.52 17.78 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 121.604 1.536 . . . . 0.0 111.21 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -129.7 81.06 1.99 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.182 173.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 8.9 mt -89.42 130.66 35.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.148 -175.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.0 t -146.16 163.1 36.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.228 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.2 m -132.09 154.58 40.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 93.9 mt-10 -135.63 137.94 42.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.208 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 89.3 mt -104.35 132.0 51.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.67 142.98 45.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.222 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.14 -176.45 32.79 Favored Glycine 0 CA--C 1.522 0.523 0 N-CA-C 111.215 -0.754 . . . . 0.0 111.215 178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -69.19 141.26 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.743 1.629 . . . . 0.0 111.232 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -97.26 -18.81 18.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.228 -178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 87.9 t -126.12 125.94 68.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.259 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 29.3 m -129.57 154.27 39.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.195 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.27 158.1 43.49 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 1.8 p -79.15 142.57 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.799 0.333 . . . . 0.0 111.232 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 63.0 m-20 63.11 29.41 16.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.22 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -125.93 145.11 50.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.191 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 502' ' ' SER . 33.0 tp -78.53 126.79 31.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.159 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.08 143.42 49.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -109.88 135.53 50.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.298 -177.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -129.66 157.87 40.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.216 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.432 ' HG2' HG22 ' A' ' 500' ' ' THR . 80.2 mt-10 -130.09 139.57 50.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.268 -175.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 45.0 t -113.22 120.24 62.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.175 171.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.428 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 94.2 m-70 -99.59 114.29 27.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.237 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 462' ' ' VAL . 2.9 m -117.21 127.0 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.153 -173.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.441 ' HD2' HD21 ' A' ' 465' ' ' LEU . 25.1 pttt -138.18 151.94 48.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.17 -171.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 52.9 t-20 -111.2 127.59 55.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.276 167.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.441 HD21 ' HD2' ' A' ' 463' ' ' LYS . 68.9 mt -115.61 7.5 14.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.28 -169.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -93.98 -5.2 62.72 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -169.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.02 23.15 76.89 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -171.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.508 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 1.3 mt -130.04 155.18 41.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.867 0.365 . . . . 0.0 111.168 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.487 ' N ' ' CG2' ' A' ' 468' ' ' ILE . . . -117.08 120.47 4.82 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -172.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 491' ' ' LEU . 74.9 t -119.63 118.22 32.24 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.829 0.347 . . . . 0.0 111.185 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -84.29 -17.62 5.4 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 121.714 1.609 . . . . 0.0 111.152 -176.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 79.3 p -99.0 4.17 47.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.215 -163.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 473' ' ' THR . 3.5 t -83.67 125.34 31.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.176 -163.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.58 130.35 55.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.255 -170.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 76.6 t -113.11 128.29 69.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.269 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -127.51 154.26 45.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.2 -173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 78.0 t -127.7 132.89 68.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.201 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -120.31 147.05 45.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.174 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.3 mt -120.85 116.22 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.194 172.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 54.38 40.97 32.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.269 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 93.49 -18.79 55.68 Favored Glycine 0 CA--C 1.522 0.497 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 171.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.4 m -100.08 138.11 37.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.84 0.353 . . . . 0.0 111.149 -175.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.33 121.53 15.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.248 -178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -93.31 -39.93 10.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.287 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -168.91 159.52 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.233 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -132.08 152.34 51.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.189 -175.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 32.8 m-90 -136.3 141.44 43.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.167 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.7 m -109.95 124.72 51.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.122 166.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 25.9 m -138.74 167.54 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.212 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 78.6 p -114.44 141.08 48.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.24 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 470' ' ' VAL . 82.4 mt -129.82 129.76 44.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.201 174.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -93.76 -173.43 39.56 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.99 111.36 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.656 1.571 . . . . 0.0 111.203 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.4 mttt 63.62 43.64 5.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.191 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -104.52 142.96 33.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 173.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -121.36 139.51 53.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.223 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -128.79 147.25 50.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.199 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 83.2 t -111.62 119.13 59.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.189 -176.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 66.6 mt -104.85 143.93 32.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.179 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.432 HG22 ' HG2' ' A' ' 459' ' ' GLU . 61.0 p -124.77 153.65 42.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.143 175.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -154.3 157.0 37.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.208 170.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.443 ' HB3' HD11 ' A' ' 455' ' ' LEU . 60.9 m -122.27 134.77 54.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.199 -175.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 42.3 t90 -140.33 129.49 23.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.215 -168.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.0 m -118.88 112.42 36.61 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.182 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.74 151.55 41.02 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 121.769 1.646 . . . . 0.0 111.286 172.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 70.1 p -122.02 -15.13 7.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.177 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -120.59 139.46 52.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.233 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -75.79 140.16 42.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.211 177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.67 177.13 26.84 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.7 mmm -86.36 129.42 34.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.781 0.324 . . . . 0.0 111.222 176.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.84 132.62 55.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.263 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -104.74 118.19 35.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.126 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 89.1 mt -105.91 122.95 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.178 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -122.41 150.23 42.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.146 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.74 141.05 52.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.259 173.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 59.5 p -130.82 155.08 47.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.23 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 8.2 p -132.16 144.43 37.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.16 172.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.83 16.55 6.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.241 166.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -61.15 -45.22 95.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.235 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -97.95 -23.82 15.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.178 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -77.82 68.9 3.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 80.9 p -74.88 69.21 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.218 -163.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 4.3 p -100.99 140.74 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.147 167.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 95.2 t -82.84 125.51 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.248 -162.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -100.31 173.95 6.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.184 -172.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 92.7 mt -71.98 -28.55 63.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.142 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -155.78 114.63 3.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.195 175.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -104.67 5.74 33.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.152 -170.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -93.88 -25.24 17.41 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.118 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -103.45 34.42 2.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.188 -173.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -120.18 24.54 10.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.219 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.42 141.65 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.147 171.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -124.38 131.71 53.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.176 -176.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.5 m -116.98 126.55 53.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.195 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -131.95 130.28 41.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.258 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -101.32 129.27 47.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.239 -174.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 93.6 t -121.14 136.4 58.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.207 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 40.2 t -104.96 124.75 50.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.185 173.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.6 t -101.7 127.04 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.173 174.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 31.8 m -124.71 165.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.249 -176.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 69.4 mt -90.42 10.72 24.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.24 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 . . . . . 0 C--O 1.199 -1.581 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.227 -177.342 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . 0.682 ' CB ' ' CA ' ' A' ' 436' ' ' GLU . 42.4 mmm . . . . . 0 CA--C 1.523 -0.08 0 CA-C-O 120.861 0.362 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . 0.682 ' CA ' ' CB ' ' A' ' 435' ' ' MET . 12.4 pt-20 -115.09 176.35 5.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.082 31.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -98.55 108.47 48.23 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.183 -147.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.491 ' HG3' HG21 ' A' ' 470' ' ' VAL . 84.7 Cg_endo -72.35 172.06 15.71 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.772 1.648 . . . . 0.0 111.263 174.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . 0.456 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 62.0 t0 -122.49 73.91 1.15 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.278 167.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.48 137.09 36.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -173.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' A' ' 530' ' ' ASN . 8.2 t -144.19 154.33 43.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.185 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.3 m -128.46 153.65 38.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.153 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.4 mt-10 -141.01 137.82 33.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 95.2 mt -107.66 127.25 63.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.207 174.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -136.13 145.2 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.117 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 165.5 -166.5 38.47 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.206 -0.757 . . . . 0.0 111.206 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.1 143.36 64.96 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.694 1.596 . . . . 0.0 111.249 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -90.35 -39.17 12.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.193 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 70.2 t -121.15 130.15 74.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.253 175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.63 153.31 38.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.205 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -82.78 157.27 35.62 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.5 138.07 22.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.833 0.349 . . . . 0.0 111.215 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 62.63 25.19 14.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.258 178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -114.78 150.97 34.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.197 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 42.5 tp -87.41 127.21 35.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 -175.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.32 144.57 48.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.232 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -110.08 138.15 46.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.189 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.03 156.65 44.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.241 178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -129.49 139.36 51.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.15 120.81 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.235 173.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 95.4 m-70 -102.42 107.72 18.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.184 -176.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.3 m -118.48 129.95 74.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.166 -173.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.407 ' HD3' HD21 ' A' ' 465' ' ' LEU . 19.1 ptpt -143.72 154.72 43.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.192 -171.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 39.7 t-20 -108.26 143.67 36.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.223 170.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 43.6 mt -133.01 3.37 3.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.204 -172.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -96.97 4.63 63.1 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.289 -0.724 . . . . 0.0 111.289 -170.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.07 17.57 75.76 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 174.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.55 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 2.2 tt -125.87 149.72 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.733 0.301 . . . . 0.0 111.181 167.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -95.91 131.76 10.79 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 177.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.491 HG21 ' HG3' ' A' ' 438' ' ' PRO . 99.5 t -119.33 119.63 31.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 111.218 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -82.17 -19.2 6.94 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 121.632 1.555 . . . . 0.0 111.189 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 91.2 p -94.12 16.51 14.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.185 -164.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 94.7 m -82.36 111.71 18.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.262 -165.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -111.57 127.24 55.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 85.3 t -118.14 128.8 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.159 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -125.05 154.69 40.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.2 -173.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 60.8 t -128.71 134.37 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.23 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -122.04 149.17 43.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.211 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 81.6 mt -120.54 115.69 47.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.198 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 54.26 41.44 31.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.236 -178.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.94 -8.66 79.2 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.0 m -97.97 135.92 38.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.788 0.328 . . . . 0.0 111.298 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 68.2 tp -68.76 118.79 12.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -99.78 -40.42 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.262 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -166.99 158.85 12.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -140.5 151.97 45.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.21 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -137.36 142.23 41.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.168 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.9 m -109.5 124.38 50.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.223 166.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.93 168.09 19.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.125 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.1 m -118.79 142.0 48.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.182 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.31 131.08 48.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.194 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.39 -175.48 48.72 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 174.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.46 113.32 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.7 1.6 . . . . 0.0 111.159 176.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.7 mttt 65.9 35.32 6.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.173 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -102.97 143.63 32.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.237 176.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -121.9 141.08 51.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.189 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -128.18 146.76 50.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.28 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 95.0 t -111.69 119.58 60.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.225 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 41.3 mt -101.82 143.35 31.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.136 173.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 59.5 p -122.21 151.85 40.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.184 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.72 156.21 35.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.218 167.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.2 m -123.01 133.98 54.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.179 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 45.5 t90 -140.21 130.0 24.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.195 -167.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 95.2 m -118.17 111.78 38.4 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.296 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.12 155.53 56.65 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 121.596 1.53 . . . . 0.0 111.247 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 76.9 p -125.25 -13.02 6.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.271 178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.39 137.57 49.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.17 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.97 142.17 52.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.152 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.42 175.59 24.96 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.2 mmm -85.62 126.86 34.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.721 0.296 . . . . 0.0 111.259 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -119.79 126.94 52.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.206 173.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -103.31 119.24 38.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.252 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.41 124.12 56.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.218 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -116.86 145.14 43.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.151 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.24 139.55 53.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.254 173.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 76.8 p -131.05 151.51 51.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.235 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.5 p -126.47 144.6 36.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 169.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 30.1 t70 65.12 41.3 4.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.236 173.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -59.17 -39.85 83.8 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 174.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -81.01 -3.82 53.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.173 -173.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 60.5 t30 63.1 59.74 1.28 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.264 -177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 77.3 p -90.13 -30.26 17.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.211 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.465 HG23 ' HE2' ' A' ' 435' ' ' MET . 8.1 p -137.76 133.13 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.191 174.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 91.8 t -91.12 118.17 35.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.247 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -106.5 167.09 10.08 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.181 -171.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 85.5 mt -75.02 -28.57 60.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -119.04 120.81 38.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 -169.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -107.43 2.36 24.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.238 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -90.1 -28.23 19.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.286 -175.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.537 ' HB3' ' OG1' ' A' ' 441' ' ' THR . 92.6 m-20 -100.16 5.92 44.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.209 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -63.08 -26.34 68.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.216 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.22 143.28 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.178 -174.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.79 132.37 51.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.174 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 88.0 m -116.32 125.63 52.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.169 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -131.14 130.39 43.02 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.265 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -102.34 129.98 48.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.23 -173.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 92.3 t -120.52 136.54 57.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.168 177.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.8 t -105.84 124.82 50.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.172 173.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.9 t -102.85 129.22 54.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.196 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.3 m -124.92 164.45 23.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.14 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.9 mt -89.44 11.2 19.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.248 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 . . . . . 0 C--O 1.199 -1.567 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.222 -176.222 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 28.7 ttt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.761 0.315 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . 0.404 ' HB2' HD12 ' A' ' 468' ' ' ILE . 74.6 mm-40 -104.85 172.64 6.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.154 157.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -113.02 106.67 54.9 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.164 -170.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.49 164.15 9.55 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 121.665 1.577 . . . . 0.0 111.254 176.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -130.28 58.37 1.67 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.285 166.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 86.5 mt -66.08 134.67 53.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 -175.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 531' ' ' ASN . 10.0 t -142.08 153.3 44.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.207 177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.9 m -131.63 154.07 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.237 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.1 mt-10 -139.2 137.08 35.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.174 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 91.3 mt -107.16 127.4 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.244 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.93 148.76 48.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.205 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 152.5 -163.57 30.36 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.96 144.45 94.29 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.755 1.637 . . . . 0.0 111.196 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -98.55 -37.01 9.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.183 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 84.9 t -122.15 130.74 74.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.228 172.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.81 151.1 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.108 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -77.09 155.86 44.81 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.93 135.76 27.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.788 0.328 . . . . 0.0 111.21 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 63.02 26.57 15.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.166 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -114.0 154.92 26.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.147 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 40.2 tp -94.4 128.09 40.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.261 -174.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.29 143.45 50.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.172 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -105.64 136.5 45.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.25 174.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -130.33 156.57 44.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.183 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 500' ' ' THR . 92.9 mt-10 -130.19 140.99 50.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 -177.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 53.1 t -113.14 121.39 65.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.239 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 87.5 m-70 -96.57 111.47 23.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.241 177.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.504 HG11 HG21 ' A' ' 475' ' ' VAL . 2.6 m -119.91 129.18 75.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.272 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -145.35 155.29 43.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.185 -173.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 36.7 t-20 -106.61 142.22 36.61 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.225 171.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 65.0 mt -134.08 5.06 3.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.231 -172.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -89.14 2.45 83.72 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -175.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.22 16.3 77.0 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.54 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 6.4 tt -126.45 146.06 32.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.25 171.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -87.11 132.56 11.24 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 173.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 80.7 t -116.17 115.5 40.44 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.841 0.353 . . . . 0.0 111.263 171.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -81.02 -18.25 8.94 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 121.591 1.528 . . . . 0.0 111.162 -176.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.9 p -93.33 11.52 27.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.212 -166.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 86.9 m -75.76 114.38 14.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.161 -158.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -109.71 128.18 55.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.206 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.504 HG21 HG11 ' A' ' 462' ' ' VAL . 63.4 t -116.76 128.75 74.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.231 -178.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -125.43 154.25 42.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.21 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 76.6 t -128.41 134.01 65.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.238 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.58 147.41 45.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.197 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.7 mt -120.7 116.81 51.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.204 171.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 54.41 41.48 31.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.24 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 90.73 -14.27 63.51 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.3 m -97.28 137.43 36.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.773 0.32 . . . . 0.0 111.26 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 67.5 tp -69.52 120.69 15.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.154 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 26.1 t80 -97.61 -40.19 8.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.258 -177.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 50.9 tptt -165.7 158.79 15.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -140.05 152.34 46.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.23 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -138.49 142.87 39.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.178 172.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.8 m -107.27 125.71 51.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 168.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.3 m -139.65 168.06 18.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.144 -177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 62.7 m -119.58 141.77 48.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.209 171.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 87.9 mt -129.39 130.19 45.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.202 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.03 -172.86 47.45 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 173.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.16 112.65 1.76 Allowed 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 121.655 1.57 . . . . 0.0 111.212 176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.5 mttt 65.7 35.34 6.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -101.91 142.55 33.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.256 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -120.74 141.47 50.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.133 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -127.35 146.27 50.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.264 174.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.7 t -111.55 119.5 59.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.146 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 55.0 mt -102.54 143.02 32.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.447 HG22 ' HG2' ' A' ' 459' ' ' GLU . 41.6 p -120.84 151.5 39.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.225 177.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -154.44 156.65 37.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 167.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 67.3 m -122.05 132.5 54.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.139 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 46.6 t90 -138.39 129.04 26.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.164 -168.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 88.3 m -116.48 110.29 42.94 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.192 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.99 144.6 58.68 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.638 1.559 . . . . 0.0 111.151 171.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 76.2 p -117.36 -14.89 10.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.24 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -118.97 137.31 53.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.129 173.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 22.0 pm0 -77.04 145.47 37.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.137 177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 147.18 178.16 22.26 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -85.33 129.6 34.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.749 0.309 . . . . 0.0 111.257 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -119.43 133.38 55.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.165 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -106.05 119.16 38.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.257 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 83.1 mt -104.28 124.1 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.252 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -117.62 145.93 44.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.225 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.55 138.8 53.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.3 p -131.6 151.03 51.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.22 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.0 p -127.73 147.52 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.2 172.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 8.7 t70 69.04 25.38 5.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.205 171.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -61.67 -45.01 95.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.204 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -94.02 -18.79 21.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.261 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . 0.714 ' O ' ' N ' ' A' ' 523' ' ' VAL . 70.5 m-80 -82.97 13.44 3.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.26 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . 0.644 ' C ' ' O ' ' A' ' 521' ' ' ASN . 30.9 p -11.66 75.15 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.288 -179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.714 ' N ' ' O ' ' A' ' 521' ' ' ASN . 14.0 p -107.94 143.45 18.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.199 169.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 86.4 t -81.78 125.0 39.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.224 -173.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -114.06 177.17 4.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.329 -168.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.33 -26.85 62.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.202 171.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -159.27 111.17 2.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.274 174.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 53.1 mp0 -94.05 -1.44 54.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.218 -175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -86.29 -15.45 40.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.279 -176.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -101.81 1.71 37.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.182 -175.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 441' ' ' THR . 44.1 p-10 -92.6 17.25 10.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.2 -177.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 79.8 t -128.99 142.31 44.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.227 171.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.76 132.01 49.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.189 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.0 m -116.68 125.83 52.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.175 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -130.86 131.35 44.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.321 -174.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -101.06 125.88 47.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -173.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 85.4 t -120.15 135.62 59.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.16 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -106.94 125.56 51.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.221 171.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 95.5 t -100.77 126.17 54.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.156 174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.5 m -123.83 170.41 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.158 -174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 97.0 mt -87.96 14.03 9.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.204 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 C--O 1.2 -1.509 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.194 -176.958 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 98.5 mmm . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.876 0.369 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . 0.438 ' HB3' HD12 ' A' ' 468' ' ' ILE . 88.0 tt0 -88.67 149.81 23.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.175 156.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -109.91 112.25 58.12 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.228 -157.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.469 ' HG3' HG21 ' A' ' 470' ' ' VAL . 72.8 Cg_endo -74.09 169.74 21.73 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.649 1.566 . . . . 0.0 111.231 175.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 465' ' ' LEU . 56.7 t0 -116.56 62.1 0.72 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 169.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.84 137.13 57.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.222 -175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.484 ' HB ' ' HB3' ' A' ' 530' ' ' ASN . 13.1 t -146.66 156.97 43.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.204 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.09 155.21 39.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.175 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 47.5 mt-10 -138.75 135.71 34.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.126 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . 0.43 HD13 HG22 ' A' ' 513' ' ' ILE . 89.6 mt -107.57 125.52 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.156 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -136.86 147.19 46.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.2 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 158.73 -165.75 34.17 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -56.96 136.67 78.04 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.712 1.608 . . . . 0.0 111.178 -177.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -86.39 -38.63 17.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.188 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.405 HG22 ' HB3' ' A' ' 538' ' ' SER . 92.2 t -124.84 133.91 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.221 174.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.8 m -130.45 152.65 37.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -82.4 160.42 39.91 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 540' ' ' VAL . 4.9 p -76.45 139.25 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.77 0.319 . . . . 0.0 111.144 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 62.57 27.3 16.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.273 -177.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -123.95 142.39 51.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.163 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.515 HD11 ' HB3' ' A' ' 502' ' ' SER . 36.7 tp -85.76 127.29 34.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.237 -174.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.58 144.17 49.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.221 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -110.1 135.14 51.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.156 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -129.09 157.64 41.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.501 ' HG2' HG22 ' A' ' 500' ' ' THR . 81.7 mt-10 -130.45 139.23 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.223 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . 0.463 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 59.4 t -112.09 120.63 62.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.135 172.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 88.3 m-70 -97.86 118.38 34.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.141 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.505 HG11 HG21 ' A' ' 475' ' ' VAL . 11.8 m -117.97 131.86 69.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -127.04 155.22 43.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.229 -175.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.579 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 54.8 t-20 -117.06 131.26 56.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.245 157.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 439' ' ' ASP . 50.8 mt -127.25 4.7 6.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.171 -167.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -91.8 3.73 78.14 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 -175.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.8 20.24 75.78 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.579 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.1 tt -131.81 144.34 37.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.754 0.312 . . . . 0.0 111.231 175.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -85.8 133.18 11.6 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.469 HG21 ' HG3' ' A' ' 438' ' ' PRO . 85.9 t -119.61 118.11 32.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.778 0.323 . . . . 0.0 111.209 170.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -81.2 -19.08 8.24 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 C-N-CA 121.679 1.586 . . . . 0.0 111.133 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 91.5 p -93.07 10.14 32.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.177 -163.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.6 m -78.28 111.58 14.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.269 -161.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -110.4 127.28 55.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.167 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.505 HG21 HG11 ' A' ' 462' ' ' VAL . 88.8 t -115.78 128.75 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.236 -178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -123.6 151.7 42.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -174.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 87.8 t -130.12 134.77 62.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.205 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -118.41 145.77 44.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 178.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 88.3 mt -119.74 117.93 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.202 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 50.7 t30 54.41 41.79 31.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.215 173.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 96.66 -22.91 37.7 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 172.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.1 m -100.27 139.43 35.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.889 0.376 . . . . 0.0 111.174 -175.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 67.1 tp -68.77 121.64 16.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.231 175.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -98.18 -41.02 8.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.217 -173.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -167.45 162.53 14.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.217 -172.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -141.81 153.44 44.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.26 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -137.49 142.08 41.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.234 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 97.1 m -108.14 127.58 53.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.248 169.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.8 m -138.97 167.6 20.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.205 -176.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 49.8 m -121.15 142.22 50.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.215 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 82.4 mt -130.47 128.1 40.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.245 -177.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.37 -170.85 46.87 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.57 112.55 1.64 Allowed 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 121.702 1.601 . . . . 0.0 111.205 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.3 mttt 62.08 35.67 15.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.268 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -99.55 144.32 28.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.138 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -120.52 141.69 50.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -126.54 146.76 50.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.188 173.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.7 t -112.44 119.34 60.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.082 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.463 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 43.7 mt -103.17 141.1 36.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.2 174.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.501 HG22 ' HG2' ' A' ' 459' ' ' GLU . 60.7 p -124.76 152.07 44.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.207 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -154.62 157.12 37.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.285 170.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.515 ' HB3' HD11 ' A' ' 455' ' ' LEU . 71.5 m -119.43 131.42 55.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.208 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 42.2 t90 -140.71 129.72 23.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.15 -169.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 88.9 m -115.94 109.28 45.21 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.279 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.84 118.86 5.61 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 121.743 1.629 . . . . 0.0 111.104 171.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 68.2 p -99.02 1.1 45.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.208 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.25 137.03 49.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.098 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.462 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 37.7 tt0 -73.79 138.49 44.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.184 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.34 174.48 23.69 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.1 mmm -85.22 129.24 34.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.806 0.336 . . . . 0.0 111.185 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -119.48 128.48 54.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.173 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -106.04 119.38 39.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.43 HG22 HD13 ' A' ' 444' ' ' ILE . 79.7 mt -102.96 122.25 55.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.1 -176.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -119.97 144.74 47.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.166 -176.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -125.91 140.16 52.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.4 p -131.63 151.17 51.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 10.9 p -118.64 143.72 28.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.218 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 23.9 t0 46.59 56.49 6.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.206 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -58.17 -38.01 75.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.246 172.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 49.6 mm-40 -73.77 -8.36 55.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.256 -174.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.7 t30 58.7 58.32 3.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.175 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 70.7 p -93.07 -21.85 19.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.208 176.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 12.7 p -135.38 133.82 52.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 99.3 t -93.26 127.29 45.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.204 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.424 ' HG3' ' HG2' ' A' ' 438' ' ' PRO . 40.6 mp0 -100.3 164.13 12.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.297 -176.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 93.3 mt -74.48 -29.69 61.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.209 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -111.85 156.18 22.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.238 178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -117.69 -10.31 10.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.239 177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -90.97 -8.82 48.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.189 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.484 ' HB3' ' HB ' ' A' ' 441' ' ' THR . 95.6 m-20 -96.73 -6.03 37.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 -177.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -76.48 -19.84 57.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.167 -173.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 63.5 t -128.09 141.07 47.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.158 -174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.88 133.43 45.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.179 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 96.9 m -115.98 126.31 53.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.211 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -131.25 130.13 42.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.151 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -100.32 129.14 46.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.181 -172.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.6 t -121.22 135.56 61.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.207 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . 0.405 ' HB3' HG22 ' A' ' 449' ' ' VAL . 36.3 t -104.82 126.0 51.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.189 174.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 93.5 t -102.37 127.76 55.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.177 176.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 452' ' ' VAL . 35.7 m -122.23 159.23 25.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.131 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . 0.549 ' O ' ' HB3' ' A' ' 542' ' ' GLU . 83.6 mt -81.23 57.74 3.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.109 176.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 541' ' ' LEU . 24.9 pt-20 . . . . . 0 C--O 1.2 -1.511 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.256 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 95.9 mtp . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.838 0.351 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -113.67 132.56 55.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.185 -166.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . 0.485 ' HB2' ' HG ' ' A' ' 526' ' ' LEU . 34.4 m-85 -130.06 132.88 24.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 175.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -69.97 166.45 27.8 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.685 1.59 . . . . 0.0 111.188 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -138.26 89.68 2.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.6 133.21 37.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.165 -169.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.47 ' OG1' ' HB3' ' A' ' 530' ' ' ASN . 10.0 t -146.36 155.31 42.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.207 -179.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.477 HG13 ' HB ' ' A' ' 517' ' ' VAL . 28.6 m -129.31 153.75 39.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.177 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -135.59 133.69 38.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.251 176.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 77.6 mt -104.48 124.99 59.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.208 178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -135.98 146.55 47.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.182 -179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.55 -167.44 33.04 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -56.16 133.89 60.8 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.636 1.558 . . . . 0.0 111.181 -178.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -82.66 -40.42 20.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.16 172.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 64.1 t -122.94 130.88 74.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.171 175.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.6 m -129.04 154.43 40.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.191 179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.05 152.35 36.41 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 5.5 p -68.68 137.25 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.797 0.332 . . . . 0.0 111.222 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 64.15 30.78 13.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.213 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -125.02 143.42 50.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.218 178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 44.0 tp -81.18 127.2 32.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.259 -175.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.9 144.88 48.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.151 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -103.97 136.43 43.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.18 176.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -130.04 156.66 44.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.195 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.405 ' HG2' HG22 ' A' ' 500' ' ' THR . 91.3 mt-10 -130.65 140.4 50.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.223 -175.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.8 t -112.69 121.26 64.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.175 172.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -100.46 117.52 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.175 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.52 131.38 71.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.156 -174.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -125.5 154.93 41.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.204 -175.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 61.8 t-20 -117.85 121.7 41.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.222 157.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 61.4 mt -113.75 14.71 18.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.191 -170.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -98.42 -4.83 57.18 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 -174.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.9 23.07 78.34 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.49 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.3 tt -134.54 146.92 30.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.784 0.326 . . . . 0.0 111.188 172.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -82.55 135.44 14.09 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 86.0 t -121.88 119.96 28.72 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.741 0.305 . . . . 0.0 111.225 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -84.24 -17.46 5.53 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 121.668 1.579 . . . . 0.0 111.199 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 84.4 p -91.75 7.98 39.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.192 -162.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 88.4 m -81.23 108.29 14.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.226 -162.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -110.58 124.4 51.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 176.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 98.8 t -111.19 126.98 68.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 -173.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -125.53 151.92 45.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.232 -172.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 73.5 t -126.88 132.8 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.213 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -120.1 147.41 44.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.201 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.87 115.07 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.233 171.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 54.49 40.91 32.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.185 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 95.01 -17.63 58.93 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 171.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.7 m -99.5 135.97 40.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.832 0.349 . . . . 0.0 111.146 -175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 62.9 tp -67.99 120.54 14.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.195 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -96.41 -40.35 9.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.238 -175.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -167.05 158.28 12.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -137.41 152.03 49.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.187 -173.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.9 m-90 -136.73 142.68 43.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.194 174.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.5 m -108.91 124.8 51.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.253 168.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.5 m -139.12 166.81 21.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.152 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 86.8 p -118.02 144.56 45.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 169.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.9 mt -126.72 130.93 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.191 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -92.43 -177.34 41.59 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 174.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.21 121.04 9.2 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.68 1.586 . . . . 0.0 111.222 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.8 mttt 55.03 41.9 31.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.215 175.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -106.91 143.62 34.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.217 178.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -117.71 140.42 49.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.228 175.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -126.95 145.85 50.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 174.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 79.3 t -111.74 119.47 60.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.178 -175.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 45.4 mt -103.45 143.11 33.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.196 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.405 HG22 ' HG2' ' A' ' 459' ' ' GLU . 52.9 p -122.82 153.23 39.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 177.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -154.25 156.14 36.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.198 166.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 57.6 m -122.18 133.63 54.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.223 -177.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 47.7 t90 -139.86 129.68 24.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 -165.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.5 m -117.8 114.21 37.66 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.221 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -71.32 154.85 61.12 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 121.706 1.604 . . . . 0.0 111.203 172.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 74.1 p -124.64 -14.53 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.182 175.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -122.91 136.51 54.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.254 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 21.7 pm0 -76.51 145.76 38.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.158 179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 146.58 179.57 22.81 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -173.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.04 129.96 34.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.741 0.305 . . . . 0.0 111.189 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.45 133.49 55.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.226 174.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -105.21 119.36 38.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.186 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 94.5 mt -103.86 124.88 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -118.73 145.76 45.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.154 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.23 143.28 51.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.215 173.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 68.1 p -130.89 151.26 51.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.194 176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.477 ' HB ' HG13 ' A' ' 442' ' ' VAL . 12.4 p -116.81 143.8 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.224 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.6 t0 37.98 60.99 1.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.196 -167.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -56.75 -37.51 71.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.214 -170.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -74.56 -5.29 42.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.204 -173.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 60.1 t30 63.1 60.17 1.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.223 173.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 73.0 p -112.7 12.35 19.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.226 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 12.4 p -134.66 137.11 51.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 84.7 t -91.54 116.27 32.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.208 169.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -126.75 172.22 10.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.209 -174.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . 0.485 ' HG ' ' HB2' ' A' ' 437' ' ' PHE . 69.1 mt -76.12 -26.4 56.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 177.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 54.1 t-20 -111.12 124.08 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.151 -162.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -117.91 -4.67 11.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.235 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -93.54 -35.18 13.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.227 -171.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.47 ' HB3' ' OG1' ' A' ' 441' ' ' THR . 96.5 m-20 -98.79 7.78 45.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.124 -171.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -65.77 -22.67 66.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.204 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 55.9 t -123.56 139.76 49.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.219 -176.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -127.35 133.02 50.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.9 m -116.67 127.15 54.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.24 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -132.55 129.86 39.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.196 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -100.1 128.5 46.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.206 -172.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 96.6 t -121.26 136.22 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.207 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 40.2 t -105.52 124.43 49.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.195 174.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 70.2 t -101.16 125.45 55.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.213 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.4 m -124.96 161.4 28.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.197 -172.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.68 56.84 4.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.175 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 . . . . . 0 C--O 1.2 -1.518 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.225 -179.093 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 98.7 mmm . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.768 0.318 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -108.82 147.9 31.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.232 167.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . 0.411 ' CD1' ' O ' ' A' ' 524' ' ' VAL . 17.8 m-30 -109.65 104.6 55.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.159 -163.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.97 163.0 39.57 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.694 1.596 . . . . 0.0 111.223 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -111.47 90.32 3.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.14 166.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 78.1 mt -85.28 145.69 27.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.179 -176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 530' ' ' ASN . 13.0 t -144.28 154.77 43.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.275 176.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 32.6 m -130.62 156.43 42.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.228 179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.484 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.9 mt-10 -140.11 137.43 34.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.204 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 92.7 mt -107.62 127.16 63.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.249 174.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -136.83 149.04 47.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.23 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 153.46 -165.1 31.3 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.72 120.66 7.57 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 121.708 1.605 . . . . 0.0 111.256 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 56.7 p-10 -83.33 -8.68 59.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.181 177.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.24 128.45 64.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 169.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 25.4 m -131.08 155.59 42.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.116 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -93.67 154.5 21.7 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.89 137.91 23.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 62.89 27.44 15.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.23 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -125.36 142.08 51.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.199 178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 502' ' ' SER . 37.2 tp -91.07 127.82 36.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.224 -174.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.71 145.55 48.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -106.93 138.02 43.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.184 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -129.09 157.04 42.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.207 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -129.96 139.6 51.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.267 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 47.7 t -112.33 121.22 64.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.196 172.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.484 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.5 m-70 -101.39 105.91 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.284 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.419 HG11 HG21 ' A' ' 475' ' ' VAL . 3.2 m -118.51 130.78 72.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -173.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -142.38 152.82 43.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.222 -171.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.63 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.9 t-20 -98.53 140.8 32.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.259 170.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 72.6 mt -130.55 5.4 4.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.221 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -101.37 -1.39 53.79 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 69.2 27.02 74.15 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.63 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 0.6 OUTLIER -120.69 141.74 39.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.747 0.308 . . . . 0.0 111.201 175.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . 0.505 ' HA2' ' HA2' ' A' ' 492' ' ' GLY . . . -81.39 99.61 1.97 Allowed Glycine 0 CA--C 1.522 0.486 0 N-CA-C 111.264 -0.734 . . . . 0.0 111.264 176.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.685 ' O ' ' CG1' ' A' ' 470' ' ' VAL . 0.4 OUTLIER -103.16 110.53 63.82 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 111.188 -179.872 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.71 -15.33 27.05 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.721 1.614 . . . . 0.0 111.271 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.6 p -89.75 11.18 20.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.195 -157.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . 0.453 ' OG1' ' CG1' ' A' ' 470' ' ' VAL . 97.3 m -77.16 109.59 11.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.175 -166.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -110.55 125.75 53.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.266 172.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.419 HG21 HG11 ' A' ' 462' ' ' VAL . 86.3 t -117.35 128.17 74.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.192 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -127.46 154.35 45.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.232 -173.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.2 t -128.16 134.56 64.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.19 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -122.01 148.0 45.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.297 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 89.6 mt -119.98 117.26 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.135 172.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 54.16 41.48 31.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.183 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.65 -8.65 74.41 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 175.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.9 m -97.55 137.51 36.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.825 0.345 . . . . 0.0 111.288 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 68.5 tp -70.69 120.77 16.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.148 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -98.45 -40.51 8.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.245 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . 0.423 ' HG2' ' CZ2' ' A' ' 487' ' ' TRP . 51.1 tptt -165.95 159.17 15.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.189 -172.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -141.26 152.8 44.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.233 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . 0.423 ' CZ2' ' HG2' ' A' ' 485' ' ' LYS . 24.1 m-90 -138.16 142.4 40.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.2 171.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.9 m -106.79 124.33 49.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.227 169.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.73 167.44 19.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.263 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 70.7 m -121.21 144.16 48.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.14 172.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 94.6 mt -127.07 129.32 47.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.264 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . 0.505 ' HA2' ' HA2' ' A' ' 469' ' ' GLY . . . -83.91 -173.99 50.09 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 174.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -60.93 111.03 0.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.734 1.623 . . . . 0.0 111.27 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 64.48 34.61 10.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.162 177.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -99.19 143.31 29.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.236 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -122.2 140.87 52.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.243 178.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.46 147.36 49.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.164 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 96.3 t -112.45 119.55 60.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 54.2 mt -103.51 142.72 33.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.25 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 53.3 p -122.24 153.17 39.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -154.24 156.15 36.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 167.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.444 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.3 m -121.29 128.28 52.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.212 -176.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -128.25 129.8 46.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.235 -171.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.9 m -117.84 109.04 41.81 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.26 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -73.77 152.19 47.05 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 121.697 1.598 . . . . 0.0 111.247 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 61.7 p -124.74 -0.77 7.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.193 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -130.25 136.21 48.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.202 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -79.85 143.94 33.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.247 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.28 175.92 22.83 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -82.25 126.6 32.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.776 0.322 . . . . 0.0 111.13 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -119.84 130.82 55.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.161 176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -105.79 118.93 37.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.193 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 84.1 mt -104.22 123.19 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.292 -178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -119.44 145.7 46.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.249 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.35 142.0 51.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.156 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 69.8 p -130.76 151.38 51.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.195 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 11.1 p -124.88 145.8 31.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.216 169.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 19.7 t70 65.3 34.61 8.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -58.44 -39.66 80.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.192 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -79.13 -4.15 48.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 -177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.9 t30 63.29 64.54 0.82 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.282 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 76.3 p -98.6 -31.48 11.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.219 -176.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 8.1 p -128.96 138.89 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.147 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . 0.411 ' O ' ' CD1' ' A' ' 437' ' ' PHE . 86.0 t -89.04 124.85 42.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.178 174.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -110.9 165.13 12.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 -166.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 86.2 mt -78.02 -25.54 47.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -145.76 111.1 5.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.084 -172.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -101.5 4.42 41.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -175.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -80.97 -22.54 39.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.184 -173.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.503 ' HB3' ' OG1' ' A' ' 441' ' ' THR . 95.2 m-20 -101.3 2.1 39.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.194 -178.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -73.5 -5.5 40.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.168 -174.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.3 141.31 46.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.167 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.65 135.62 48.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.129 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.3 m -114.86 125.58 53.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.219 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -131.46 129.85 41.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.165 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -99.61 124.59 44.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -173.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 97.0 t -121.28 135.58 60.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.186 178.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 36.3 t -104.78 129.33 53.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.224 172.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 86.3 t -102.41 126.71 56.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.245 174.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 27.6 m -127.32 157.65 38.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.187 -177.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . 0.497 ' O ' ' O ' ' A' ' 542' ' ' GLU . 79.8 mt -68.14 -17.64 64.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.174 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 541' ' ' LEU . 88.7 tt0 . . . . . 0 C--O 1.2 -1.532 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.211 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 436' ' ' GLU . 96.0 mtp . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.87 0.367 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 435' ' ' MET . 25.1 pt-20 -84.68 -179.24 7.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.216 -2.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -111.51 117.14 49.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.16 -154.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.41 ' HG3' HG21 ' A' ' 470' ' ' VAL . 72.2 Cg_endo -78.86 168.01 21.44 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 121.681 1.587 . . . . 0.0 111.203 -173.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -118.74 82.4 1.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.146 163.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 87.3 mt -81.1 127.4 32.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.122 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.1 t -148.45 160.92 42.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.196 -176.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.8 m -131.07 155.75 42.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.276 -176.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -135.99 139.69 43.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.243 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 61.9 mt -108.05 137.27 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.179 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -135.33 142.45 45.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 179.97 179.45 48.8 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.681 ' O ' ' HB2' ' A' ' 448' ' ' ASP . 33.8 Cg_endo -70.98 -31.49 15.04 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.679 1.586 . . . . 0.0 111.224 -172.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . 0.681 ' HB2' ' O ' ' A' ' 447' ' ' PRO . 82.7 m-20 75.59 -11.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.271 -175.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.13 117.15 12.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.162 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.7 m -131.68 152.54 37.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.229 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.51 157.74 44.52 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 175.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.5 p -76.43 140.22 17.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.85 0.357 . . . . 0.0 111.127 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 63.13 29.6 16.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 -177.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -124.73 139.0 54.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.193 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 37.3 tp -76.5 126.39 30.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.137 -178.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.87 145.05 48.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.19 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -103.03 136.15 43.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.188 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -129.16 156.68 43.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.213 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -128.22 139.24 52.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.234 -171.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 57.0 t -115.85 120.3 64.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.127 173.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -99.56 113.31 25.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.295 176.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.43 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -116.14 127.33 73.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.164 -177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.467 ' HD2' HD21 ' A' ' 465' ' ' LEU . 11.3 pttt -131.83 150.49 52.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.224 -170.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.5 t-20 -105.24 137.99 42.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.241 162.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.467 HD21 ' HD2' ' A' ' 463' ' ' LYS . 56.5 mt -123.61 0.07 8.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.167 -169.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -95.53 -15.4 43.73 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -175.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 72.49 31.19 63.42 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.519 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 0.1 OUTLIER -132.95 130.08 58.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 111.182 177.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -78.23 131.34 10.81 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -170.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.435 HG11 HG21 ' A' ' 523' ' ' VAL . 97.9 t -123.3 120.11 27.29 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 120.734 0.302 . . . . 0.0 111.148 170.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.62 -19.01 6.48 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.654 1.57 . . . . 0.0 111.12 -176.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.8 p -95.95 12.93 28.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.256 -163.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 92.9 m -77.32 117.66 19.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.192 -162.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -109.95 128.26 55.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.285 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.42 128.15 73.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.198 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -125.9 152.8 45.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.258 -171.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 72.9 t -127.95 132.72 68.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.214 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -120.0 148.76 43.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.234 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 82.8 mt -120.96 115.91 48.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.261 170.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 54.52 41.35 32.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.2 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 95.42 -19.94 51.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 171.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -98.13 137.03 37.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.828 0.347 . . . . 0.0 111.223 -174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 59.9 tp -68.03 120.62 14.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.257 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -97.3 -39.89 9.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -176.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -166.11 157.95 13.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.144 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 17.6 p30 -141.73 154.63 45.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.175 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -135.29 142.3 45.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.238 169.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.9 m -102.31 122.51 44.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.201 165.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.56 166.92 22.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.204 -172.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 67.4 m -120.12 142.28 49.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 172.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 96.9 mt -128.9 131.45 47.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.251 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -92.42 -165.68 38.82 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.37 114.2 2.77 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 121.676 1.584 . . . . 0.0 111.205 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 95.4 mttt 61.7 41.05 12.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.266 176.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -102.49 141.32 35.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.162 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -120.76 137.95 54.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.267 174.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -123.42 145.59 48.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.203 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.66 117.85 55.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 177.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 19.0 mt -109.46 136.14 49.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.24 176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 44.6 p -120.09 155.24 33.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.174 -172.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -153.52 156.57 38.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.215 171.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.8 m -121.1 133.35 55.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.207 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 41.2 t90 -140.19 130.1 24.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.188 -166.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.6 m -116.33 112.34 41.66 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.216 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.52 152.37 48.61 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 121.712 1.608 . . . . 0.0 111.142 172.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 71.1 p -122.37 -15.07 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.228 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -120.07 139.74 52.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -77.24 139.98 39.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.244 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 151.22 178.38 25.97 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.1 131.14 34.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.781 0.324 . . . . 0.0 111.153 176.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -117.34 137.51 52.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.245 176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -104.85 118.69 37.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.152 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 86.2 mt -104.14 125.24 58.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.205 176.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -116.74 146.92 42.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.147 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.93 142.31 51.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.283 169.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 36.8 p -131.28 151.05 51.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.257 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.75 140.39 46.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.26 171.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 22.1 t0 51.81 51.14 17.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.206 -173.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -58.22 -38.26 76.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.196 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -77.3 -8.54 57.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.174 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 59.5 t30 64.74 59.83 0.9 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.193 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 69.3 p -101.75 -9.78 20.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.265 176.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . 0.435 HG21 HG11 ' A' ' 470' ' ' VAL . 87.5 t -112.3 131.95 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.264 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 80.1 t -90.61 116.93 32.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.259 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -120.37 177.46 5.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.187 -170.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 83.7 mt -75.19 -24.44 57.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.134 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -147.9 117.32 6.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.211 -175.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -95.49 -3.5 46.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.17 -173.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -94.51 -0.75 54.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.22 176.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -102.55 23.26 12.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.174 -173.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -97.27 -19.2 18.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.194 -169.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.8 t -123.34 140.0 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.21 -166.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -129.74 136.09 49.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.257 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.5 m -114.99 128.44 56.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.186 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -133.21 127.93 34.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.08 -171.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -102.38 128.28 49.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.21 -170.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 86.8 t -122.33 137.15 56.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.149 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 41.2 t -103.91 124.67 49.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.158 171.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 93.0 t -102.73 126.27 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.162 171.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.96 159.61 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.167 -175.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 59.1 mt -84.8 57.04 4.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.163 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 C--O 1.199 -1.585 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.179 -179.359 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.814 0.34 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . 0.412 ' HB3' HD12 ' A' ' 468' ' ' ILE . 88.3 tt0 -101.73 150.94 22.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.246 156.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -106.43 108.65 62.2 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.199 -158.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . 0.479 ' HB3' HG23 ' A' ' 468' ' ' ILE . 73.5 Cg_endo -72.8 162.51 40.96 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 121.717 1.611 . . . . 0.0 111.257 177.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -111.01 76.09 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.243 164.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 72.4 mt -74.84 137.9 42.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.203 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 531' ' ' ASN . 11.3 t -144.34 155.1 43.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.112 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 33.4 m -132.02 155.74 41.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.304 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 97.8 mt-10 -137.32 139.64 40.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.161 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 87.6 mt -107.85 132.07 56.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.225 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -136.27 142.8 43.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.229 177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 162.18 -173.49 38.5 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.58 134.86 34.23 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.727 1.618 . . . . 0.0 111.229 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -75.9 -40.7 53.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.191 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.4 t -122.31 132.4 71.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.179 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.05 152.13 36.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.188 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.5 159.9 46.9 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.3 p -79.52 149.2 5.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.73 0.3 . . . . 0.0 111.174 -179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 19.0 m120 63.38 26.47 14.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.147 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -128.31 143.3 51.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.082 -177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 37.3 tp -86.38 127.83 34.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.191 -176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.35 144.19 49.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.218 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -102.46 135.15 44.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.174 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 501' ' ' PHE . 87.2 m-85 -129.16 157.12 42.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.193 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . 0.445 ' HG2' HG22 ' A' ' 500' ' ' THR . 90.6 mt-10 -129.82 141.11 50.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.195 -174.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 46.9 t -113.24 121.03 64.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.156 172.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.465 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 94.6 m-70 -99.42 111.1 23.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.156 177.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 2.8 m -118.27 130.91 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.161 -175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.435 ' HD3' HD21 ' A' ' 465' ' ' LEU . 19.2 ptpt -143.78 154.1 43.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.141 -175.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.58 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 42.4 t-20 -104.77 141.46 36.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.208 172.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.435 HD21 ' HD3' ' A' ' 463' ' ' LYS . 63.8 mt -131.69 4.3 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.203 -169.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 438' ' ' PRO . . . -91.78 0.06 72.84 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.28 19.04 75.59 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.58 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 5.5 tt -126.72 143.84 38.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.765 0.317 . . . . 0.0 111.289 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -84.9 132.11 10.86 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . 0.45 HG21 ' HG3' ' A' ' 438' ' ' PRO . 85.6 t -118.89 116.01 34.6 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.732 0.301 . . . . 0.0 111.21 173.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.29 -18.19 9.91 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.689 1.592 . . . . 0.0 111.209 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 94.3 p -91.53 12.56 20.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.259 -167.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 89.8 m -79.64 111.26 15.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.22 -163.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -113.84 125.62 54.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.244 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 93.0 t -114.0 131.02 67.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.198 -173.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 92.5 mtt-85 -120.42 154.2 35.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.173 -177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.1 t -128.93 134.81 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.195 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -120.73 147.28 45.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.167 -174.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 93.3 mt -124.24 117.5 50.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.21 174.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 45.4 t30 54.8 42.18 31.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.195 172.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 96.07 -19.99 52.05 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 174.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 98.2 m -101.53 138.99 37.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.764 0.316 . . . . 0.0 111.251 -174.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 61.7 tp -69.96 121.75 18.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.166 172.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -97.71 -40.43 8.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.219 -173.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -165.56 158.9 16.11 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.185 -171.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -140.0 152.77 46.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.221 -177.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 26.0 m-90 -138.49 142.61 39.39 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.213 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.6 m -106.34 126.01 51.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.224 170.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.7 m -139.66 167.85 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.21 -177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.6 m -120.47 143.34 48.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.15 170.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 95.5 mt -129.03 129.21 45.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.259 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -86.44 -173.44 49.1 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 173.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.96 112.06 1.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.681 1.587 . . . . 0.0 111.196 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.0 mttt 64.68 33.69 10.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.21 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -101.15 144.96 29.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.167 176.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -123.5 141.3 52.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.176 -178.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.78 147.22 50.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.182 174.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.9 t -111.87 119.39 59.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.134 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 43.3 mt -103.81 142.03 35.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.213 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . 0.445 HG22 ' HG2' ' A' ' 459' ' ' GLU . 47.4 p -122.99 152.95 40.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.226 177.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 458' ' ' TYR . 54.1 p90 -153.97 156.58 37.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.147 168.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 67.1 m -121.28 131.61 54.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.184 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . 0.456 ' CH2' ' HB3' ' A' ' 505' ' ' PRO . 41.1 t90 -140.11 129.92 24.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.154 -169.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 82.1 m -111.47 110.84 55.32 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.256 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . 0.456 ' HB3' ' CH2' ' A' ' 503' ' ' TRP . 74.0 Cg_endo -70.96 111.57 3.08 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 121.726 1.618 . . . . 0.0 111.165 174.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 80.8 p -83.61 -20.31 33.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.195 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -121.75 140.9 51.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.189 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.48 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 31.7 tt0 -72.26 141.0 48.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.168 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.05 174.58 23.58 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -176.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.8 mmm -85.48 127.83 34.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.783 0.325 . . . . 0.0 111.157 176.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -120.38 132.04 55.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.295 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -105.53 119.58 39.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.256 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 92.8 mt -100.73 122.74 53.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 -178.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -120.75 147.06 45.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.128 -178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.57 140.17 52.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.216 174.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 70.2 p -130.91 150.64 51.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.113 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.565 ' CG1' ' HB2' ' A' ' 531' ' ' ASN . 12.0 p -123.42 149.75 27.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.199 176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 23.8 t0 46.0 48.96 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.162 -165.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -57.37 -37.22 72.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.289 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.91 -6.37 46.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.24 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 61.4 t30 57.84 60.12 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.22 175.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 69.7 p -99.86 -20.74 16.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 9.9 p -130.29 136.41 58.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.188 177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 88.9 t -89.59 126.78 42.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.186 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -99.81 171.63 7.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 -171.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.36 -26.49 61.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.236 173.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -139.36 147.77 41.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.232 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -111.97 -17.19 12.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.216 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -95.24 -6.56 41.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.18 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -99.26 0.75 43.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.2 -175.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . 0.565 ' HB2' ' CG1' ' A' ' 517' ' ' VAL . 49.5 p-10 -111.75 24.44 12.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.141 -175.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 89.5 t -132.12 145.45 34.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.155 177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.37 134.11 48.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.273 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 98.7 m -116.03 126.38 53.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.156 177.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -132.68 130.69 40.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.332 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.5 129.42 47.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.164 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 89.9 t -121.59 136.22 59.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.103 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.8 t -106.29 126.8 52.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.211 173.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.9 t -102.3 128.63 54.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.203 176.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.3 m -121.96 159.94 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.185 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . 0.48 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 93.2 mt -83.48 0.89 44.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.224 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 . . . . . 0 C--O 1.201 -1.498 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.143 -177.595 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 CA--C 1.522 -0.099 0 CA-C-O 120.824 0.345 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -106.02 125.53 51.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.185 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -127.22 140.97 39.36 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.083 -175.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.76 162.6 40.61 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.715 1.61 . . . . 0.0 111.125 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -133.38 83.47 2.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 13.9 mt -91.7 127.08 37.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.253 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 9.0 t -145.77 157.82 43.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.199 179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.55 154.75 39.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.199 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 94.9 mt-10 -135.62 137.48 41.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.204 178.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 88.6 mt -103.65 131.58 51.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.202 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -135.98 142.24 44.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.186 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 155.9 -176.02 33.51 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.79 141.19 44.47 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.666 1.577 . . . . 0.0 111.323 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -95.82 -17.24 21.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.204 -178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 99.6 t -126.61 124.97 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.215 171.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 32.8 m -130.03 154.24 40.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.124 177.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -83.44 150.84 27.5 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 177.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.79 140.01 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 0.0 111.16 174.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 63.69 30.11 14.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.161 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -126.02 142.93 51.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 175.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 502' ' ' SER . 36.7 tp -83.48 126.67 33.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.196 -176.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.79 144.98 48.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.129 177.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -102.78 135.87 43.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.133 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.94 157.2 42.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.185 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -130.01 139.51 51.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.157 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 45.8 t -111.83 120.09 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.1 m-70 -100.68 116.08 31.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.114 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.431 HG11 HG21 ' A' ' 475' ' ' VAL . 1.4 m -117.41 128.09 74.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 -175.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.452 ' HD2' HD21 ' A' ' 465' ' ' LEU . 13.4 pttt -133.69 150.76 51.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.176 -174.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 57.8 t-20 -111.51 123.97 51.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.214 167.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.452 HD21 ' HD2' ' A' ' 463' ' ' LYS . 56.0 mt -110.52 5.63 21.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.272 -170.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.77 -14.96 54.34 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -174.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.23 21.88 78.4 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.463 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 11.0 tt -129.49 139.9 50.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.88 0.371 . . . . 0.0 111.12 167.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -83.09 134.1 12.53 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -169.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 84.8 t -122.16 119.0 28.83 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.758 0.314 . . . . 0.0 111.263 176.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -86.15 -18.16 3.54 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 121.652 1.568 . . . . 0.0 111.137 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.6 p -97.11 4.0 51.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.178 -160.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 473' ' ' THR . 10.2 t -85.31 123.52 30.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.22 -166.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -113.34 128.93 56.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.22 -174.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.431 HG21 HG11 ' A' ' 462' ' ' VAL . 88.4 t -112.02 125.79 69.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 -174.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.02 155.77 44.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.214 -171.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 74.9 t -126.31 133.31 69.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.213 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -120.5 148.26 44.06 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.219 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 70.5 mt -120.24 114.73 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.226 169.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 53.96 40.97 32.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.124 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 91.64 -11.79 71.17 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.6 m -98.29 134.3 41.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 111.195 -176.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 63.5 tp -68.54 119.18 12.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.278 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -99.08 -40.58 7.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.231 -175.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -167.33 157.51 11.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.168 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -140.4 151.97 45.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.229 -175.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -136.46 142.15 43.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.222 168.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.2 m -103.26 125.0 49.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.21 163.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.43 166.05 25.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.227 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 71.4 m -121.95 142.43 50.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.169 175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . 0.433 HD21 ' HB2' ' A' ' 497' ' ' LYS . 87.3 mt -129.64 131.44 46.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.167 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -89.76 -167.08 42.14 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 172.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -66.47 117.53 4.79 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.708 1.605 . . . . 0.0 111.224 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.1 mttt 59.69 41.78 18.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.172 177.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -103.83 144.56 31.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.256 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -120.32 143.25 48.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.163 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.433 ' HB2' HD21 ' A' ' 491' ' ' LEU . 1.8 tttp -137.46 130.75 30.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.217 -173.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 69.4 t -106.37 118.53 54.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.161 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 37.2 mt -107.07 144.02 34.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.196 174.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 41.7 p -122.35 152.68 39.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.175 178.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.9 156.4 37.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.182 168.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.406 ' HB3' HD11 ' A' ' 455' ' ' LEU . 68.8 m -120.41 134.02 55.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.286 -176.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -130.31 129.37 43.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.236 -171.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 96.6 m -118.49 110.55 38.92 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.149 170.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.61 152.26 47.98 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.74 1.627 . . . . 0.0 111.168 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 59.4 p -123.88 -15.07 7.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.222 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -119.26 135.16 54.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.701 ' CD ' ' H ' ' A' ' 508' ' ' GLU . 2.9 pm0 -80.08 124.82 29.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.168 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 174.47 -179.99 45.45 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 -178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.3 mmm -84.39 127.21 33.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.352 . . . . 0.0 111.253 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -122.1 133.03 54.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.154 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -105.31 119.17 38.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.289 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.0 123.73 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.134 -176.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -115.19 146.51 41.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.175 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.46 142.74 51.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.237 168.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 77.2 p -130.8 150.39 51.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.22 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.79 147.43 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.278 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 35.5 t70 22.62 85.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.22 -156.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -61.2 -40.56 94.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.237 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -81.21 -7.29 59.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.268 -165.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 63.86 46.37 3.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.146 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 72.0 p -90.13 -14.9 32.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.248 177.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 92.4 t -107.41 131.47 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.222 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 87.7 t -89.52 120.15 37.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.19 173.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -117.33 170.03 9.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.163 -167.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.5 mt -73.36 -26.66 61.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.124 171.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 42.0 p30 -96.74 164.03 12.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.203 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -130.04 -30.04 2.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.174 169.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -100.83 -8.39 22.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 -169.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -99.0 21.24 11.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.188 -170.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -99.99 -2.06 35.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.203 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 79.4 t -128.81 139.17 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.235 178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.86 133.15 45.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.288 174.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 99.5 m -117.51 127.03 53.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.193 -175.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -133.6 129.34 36.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.245 178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -100.22 126.46 46.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.195 -172.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 82.1 t -121.0 135.83 59.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.188 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.4 t -105.17 127.75 53.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.239 173.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.03 127.73 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.183 173.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.3 m -113.51 150.88 15.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.178 -172.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 541' ' ' LEU . 39.8 tp -111.03 55.83 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.178 -174.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--O 1.199 -1.573 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 178.185 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 97.9 mmm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.758 0.313 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -126.55 133.06 51.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.197 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -127.21 145.1 52.97 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -70.83 165.71 31.31 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 121.653 1.569 . . . . 0.0 111.227 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -147.78 98.91 3.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.193 175.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.437 ' O ' ' HB3' ' A' ' 531' ' ' ASN . 60.3 mt -96.18 142.64 28.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.192 -176.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 11.5 t -148.53 159.17 44.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.227 174.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.5 m -133.05 154.91 40.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.184 -175.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 93.7 mt-10 -135.79 138.72 42.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.231 176.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 82.5 mt -106.19 128.23 60.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -135.75 149.04 49.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.231 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.84 -173.53 35.15 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.16 145.47 60.74 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 121.718 1.612 . . . . 0.0 111.117 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -90.07 -41.78 11.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.139 -177.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 74.9 t -118.25 126.18 74.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.267 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.5 m -129.73 152.23 37.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.232 -178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.79 158.71 45.14 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 3.1 p -79.42 146.02 8.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.839 0.352 . . . . 0.0 111.133 178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 62.4 m-20 63.65 29.06 15.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.25 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -126.91 141.87 51.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 35.0 tp -81.57 127.55 32.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.205 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.16 144.5 48.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.202 176.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -103.01 135.78 44.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.191 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -129.34 157.08 42.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.237 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -129.68 139.63 51.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.218 -174.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 44.5 t -112.01 120.44 62.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.186 170.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 96.8 m-70 -101.54 113.17 26.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.412 HG11 HG21 ' A' ' 475' ' ' VAL . 1.5 m -119.66 130.72 73.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.23 -174.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -142.73 154.97 44.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.206 -172.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.469 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 41.2 t30 -106.71 140.12 40.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.208 170.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 65.1 mt -125.88 4.76 7.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.182 -174.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -89.42 -15.33 58.77 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.53 24.28 73.18 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.469 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.3 tt -137.67 136.39 45.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 111.174 171.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -74.45 136.54 21.31 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 -168.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.64 118.15 30.95 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.802 0.334 . . . . 0.0 111.216 175.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -83.74 -18.5 5.54 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.649 1.566 . . . . 0.0 111.266 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 92.6 p -94.11 13.06 24.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.18 -163.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 100.0 m -78.83 111.62 15.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.16 -161.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -109.83 125.89 53.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.224 177.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.412 HG21 HG11 ' A' ' 462' ' ' VAL . 60.1 t -119.9 127.0 75.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.177 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -135.28 157.24 47.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.178 -172.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 69.4 t -127.68 134.38 65.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.244 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -116.85 146.73 42.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.174 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 80.2 mt -120.1 115.05 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.171 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 53.68 41.29 32.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.178 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 93.01 -15.4 62.95 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 172.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -99.64 133.71 43.58 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.803 0.335 . . . . 0.0 111.25 -174.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 56.0 tp -68.79 120.23 14.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.222 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -97.36 -40.96 8.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.211 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -168.31 157.44 9.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.193 -178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -140.5 155.17 46.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.228 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -135.21 142.38 46.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.252 175.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.4 m -109.67 123.32 49.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.206 166.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 33.2 m -139.11 167.74 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.277 -175.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 82.9 p -116.75 143.89 45.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.143 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 96.4 mt -129.16 131.23 47.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.201 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -90.15 -179.19 44.27 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 172.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.49 120.24 7.72 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 121.686 1.591 . . . . 0.0 111.255 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.9 mttt 57.08 36.62 27.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.249 176.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -103.24 144.08 31.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.162 177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -122.95 140.67 52.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.243 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -126.81 147.68 50.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.185 177.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 90.0 t -110.89 119.16 58.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.129 -176.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 35.7 mt -104.16 141.65 35.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.199 173.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 46.3 p -124.55 153.86 41.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.12 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -154.23 156.28 36.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.211 166.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 52.7 m -122.47 134.37 54.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 41.3 t90 -140.17 129.77 24.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.211 -166.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 99.3 m -117.15 112.88 39.55 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.228 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -75.28 150.32 36.83 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.703 1.602 . . . . 0.0 111.237 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 66.9 p -122.68 -11.71 8.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.194 178.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -120.03 139.19 52.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.173 174.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -80.74 143.6 32.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.135 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 150.93 177.84 25.18 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.166 -0.773 . . . . 0.0 111.166 -174.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.7 mmm -86.31 130.75 34.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.788 0.328 . . . . 0.0 111.184 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -118.71 134.93 54.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.225 177.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -106.95 119.6 39.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.158 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 85.2 mt -103.5 124.9 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.193 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -117.71 145.7 44.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.228 177.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.75 141.4 51.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.192 170.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 68.0 p -131.05 150.56 52.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.169 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 531' ' ' ASN . 7.3 p -125.73 143.19 40.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.177 169.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 29.9 t70 59.41 36.04 23.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.167 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -58.76 -37.64 76.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.196 177.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.87 -4.59 50.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.208 -175.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 59.6 t30 65.18 59.63 0.82 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.209 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 66.9 p -92.53 -29.12 16.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.314 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 14.4 p -130.89 138.69 52.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.275 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 87.6 t -90.01 121.68 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.18 176.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -120.08 178.24 4.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.148 -174.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 87.9 mt -69.83 -27.28 64.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.21 -175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -157.36 121.55 4.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.208 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -103.24 1.73 33.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.212 -174.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -97.93 -9.64 25.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.134 168.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.49 ' O ' ' HB3' ' A' ' 531' ' ' ASN . 63.4 t30 -98.08 65.66 1.76 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.14 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 530' ' ' ASN . 25.7 p-10 164.68 25.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.112 -157.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . 0.403 ' H ' ' H ' ' A' ' 531' ' ' ASN . 71.5 t -130.96 138.47 53.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.153 161.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -126.03 130.61 51.5 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 -172.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 95.2 m -117.29 127.05 53.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.247 176.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -130.65 130.2 43.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.206 -175.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -99.08 125.59 44.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -173.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.54 135.58 60.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.166 177.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.5 t -105.79 122.41 46.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.221 171.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 98.2 t -102.76 127.08 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 174.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 33.5 m -124.15 165.06 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 96.3 mt -63.84 -47.09 82.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.287 177.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 . . . . . 0 C--O 1.2 -1.509 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.113 173.777 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 94.7 mtp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.824 0.345 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -100.77 147.57 25.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.225 161.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -115.16 113.72 43.62 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.258 -162.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.94 166.94 7.84 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.713 1.609 . . . . 0.0 111.118 174.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -141.16 73.52 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.204 165.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.01 143.36 34.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.141 -177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 44.7 p -127.8 162.39 26.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.183 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . 0.412 ' CG1' ' HB ' ' A' ' 517' ' ' VAL . 29.1 m -131.82 152.08 36.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.26 163.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 86.2 mt-10 -139.96 135.69 33.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.166 175.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 84.5 mt -109.66 124.18 66.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.211 175.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -137.0 148.66 47.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.227 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.22 -163.92 32.17 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 176.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -56.25 136.77 77.07 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.674 1.582 . . . . 0.0 111.247 -177.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -86.99 -37.63 17.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.203 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 93.1 t -124.85 132.87 70.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.203 174.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.8 m -129.84 151.85 36.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.24 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -79.61 158.78 43.62 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.8 136.17 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 111.22 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 62.56 21.99 13.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.19 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -110.3 130.98 55.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.17 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 35.3 tp -74.73 126.81 31.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.156 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.56 146.47 48.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.172 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -108.66 132.26 54.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.169 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -128.18 157.2 41.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.172 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -130.35 140.36 50.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.211 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . 0.436 ' HA ' ' O ' ' A' ' 443' ' ' GLU . 48.8 t -111.77 120.39 62.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 170.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.1 m-70 -105.98 109.09 20.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.195 -178.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . . . . . . . . . 14.6 m -116.42 132.61 65.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.131 -172.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 55.4 mttp -119.77 159.16 25.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 44.5 t-20 -111.82 121.75 45.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.18 156.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 48.5 mt -117.16 1.0 12.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.207 -177.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -91.72 -19.29 41.17 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 75.28 28.87 61.14 Favored Glycine 0 CA--C 1.523 0.574 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 174.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . . . . . . . . . 15.2 tt -128.14 136.03 61.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.827 0.346 . . . . 0.0 111.193 174.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -68.7 122.24 13.76 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.09 112.07 31.94 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.839 0.352 . . . . 0.0 111.169 173.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -79.23 -17.42 11.7 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 121.738 1.625 . . . . 0.0 111.206 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 58.5 m -87.98 10.73 17.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.188 -162.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 85.9 m -79.97 108.54 13.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.219 -162.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -109.54 127.44 54.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.194 175.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 80.4 t -113.45 126.16 70.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.303 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -127.87 153.84 46.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.243 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 71.2 t -128.75 134.38 64.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -120.99 147.55 45.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.219 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.452 HG12 HG12 ' A' ' 513' ' ' ILE . 86.3 mt -120.39 117.41 53.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.237 170.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 54.31 41.43 31.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.268 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 86.95 -9.51 71.94 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.309 -0.717 . . . . 0.0 111.309 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.1 m -98.14 137.81 36.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.745 0.307 . . . . 0.0 111.208 -178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.0 tp -69.76 120.31 15.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -98.09 -40.39 8.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -165.15 158.07 16.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.213 -173.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -142.23 152.04 42.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.234 -177.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 23.3 m-90 -137.79 142.66 40.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.288 170.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.7 m -105.97 125.12 50.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.231 170.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.0 m -138.98 167.21 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.164 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 69.5 m -122.79 143.31 49.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.161 169.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 90.8 mt -128.57 128.81 44.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.268 -178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -88.37 -167.79 43.59 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 177.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.79 112.84 1.75 Allowed 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 121.658 1.572 . . . . 0.0 111.205 176.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 94.0 mttt 66.86 36.19 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.217 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -96.61 143.81 27.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.235 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -125.37 141.48 52.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.233 176.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . 0.43 ' HB3' ' HE3' ' A' ' 497' ' ' LYS . 26.4 mmmt -129.8 144.82 51.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.189 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 95.8 t -113.3 119.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.128 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 64.6 mt -104.03 143.3 33.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 47.1 p -122.36 152.77 39.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.211 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -153.82 156.61 37.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.236 168.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 69.2 m -121.1 129.25 53.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.189 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 25.4 t90 -127.27 129.5 47.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.15 -172.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.9 m -113.89 110.47 49.02 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.192 173.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.29 150.99 53.9 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 121.691 1.594 . . . . 0.0 111.179 175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 79.9 p -123.41 -13.53 7.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.223 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -125.76 137.12 53.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.192 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.462 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 30.9 tt0 -77.02 140.05 40.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.242 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 152.8 175.12 23.95 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.7 mmm -85.67 129.91 34.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.191 176.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -119.63 130.32 55.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -104.01 119.39 38.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.195 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.452 HG12 HG12 ' A' ' 479' ' ' ILE . 82.5 mt -104.05 123.76 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.201 -177.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -119.76 145.14 46.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.208 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -124.04 143.09 50.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.192 177.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 82.7 p -131.17 153.2 49.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.289 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.43 HG22 ' HB2' ' A' ' 518' ' ' ASP . 9.1 p -126.78 140.85 47.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.238 173.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . 0.58 ' OD1' ' HB3' ' A' ' 521' ' ' ASN . 3.3 t0 64.09 38.84 8.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.19 167.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -58.76 -44.14 90.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.226 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -90.33 -22.53 21.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.187 -169.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . 0.58 ' HB3' ' OD1' ' A' ' 518' ' ' ASP . 55.2 t30 -85.14 78.03 9.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.225 171.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 56.6 p -70.44 65.32 0.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.199 -174.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.2 p -101.87 146.26 10.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.133 -175.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 86.9 t -83.21 125.08 40.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.281 -175.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.463 ' HB2' ' HG3' ' A' ' 528' ' ' GLU . 58.8 mt-10 -114.23 175.89 5.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.265 -171.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.91 -26.18 62.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.112 170.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 59.5 t-20 -155.52 108.65 2.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.221 175.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 525' ' ' GLU . 36.4 mt-10 -100.67 1.32 40.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.165 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -87.78 -10.66 50.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.195 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -101.53 12.74 36.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.184 -178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -84.27 0.99 46.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.16 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 59.1 t -130.86 140.4 48.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.228 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.18 137.18 49.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.153 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 97.0 m -115.21 126.52 54.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.192 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -134.71 129.75 35.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.181 179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -100.19 128.71 46.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.226 -173.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 91.9 t -121.13 135.99 59.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.242 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 37.6 t -105.66 124.42 49.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.145 174.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 90.6 t -102.03 126.61 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 174.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 35.7 m -123.73 155.23 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.235 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . 0.462 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 83.4 mt -80.93 52.83 1.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.238 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 . . . . . 0 C--O 1.2 -1.5 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.209 -177.446 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 98.2 mtp . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.782 0.325 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -119.24 157.42 28.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.267 158.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -112.62 95.48 32.7 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.265 -163.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.28 168.68 22.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.723 1.615 . . . . 0.0 111.243 173.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -127.62 81.57 2.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.267 172.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.6 136.01 33.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 -174.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 530' ' ' ASN . 8.0 t -141.0 153.14 45.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.324 176.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 26.2 m -131.62 154.9 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.131 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 96.7 mt-10 -139.4 135.69 33.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.2 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 87.7 mt -107.34 126.86 63.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.192 175.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -135.9 147.93 48.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.243 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 157.89 -169.66 34.67 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.42 114.46 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 121.693 1.595 . . . . 0.0 111.163 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -69.04 -26.96 65.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.185 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 97.5 t -123.69 130.96 73.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.221 172.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.2 152.01 36.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.187 178.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -80.58 158.91 41.9 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 6.8 p -74.53 137.91 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.757 0.313 . . . . 0.0 111.248 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 62.21 25.5 15.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.299 -178.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -116.56 150.2 38.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.176 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.403 HD11 ' HB3' ' A' ' 502' ' ' SER . 37.9 tp -88.87 127.61 35.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.279 -175.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -123.41 143.99 49.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.228 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -107.71 137.32 45.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.187 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -129.86 157.67 41.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.172 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -129.27 141.2 51.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.155 -177.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 499' ' ' LEU . 47.1 t -113.13 120.95 64.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.162 170.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 97.7 m-70 -103.29 108.17 19.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.442 HG11 HG21 ' A' ' 475' ' ' VAL . 2.3 m -118.42 130.55 73.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.224 -171.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -144.99 151.72 39.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.167 -173.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 44.6 t-20 -106.81 139.58 41.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.163 173.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 73.7 mt -129.37 4.09 5.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.214 -171.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -88.0 -2.04 81.42 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 70.94 21.4 78.23 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.437 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.8 tt -126.55 148.85 31.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.773 0.32 . . . . 0.0 111.186 175.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -94.06 115.69 5.06 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 94.3 t -104.76 114.48 63.87 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 120.757 0.313 . . . . 0.0 111.194 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -79.7 -17.98 10.79 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.698 1.598 . . . . 0.0 111.201 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 97.7 p -91.42 12.08 21.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.164 -164.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . . . . . . . . . 91.1 m -78.75 108.17 11.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.229 -162.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -111.07 128.26 55.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.218 177.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . 0.442 HG21 HG11 ' A' ' 462' ' ' VAL . 67.1 t -115.05 128.46 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.144 -176.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -123.67 152.61 41.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 79.7 t -127.7 133.71 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.284 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -120.22 147.51 44.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.169 -177.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . 0.466 HG12 HG12 ' A' ' 513' ' ' ILE . 84.1 mt -119.86 117.19 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.292 171.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 54.55 41.16 32.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.176 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 88.56 -11.82 67.12 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 173.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.2 m -97.71 137.64 36.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.728 0.299 . . . . 0.0 111.224 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 66.5 tp -69.3 120.69 15.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.263 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -98.11 -40.47 8.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 -176.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -166.16 159.91 15.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 -173.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -141.17 153.13 45.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.182 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 27.1 m-90 -139.17 142.79 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.196 171.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 96.8 m -107.55 125.09 50.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.204 169.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.61 168.07 18.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 59.4 m -121.98 143.09 49.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.173 170.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.4 mt -127.38 129.53 47.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.216 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -87.38 -179.74 48.15 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 172.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.06 113.87 1.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 121.647 1.565 . . . . 0.0 111.211 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 95.5 mttt 64.73 34.14 9.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.141 177.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -101.5 143.47 31.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.28 175.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -122.81 140.3 53.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.208 -178.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -128.29 146.43 50.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.206 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 99.9 t -112.34 119.45 60.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.186 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 460' ' ' VAL . 49.5 mt -102.86 142.25 34.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.239 174.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 45.7 p -123.82 152.78 41.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.23 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -153.95 156.84 38.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.314 167.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.403 ' HB3' HD11 ' A' ' 455' ' ' LEU . 70.5 m -120.12 129.81 54.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.206 -176.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -130.69 129.57 42.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.219 -170.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.1 m -117.34 107.3 45.41 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.222 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -74.35 143.48 31.47 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.713 1.608 . . . . 0.0 111.202 173.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 67.4 p -115.41 -14.85 11.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.169 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -119.94 138.02 53.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.215 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . 0.437 ' CD ' ' HG ' ' A' ' 541' ' ' LEU . 33.2 tt0 -75.0 140.11 43.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.197 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.87 174.44 24.05 Favored Glycine 0 CA--C 1.523 0.552 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -176.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.6 mmm -85.17 127.82 34.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.842 0.353 . . . . 0.0 111.111 177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -120.89 131.96 54.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.18 176.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 60.3 ttp180 -104.17 118.07 35.75 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.165 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . 0.466 HG12 HG12 ' A' ' 479' ' ' ILE . 83.9 mt -104.52 120.22 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -123.02 149.4 44.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.239 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -126.4 140.81 52.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.233 175.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 60.1 p -131.75 151.75 51.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.163 174.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.498 ' CG1' ' HB2' ' A' ' 531' ' ' ASN . 8.1 p -124.83 145.05 32.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.216 173.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 5.7 t0 70.85 16.56 6.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.136 170.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -61.78 -43.06 99.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.196 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -90.16 -16.59 29.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.151 -175.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -117.27 57.93 0.79 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.192 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 69.5 p -58.13 97.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.25 -163.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.49 140.66 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.159 172.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 85.0 t -82.78 123.45 38.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.32 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -110.85 170.49 8.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.283 -164.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.34 -26.44 60.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.143 171.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -150.09 106.15 3.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.295 174.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -98.3 5.95 47.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.18 -172.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -89.12 -16.32 31.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.201 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . 0.473 ' HB3' ' OG1' ' A' ' 441' ' ' THR . 94.5 m-20 -99.24 -13.47 19.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.162 -175.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . 0.498 ' HB2' ' CG1' ' A' ' 517' ' ' VAL . 36.6 p30 -80.87 11.86 3.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.2 -174.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 88.6 t -130.29 141.48 46.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.157 167.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -130.87 133.98 46.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.239 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 85.8 m -116.19 125.89 52.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -131.21 129.09 41.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.191 176.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -101.14 125.65 47.78 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.249 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 85.3 t -121.25 136.26 58.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 35.9 t -104.61 127.34 52.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.179 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 85.2 t -101.24 126.85 54.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.144 173.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 32.2 m -122.87 159.77 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.12 -175.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . 0.437 ' HG ' ' CD ' ' A' ' 508' ' ' GLU . 94.3 mt -85.29 0.42 52.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.153 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 . . . . . 0 C--O 1.2 -1.537 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.219 -176.848 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 82.9 mmm . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.847 0.356 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -145.19 129.47 17.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 165.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -128.56 104.95 19.18 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 174.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -66.24 162.95 33.76 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 121.73 1.62 . . . . 0.0 111.233 170.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -143.17 78.07 1.59 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.232 177.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 14.7 mt -80.28 125.86 30.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.198 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 14.5 t -138.74 157.15 46.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.159 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 34.9 m -132.37 155.48 41.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.308 -176.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 91.5 mt-10 -137.05 133.75 35.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.193 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 92.6 mt -104.56 127.28 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -135.48 146.48 48.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.226 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 156.61 -171.17 34.19 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.96 140.39 45.58 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 121.71 1.607 . . . . 0.0 111.205 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -86.03 -36.52 19.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.237 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 65.2 t -120.03 129.57 75.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.231 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.09 153.18 38.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.232 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -78.37 156.54 43.3 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 2.1 p -76.19 140.29 17.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.842 0.353 . . . . 0.0 111.201 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 63.46 28.65 15.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.239 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -121.73 148.04 45.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.181 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . . . . . . . . . 34.9 tp -85.82 127.06 34.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.28 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -122.25 143.38 49.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.177 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -103.99 135.17 46.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.121 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -130.27 157.22 43.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.147 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -129.81 139.83 51.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.221 -175.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 47.7 t -113.45 121.9 66.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.172 173.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.476 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.5 m-70 -101.71 112.05 24.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.15 -179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.408 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -117.89 128.83 74.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.256 -171.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . 0.449 ' HD2' HD21 ' A' ' 465' ' ' LEU . 45.7 pttt -145.07 154.97 43.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.202 -172.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 494' ' ' LYS . 63.4 t-20 -113.77 120.88 42.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.156 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . 0.449 HD21 ' HD2' ' A' ' 463' ' ' LYS . 82.6 mt -112.16 15.36 20.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.176 -170.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -92.28 -9.62 61.7 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -177.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 71.96 16.79 76.65 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.474 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 3.7 tt -127.03 146.21 33.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.701 0.286 . . . . 0.0 111.264 170.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -83.6 132.06 10.82 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -176.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 94.0 t -120.7 114.55 32.66 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.851 0.358 . . . . 0.0 111.222 168.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -84.71 -19.17 4.27 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.811 1.674 . . . . 0.0 111.242 -174.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 99.1 p -97.92 5.32 49.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.233 -160.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 473' ' ' THR . 8.9 t -84.99 127.03 34.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.212 -160.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -109.94 130.92 55.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.249 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 71.6 t -111.89 130.21 65.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.268 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -129.49 155.09 46.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.176 -170.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 41.4 t -125.55 135.02 65.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.228 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -124.04 150.15 45.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.218 -174.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 86.3 mt -124.03 116.45 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.221 172.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 54.49 41.19 32.11 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.181 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 92.19 -13.52 66.87 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 170.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.6 m -99.76 138.53 36.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.764 0.316 . . . . 0.0 111.257 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 64.7 tp -67.85 120.44 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -99.01 -40.28 8.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.156 -175.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 22.9 mtmt -158.26 162.9 37.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.178 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -138.12 148.32 44.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.157 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -138.48 142.03 39.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.135 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 93.2 m -109.75 126.68 54.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.286 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 32.5 m -138.19 167.1 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.242 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.7 m -117.32 140.28 49.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.184 172.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 88.9 mt -129.44 130.24 45.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.136 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -91.15 -167.21 41.04 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 173.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.2 111.73 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 121.731 1.62 . . . . 0.0 111.239 175.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 464' ' ' ASN . 96.1 mttt 60.01 43.69 14.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.181 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -100.06 142.67 31.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.238 172.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -122.14 137.92 54.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.145 177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -127.97 148.61 50.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.188 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 85.9 t -111.2 118.53 57.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.186 -177.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 48.1 mt -104.84 145.65 30.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.259 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 55.5 p -120.51 154.0 35.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.218 176.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -152.93 155.04 36.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.229 165.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . . . . . . . . . 65.2 m -124.25 131.59 53.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.256 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 27.0 t90 -131.42 131.53 43.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.201 -170.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 98.4 m -118.02 110.3 40.02 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.221 174.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.85 154.44 43.28 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 121.806 1.671 . . . . 0.0 111.107 172.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 74.3 p -124.19 -19.16 5.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.242 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -120.13 138.92 53.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.22 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.21 140.44 46.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.188 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 153.46 176.61 26.1 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -176.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 99.1 mmm -86.64 128.94 35.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.754 0.312 . . . . 0.0 111.17 175.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -121.92 136.55 54.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.209 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -104.68 119.09 38.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.243 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 93.0 mt -103.73 124.05 57.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.175 176.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -121.37 151.16 40.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 -178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -127.27 143.18 51.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.163 173.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 64.6 p -131.07 154.1 48.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.215 172.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.7 138.33 54.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.235 165.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 25.0 t0 54.97 61.24 3.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.19 -171.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -57.05 -38.77 73.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.18 -176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.535 ' O ' ' C ' ' A' ' 521' ' ' ASN . 11.4 pt-20 -81.15 20.01 0.86 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.158 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . 0.535 ' C ' ' O ' ' A' ' 520' ' ' GLU . 55.7 t30 -29.81 107.73 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.198 -159.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 70.5 p -101.06 11.72 39.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.206 168.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 94.7 t -116.14 136.17 53.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.156 -170.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 90.8 t -88.62 121.38 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.287 175.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -108.88 -178.4 3.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.232 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 86.8 mt -67.42 -30.52 70.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -115.34 -121.99 0.3 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.181 166.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -163.49 -45.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.168 166.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -98.57 5.99 47.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 -162.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -94.92 11.3 32.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.213 -171.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -101.41 20.26 16.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.173 178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.57 142.01 44.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.203 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -128.4 131.74 48.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.197 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 80.1 m -115.25 125.34 53.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.171 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -132.58 130.83 40.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.149 -176.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -104.05 129.63 51.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.224 -174.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.0 t -121.27 137.19 55.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.257 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 39.6 t -103.97 124.13 48.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.199 174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 83.9 t -102.17 126.47 56.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.242 175.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.07 160.54 30.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.26 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 76.0 mt -84.5 -4.63 59.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.185 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 . . . . . 0 C--O 1.2 -1.506 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.114 -175.801 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' MET . . . . . . . . . . . . . 28.7 ttt . . . . . 0 CA--C 1.523 -0.084 0 CA-C-O 120.884 0.373 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -91.55 144.83 25.15 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.249 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -120.23 121.01 29.68 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.165 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -67.24 165.37 26.97 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 121.74 1.627 . . . . 0.0 111.064 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -143.36 89.72 2.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 174.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 15.4 mt -90.14 128.3 36.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.187 -176.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' THR . . . . . . . . . . . . . 13.4 t -143.76 157.59 44.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.199 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' VAL . . . . . . . . . . . . . 35.5 m -128.63 154.59 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.25 -177.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' GLU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 461' ' ' HIS . 50.3 mt-10 -135.95 139.82 43.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.233 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' ILE . . . . . . . . . . . . . 85.4 mt -105.38 132.17 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.125 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -136.24 142.52 44.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.189 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' GLY . . . . . . . . . . . . . . . 160.41 -174.97 37.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 177.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.15 142.72 42.53 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.762 1.642 . . . . 0.0 111.208 -176.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -75.24 -46.36 34.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.251 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . . . . . . . . . 59.9 t -118.18 130.13 73.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.192 -176.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 33.2 m -129.37 153.09 38.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.249 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' GLY . . . . . . . . . . . . . . . -85.65 159.81 33.62 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' VAL . . . . . . . . . . . . . 4.7 p -72.41 139.96 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 0.0 111.242 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 63.31 29.95 15.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.22 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -124.52 138.64 54.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.22 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' LEU . . . . . 0.416 HD11 ' HB3' ' A' ' 502' ' ' SER . 34.4 tp -81.49 126.9 32.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.24 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' ALA . . . . . . . . . . . . . . . -121.81 144.47 48.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.223 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -101.88 134.19 45.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.213 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -129.42 156.88 43.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.106 175.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -130.1 139.94 50.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.124 -174.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' VAL . . . . . . . . . . . . . 44.9 t -111.54 120.1 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' HIS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 443' ' ' GLU . 98.0 m-70 -99.63 114.17 27.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.225 178.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' VAL . . . . . 0.4 ' O ' ' CG2' ' A' ' 462' ' ' VAL . 1.5 m -117.42 129.43 73.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.224 -175.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -144.26 153.07 41.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.23 -169.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' ASN . . . . . 0.421 ' ND2' ' O ' ' A' ' 468' ' ' ILE . 31.0 t30 -111.72 130.05 55.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.185 173.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' LEU . . . . . . . . . . . . . 78.9 mt -114.61 4.03 15.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.204 -173.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' GLY . . . . . . . . . . . . . . . -88.7 -20.54 47.04 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . 74.91 24.37 72.16 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' ILE . . . . . 0.421 ' O ' ' ND2' ' A' ' 464' ' ' ASN . 12.6 tt -134.44 138.97 48.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 111.173 169.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' GLY . . . . . . . . . . . . . . . -76.07 131.68 12.06 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -166.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' VAL . . . . . . . . . . . . . 96.3 t -121.38 117.63 30.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 120.814 0.34 . . . . 0.0 111.251 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -86.72 -17.74 3.24 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 121.639 1.559 . . . . 0.0 111.175 -176.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' SER . . . . . . . . . . . . . 98.5 p -95.59 4.36 53.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.259 -160.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 473' ' ' THR . 9.6 t -86.57 124.33 32.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.265 -164.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -113.6 129.13 56.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.191 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' VAL . . . . . . . . . . . . . 97.0 t -112.22 127.54 69.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.234 -174.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.69 157.65 41.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.27 -171.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 70.3 t -126.33 133.63 68.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.145 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -120.85 148.53 43.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.188 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' ILE . . . . . . . . . . . . . 77.5 mt -119.77 115.71 48.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.232 169.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 54.23 41.0 32.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.187 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' GLY . . . . . . . . . . . . . . . 94.18 -16.0 61.96 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 171.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' THR . . . . . . . . . . . . . 99.8 m -97.88 136.18 38.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.84 0.352 . . . . 0.0 111.207 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' LEU . . . . . . . . . . . . . 65.5 tp -68.49 120.0 13.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.099 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -98.37 -40.06 8.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.191 -176.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -166.36 157.41 12.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.268 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' ASN . . . . . . . . . . . . . 16.1 p30 -139.96 151.18 45.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.181 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' TRP . . . . . . . . . . . . . 30.0 m-90 -136.82 142.05 42.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.178 170.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 95.7 m -102.82 125.03 49.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.24 164.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.74 166.0 25.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.234 -172.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' SER . . . . . . . . . . . . . 68.8 m -122.48 143.53 49.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 171.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' LEU . . . . . . . . . . . . . 92.9 mt -128.54 130.26 47.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.146 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' GLY . . . . . . . . . . . . . . . -91.32 -165.09 39.61 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 175.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.49 112.35 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 121.723 1.616 . . . . 0.0 111.182 176.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 59.94 48.31 8.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.209 177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -104.56 142.98 33.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.146 175.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -117.59 141.76 47.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.269 172.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -139.25 130.13 26.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.227 -172.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' VAL . . . . . . . . . . . . . 73.7 t -105.58 118.41 53.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.189 -170.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' LEU . . . . . . . . . . . . . 36.0 mt -105.73 143.6 33.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.181 173.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' THR . . . . . . . . . . . . . 50.7 p -122.87 152.67 40.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.238 179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -153.81 156.41 37.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.189 168.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' SER . . . . . 0.416 ' HB3' HD11 ' A' ' 455' ' ' LEU . 67.7 m -121.07 133.57 55.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.234 -176.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' TRP . . . . . . . . . . . . . 26.3 t90 -133.46 131.21 39.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.165 -171.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' THR . . . . . . . . . . . . . 97.6 m -116.58 109.74 43.35 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.278 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -76.54 153.53 34.73 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.714 1.609 . . . . 0.0 111.19 174.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' THR . . . . . . . . . . . . . 69.9 p -128.52 -2.3 5.5 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.203 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -133.95 135.31 43.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.206 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -72.24 141.79 48.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.191 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' GLY . . . . . . . . . . . . . . . 154.4 175.22 25.33 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' MET . . . . . . . . . . . . . 98.2 mmm -86.03 127.17 34.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.0 111.188 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -119.98 137.45 54.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.311 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -106.79 119.2 38.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.205 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' ILE . . . . . . . . . . . . . 83.7 mt -102.98 123.8 56.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.214 178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -116.46 144.98 43.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.184 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' ALA . . . . . . . . . . . . . . . -123.45 141.41 52.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.252 170.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' THR . . . . . . . . . . . . . 73.0 p -131.0 150.55 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.272 -177.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.615 ' O ' ' C ' ' A' ' 518' ' ' ASP . 14.6 p -123.54 150.65 27.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.261 174.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . 0.615 ' C ' ' O ' ' A' ' 517' ' ' VAL . 30.6 t0 2.83 85.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.242 -166.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.87 -41.81 87.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.213 -175.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 521' ' ' ASN . 74.5 mm-40 -80.24 -24.91 39.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.167 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 520' ' ' GLU . 77.4 m-20 76.98 -65.01 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.264 176.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' THR . . . . . . . . . . . . . 69.6 p 36.63 35.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.199 -162.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' VAL . . . . . . . . . . . . . 13.3 p -153.55 138.86 10.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.225 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' VAL . . . . . . . . . . . . . 91.9 t -87.7 117.6 31.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.191 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -115.45 170.84 8.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.255 -169.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.69 -27.01 61.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -154.94 121.41 5.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.186 -178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -101.86 0.47 35.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.225 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -89.73 -12.83 38.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.158 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -101.45 15.11 29.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.221 -175.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -69.27 -17.12 63.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.218 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.49 140.09 48.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.141 -171.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' ALA . . . . . . . . . . . . . . . -129.49 134.01 47.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.1 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 83.0 m -116.85 127.97 54.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.227 -175.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -132.23 131.65 42.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.31 -178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -99.34 128.94 45.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.166 -172.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' VAL . . . . . . . . . . . . . 87.5 t -121.27 136.79 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.175 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' SER . . . . . . . . . . . . . 38.2 t -106.38 123.99 48.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.187 172.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' VAL . . . . . . . . . . . . . 89.3 t -103.1 128.31 56.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.138 175.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.24 165.02 21.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.204 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' LEU . . . . . . . . . . . . . 87.8 mt -83.25 58.9 4.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.157 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 . . . . . 0 C--O 1.2 -1.525 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.21 176.827 . . . . . . . . 0 0 . 1 stop_ save_